<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-HEADER AEXT-CLASS="Y">
<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION SUBVER="3" ADATE="20210122">4.2</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="00427483">대웅제약</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">C</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH"></EXTRACTION>
</SUMMARY>
</DOCUMENT-HEADER>

<BODY>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 정정문서 작성시 『정오표』 삽입</COMMENT>
<LIBRARYLIST>정정신고(보고)-대표이사등의확인.LCommon</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="LCommon">정정신고(보고)-대표이사등의확인</FILENAME>

<CORRECTION>
<TITLE ATOC="Y" AASSOCNOTE="CORRECTION">정 정 신 고 (보고)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">2021년 8월 17일</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<P USERMARK="F-14">1. 정정대상 공시서류 : 제19기 사업보고서</P>
<P></P>
<P USERMARK="F-14">2. 정정대상 공시서류의 최초제출일 : 2021년 3월 18일</P>
<P></P>
<P USERMARK="F-14">3. 정정사항</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="280"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="289" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">항  목</TH>
<TH ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정정사유 </TH>
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 전</TH>
<TH ALIGN="CENTER" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="122" VALIGN="MIDDLE">XI. 그 밖에 투자자 보호를 위하여 필요한 사항&cr;3. 우발채무와 약정사항 등 (연결기준)&cr;(1) 소송사건&cr;가. 메디톡스 영업비밀침해 소송</TD>
<TD WIDTH="98" HEIGHT="122" VALIGN="MIDDLE">추가 기재</TD>
<TD WIDTH="108" HEIGHT="122" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="105" HEIGHT="122" VALIGN="MIDDLE">주2)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" 0X3B70BE"></SPAN>
<SPAN USERMARK=" 0X3B70BE B">주1) 정정전&cr;</SPAN>
</P>

<P>
<SPAN>가. 메디톡스 영업비밀침해 소송</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="664">

<COLGROUP>
<COL WIDTH="131"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계류법원</P>
</TH>

<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>원고</P>
</TH>

<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>피고</P>
</TH>

<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사건내용</P>
</TH>

<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>진행상황</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="140" HEIGHT="76" ALIGN="CENTER">
<P>미국 무역위원회 &cr;(International Trade Commission)</P>
</TD>

<TD WIDTH="151" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>앨러간, 메디톡스</P>
</TD>

<TD WIDTH="104" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">

<P>대
<SPAN>웅제약 및&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN>에볼루스</SPAN>
</P>
</TD>

<TD WIDTH="168" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>영업비밀침해</P>
</TD>
<TD WIDTH="101" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">최종판결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="140" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>서울중앙지방법원</P>
</TD>

<TD WIDTH="151" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>메디톡스</P>
</TD>

<TD WIDTH="104" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대웅 및&cr;대웅제약</P>
</TD>

<TD WIDTH="168" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>영업비밀침해</P>
</TD>

<TD WIDTH="101" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1심 진행중</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>2019년 2월 4일 미국국제무역위원회에 제기되었던 영업비밀침해 소송에 대해서 2020년 12월 16일 미국국제무역위원회 행정판사는 최종판결에서 대웅제약의 보툴리늄 톡신 제제가 관세법 337조를 위반했다고 판결하고 21개월간의 미국 수입금지명령을 내렸으나 그 결과가 재무제표에 미치는 영향이 없다고 판단되어 기말 현재 충당부채로 인식한 금액은 없습니다. 또한, 2021년 2월 15일 지배기업은 미국국제무역위원회의 최종결정에 대해서 미국 연방순회항소법원(CAFC)에 항소하였고, 신속절차진행을 요청하였으며 법원은 미국국제무역위원회의 최종결정에 대해서 지배기업이 신청한 임시가처분 신청을 인용하였습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" 0X3B70BE B">주2) 정정후&cr;</SPAN>&cr;가. 메디톡스 영업비밀침해 소송&cr;&cr;*아래 내용은 2021년 8월 17일 보고서 제출일 기준입니다.
</P>

<P>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1314">

<COLGROUP>
<COL WIDTH="154"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="273"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="341"></COL>
<COL WIDTH="74"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">계류법원</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">소송 제기일</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">원고</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">피고</TH>
<TH WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">사건내용</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">진행상황</TH>
<TH WIDTH="350" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">향후 일정</TH>
<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">미국 무역위원회&cr;(International Trade&cr; Commission)</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">2019.01.30</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">앨러간,&cr;메디톡스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">대웅제약 및 &cr;에볼루스</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">영업비밀침해&cr;(원고가 피고에 대해 영업비밀침해를 이유로&cr;미국내 수입 및 판매 금지를 요청하는 사건)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">최종판결&cr;완료</TD>
<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10">-</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10 B">주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">서울중앙지방법원</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">2017.10.30</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">메디톡스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">대웅제약 외 1명</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">영업비밀침해&cr;(원고가 피고에 대해 영업비밀침해를 이유로 &cr;손해배상금 등을 청구하는 사건)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">1심 진행중</TD>
<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10">2017.10.30. 소장 접수&cr;2019.9.15 전문가 감정보고서 제출&cr;2021.1.13, 2021.2.17, 2021.4.14, 2021.7.7 변론 준비기일&cr;2021.8. 27 변론준비기일 예정</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10 B">주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">미국 연방항소법원 &cr;(US Court of Appeals for the Federal Circuit)</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">2021.02.12</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">대웅제약,&cr;에볼루스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">미국 무역위원회&cr;(International Trade&cr;Commission)</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">영업비밀침해&cr;(미국 ITC 최종결정에 대해서 &cr;연방항소법원에 항소한 항소심 사건)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">기각 및 환송 결정</TD>
<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="154" USERMARK="F-10">2021.2.12 가처분 신청&cr;2021.2.15 임시가처분 인용 결정&cr;2021.2.18 메디톡스, 엘러간, 에볼루스 3자 합의  &cr;2021.5.17 앨러간, 에볼루스 - 항소심 철회 의견 제출&cr;2021.6.8 대웅, ITC - 항소심 기각요청서면 제출&cr;2021.6.22 메디톡스 - 항소심 기각에 동의한다는 서면 제출&cr;2021.7.27 미국국제무역위원회에 환송 결정</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="154" USERMARK="F-10 B">주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">캘리포니아 중부지방법원</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">2021.05.14</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">메디톡스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">대웅제약 및 &cr;이온바이오파마</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">영업비밀침해&cr;(원고가 피고에 대해 미국 영업비밀보호법(DTSA) 위반을 이유로 손해배상 등을 청구한 사건</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">소장접수</TD>
<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10">2021.5.14 소장 제출&cr;2021.6.22 메디톡스- 이온바이오파마와 합의&cr;2021.6.28 메디톡스 - 이온바이오파마 상대 소취하</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10 B">주3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">버지니아 중부지방법원</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">2021.05.14</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">메디톡스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">대웅제약, 대웅</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">특허 &cr;(원고가 피고에 대해 대웅의 미국 특허를 &cr;양도해 줄 것을 청구하는 사건)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">소장접수</TD>

<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10">
<SPAN>2021.5.14 소장 제출</SPAN>&cr;미정 (송달 당사 도달 전)
</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10 B">주4)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">주1)</SPAN>
</P>

<P>
<SPAN>  </SPAN>
<SPAN>2019년 1월 메디톡스와 미국 앨러간은 미국 ITC(국제무역위원회)에 당사 및 에볼루스를 상대로 영업비밀 침해를 이유로 나보타 제품의 미국내 수입 및 판매금지 등을 내용으로 제소하였습니다. 본 소송은 미국 관세법 337조항에 따라 진행되는 지적재산권 침해 여부를 가리는 소송으로, 특허권, 상표권, 저작권 등의 침해에 따른 불공정 무역관행을 규제하기 위하여 해당 상품의 수입을 금지시키거나 불공정 행위를 정지시킬 수 있습니다. 그러나 미국 ITC(국제무역위원회)의 영업비밀 침해 소송은 미국에서 경쟁품이 출시될 때 통상적으로 시장방어 전략 차원에서 진행되기도 하며, 나보타 제품은 2019년 2월 미국 FDA로부터 최종 시판허가가 승인되어 2019년 4월부터 미국 출시가 완료되었습니다. </SPAN>
<SPAN></SPAN>
<SPAN>ITC 재판부의 결정으로 메디톡스 및 당사는 보툴리눔 균주에 대해 각사가 선임한 전문가를 통해 감정 시험을 진행하고, ITC의D06962 일정에 맞춰 메디톡스는 9월 균주에 대한 유전자 분석 보고서 제출을 완료하였습니다. 이후, 당사는10월 그에 따른 반박 보고서를 제출하였습니다. &cr;  2020년 12월 나보타(주보)의 수입이 21개월간 금지되는 내용의 ITC 최종결정이 판결되었고, 이에 당사는 2021년 2월 12일 CAFC(미국 연방순회항소법원)에 수입금지 명령 집행정지 관련 긴급 임시 가처분 신청을 하였습니다. 2월 15일 CAFC(연방순회항소법원) 수입금지 명령 관련 긴급가처분 신청이 인용되었습니다. 한편, 2021년 2월 18일 메디톡스, 엘러간 및 에볼루스의 제3자 합의 계약이 체결되었습니다. 이후 5월 17일 앨러간과 에볼루스는 항소심 철회 의견을 제출하였으며, 6월 8일 대웅에서 항소심 기각요청 서면을, 6월 22일에는 메디톡스에서 항소심 기각에 동의한다는 서면을 제출하였습니다. </SPAN>
<SPAN>2021년 7월 27일 미국연방순회항소법원은 미국국제무역위원회의 최종명령에 항소가 무의미하므로 해당 명령을 무효화 시킬 수 있도록 미국국제무역위원회에 환송한다는 결정을 내렸습니다.</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">주2)&cr;</SPAN>
<SPAN>  2017년 10월 메디톡스는 당사 등을 상대로 국내에서 보톨리눔 균주 및 독소제제 제조기술정보의 사용금지 및 손해배상청구 내용의 민사소송을 제기하였습니다. 해당 소송은 2019년 4월부터 1심 재판을 시작하여 7월 균주 포자에 대한 감정을 실시하였고, 8월 균주에 대한 유전자 감정 보고서 제출을 완료하였습니다. 국내에서 진행되는 소송은 현재 진행중이며, 당사는 보고서 제출일 현재로서는 소송사건의 결과와 소송 결과에 따른 나보타 제품의 판매영향에 대하여 합리적인 결과를 예측하기 어렵습니다. &cr;&cr;</SPAN>
<SPAN USERMARK=" B">주3)&cr;</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>2021년 5월 14일 메디톡스는 당사와 당사의 미국 파트너스 이온바이오파마를 상대로 미국 캘리포니아 중부지방법원에 영업비밀침해 관련 청구 소송을 제기하였고, 6월 22일 메디톡스와 이온바이오파마의 합의가 진행되었습니다. 이후 6월 28일 메디톡스</SPAN>
<SPAN>는</SPAN>
<SPAN> 이오이온바이오파마를 상대</SPAN>
<SPAN>로 소취하 하였</SPAN>
<SPAN>으</SPAN>
<SPAN>며, 당사는 소장을 송달 받은 후에 대응할 예정입니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">주4)&cr;</SPAN>
<SPAN>   2021년 5월 14일 메디톡스(원고)가 대웅제약, 대웅(피고)에 대해 대웅의 미국 특허를 양도해줄 것을 청구하였으며, 당사는 소장을 송달 받은 후에 대응할 예정입니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>
</CORRECTION>

<SECTION-1 AID="CEO-CERT-COR" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT_COR">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">21.8.17_대웅제약 대표이사 서명_사업보고서.jpg</IMG>
<IMG-CAPTION ATOC="N">21.8.17_대웅제약 대표이사 서명_사업보고서</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>
</LIBRARY>
</INSERTION>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P>&cr;&cr;&cr;</P>
<P USERMARK="F-16">                                    (제 19 기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20200101">2020년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2021년    3월   18일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">(주)대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">전 승 호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="30">경기도 화성시 향남읍 제약공단4길 35-14</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화)02-550-8800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.daewoong.co.kr</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 재무기획실장    (성  명) 장 영 호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 02-2190-6969</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TOC>
<TITLE ATOC="N">목     차</TITLE>
<P></P>
<PGBRK></PGBRK>
</TOC>

<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">대표이사등의 확인서명.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사등의 확인서명</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『연결재무제표를작성하는주권상장법인』 삽입</COMMENT>
<LIBRARYLIST>11011#*연결재무제표를작성하는주권상장법인.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">1_연결재무제표를작성하는주권상장법인</FILENAME>

<P>&cr;
<SPAN USERMARK=" B">1)  연결대상 종속회사 개황</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CMPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1029" BORDER="0">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="719"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="728" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1034" BORDER="1">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="300" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상호</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">설립일</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주소</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주요사업</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">최근사업연도말&cr;자산총액</TH>
<TH WIDTH="203" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">지배관계 근거</TH>
<TH WIDTH="134" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주요종속&cr;회사 여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">(주)힐리언스</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">대한민국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">생활습관병 예방연구</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">31,160,612 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">DAEWOONG PHARMACEUTICAL HONGKONG</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">홍콩</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">지주회사</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">41,979,007 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="47" ACODE="CRP_NM" USERMARK="F-9">요녕대웅제약유한공사</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="ADR" USERMARK="F-9">중국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="M_IND" USERMARK="F-9">의약품 제조 및 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="47" ACODE="KEY_IND" USERMARK="F-9">32,712,153 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="RUL_REL" USERMARK="F-9">DAEWOONG PHARMACEUTICAL &cr;HONGKONG의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">인도네시아</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">2,386,331 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="47" ACODE="CRP_NM" USERMARK="F-9">PT. DAEWOONG INFION</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="ADR" USERMARK="F-9">인도네시아</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="M_IND" USERMARK="F-9">의약품 제조 및 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="47" ACODE="KEY_IND" USERMARK="F-9">10,168,101 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="RUL_REL" USERMARK="F-9">PT. Daewoong Pharmaceutical&cr;(Indonesia)Co.,Ltd.의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="47" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">Daewoong Pharma PHILIPPINES INC.</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">필리핀</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">2,610,449 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">Daewoong Pharmaceutical(Thailand)Co.,Ltd</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">태국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">3,542,105 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="67" ACODE="CRP_NM" USERMARK="F-9">한올바이오파마(주) (*2)</TE>

<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="67" ACODE="EST_DT">
<SPAN USERMARK="F-9">1973.11.20</SPAN>
</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="67" ACODE="ADR" USERMARK="F-9">대한민국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="67" ACODE="M_IND" USERMARK="F-9">의약품 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="67" ACODE="KEY_IND" USERMARK="F-9">219,483,648 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="67" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>

<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="67" ACODE="M_SUB_COM">
<SPAN USERMARK="F-9">○&cr;(지배회사 자산총액의 10% 이상)</SPAN>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">HPI,INC. (*2)</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">미국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">FDA임상시험 진행</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">347,327 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">한올바이오파마(주)의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">북경대웅위업의약과기유한공사</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">중국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 연구</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">4,193,618 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">Daewoong Pharmaceutical India Pvt.,Ltd.</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">인도</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 연구</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">849,678 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">Daewoong America, Inc.</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">미국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 연구</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">97,103 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">Daewoong Pharmaceutical(Japan)Co., Ltd.</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">일본</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 제조 및 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">7,671,647 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">아피셀테라퓨틱스(*3)</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">대한민국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 연구</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">5,688,129 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="300" VALIGN="MIDDLE" HEIGHT="27" ACODE="CRP_NM" USERMARK="F-9">아이엔테라퓨틱스(*3)</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="EST_DT" USERMARK="F-9">-</TE>
<TE WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="ADR" USERMARK="F-9">대한민국</TE>
<TE WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_IND" USERMARK="F-9">의약품 연구</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" ACODE="KEY_IND" USERMARK="F-9">2,125,940 </TE>
<TE WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="RUL_REL" USERMARK="F-9">지배기업의 종속기업</TE>
<TE WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="27" ACODE="M_SUB_COM" USERMARK="F-9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN>(*1) 연결실체가 보유한 소유지분율의 단순합계 입니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(*2) 사실상의 지배력이 있다고 판단하여 연결대상으로 포함하였습니다. &cr;(*3) 당기중 출자설립하여 연결대상으로 포함되었습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>1-1. 연결대상회사의 변동내용</P>

<TABLE-GROUP ACLASS="CONT_CHG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="66"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="335"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">자회사</TH>
<TH WIDTH="344" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사 유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">신규&cr;연결</TD>

<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_CPY">
<SPAN USERMARK="F-9 BC0X31FFFF"></SPAN>아피셀테라퓨틱스
</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_RES">기업 의결권의 과반수 소유</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_CPY">
<SPAN USERMARK="F-9 BC0X31FFFF"></SPAN>아이엔테라퓨틱스
</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_RES">기업 의결권의 과반수 소유</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">연결&cr;제외</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_RES">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_RES">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>- '건강한삶기술창업벤처'는 2020년 1분기말 기준으로 연결대상회사로 추가되었다가, 2020년 3분기말 기준으로 연결대상회사에서 제외되었습니다.&cr;</P>
</LIBRARY>
</INSERTION>
<P>회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;여부</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHK">주권상장</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="SPC_DATE" AUNITVALUE="20021101">2002년 11월 01일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHP">-</TE>
<TE WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_LAW">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK=" B">2) 회사의 법적ㆍ상업적 명칭&cr; </SPAN>
<SPAN>- 주식회사 대웅제약 (영문명: Daewoong pharmaceutical Co.,Ltd.)&cr;</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B">3) 설립일자 및 상장일자</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>
<P> - 설립일 : 2002년 10월 2일</P>

<P> - 주권재상장일 : 2002년 11월 1일&cr;&cr;
<SPAN USERMARK=" B">4) 본사의 주소, 전화번호, 홈페이지 주소</SPAN>&cr; - 주      소 : 경기도 화성시 향남읍 제약공단4길 35-14&cr; - 전화번호 : 02-550-8800&cr; - 홈페이지 : http://www.daewoong.co.kr&cr;&cr;
<SPAN USERMARK=" B">5) 중소기업 해당 여부&cr; </SPAN>
<SPAN>- 당사는 본 보고서 제출일 현재 중소기업기본법 제 2조에 의한 중소기업에 해당되지 않습니다.&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>&cr;
<SPAN USERMARK=" B">6) 주요 사업의 내용</SPAN>
</P>
<P> 주식회사 대웅제약은 2002년 10월 1일을 기준일로 주식회사 대웅(분할 전 상호: 주식회사 대웅제약)이 사업부문을 인적분할하여 2002년 10월 2일자로 설립되었으며, 의약품 생산 및 판매를 주요 사업으로 영위하고 있습니다. 2002년 11월 1일자로 한국거래소(구, 한국증권선물거래소)가 개설한 유가증권 시장에 상장하였으며, 보고기간 종료일 현재 화성군 향남공단 및 오송공장 내에 정제의약품 생산 KGMP 기준에 부합하는 제조시설을 두고 있습니다.&cr;&cr;(1) 주요사업 내용 : 의약품 제조 및 판매&cr;(2) 주요제품 : 나보타, 우루사, 올메텍, 임팩타민, 가스모틴 등&cr;&cr;※상세한 내용은 동 공시서류의 'II. 사업의 내용' 을 참조하시기 바랍니다.&cr;</P>

<P>
<SPAN USERMARK=" B">7) 계열회사의 현황&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="839">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="376"></COL>
<COL WIDTH="259"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="385" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회사명</P>
</TH>

<TH WIDTH="268" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주업종</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>상장법인</P>
</TD>
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">지주회사(기타서비스업)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지주회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅제약</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">한올바이오파마(주)</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">손자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="30" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="900">
<P>비상장법인</P>
</TD>
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">대웅바이오(주)</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">원료의약품 제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅생명과학</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">식품 가공업 및 판매업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅경영개발원</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">경영 및 산업연수사업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)산웅개발</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">용역업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅이엔지</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">공무, 시설관리 용역업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)팜팩</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약외품의 포장업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">부동산 임대 및 공급업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)아이디에스앤트러스트</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">통신관련 기기의 제조 및 판매업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">㈜에이치알그룹</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">리더십교육, 코칭, HR컨설팅, 솔루션</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">㈜에스티에이치이솔루션</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">구강위생용품 개발 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅테라퓨틱스</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">신규 의약 기술개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)힐리언스</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">생활습관병 예방 및 연구업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">손자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">다나아데이터㈜</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">응용소프트웨어 개발 및 공급업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)엠디웰아이엔씨</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">환자식 제조판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">농업회사법인(주)대웅낙원</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">농지임대 및 매매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">아피셀테라퓨틱스</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">신규 의약 기술개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">아이엔테라퓨틱스</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">신규 의약 기술개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해외법인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 연구개발, 기술이전, 기술개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical(Thailand)Co.,Ltd</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong America, Inc.</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">PT. Daewoong Pharmaceutical(Indonesia)Co.Ltd</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">사천대웅생물기술유한공사</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">연구개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">지주회사</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical India Pvt.,Ltd</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical Japan Co., Ltd.</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">HPI,INC</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">해외임상 진행 및 라이센싱아웃 업무</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">요녕대웅제약유한공사</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">PT. DAEWOONG INFION</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Bio Indonesia</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계</P>
</TD>
<TD WIDTH="385" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">33개사</TD>
<TD WIDTH="268" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">&cr;8) 신용평가에 관한 사항</SPAN>
</P>
<P>1) 최근 3년간 신용평가에 관한 내용</P>

<TABLE BORDER="1" WIDTH="569" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="62"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">평가일</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">평가대상&cr;유가증권 등</TH>
<TH WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">평가대상 유가증권의 &cr;신용등급</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">평가회사&cr;(신용평가등급범위)</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">평가구분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.06</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+ Stable</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NICE, 한기평&cr;( D  ～ AAA   )</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">정기평가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019.10</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+ Stable</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NICE, 한기평&cr;( D  ～ AAA   )</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">본평가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019.04</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+ Stable</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NICE, 한기평&cr;( D  ～ AAA   )</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">정기평가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019.04</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+ Stable</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NICE, 한기평&cr;( D  ～ AAA   )</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">본평가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2018.06</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+ Stable</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NICE, 한기평&cr;( D  ～ AAA   )</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">본평가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2017.09</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+ Stable</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NICE, 한기평&cr;( D  ～ AAA   )</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">본평가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2017.06</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+ Stable</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NICE, 한신평, 한기평&cr;( D  ～ AAA   )</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">정기평가</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">1) 회사의 본점소재지 및 그 변경</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="234"></COL>
<COL WIDTH="350"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="243" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경일</TH>
<TH WIDTH="359" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" HEIGHT="30" ALIGN="CENTER">2002.10.01</TD>
<TD WIDTH="359" HEIGHT="30">경기도 화성시 향남면 상신리 향남제약 공단 906-10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" HEIGHT="31" ALIGN="CENTER">2003.05.30</TD>
<TD WIDTH="359" HEIGHT="31">경기도 성남시 중원구 갈마치로 244 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" HEIGHT="31" ALIGN="CENTER">2018.03.23</TD>
<TD WIDTH="359" HEIGHT="31">경기도 화성시 향남읍 제약공단 4길 35-14</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">2) 경영진의 중요한 변동 </SPAN>
</P>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="205"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">직 위</TH>
<TH WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">성 명</TH>
<TH WIDTH="214" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">임 기 (3년)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" ALIGN="CENTER" HEIGHT="30">대표이사</TD>
<TD WIDTH="188" ALIGN="CENTER" HEIGHT="30">전승호</TD>
<TD WIDTH="214" ALIGN="CENTER" HEIGHT="30">2018.03.23  ~ 2021.03.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" ALIGN="CENTER" HEIGHT="30">대표이사</TD>
<TD WIDTH="188" ALIGN="CENTER" HEIGHT="30">윤재춘</TD>
<TD WIDTH="214" ALIGN="CENTER" HEIGHT="30">2018.03.23  ~ 2021.03.23</TD>
</TR>
</TBODY>
</TABLE>
<P>※ 당사는 2인의 각자대표체제입니다.&cr;</P>

<P>
<SPAN USERMARK=" B">3) 최대주주의 변동</SPAN>
<SPAN USERMARK=" B"> </SPAN>
<SPAN USERMARK=" B">(2014년 5월 9일)&cr;</SPAN>
<SPAN>- 변경전 : 윤영환&cr;- 변경후 : (주)대웅&cr;- 변경사유 : 기존 최대주주(윤영환)의 재단출연으로 4,719,211주를 보유한 (주)대웅으로 최대주주가 변경됨&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">4) 주요 자회사에 관한 사항</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">4-1) 한올바이오파마(주)&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">가. 회사의 본점소재지 및 그 변경 &cr;</SPAN>     1) 1973. 11. 20. 대전광역시 중구 대흥동 36-10  &cr;     2) 1982. 02. 27. 대전광역시 대덕구 상서동 400-1&cr;     3) 2013. 07. 09. 대전광역시 대덕구 상서당1길 43 (도로명주소 변경)&cr;
</P>

<P>
<SPAN USERMARK=" B">나. 경영진의 중요한 변동</SPAN>
<SPAN>&cr;보고서 기준일 현재 당사는 박승국, 윤재춘 총 2명의 공동대표이사 체제로 운영되고 있으며 최근 5사업연도의 경영진 변동내역은 다음과 같습니다.&cr;</SPAN>
<SPAN>      1) 2017. 03. 24. 공동대표이사 박승국 연임 (공동대표이사 박승국, 윤재춘)&cr;      2) 2018. 03. 23. 공동대표이사 윤재춘 연임 (공동대표이사 박승국, 윤재춘)&cr;      3) 2020. 03. 20. 공동대표이사 박승국 연임 (공동대표이사 박승국, 윤재춘)&cr;&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">다. 최대주주의 변동 &cr;</SPAN>
<SPAN>       2015. 07. 30. 최대주주 김성욱 → (주)대웅제약으로 변경 &cr;       (최대주주 특수관계인의 지분매각 완료 및 제3자배정 유상증자)&cr;&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">라. 상호의 변경 &cr;</SPAN>
<SPAN>    1) 1973. 11. 20. 선경제약(주) 창립&cr;    2) 1978. 06. 14. 주식회사 한올(선경그룹의 계열사라는 오해 불식하기 위해 변경)&cr;    3) 1987. 10. 02. 한올제약주식회사&cr;    4) 2010. 03. 19. 한올바이오파마주식회사</SPAN>
</P>

<P>&cr;
<SPAN USERMARK=" B">마. 경영활동과 관련한 중요한 사항의 발생내용 </SPAN>
</P>
<P>   - 2017.09 하버바이오메드와 8100만달러 규모 기술이전 계약 (중국지역)&cr;   - 2017.12 Roivant와 5억250만달러 규모 기술이전 계약 &cr;      (미국 포함 북미, 중남미, 스위스, 영국, EU국가, 중동, 북아프리카 지역)&cr;   - 2017.12 제14회 대한민국 신성장경영대상 과학기술부문 국무총리상 수상    &cr;   - 2018.02 제19회 대한민국신약개발상 기술수출상 수상&cr;   - 2018.09 대한민국 바이오의약품대상 GE에디슨상 수상&cr;   - 2019.11 ISO37001(부패방지경영시스템) 인증 획득&cr; 주] 기업공시서식 작성기준에 근거, 최근 5사업연도 변동사항입니다.&cr;&cr;</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P></P>
<P>증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="598" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="629" BORDER="1">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행&cr;(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)&cr;형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="447" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당&cr;액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행&cr;(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20130101">2013.01.01</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">300,607</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">2,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">3%무상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20120101">2012.01.01</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">291,851</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">2,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">3%무상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20110101">2011.01.01</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">285,801</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">2,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">3%무상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20100401">2010.04.01</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">281,269</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">2,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">3%무상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20090401">2009.04.01</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">274,828</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">2,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">3%무상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20080401">2008.04.01</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">273,681</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">2,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">3%무상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20011002">2001.10.02</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="INC_CNT">9,878,538</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">2,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">회사분할</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환사채 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환사채발행현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 신주인수권부사채 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환신주인수권부사채등발행현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환형 조건부자본증권 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환형조건부자본증권등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P></P>
<P>1) 주식의 총수 현황</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">우선주</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">32,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK1">32,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">11,586,575</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK2">11,586,575</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RST">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RDC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RFD_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ETC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">11,586,575</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK3">11,586,575</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">823,880</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_TRS_STK">823,880</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK"> 10,762,695</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_FLT_STK"> 10,762,695</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『자기주식 취득 및 처분 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*자기주식취득및처분현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">5_자기주식취득및처분현황</FILENAME>
<P>2) 자기주식 취득 및 처분 현황</P>

<TABLE-GROUP ACLASS="OWN_SHR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="766" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="377"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="148" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="386" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="789" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="274" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2" COLSPAN="3">취득방법</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기초수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">변동 수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기말수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취득(+)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">처분(-)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소각(-)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="14" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="420" AUPDATECONT="N">배당&cr;가능&cr;이익&cr;범위&cr;이내&cr;취득</TD>
<TD ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="240" AUPDATECONT="N">직접&cr;취득</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">장내 &cr;직접 취득</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AJ_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AJ_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AJ_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="AJ_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AJ_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AJ_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AJ_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="AJ_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">장외&cr;직접 취득</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AO_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AO_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AO_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="AO_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AO_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AO_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AO_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="AO_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE9">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">공개매수</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AK_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AK_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AK_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="AK_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AK_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AK_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AK_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="AK_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">소계(a)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="ASUM_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ASUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ASUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="ASUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="ASUM_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ASUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ASUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="ASUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="180" AUPDATECONT="N">신탁&cr;계약에 의한&cr;취득</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">수탁자 보유물량</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BS_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BS_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BS_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="BS_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BS_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BS_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BS_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="BS_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">현물보유물량</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BH_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BH_STK_BGN">1,265,705</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BH_STK_TRD">441,826</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="BH_STK_END">823,879</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BH_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BH_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BH_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="BH_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">소계(b)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BSUM_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BSUM_STK_BGN">1,265,705</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BSUM_STK_TRD">441,826</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="BSUM_STK_END">823,879</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE6">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BSUM_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BSUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BSUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="BSUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="274" HEIGHT="60" AUPDATECONT="N" COLSPAN="3">기타 취득(c)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="ETC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ETC_STK_BGN">1</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ETC_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="ETC_STK_END">1</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE7">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="ETC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ETC_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ETC_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="ETC_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="274" HEIGHT="60" AUPDATECONT="N" COLSPAN="3">총 계(a+b+c)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="TOT_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="TOT_STK_BGN">1,265,706</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="TOT_STK_TRD">441,826</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="TOT_STK_END">823,880</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE8">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="TOT_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="TOT_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="TOT_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="TOT_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE8">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『종류주식(명칭) 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*종류주식발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 의결권 현황</TITLE>
<P></P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">11,586,575</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">823,880</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">자기주식</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">기타 법률에 의하여&cr;의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권을 행사할 수 있는 주식수&cr;(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK"> 10,762,695</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-6-0">6. 배당에 관한 사항 등</TITLE>

<P>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>가. 배당에</SPAN>
<SPAN> 관한 사항&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>당사는 주주가치 제고 및 주주중심 경영을 실현하고자 당사 정관에 의거 이사회 결의및 주주총회 결의를 통하여 매년 현금배당 등을 실시해오고 있습니다. 당사는 미래를 위한 성장ㆍ투자 전략, 과거 3개년 배당성향, 업계의 배당성향 등을 고려하여 배당액을 결정하고 있습니다.&cr;&cr; - 배당의 제한에 대한 사항&cr;당사가 보유 중인 자사주는 배당에서 제외함 (2020년 12월말 기준 823,880주)&cr;
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN></SPAN>
<SPAN>나. 최근 3사업연도 배당에 관한 사항</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>당사 배당정책에 따라 </SPAN>
<SPAN>제16기 6,193백만원, 제17기  6,193백만원, 제18기 6,193백만원</SPAN>
<SPAN>을 현금배당총액으로 지급하였습니다.&cr;</SPAN>
</P>
<P>다. 주요배당지표</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제19기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제18기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">2,500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">2,500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">2,500</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">12,753 </TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">22,006</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-15,152</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">3,139</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">20,228</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">1,481</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">1,196</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">2,132</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-1,468</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">6,458</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">6,193</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">6,193</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">50.6</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">28.1</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">0.3</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">0.5</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">0.3</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">600</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">600</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">600</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>*현금배당수익률 : 1주당 현금배당금/과거 1주일간 배당부 종가의 평균&cr;*과거 1주일간 배당부 종가의 평균 : 배당기준일 전전거래일(배당부종가일)부터 과거 1주일간 공표된 매일의 증권시장 또는 코스닥시장에서 형성된 최종시세가격의 산술평균가격&cr;*제19기 배당금액은 2021년 3월 11일 이사회에서 승인되었으며, 3월 26일 정기주주총회에서 보고할 예정입니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『과거배당이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*과거배당이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">48_과거배당이력</FILENAME>
<P>라. 과거 배당 이력</P>

<TABLE-GROUP ACLASS="DIVIDEND_BCK" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_QUA" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_END" VALIGN="MIDDLE">19</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_THR" VALIGN="MIDDLE">0.37</TE>
<TE ALIGN="RIGHT" WIDTH="149" HEIGHT="30" ACODE="DIV_FIV" VALIGN="MIDDLE">0.48</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>- 평균 배당수익률은 최근 3년간 및 최근 5년간 배당수익률에 대한 단순평균값임.</P>
</LIBRARY>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-7-0">7. 정관에 관한 사항</TITLE>
<P>본 사업보고서에 첨부된 정관의 최근 개정일은 2020년 3월 20일이며 2021년 3월 &cr;26일 제19기 정기주주총회 안건에는 하기의 정관 변경 안건이 포함되어 있습니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『정관변경이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*정관변경이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">49_정관변경이력</FILENAME>
<P>1) 정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="617" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="ART_DATE" AUNITVALUE="20210326" VALIGN="MIDDLE">2021년 03월 26일</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="ART_NAME" VALIGN="MIDDLE">제 19기 &cr;정기주주총회</TE>
<TE WIDTH="225" HEIGHT="53" ACODE="ART_CHN" VALIGN="MIDDLE">제23조 (이사및 감사의 선임)</TE>
<TE WIDTH="147" HEIGHT="53" ACODE="ART_RSN" VALIGN="MIDDLE">개정상법 반영</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="ART_DATE" AUNITVALUE="20200320" VALIGN="MIDDLE">2020년 03월 20일</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="ART_NAME" VALIGN="MIDDLE">제 18기 &cr;정기주주총회</TE>
<TE WIDTH="225" HEIGHT="53" ACODE="ART_CHN" VALIGN="MIDDLE">제2조 (목적)</TE>
<TE WIDTH="147" HEIGHT="53" ACODE="ART_RSN" VALIGN="MIDDLE">신규사업 추가</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="175" AUNIT="ART_DATE" AUNITVALUE="20190322" VALIGN="MIDDLE">2019년 03월 22일</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="175" ACODE="ART_NAME" VALIGN="MIDDLE">제 17기 &cr;정기주주총회</TE>

<TE WIDTH="225" HEIGHT="175" ACODE="ART_CHN" VALIGN="MIDDLE">
<P>-제2조 (목적)&cr;-제7조 (주식 및 신주인수권증서에 표시되어야 할 권리의 전자등록 등)&cr;- 제 36조의2(외부감사인의 선임)</P>
</TE>
<TE WIDTH="147" HEIGHT="175" ACODE="ART_RSN">-신규사업 추가&cr;-전자증권제도 도입 반영 등&cr;- 주식회사 등의 외부감사에 관한 법률 개정내용 반영 </TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>

<P USERMARK=" B">
<SPAN USERMARK=" !B">- 2021년 3월 26일 개최되는 제19기 정기주주총회에는 정관 변경 안건이 포함되어 있습니다.&cr;</SPAN>&cr;
<SPAN USERMARK=" !B">2) 제19기 정기주주총회 정관 변경 안건 [제1호 의안: 정관변경의 건]</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="990" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="310"></COL>
<COL WIDTH="310"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정관변경 예정일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">해당주총명</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="638" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요변경사항</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경 이유</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="319" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경 전</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="319" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경 후</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="737">2021년 3월 26일</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="737">제19기 &cr;정기주주총회</TD>

<TD WIDTH="319" HEIGHT="605">
<P USERMARK=" BU">제23조 (이사 및 감사의 선임)</P>
<P> </P>
<P>① (생략)</P>
<P> </P>

<P>② 이사와 감사의 선임은 출석한 주주의 의결권의 과반수로 하되 발행주식 총수의 4분의 1이상의 수로 하여야 한다. 
<SPAN USERMARK=" U">그러나 감사의 선임에는 의결권 있는 행사주식총수의 100분의 3을 초과하는 주식에 관하여 제 1항의 감사의 선임에 있어서는 의결권을 행사하지 못한다. 다만, 소유주식수의 산정에 있어 최대주주와 그 특수관계인 또는 그 특수관계인의 계산으로 주식을 보유하는 자, 최대주주 또는 그 특수관계인에게 의결권을 위임한 자가 소유하는 의결권 있는 주식의 수는 합산한다.</SPAN>
</P>
<P> &cr;</P>
<P>③ (신설)</P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> &cr;④ (생략)</P>
</TD>

<TD WIDTH="319" HEIGHT="605">
<P USERMARK=" BU">제23조 (이사 및 감사의 선임)</P>
<P> </P>
<P>① (현행과 동일)</P>
<P> </P>

<P>② 이사와 감사의 선임은 출석한 주주의 의결권의 과반수로 하되 발행주식 총수의 4분의 1이상의 수로 하여야 한다. 
<SPAN USERMARK=" U">다만, 상법 제368조의4 제1항에 따라 전자적 방법으로 의결권을 행사할 수 있도록 한 경우에는 출석한 주주의 의결권의 과반수로써 감사의 선임을 결의할 수 있다.</SPAN>
</P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>

<P> &cr;③ 
<SPAN USERMARK=" U">감사의 선임과 해임에는 의결권 없는 주식을 제외한 발행주식총수의 100분의 3을 초과하는 수의 주식을 가진 주주(최대주주인 경우에는 그의 특수관계인, 그 밖에 상법시행령으로 정하는 자가 소유하는 주식을 합산한다)는 그 초과하는 주식에 관하여 의결권을 행사하지 못한다.</SPAN>
</P>
<P> </P>
<P>④ (현행과 동일)</P>
</TD>

<TD WIDTH="112" HEIGHT="605">
<P> </P>
<P> </P>
<P> &cr;</P>
<P>개정상법 </P>
<P>제409조 제3항</P>
<P>반영</P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> </P>
<P> &cr;개정상법 </P>
<P>제542조의12</P>
<P>제7항 반영</P>
<P> </P>
<P> </P>
<P>  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="319" HEIGHT="132">
<P USERMARK=" BU">제 41조 (적용범위 및 시행일)</P>
<P> </P>
<P>(신설)</P>
</TD>

<TD WIDTH="319" HEIGHT="132">
<P USERMARK=" BU">제 41조 (적용범위 및 시행일)</P>
<P> </P>
<P USERMARK=" U">본 정관은 정기 주주총회에서 승인한 2021년 3월 26일부터 시행한다.</P>
</TD>

<TD WIDTH="112" HEIGHT="132">
<P> </P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>- 제19 정기주주총회의 결과에 따라 변동이 발생한 경우 정정보고서를 통해 공시할 예정입니다.&cr;</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>
<P>※ 당사 및 주요종속회사인 한올바이오파마 (종속회사 자산총액이 지배회사 자산총액의 10% 이상)는 '의약품 제조 및 판매(수출포함)'를 지배적 단일사업부문으로 영위하는 업체로 공시대상의 요건을 갖춘 다른 사업부문이 없으므로 사업의 내용을 부문별로 구분하여 표시하지 않았습니다.&cr;</P>
<P></P>

<P>
<SPAN USERMARK="F-16 0XFF0000 B">1-1. 사업의 개요</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">1) 당사의 공시대상 회사 (주요자회사 및 주요 종속회사)는 아래와 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">회사명</TH>
<TH WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주업종</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">상장법인</TD>
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)대웅제약</TD>
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">의약품 제조 및 판매</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지배회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">한올바이오파마(주)</TD>
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">의약품 제조 및 판매</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주요종속회사</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">2) 연결대상 종속회사 개황</P>
<P>당기말 현재 연결재무제표 작성대상 종속기업들의 현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="998" BORDER="1">

<COLGROUP>
<COL WIDTH="332"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="223"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="341" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH ALIGN="CENTER" WIDTH="156" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">영업활동</TH>
<TH ALIGN="CENTER" WIDTH="232" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(*1)</TH>
<TH ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결산일</TH>
<TH ALIGN="CENTER" WIDTH="95" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">생활습관병 예방연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">75.97%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">12월 31일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">대한민국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">지주회사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">89.83%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">홍콩</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="53" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="53">의약품 제조 및 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="53">DAEWOONG PHARMACEUTICAL HONGKONG의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">89.83%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">인도네시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="53" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="53">의약품 제조 및 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="53">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">55.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">인도네시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharma PHILIPPINES INC.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">필리핀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical(Thailand)Co.,Ltd</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="53">의약품 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="53">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">태국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주) (*2)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">31.48%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">대한민국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">HPI,INC. (*2)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">FDA임상시험 진행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">한올바이오파마(주)의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">31.48%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical India Pvt.,Ltd.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">3월 31일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">인도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">Daewoong America, Inc.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">12월 31일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical(Japan)Co., Ltd.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 제조 및 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">일본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">아피셀테라퓨틱스(*3)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">54.10%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">대한민국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">아이엔테라퓨틱스(*3)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">97.54%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">대한민국</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) 연결실체가 보유한 소유지분율의 단순합계 입니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(*2) 사실상의 지배력이 있다고 판단하여 연결대상으로 포함하였습니다. &cr;(*3) 당기중 출자설립하여 연결대상으로 포함되었습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK=" B">3) 종속기업 재무정보</SPAN>
</P>
<P></P>
<P>당기말 현재 연결대상 종속기업의 주요 재무정보는 다음과 같습니다.&cr;</P>
<P>가. 재무상태 및 손익</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="970" BORDER="1">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" WIDTH="970" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">  (단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="344" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산총액</TH>
<TH ALIGN="CENTER" WIDTH="127" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채총액</TH>
<TH ALIGN="CENTER" WIDTH="127" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">순자산</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">31,160,612 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">20,612,773 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">10,547,839 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">6,144,535 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">(2,964,072)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">41,979,007 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">7,017 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">41,971,990 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">(14,814)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">32,712,153 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">3,596,034 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">29,116,119 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">4,340,325 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">(1,901,628)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">2,386,331 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">1,528,245 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">858,086 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">497,152 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">(707,166)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">10,168,101 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">3,388,687 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">6,779,414 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">8,125,242 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">3,093,890 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharma PHILIPPINES INC.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">2,610,449 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">702,104 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">1,908,345 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">4,193,964 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">253,627 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical(Thailand)Co.,Ltd.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">3,542,105 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">4,393,930 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">(851,825)</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">7,231,142 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">727,562 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">219,483,648 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">38,322,293 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">181,161,355 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">88,602,270 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">19,863,538 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">HPI,INC.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">347,327 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">159,979 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">187,348 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">477,920 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">(99,039)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">4,193,618 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">3,594,245 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">599,373 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">2,103,549 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">734,568 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical India Pvt.,Ltd.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">849,678 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">159,725 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">689,953 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">1,272,950 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">225,637 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong America, Inc.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">97,103 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">2,362 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">94,741 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">259,611 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">84,033 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong Japan, Inc.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">7,671,647 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">7,426,644 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">245,003 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">19,488,952 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">659,692 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">아피셀테라퓨틱스</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">5,688,129 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">137,438 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">5,550,691 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">4,545 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">(1,174,712)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">아이엔테라퓨틱스</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">2,125,940 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">1,134,147 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">991,793 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">3,000 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">(2,566,132)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">합계</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">365,015,848 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">85,165,623 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">279,850,225 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">142,745,157 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">16,214,984 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>나. 현금흐름</SPAN>
</P>

<TABLE BORDER="1" WIDTH="970" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="333"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="970" VALIGN="MIDDLE" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30"> (단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="342" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">회사명</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">영업활동&cr;현금흐름</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">투자활동&cr;현금흐름</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">재무활동&cr;현금흐름</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">기타</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">현금및현금성자산의 순증감</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">(주)힐리언스</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,148,888)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(52,454)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,087,237 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(114,105)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,183)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,362)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(18,545)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">요녕대웅제약유한공사</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,126,697 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,872,014)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,560,620 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13,913)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">801,390 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(344,803)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(58,619)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">201 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(403,221)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">PT. DAEWOONG INFION</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,311,450 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(278,097)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,172,672)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,508)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(153,827)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,907 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,093)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,651)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,163 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical(Thailand)Co.,Ltd.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,408 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,330)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,886)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(43,306)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">192,886 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">한올바이오파마(주)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">976,174 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,528,489)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(446,479)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,322)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,002,116)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">HPI,INC.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(46,883)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(72,866)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,527)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(128,276)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">238,035 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,416 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">250,451 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical India Pvt.,Ltd.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">176,382 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,462 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,929)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">182,915 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong America, Inc.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,149 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,118)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">92,031 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong Japan, Inc.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,891,846 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">689 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(90,971)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(133,001)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,668,563 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">아피셀테라퓨틱스</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,267,524)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(549,548)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,713,011 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,895,939 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">아이엔테라퓨틱스</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,654,215)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(12,711)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,924,252 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,257,326 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,644,552 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,338,204)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,500,246 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(236,020)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,570,574 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>- 상기 재무정보는 내부거래 상계전 금액입니다.&cr;</SPAN>
</P>

<P>
<SPAN>다. 당기 중 연결대상 종속기업의 비지배지분에 대한 정보는 아래와 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="924">

<COLGROUP>
<COL WIDTH="331"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="924" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">  (단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="340" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">회사명</TH>
<TH WIDTH="158" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">비지배지분율(*)</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">비지배지분의&cr;장부금액</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">비지배지분의&cr;당기손익</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">비지배지분의&cr;총포괄손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">24.03%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,534,646 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(712,267)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(171,158)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10.17%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,268,551 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,507)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(252,856)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10.17%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,961,109 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(193,396)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,786 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">45.00%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,050,736 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,392,250 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">501,771 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">68.52%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">124,131,761 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,610,496 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,503,924 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">HPI,INC.</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">68.52%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">128,371 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(67,861)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(53,455)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">아피셀테라퓨틱스</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">45.90%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,547,767 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(539,193)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(247,489)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">아이엔테라퓨틱스</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2.46%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,398 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(63,127)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,553)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">연결조정</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,607,698 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,030,754)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,818,532 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="498" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">합           계</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">144,255,037 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,394,641 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,105,502 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 자기주식 등을 제외한 유효지분율 입니다.&cr;</P>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN USERMARK=" B">4) 영업부문</SPAN>
</P>
<P>&cr;(1) 영업부문에 대한 일반정보&cr;연결실체의 영업부문은 총 3개의 사업부문으로 구성되어 있으며, 각 사업부문의 주요 재화 및 용역유형에 따라 다음과 같이 분류할 수 있습니다.</P>

<TABLE BORDER="1" WIDTH="643" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="211"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="220" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">분류 기준</TH>
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주요 재화 및 용역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">의약품 제조 및 판매</TD>
<TD WIDTH="220" ALIGN="CENTER" HEIGHT="30">재화 및 용역제공 유형별 분류</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">원료 및 완성의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">용역제공</TD>
<TD WIDTH="220" ALIGN="CENTER" HEIGHT="30">〃</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">생활습관병 예방연구 용역</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">기타</TD>
<TD WIDTH="220" ALIGN="CENTER" HEIGHT="30">〃</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">기타 서비스</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 영업부문의 재무현황&cr;가. 당기와 전기 중 영업부문의 손익은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="716">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="716" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="141" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="288" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="287" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문매출</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문영업이익(손실)</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문매출</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문영업이익(손실)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">의약품제조및판매</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,079,812,107 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">22,848,285 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,154,926,024 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">49,440,696 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">용역제공</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,144,535 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(2,489,876)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">8,123,496 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(1,536,706)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">기타</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,540,106 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(3,419,557)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,310,794 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(7,394)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,087,496,748 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">16,938,852 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,164,360,314 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">47,896,596 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER">연결조정</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(32,073,058)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">40,872 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(50,934,393)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(3,209,499)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER">조정후금액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,055,423,690 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">16,979,724 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,113,425,921 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">44,687,097 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 당기말과 전기말 현재 영업부문의 자산 및 부채는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="714">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="714" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="286" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="286" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30">의약품제조및판매</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,469,853,957 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">673,816,849 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,363,097,534 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">633,794,673 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30">용역제공</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">31,160,612 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">20,612,773 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">32,848,339 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">19,308,034 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30">기타</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">50,739,856 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,440,689 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">45,039,213 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">25,724 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,551,754,425 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">695,870,311 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,440,985,086 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">653,128,431 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER">연결조정</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(184,846,504)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(24,211,006)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(195,316,937)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(43,380,376)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER">조정후금액</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,366,907,921 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">671,659,305 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,245,668,149 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">609,748,055 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>다. 당기와 전기 중 영업부문의 기타부문정보는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="830">

<COLGROUP>
<COL WIDTH="156"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="830" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="165" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="332" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각비</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동자산 취득(*)</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각비</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동자산 취득(*)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">의약품제조및판매</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">37,307,654 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">59,078,532 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">37,936,036 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">49,866,437 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">용역제공</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">1,370,029 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">52,689 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">1,381,948 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">198,695 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">기타</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">70,446 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">565,089 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">48,772 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">41,626 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">38,748,129 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">59,696,310 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">39,366,756 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">50,106,758 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30" ALIGN="CENTER">연결조정</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">548,022 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">828,612 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30" ALIGN="CENTER">조정후금액</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">39,296,151 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">59,696,310 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">40,195,368 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">50,106,758 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 유형자산, 투자부동산 및 무형자산의 현금 취득금액입니다.&cr;</P>
<P>(3) 지역에 대한 정보  &cr;지역부문에 대한 일반정보는 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="642" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="431"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="440" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주요 재화 및 용역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30">대한민국</TD>
<TD WIDTH="440" HEIGHT="30">의약품 제조 및 판매, 생활습관병 예방연구 용역</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30">아시아(대한민국 제외)</TD>
<TD WIDTH="440" HEIGHT="30">의약품 제조 및 판매</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;제조설비는 주로 대한민국을 포함한 아시아 지역에 위치하고 있으며, 매출의 대부분도 대한민국을 포함한 아시아 지역에 위치한 고객으로부터 발생합니다.&cr;</SPAN>
</P>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P USERMARK="F-16 0XFF0000 B">1-2. 업계의 현황</P>

<P>
<SPAN USERMARK=" B"></SPAN>&cr;◆ 의약품 제조 및 판매 : (주)대웅제약, 한올바이오파마(주)&cr;
</P>

<P>
<SPAN USERMARK=" B">1) 산업의 특성</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>제약산업은 인류의 생명과 건강, 안전에 필수적인 산업으로 국민복지 증진과 직결되는 산업입니다. 세계적인 고령화 가속 및 만성질환 증가가 진행됨으로써 의약품에 대한 수요가 증가하고 있으며 신종 질병 증가, 새로운 의료기술의 출현 등의 복합적인 요인으로 지속 성장이 가능합니다. 또한 지적</SPAN>
<SPAN>재산권에 의한 기술 보호장벽 및 기술우위에 따른 독점력이 강한 산업으로 신제품 개발에 막대한 비용 및 위험을 수반하지만동시에 고수익, 고부가가치를 창출하는 유망</SPAN>
<SPAN>산업입니다.&cr;</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">2) 산업의 성장성 </SPAN>
</P>

<P>
<SPAN>①  국내제약산업</SPAN>
</P>

<P>
<SPAN>국내 의약품 시장은 2018년 기준으로 약 23조원으로 형성되고 있으며 전세계 의약품시장 성장률과 비슷하게 성장세를 유지할 것으로 전망됩니다. 국내 제약산업은 선진국 수준의 생산 및 품질 경쟁력을 확보해 글로벌 시장에서 경쟁하고 있으며, 최근 5년간(2013~2018) 연평균 20.8%에 달하는 높은 의약품 수출증가율을 보이고 있습니다. 또한, 제약산업은 기술집약적 산업으로서 국내기업들은 신약개발 투자를 지속적으로 확대하고 있으며, 국내 제약산업의 높아진 글로벌 경쟁력으로 신약 기술수출도 활발히 진행되고 있습니다. </SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위 : 조원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="62"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="71" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">년도</TH>
<TH WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">항목</TH>
<TH WIDTH="91" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">생산액</TH>
<TH WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수출액</TH>
<TH WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수입액</TH>
<TH WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">무역수지</TH>
<TH WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">국내&cr;시장규모</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">2017</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">금액</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20.36</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4.60</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6.31</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-1.71</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전년대비</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8.25%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27.11%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-3.56%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">41.59%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.55%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">2018</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">금액</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21.11</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5.14</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7.16</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-2.01</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전년대비</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.67%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11.75%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13.44%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-18.00%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4.78%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">2019</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">금액</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22.31</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6.06</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8.05</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-2.00</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전년대비</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5.72%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17.79%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12.57%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.76%</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5.16%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>※ 상기 자료는 식품의약품안전처(MFDS) 식품의약품 산업동향통계 자료임.&cr;</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>②  글로벌 제약산업&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
<SPAN>세계 의약품시장은 2018년 기준으로 약 1조2천억달러로 추산되며, 인구 고령화 등 의약품 수요증가로 2005년 이후 연평균 6%대에 성장세를 유지하고 있습니다. 앞으로도 연평균 4~7%의 성장속도를 보이며 2023년 1조 5천억달러에 달할 전망입니다.&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="306" ALIGN="CENTER" HSPACE="0">세계의약품시장규모.jpg</IMG>
<IMG-CAPTION ATOC="N">세계의약품시장규모</IMG-CAPTION>
</IMAGE>

<P>
<SPAN></SPAN>
</P>

<P>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">3) 경기변동의 특성&cr;</SPAN>
<SPAN>제약산업은 다른 산업에 비해 높은 내수 의존도를 나타내고 있으며, 경기변동에 대해비교적 비탄력적이며, 특히 전문의약품의 경우에는 제품의 특성상 경기변동에 대해 비교적 안정적이라고 할 수 있습니다. 바로 2008년 경제공황에도 불구하고 제약시장의 지속적인 성장 및 의료비 지출액의 증가가 그러한 면을 반영하고 있습니다. 그러나, 거시경제 측면에서 해외 원료의약품 및 완제의약품의 수입에 의존도가 높은 업계특성상 불안정한 환율과 상승하는 소비자물가 지수는 제약 산업의 지속적 성장에 부정적인 영향을 끼칠 수 있습니다. </SPAN>
</P>

<P>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">4) 회사의 경쟁우위 요소</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>제</SPAN>
<SPAN>약산업은 신물질 신약의 개발을 위해서 오랜 시간과 많은 비용이 투자되어야 하는 기술 및 지식 집약적인 산업입니다. 그러나 신물질 신약의 개발 시 특허의 독점기간을 인정받을 수 있으며, 개발비용과 기간을 보상 받을 수 있는 수익을 창출할 수 있는 고부가가치 산업의 장점을 가지고 있습니다. </SPAN>&cr;
</P>
<P></P>
<P USERMARK="F-16 0XFF0000 B">1-3. 회사의 현황</P>

<P>
<SPAN USERMARK=" B"></SPAN>&cr;
<SPAN USERMARK=" B">◆ (주)대웅제약&cr;</SPAN>
</P>
<P USERMARK=" B">1) 영업개황 및 사업부문의 구분&cr;</P>

<P USERMARK=" P16">가. 영업개황&cr;당사의 19기 (2020.1.1~2020.12.31) 연결기준 매출액은 10,554억원으로 전년동기 11,134억원 대비 -5.2% 감소하였습니다. 영업이익은 170억원으로 전년동기 447억원 대비 -62.0%, 당기순이익은 241억원으로 전년동기 289억원 대비 -16.3%의 실적을 나타내었습니다. &cr;
<SPAN>&cr;</SPAN>
<SPAN></SPAN>나. 공시대상 사업부문의 구분 
</P>
<P USERMARK=" P16">당사는 의약품 제조 및 판매를 지배적 단일사업부문으로 영위하는 업체로서 공     시의 요건을 갖춘 별도의 사업부문이 없으므로 재무정보를 부문별로 구분하여      기재하지 않습니다.</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P USERMARK=" P16"></P>

<P USERMARK=" P16">
<SPAN>다. 시장점유율 등</SPAN>&cr;* 주요 상장제약사 매출액현황
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="592">

<COLGROUP>
<COL WIDTH="583"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="592" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회사명</P>
</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결산월</TH>

<TH COLSPAN="3" WIDTH="453" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매    출    액</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년</P>
</TH>

<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년</P>
</TH>

<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2017년</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>유한양행</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">12월</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">1,463,261</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>1,506,766</P>
</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>1,451,988</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>녹십자</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">12월</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">1,146,094</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>1,141,423</P>
</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>1,098,479</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>종근당</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>12월</P>
</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>1,078,618</P>
</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">955,705</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">884,277</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>대웅제약</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">12월</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>      1,005,180</P>
</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>          943,522</P>
</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>866,755</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>한미약품</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">12월</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>          863,647</P>
</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>          795,016</P>
</TD>

<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">
<P>702,636</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>※ 상기 자료는 전자공시시스템에 공시한 자료를 근거로 작성함.(K-IFRS 별도 기준)&cr;</P>
<P USERMARK=" P16">라. 시장의 특성</P>
<P USERMARK=" P16">의약분업 이후 처방의약품 시장이 고도 성장하고 있으며, 개발 및 신제품 도입능력, 병/의원 영업력, 시장지배력 등의 경쟁력을 보유한 대형 제약사 위주로 재편되고 있고 근래에는 M&A논의도 활발히 되고 있습니다.</P>
<P USERMARK=" P16">당사의 품목구성은 매출액 기준으로 처방의약품과 비처방의약품으로 대분되며 처방의약품 등 부문별로 수익성을 강화하고 있습니다.&cr;&cr;마. 조직도&cr;</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="130" ALIGN="CENTER" HSPACE="0">조 직 도.jpg</IMG>
<IMG-CAPTION ATOC="N">조 직 도</IMG-CAPTION>
</IMAGE>

<P>&cr;
<SPAN USERMARK=" B">2) 자회사의 사업현황&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">◆ 한올바이오파마(주)&cr;</SPAN>
</P>
<P USERMARK=" P16">① 영업개황&cr;2020년 연결기준 매출액은 886억원으로 전년 동기 1,085억원 대비 18.3% 감소하였습니다. 이는 코로나19로 인해 병ㆍ의원의 내원 환자 감소로 수액제, 주사제 등 의약품 매출이 감소되었기 때문입니다. 영업이익은 59억원으로 전년 동기 171억원 대비 112억 감소하였으나 당기순이익은 198억원으로 이뮤노반트 주식평가이익으로 인한 추가 이익이 발생하여 전년 동기 192억원 대비 3% 증가했습니다. </P>
<P>   ② 공시대상 사업부문의 구분</P>

<P>   당사는 의약품제조 및 판매업이 매출액의 90% 이상을  점유하고 있으며 별도 구분   되는 사업부문이 없습니다.&cr;
<SPAN USERMARK=" 0X1814FF B"></SPAN>
<SPAN USERMARK=" 0X1814FF">&cr;</SPAN>
<SPAN></SPAN>
<SPAN>* 한올바이오파마(주) 재무제표(별도기준)</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">  </SPAN>
</P>

<TABLE WIDTH="693" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="684"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="693" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="690">

<COLGROUP>
<COL WIDTH="276"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="285" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P USERMARK=" BC0XD7D7D7">과 목</P>
</TD>

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<SPAN>제 48기</SPAN>
</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 47기</TD>

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P USERMARK=" BC0XD7D7D7">제 46기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">[유동자산]</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">129,174,350,078</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,998,657,008</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">128,288,096,849</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ현금및현금성자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,032,304,257</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,034,420,904</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,217,787,149</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ당기손익-공정가치측정 금융자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,505,314,740</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,460,795,529</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,212,876,405</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ매출채권및기타채권</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,728,664,106</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,271,776,954</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,326,785,421</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ재고자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,891,326,107</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,717,381,946</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,519,616,531</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,016,740,868</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,514,281,675</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,011,031,343</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">[비유동자산]</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,685,974,421</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">57,072,693,794</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,958,884,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ장기금융상품</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,048,433</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">679,048,433</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">600,048,433</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ당기손익-공정가치측정 금융자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,072,604,290</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타포괄손익-공정가치측정 금융자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,709,606,787</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,250,161,752</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,467,913,591</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ매출채권및기타채권</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,044,666,329</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">889,846,050</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">946,435,050</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ유형자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,938,882,160</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,369,790,351</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,762,837,498</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ무형자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,077,814,620</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,717,772,252</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,524,767,810</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ이연법인세자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,203,241,521</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,894,076,406</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,234,511,446</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ사용권자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">387,459,121</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">478,280,365</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타비유동자산</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,255,255,450</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,793,718,185</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,349,766,058</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">자산총계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">219,860,324,499</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">191,071,350,802</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">162,246,981,025</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,067,190,582</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,379,961,988</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,792,242,190</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,631,778,681</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,495,216,464</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,580,944,881</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">부채총계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,698,969,263</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,875,178,452</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,373,187,071</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ자본금</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,120,319,000</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,120,319,000</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,120,319,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타불입자본</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">111,015,571,138</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">110,078,025,264</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">109,570,350,441</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타포괄손익누계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,526,460,259</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,294,100,839</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,535,210,860</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">ㆍ이익잉여금</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,499,004,839</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,296,272,753)</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(21,352,086,347)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">자본총계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">181,161,355,236</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140,196,172,350</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">116,873,793,954</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">매출액</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88,602,270,090</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">108,452,042,397</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">91,839,350,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">영업이익</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,012,796,659</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,914,015,381</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,506,386,936</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">당기순이익</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,863,537,529</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,000,569,477</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,332,660,745</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">총포괄손익</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,027,637,012</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,814,703,573</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,185,798,526</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">주당순이익(손실)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">388</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">371</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" VALIGN="MIDDLE" HEIGHT="30">종속기업 투자주식평가방법</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">원가법</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">원가법</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">원가법</TD>
</TR>
</TBODY>
</TABLE>

<P>[( )는 부(-)의 수치임]&cr;
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">2. 주요 제품 및 원재료 등</SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK=" B">&cr;&cr;◆(주)대웅제약&cr;</SPAN>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN>가. 주요 제품 등의 현황</SPAN>
</P>

<TABLE WIDTH="686" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="677"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="686" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="687" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="65"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">매출유형</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">품   목</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구체적용도</TH>
<TH WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주요상표등</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">매출액
<SPAN USERMARK=" 0X1814FF"></SPAN>
</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">제품</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">우루사(ETC,OTC)</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">피로회복, 간장해독</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">복합우루사,우루사</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,708</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9.18%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임팩타민</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">종합비타민</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">임팩타민파워정</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,287</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.84%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">올메텍</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">고혈압치료제(ARB)</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">올메텍정, 올메텍 PLUS</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,104</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.40%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가스모틴</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">기능성소화제</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">가스모틴정, 가스모틴산</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,296</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.68%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">290,606</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30.76%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">상품</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">크레스토</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">고지혈증치료제</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">크레스토정</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,834</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8.03%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">세비카</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">고혈압치료제</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">세비카, 세비카 HCT</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,110</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.41%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">넥시움</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">위염, 위궤양</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">넥시움정, 넥시움주</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,910</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.18%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">237,629</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25.15%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="542" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="4">기타</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,267</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.38%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="542" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">944,752</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>&cr;나. 주요 제품 등의 가격변동추이                                                                         
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="630">

<COLGROUP>
<COL WIDTH="621"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="630" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="631" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="232"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="241" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">품목</TH>
<TH WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제19기</TH>
<TH WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제18기</TH>
<TH WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">우루사 200mg/정</TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">180</TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">180 </TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">180 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">올메텍정 20mg/정</TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">414</TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">415 </TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">415 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">가스모틴정 5mg/정</TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">102</TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">103 </TD>
<TD WIDTH="130" ALIGN="CENTER" HEIGHT="30">103 </TD>
</TR>
</TBODY>
</TABLE>

<P>(보험약가 기준)&cr;
<SPAN></SPAN>
<SPAN>※주요 가격변동원인: 특허만료를 포함한 정부정책에 따른 약가인하&cr;</SPAN>
</P>
<P>다. 주요 원재료 등의 현황</P>

<TABLE WIDTH="882" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="873"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="882" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="881" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="274"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사업부문</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">매출유형</TH>
<TH WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">품   목</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구체적용도</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">매입액</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비율</TH>
<TH WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비    고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="17" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="510">제약</TD>
<TD ROWSPAN="11" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="330">해외&cr; 수입&cr; 원재료</TD>
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Mosapride Citrate Dihydrate</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">소화제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,096 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">DAINIPPON PHARMACEUTICAL CO.LTD</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">올메텍정</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,176 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">Sankyo Co., Ltd.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">에포시스 원액</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">호르몬제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,970 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">Infion</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Donepezil HCL</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">뇌기능개선제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,963 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">EISAI CO., LTD</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Erdosteine</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">진해거담제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,661 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">Interquim</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Metformin Hydrochloride</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,494 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">Merck Sante S.A.S.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">올메텍플러스정</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,074 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">Sankyo Co., Ltd.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Minocycline Hydrochloride</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">항생제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,354 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">Euticals S.P.A.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Tiropramide HCl</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">진경제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,324 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">Rotta Research Laboratorium s.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Rosuvastatin Calcium</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">동맥경화용제 </TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,536 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">MSN Laboratories Limited</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Dioctahedral Smectite</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">지사제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">926 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">Ipsen CHC</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">국내&cr; 매입&cr; 원재료</TD>
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Ursodesoxycholic Acid</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">간장질환용제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,929 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">대웅바이오(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Benfotiamine</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">비타민제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,846 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">(주)국전약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Sarpogrelate Hydrochloride</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">대사성 의약품</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,508 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">(주)한서켐</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Sucralfate</TD>
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">소화성궤양용제</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">389 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" HEIGHT="30">(주)세창인터내셔날</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="399" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,094 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="399" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">129,343 </TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100%</TD>
<TD WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;라. 주요 원재료 등의 가격변동추이</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">품목</TH>
<TH WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제19기</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제18기</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">Donepezil HCL</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">99,387,280 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">60,576,899 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">47,164,125 / KG</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">Ursodesoxycholic Acid</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">370,976 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">420,258 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">414,318 / KG</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">올메텍정</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">102 / TT</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">122 / TT</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">107 / TT</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">Mosapride Citrate Dihydrate</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">4,492,940 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">4,413,513 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">4,078,775 / KG</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">Cefodizime Sodium</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">600,000 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">600,000 / KG</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">Sucralfate</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">18,500 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">18,500 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">18,500 / KG</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">Erdosteine</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">198,248 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">200,722 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">207,349 / KG</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">Dioctahedral Smectite</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">23,303 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">18,040 / KG</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">20,481 / KG</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(1)산출기준&cr;- 단순평균가격&cr;&cr;(2)주요가격변동원인&cr;- 구매단가 변동 및 환율변동&cr;</P>

<P>
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B">한올바이오파마(주)</SPAN>
<SPAN></SPAN>
</P>
<P USERMARK=" 0X0000FF"></P>

<P>
<SPAN>가. 주요 제품 등의 현황</SPAN>
</P>

<TABLE WIDTH="686" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="677"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="686" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="689" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출유형</TH>
<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품   목</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구체적용도</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요상표등</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="10" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="300">의약품</TD>
<TD ROWSPAN="5" WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">제품</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">바이오탑</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">위장관용제</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">바이오탑캡슐</TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">5,804</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6.6%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">헤어그로정</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">탈모치료제</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">헤어그로정</TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,045</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4.6%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">알파본연질캡슐</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">비타민제</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">알파본연질캡슐</TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,619</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4.1%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">기  타</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">29,784</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">33.5%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소  계</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">43,252</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">48.8%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">상품</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">노르믹스정</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">항생제</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">노르믹스</TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">10,831</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">12.2%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">엘리가드 주</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">항암제</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">엘리가드 주</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,589</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8.6%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">하노마린연질캡슐</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">간장질환용제</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">하노마린연질캡슐</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,955</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.2%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">기  타</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-   </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">12,304</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">13.9%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소  계</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-　</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">32,679</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">36.9%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="555" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER"> 기타</TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">12,671</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">14.3%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="555" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계</TD>
<TD WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">88,602</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">100.0%</TD>
</TR>
</TBODY>
</TABLE>
<P>주] 당사가 생산하고 있는 의약품(전문의약품)의 경우 정부에서 가격을 통제하고 &cr;  있어 약가인하 등 특별한 사유가 없는 한 제품별로 급격한 가격의 변동 등은 없습     니다.&cr;</P>

<P>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK=" B">나. 주요 원재료 매입 현황</SPAN>
</P>

<TABLE WIDTH="632" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="623"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="632" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원,% )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="635" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="208"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="65"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입유형</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원재료명</TH>
<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구체적용도</TH>
<TH WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입액</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="7" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">의약품</TD>
<TD ROWSPAN="7" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">원재료</TD>
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Permethrin</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">피부질환용제</TD>
<TD WIDTH="80" ALIGN="RIGHT" HEIGHT="30">806</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">12.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Mupirocin</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">항생제</TD>
<TD WIDTH="80" ALIGN="RIGHT" HEIGHT="30">525</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">7.8%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Diosmin</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈관강화제</TD>
<TD WIDTH="80" ALIGN="RIGHT" HEIGHT="30">477</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">7.1%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Hypromellose(2208)</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내분비제</TD>
<TD WIDTH="80" ALIGN="RIGHT" HEIGHT="30">365</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">5.4%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Itraconazole</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">항진균제</TD>
<TD WIDTH="80" ALIGN="RIGHT" HEIGHT="30">244</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">3.6%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기  타</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="80" ALIGN="RIGHT" HEIGHT="30">4,320</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">64.1%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소  계</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="80" ALIGN="RIGHT" HEIGHT="30">6,737</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">다. 주요 원재료 등의 가격변동추이</SPAN>
</P>

<TABLE WIDTH="588" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="579"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="588" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="589" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원재료명</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 48기</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 47기</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 46기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Permethrin</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">1,535</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">1,489</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">1,403</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Mupirocin</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">1,500</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">1,500</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">1,425</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Diosmin</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">95</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">99</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">96</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Hypromellose(2208)</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">38</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">37</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">35</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Itraconazole</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">400</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">408</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">420</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주1] 총 구매 원재료금액을 1g기준으로 나누어 산출한 단순평균가격입니다.&cr;주2] 가격 주요 변동원인은 원재료비의 환율변동에 따른 가격변동 때문입니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" 0X0000FF B"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">3. 생산 및 설비에 관한 사항</SPAN>&cr;
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN USERMARK=" B">◆(주)대웅제약&cr;</SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
</P>
<P USERMARK=" B">가. 생산능력 및 생산능력의 산출근거</P>
<P>(1) 생산능력</P>

<TABLE WIDTH="634" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="625"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="634" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 :억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="634" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제형</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제19기</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제18기</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="143" VALIGN="MIDDLE" HEIGHT="270">의약품제조및 판매</TD>
<TD ROWSPAN="5" WIDTH="63" VALIGN="MIDDLE" HEIGHT="150">향남</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">정제/캡슐</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,665 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,807 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,770 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">생물학제제</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              93 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              62 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              58 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">액제</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              73 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            111 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            122 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            108 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            130 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            314 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">소계</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,940 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,110 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,264 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="63" VALIGN="MIDDLE" HEIGHT="90">오송</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">정제/캡슐</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,050 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,877 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,927 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">항암제</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            359 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            134 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                3 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">소계</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,408 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,010 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,930 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="156" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          4,348 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          4,120 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          4,194 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 생산능력의 산출근거</P>
<P> (가) 산출방법 등</P>
<P>  ① 산출기준</P>
<P>    - 생산능력: 근무일수  x 근무시간시 생산가능수량 및 금액&cr;  ② 산출방법</P>
<P>    - 생산실적/ 가동률&cr;  ③ 평균가동시간&cr;    - 1일 8시간, 1개월 20.3일, 1년 12개월 가동기준&cr;</P>
<P USERMARK=" B">나. 생산실적 및 가동률</P>
<P>(1) 생산실적</P>

<TABLE WIDTH="613" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="604"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="613" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 :억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="614" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제형</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제19기</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제18기</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="143" VALIGN="MIDDLE" HEIGHT="270">의약품제조및 판매</TD>
<TD ROWSPAN="5" WIDTH="63" VALIGN="MIDDLE" HEIGHT="150">향남</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">정제/캡슐</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,487 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,821 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,814 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">생물학제제</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            139 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              97 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              92 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">액제</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            110 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            173 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            194 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            162 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            203 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            499 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">소계</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,898 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          3,294 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          3,598 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="90" ROWSPAN="3">오송</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">정제/캡슐</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,818 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,342 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,351 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">항암제</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            318 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            167 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                2 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">소계</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,136 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          2,509 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,353 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="156" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          5,034 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          5,802 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          4,951 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기 가동률</P>

<TABLE WIDTH="437" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="428"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="437" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 억정)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="436" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제19기</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">운영캐파</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평균가동률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">향남공장</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               12.7 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">             8.5 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">오송공장</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               10.2 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            11.5 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">89%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">다. 생산설비의 현황 등</P>
<P>(1) 생산설비의 현황</P>

<TABLE WIDTH="906" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="596"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 토지]</TD>
<TD WIDTH="605" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="907" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">소유형태</TH>
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">소재지</TH>
<TH ROWSPAN="2" WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">구분</TH>
<TH ROWSPAN="2" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">기초장부가액 </TH>
<TH COLSPAN="2" WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당기증감 </TH>
<TH ROWSPAN="2" WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">당기상각</TH>
<TH ROWSPAN="2" WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">기말장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">증가</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">향남</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">화성향남</TD>
<TD WIDTH="50" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35.46</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35.46</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강남삼성</TD>
<TD WIDTH="50" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56.02</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56.02</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기도</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기가평</TD>
<TD WIDTH="50" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.32</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.32</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">동구가양</TD>
<TD WIDTH="50" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.31</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경남</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">창원도계</TD>
<TD WIDTH="50" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.44</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.44</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">충북</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">충북오송</TD>
<TD WIDTH="50" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">106.89</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">106.89</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강원</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강원평창</TD>
<TD WIDTH="50" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.29</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.29</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강서마곡</TD>
<TD WIDTH="50" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">296.57</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">296.57</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="283" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합                    계</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">498.30</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">498.30</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="912" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="602"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 건물]</TD>
<TD WIDTH="611" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="914" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">소유형태</TH>
<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">소재지</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">구분</TH>
<TH ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">기초장부가액 </TH>
<TH COLSPAN="2" WIDTH="233" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당기증감 </TH>
<TH ROWSPAN="2" WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">당기상각</TH>
<TH ROWSPAN="2" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">기말장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">증가</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">향남</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">화성향남</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">296.38</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12.92</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">283.46</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강남삼성</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34.34</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.02</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기도</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기가평</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.71</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.02</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.69</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">동구가양</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.82</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.05</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.77</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경남</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">창원도계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.18</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.06</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">용인</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">충북오송</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">658.18</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.68</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17.66</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">645.20</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강원</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강원평창</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.35</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.12</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.24</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">충북</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가보유</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기용인</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158.22</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.79</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152.43</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합                    계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,156.19</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.68</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37.65</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,123.22</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="806" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="496"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 구축물]</TD>
<TD WIDTH="505" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="805" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액</TH>
<TH COLSPAN="2" WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감 </TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상각</TH>
<TH ROWSPAN="2" WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">향남/오송</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">자가보유</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">충북/오송&cr;화성/향남</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">187.85</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">11.27</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">15.29</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">183.83</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">187.85</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11.27</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15.29</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">183.83</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="804" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="494"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 기계장치]</TD>
<TD WIDTH="503" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="806" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액 </TH>
<TH COLSPAN="2" WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감 </TH>
<TH ROWSPAN="2" WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상각</TH>
<TH ROWSPAN="2" WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">향남/오송</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">자가보유</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">충북/오송 화성/향남</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">954.07 </TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">61.67 </TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">0.04 </TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">146.09 </TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">869.60 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">954.07 </TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61.67 </TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.04 </TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">146.09 </TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">869.60 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="801" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="491"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 차량운반구]</TD>
<TD WIDTH="500" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="803" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액 </TH>
<TH COLSPAN="2" WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감 </TH>
<TH ROWSPAN="2" WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상각</TH>
<TH ROWSPAN="2" WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">향남/오송</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">자가보유</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">충북/오송&cr;화성/향남</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2.34</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">0.19</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">          -</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1.04</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1.49</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.34</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.19</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.04</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.49</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="799" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="489"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 공구기구]</TD>
<TD WIDTH="498" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="801" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액 </TH>
<TH COLSPAN="2" WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감 </TH>
<TH ROWSPAN="2" WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상각</TH>
<TH ROWSPAN="2" WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">향남/오송</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">자가보유</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">충북/오송&cr;화성/향남</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">14.90</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">8.55</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">7.09</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">16.36</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14.90</TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8.55</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.09</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16.36</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="798" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 비품]</TD>
<TD WIDTH="497" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="801" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액 </TH>
<TH COLSPAN="2" WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감 </TH>
<TH ROWSPAN="2" WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상각</TH>
<TH ROWSPAN="2" WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">향남/오송</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">자가보유</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">충북/오송&cr;화성/향남</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">　</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">72.05 </TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3.66 </TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">0.04 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">26.29 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">49.38 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72.05 </TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.66 </TD>
<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.04 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26.29 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49.38 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="805" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="495"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 기타유형자산]</TD>
<TD WIDTH="504" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="803" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액</TH>
<TH COLSPAN="2" WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH ROWSPAN="2" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;상각</TH>
<TH ROWSPAN="2" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">서울</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">자가보유</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">충북/오송&cr;화성/향남</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">　</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1.15</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1.66</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1.07</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1.74</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="299" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.15</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.66</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.07</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.74</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE WIDTH="800" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="490"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 건설중인자산]</TD>
<TD WIDTH="499" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 억원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="801" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액</TH>
<TH COLSPAN="2" WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH ROWSPAN="2" WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;상각</TH>
<TH ROWSPAN="2" WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" ALIGN="CENTER" HEIGHT="53">향남/오송&cr; 공장</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">자가보유</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">화성/향남&cr;충북오송</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">172.28</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">126.45</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">0.00</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">298.72</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="299" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">172.28</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">126.45</TD>
<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">298.72</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">라. 설비의 신설, 매입 계획 등&cr;</SPAN>(1) 신규 시설 투자&cr;- 투자대상: 마곡 C&D (connected collaboration & Development) 센터&cr;- 투자목적: R&D 파이프라인 기반조성을 위한 C&D 센터 구축&cr;- 투자예상금액: 705억원
</P>

<P>- 투자기간: 2019.05.31~2023.07.031&cr;* 투자금액과 투자기간은 향후 진행과정과 경영 환경에 따라 변동될수 있습니다.&cr;* 자세한 내용은 2019년 3월 6일 공시된 '신규 시설투자 등' 을 참고하시기 바랍니다. &cr;&cr;
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B">한올바이오파마</SPAN>
<SPAN USERMARK=" B">(주)&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK="F-16 B"></SPAN>
<SPAN USERMARK=" B">가. 생산능력 및 생산능력의 산출근거</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>(1) 생산능력 </SPAN>
</P>

<TABLE WIDTH="603" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="594"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="603" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : EA)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품 목</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 48기</TH>
<TH WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 47기</TH>
<TH WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 46기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">PO제</TD>
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">정제</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">302,400,000</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">297,600,000</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">295,200,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">캡슐제</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,800,000</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,200,000</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">98,400,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연고제</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,800,000</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,200,000</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,900,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">주사제</TD>
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">앰플제</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,894,644</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,578,856</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,420,962</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">바이알제</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,528,000</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,472,000</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,444,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수액제</TD>
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">병수액제</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,239,838</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,188,412</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,162,699</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계　</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">467,662,482</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">460,239,268</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">456,527,661</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 생산능력의 산출근거&cr;가) 산출방법 등&cr;① 산출기준&cr;생산라인별 공수 가동능력을 기준&cr;&cr;② 산출방법&cr;라인별 일 최대 생산가능수량 × 연간 작업일 수&cr;&cr;(나) 평균가동시간</P>

<TABLE BORDER="1" WIDTH="516" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일일</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">월간</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연간</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8시간</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">164시간</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2,016시간</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">나. 생산실적 및 가동률&cr;</SPAN>
<SPAN>(1) 생산실적 </SPAN>
</P>

<TABLE WIDTH="602" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="602" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 : EA )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품 목</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 48기</TH>
<TH WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 47기</TH>
<TH WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 46기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">PO제</TD>
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">정제</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">141,445,110</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">146,584,937</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,525,719</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">캡슐제</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,264,230</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,425,110</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,034,280</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연고제</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,955,450</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,343,500</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,213,450</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">주사제</TD>
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">앰플제</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,684,600</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,065,650</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,938,250</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">바이알제</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">419,425</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">352,875</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수액제</TD>
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">병수액제</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,608,190</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,705,193</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,573,899</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계　</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">228,957,580</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">224,543,815</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">223,638,473</TD>
</TR>
</TBODY>
</TABLE>
<P>※ 생산실적 금액은 당기제조원가명세서에 근거하여 작성함.&cr;&cr;(2) 당기의 가동률</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 시간,%)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="170"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소(사업부문)</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가동가능시간</TH>
<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실제가동시간</TH>
<TH WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평균가동률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">의약품</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,016 </TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,342 </TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">67%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" 0X0000FF B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">다. 생산설비의 현황 등&cr;</SPAN>
<SPAN>(1) 생산설비의 현황 </SPAN>
</P>

<TABLE WIDTH="770" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="461"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 토지]</TD>
<TD WIDTH="470" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="774" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="79"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유&cr;형태</TH>
<TH ROWSPAN="2" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분(㎡)</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초&cr;장부가액</TH>
<TH COLSPAN="2" WIDTH="169" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH ROWSPAN="2" WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;상각</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;장부가액</TH>
<TH ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고&cr;(공시지가)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공장</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">자가&cr;보유</TD>
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,645</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">1,373,677</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">1,373,677</TD>
<TD WIDTH="88" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6,663,475</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구소</TD>
<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">539</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">120,427</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">120,427</TD>
<TD WIDTH="88" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">269,250</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="280" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">1,494,104</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="62" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">1,494,104</TD>
<TD WIDTH="88" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6,932,725</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="767" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="458"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 건물]</TD>
<TD WIDTH="467" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="768" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="48"></COL>
<COL WIDTH="40"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유&cr;형태</TH>
<TH ROWSPAN="2" WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분(㎡)</TH>
<TH ROWSPAN="2" WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초&cr;장부가액</TH>
<TH COLSPAN="2" WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH ROWSPAN="2" WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;상각</TH>
<TH ROWSPAN="2" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;장부가액</TH>
<TH ROWSPAN="2" WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공장</TD>
<TD ROWSPAN="2" WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">자가&cr;보유</TD>
<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30">11,950</TD>
<TD WIDTH="91" ALIGN="RIGHT" HEIGHT="30">5,061,094</TD>
<TD WIDTH="90" ALIGN="RIGHT" HEIGHT="30">2,143,905</TD>
<TD WIDTH="83" ALIGN="RIGHT" HEIGHT="30">(15,770)</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">(430,892)</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">6,758,337</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구소</TD>
<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30">1,744</TD>
<TD WIDTH="91" ALIGN="RIGHT" HEIGHT="30">1,103,780</TD>
<TD WIDTH="90" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="83" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">(55,409)</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">1,048,371</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구소</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임차</TD>
<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수원</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30">703</TD>
<TD WIDTH="91" ALIGN="RIGHT" HEIGHT="30">58,754</TD>
<TD WIDTH="90" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="83" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">(7,500)</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">51,254</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="235" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="91" ALIGN="RIGHT" HEIGHT="30">6,223,628</TD>
<TD WIDTH="90" ALIGN="RIGHT" HEIGHT="30">2,143,905</TD>
<TD WIDTH="83" ALIGN="RIGHT" HEIGHT="30">(15,770)</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">(493,801)</TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">7,857,962</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="806" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="399"></COL>
<COL WIDTH="389"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="408" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 구축물]</TD>
<TD WIDTH="398" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="806" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="51"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초&cr;장부가액</TH>
<TH COLSPAN="2" WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;상각</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;장부가액</TH>
<TH ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공 장</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">폐수처리시설외</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">169,998</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">150,829</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30">(1)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">(20,133)</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">300,693</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="319" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">169,998</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">150,829</TD>
<TD WIDTH="71" ALIGN="RIGHT" HEIGHT="30">(1)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">(20,133)</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">300,693</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="993" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="684"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 기계장치 ]</TD>
<TD WIDTH="693" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="995" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="327"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액</TH>
<TH COLSPAN="2" WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH ROWSPAN="2" WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상각</TH>
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;장부가액</TH>
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="11" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="330">공장</TD>
<TD ROWSPAN="11" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="330">자가</TD>
<TD ROWSPAN="11" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="330">대전</TD>
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">키트 조립기</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">498,580</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(73,864)</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">424,716</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">키트 주사제라인 구축공사</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">411,919</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(61,025)</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">350,894</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">병수액열수멸균기</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">346,621</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(51,351)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">295,270</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">키트 백 충전기</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">294,469</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(43,625)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">250,844</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">공조기(10호,11호)</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">300,632</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(39,213)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">261,419</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">조립자재 자동이동레일</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">250,824</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(37,159)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">213,665</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">정제캡슐겸용 자동선별기</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">247,903</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(31,988)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">215,915</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">고형제 PTP 자동포장용 카토너</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">213,503</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(31,244)</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">182,259</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">병수액 로딩 장치</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">205,768</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(28,382)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">177,386</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">정제자동선별기(TVIS-NS2)</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">157,077</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(44,879)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">112,198</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="336" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기타</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">1,352,688</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">711,853</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">(15)</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(418,625)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">1,645,901</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="540" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">4,279,983</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">711,853</TD>
<TD WIDTH="74" ALIGN="RIGHT" HEIGHT="30">(15)</TD>
<TD WIDTH="76" ALIGN="RIGHT" HEIGHT="30">(861,355)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">4,130,466</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="720" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="388"></COL>
<COL WIDTH="314"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="397" VALIGN="BOTTOM" HEIGHT="30">[자산항목 :  차량운반구]</TD>
<TD WIDTH="323" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="721" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="52"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초&cr;장부가액</TH>
<TH COLSPAN="2" WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;상각</TH>
<TH ROWSPAN="2" WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;장부가액</TH>
<TH ROWSPAN="2" WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">승용</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="62" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="72" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공장</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">승합외</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">13,015</TD>
<TD WIDTH="62" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="72" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">(11,822)</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">1,193</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="267" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">13,016</TD>
<TD WIDTH="62" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="72" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">(11,822)</TD>
<TD WIDTH="95" ALIGN="RIGHT" HEIGHT="30">1,194</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="888" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="392"></COL>
<COL WIDTH="478"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="401" VALIGN="BOTTOM" HEIGHT="30">[자산항목 : 기타]</TD>
<TD WIDTH="487" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="890" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="38"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업소</TH>
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초&cr;장부가액</TH>
<TH COLSPAN="2" WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH ROWSPAN="2" WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;상각</TH>
<TH ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기&cr;장부가액</TH>
<TH ROWSPAN="2" WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>공장&cr;연구소등</P>
</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공구와기구</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30">81</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="88" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">81</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전, 서울</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">집기비품</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30">386,488</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">95,075</TD>
<TD WIDTH="88" ALIGN="RIGHT" HEIGHT="30">(112)</TD>
<TD WIDTH="106" ALIGN="RIGHT" HEIGHT="30">(184,680)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">296,771</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전, 수원</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시험기구</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30">948,050</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">155,720</TD>
<TD WIDTH="88" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" ALIGN="RIGHT" HEIGHT="30">(263,001)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">840,769</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="265" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="30">1,334,619</TD>
<TD WIDTH="94" ALIGN="RIGHT" HEIGHT="30">250,795</TD>
<TD WIDTH="88" ALIGN="RIGHT" HEIGHT="30">(112)</TD>
<TD WIDTH="106" ALIGN="RIGHT" HEIGHT="30">(447,681)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">1,137,621</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-16 0XFF0000 B">4. 매출에 관한 사항</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">◆(주)대웅제약&cr;</SPAN>&cr;가. 매출실적 (별도)
</P>

<TABLE WIDTH="689" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="680"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="689" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 :백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="685" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사업부문</TH>
<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">매출유형</TH>
<TH COLSPAN="2" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">품 목</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30"> 제 19기</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30"> 제 18기 </TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30"> 제 17기 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="30" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="900">의약품 &cr;제조 및 판매</TD>
<TD ROWSPAN="18" WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="540">제품</TD>
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">우루사&cr; (ETC, OTC)</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,253</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,992</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,324</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,455</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">81,810</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">79,525</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,708</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88,802</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">92,849</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">임팩타민</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,287</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,146</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,249</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,287</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,146</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,257</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">올메텍&cr;/올메텍PLUS</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,104</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,349</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,290</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,104</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,349</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,290</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">가스모틴군</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,296</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,941</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,915</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,296</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,941</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,915</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">다이아벡스</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,747</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,039</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,075</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,747</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,039</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,075</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">기타</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,070</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,494</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,381</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">236,790</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">294,063</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">295,161</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">274,860</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">339,557</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">326,542</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="12" WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="360">상품</TD>
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">크레스토</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,834</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,210</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,661</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,834</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,210</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,661</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">세비카&cr;/세비카HCT</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,110</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,172</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,066</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,110</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,172</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,066</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">넥시움</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,910</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,353</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,213</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,910</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,353</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,213</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">기타</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,287</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,196</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">235,342</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">204,366</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,363</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">237,629</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,561</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">204,398</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="295" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" COLSPAN="3">기타</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,178</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,090</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,955</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,255</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,267</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,051</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,255</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ROWSPAN="3" WIDTH="295" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">합 계</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,788</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88,777</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,749</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">899,964</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">916,403</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">846,774</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">944,752</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,005,180</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">943,522</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 판매경로 및 판매방법 등</P>
<P>(1) 판매조직</P>
<P>1) ETC 본부 : 서울 1~4사업부, 지방 1~4사업부, 입찰전략팀&cr;2) CH 본부 : CH 1~2사업부, CH일반유통팀&cr;</P>
<P>(2) 판매경로</P>
<P>1) 직거래유통 &cr;  ① 병원/의원&cr;  ② 약국&cr;2) 도매유통 &cr;  ① 병원/의원&cr;  ② 약국&cr;</P>
<P>(3) 판매방법 및 조건&cr;1) 판매방법</P>
<P>① 판매방법 : 약국, 의원, 병원은 영업사원을 통한 직접판매의 방식을 취하고 있음.&cr;* 약국의 경우는 대부분이 온라인쇼핑몰을 통해 매출이 이루어지고 있음&cr;② 간접판매 : 병원의 경우는 영업사원을 통한 제품 홍보와 도매상을 통한 간접판매로 매출이 이루어지고 있음.&cr;&cr;2) 판매조건&cr;① 대금결제는 현금, 카드, 어음으로 이루어짐&cr;② 유통별로 대금회수기간은 다소 차이가 있으며, 전사 회전기간은 평균 30일 이내임.&cr;</P>
<P>(4) 판매전략</P>

<P> 영업사원에 대한 Detail 능력향상, 제품차별화 Point, 선진 마케팅기법 주기별 교육실시 등을 통해 판매를 강화시키고 있음&cr;
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">◆한올바이오파마(주)&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">가. 매출실적</SPAN>
</P>

<TABLE WIDTH="708" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="699"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="708" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 :백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="710" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="65"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출유형</TH>
<TH COLSPAN="2" WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품 목</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 48기</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 47기</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 46기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="21" WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="722">의약품</TD>
<TD ROWSPAN="9" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="316">제품</TD>
<TD ROWSPAN="3" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">바이오탑</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">5,804</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">5,273</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">3,071</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">5,804</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">5,273</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">3,071</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">기  타</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">수 출</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="53">-</TD>

<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="53">
<P>268 </P>
<P>($226,468)</P>
</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="53">131</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">37,448</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">51,294</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">49,494</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">37,448</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">51,562</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">49,625</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">소계</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">수 출</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="53">-</TD>

<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="53">
<P>268 </P>
<P>($226,468)</P>
</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="53">131&cr;-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">43,252</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">56,567</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">52,565</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">43,252</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">56,835</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">52,696</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="316">상품</TD>
<TD ROWSPAN="3" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">노르믹스</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">10,831</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">12,488 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">10,529</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">10,831</TD>
<TD WIDTH="139" ALIGN="RIGHT" HEIGHT="30">12,488 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">10,529</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">기  타</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">수 출</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>144</P>
<P>($121,882)</P>
</TD>

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>52</P>
<P>($43,356)</P>
</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">285&cr;($277,221)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">21,704</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,366</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">19,460</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">21,848</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,418</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">19,745</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">소계</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">수 출</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>144</P>
<P>($121,882)</P>
</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">52&cr;($43,356)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">285&cr;($277,221)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">32,535</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,854</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">29,989</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">32,679</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,906</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">30,274</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="3" WIDTH="175" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">기타</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">12,671</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,711</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">8,869</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">12,671</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,711</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">8,869</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ROWSPAN="3" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">합 계</TD>
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">수 출</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>144</P>
<P>($121,882)</P>
</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">320 &cr;($269,824)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">416 &cr;($277,221)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">88,458</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">108,132</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">91,423</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="47" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">88,602</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">108,452</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">91,839</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">나. 판매경로 및 판매방법 등&cr;</SPAN>
<SPAN>(1) 판매조직&cr;Ⅱ. 사업의 내용중  나.회사의 현황  3) 조직도 참조&cr;</SPAN>
</P>
<P>(2) 판매경로</P>
<P>당사의 의약품은 병원용 및 약국용으로 분류되며, 전국의 병,의원 및 약국과 거래를</P>
<P>하고 있으며 판매경로는 다음과 같습니다.&cr;간납 : 제조원 → 약품도매상 → 병원(약국) → 소비자&cr;직납 : 제조원 → 병원(약국) → 소비자 &cr;</P>
<P>(3) 판매방법 및 조건</P>
<P>거래관행상 병원, 의원, 약국, 도매상에 현금, 신용카드 및 어음 판매가 이루어지고   있습니다.&cr;</P>
<P>(4) 판매전략</P>
<P>당사는 병의원의 전문치료제가 주력품목으로 대중매체에 의한 광고는 불가하나 의약전문지 등을 통한 광고 및 세미나를 실시하고 있으며 인터넷을 통한 의사들과의 커뮤니티를 형성하여 인터넷을 통한 의약정보등 다양한 서비스 제공을 통하여 고객관리를 시행하고 있습니다.&cr;마케팅 전략은 부가가치가 높은 마진품목의 판매에 중점을 두어 이익극대화를 도모하고 있고 특히 의약분업시대에 대응하기 위해 제품력이 뛰어난 우수의약품의 개발에 전력을 다하고 있습니다. &cr;</P>

<P>
<SPAN USERMARK="F-16 0X1814FF B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">5. 시장위험과 위험관리</SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN>(1) 금융위험관리 &cr;연결실체는 여러 활동으로 인하여 시장위험(외환위험, 가격위험, 현금흐름 및 공정가치 이자율 위험), 신용위험 및 유동성위험과 같은 다양한 금융위험에 노출되어 있습니다. 연결실체의 전반적인 위험관리는 연결실체의 재무성과에 잠재적으로 불리할 수 있는 효과를 최소화하는데 중점을 두고 있습니다. &cr;&cr;위험관리는 이사회에서 승인한 정책에 따라 중앙 자금부서(연결실체 재무팀)에 의해 이루어지고 있습니다. 연결실체의 재무팀은 영업부서들과 긴밀히 협력하여 금융위험을 식별, 평가 및 회피하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>가. 시장위험 &cr;</SPAN>
<SPAN>① 외환위험&cr;연결실체의 외환위험은 주로 인식된 자산과 부채의 환율변동과 관련하여 발생하고 있습니다. 연결실체의 영업거래 및 자본거래 상 외환위험에 대한 회피가 필요하다고 판단되는 경우 통화선도거래 등을 통해 외환위험을 관리하고 있습니다. 외환위험은 미래예상거래 및 인식된 자산ㆍ부채가 기능통화 외의 통화로 표시될 때 발생하고 있습니다. &cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>당기말과 전기말 현재 연결실체가 보유하고 있는 외화표시 화폐성자산 및 화폐성부채의 장부금액은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="669" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="176"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="669" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="185" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="242" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="242" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">자산</TH>
<TH WIDTH="121" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">부채</TH>
<TH WIDTH="121" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">자산</TH>
<TH WIDTH="121" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30">USD</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">102,307,565 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">9,098,372 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">47,769,894 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">12,114,640 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30">JPY</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">68,160 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">4,330,197 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">11,992,605 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">2,086,098 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30">기타통화</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">3,986,258 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">4,275,663 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">7,002,500 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">5,243,904 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>당기말과 전기말 현재 장부통화인 원화에 대한 환율이 10% 상승하는 경우 법인세비용 차감전 손익에 미치는 효과는 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="668" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="181"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="668" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="190" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="240" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="238" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10%상승시</TH>
<TH WIDTH="120" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10%하락시</TH>
<TH WIDTH="119" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10%상승시</TH>
<TH WIDTH="119" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10%하락시</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="30">USD </TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">9,320,919 </TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">(9,320,919)</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">3,565,525 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(3,565,525)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="30">JPY </TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">(426,204)</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">426,204 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">990,651 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(990,651)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="30">기타통화</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">(28,940)</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">28,940 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">175,860 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(175,860)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>② 가격위험&cr;연결실체는 기타포괄손익-공정가치측정 금융자산에서 발생하는 가격변동위험에 노출되어 있습니다. 당기말 현재 공정가치로 평가하는 기타포괄손익-공정가치측정 금융자산은</SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>58,573,590천</SPAN>
<SPAN>원으로, 다른 변수가 일정하고 지분상품의 가격이 10% 증가 및 감소할 경우 가</SPAN>
<SPAN>격변동이 자본에 미치는영향은</SPAN>
<SPAN> </SPAN>
<SPAN>4,439,878천원(</SPAN>
<SPAN>법인세효과 고려 후)입니다. 당기말 공정가치로 평가하는 당기손익-공정가치측정 금융상품은 </SPAN>
<SPAN>75,342,100</SPAN>
<SPAN>천원으로 다른 변수가 일정하고 지분상품의 가격이 10% 증가 및 감소할 경우 가격변동이 손익에 미치는 영향은 </SPAN>
<SPAN>5,710,931</SPAN>
<SPAN>천원(법인세효과 고려 후)입니다. &cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>③ 이자율 위험&cr;연결실체는 차입금과 관련하여 이자율변동위험에 노출되어 있습니다. 연결실체의 경영진은 시장이자율의 변동으로 인하여 금융상품의 공정가치 또는 미래현금흐름이 변동할 위험을 정기적으로 측정하고 있습니다. 한편, 당기말 현재 연결실체의 변동이자율을 적용받는 이자부부채의 규모를 고려할 때 이자율변동이 금융부채의 공정가치 또는 미래현금흐름에 미치는 영향은 중요하지 아니합니다.</P>
<P></P>
<PGBRK></PGBRK>

<P USERMARK=" B">
<SPAN USERMARK=" !B">나. 신용위험 &cr;신용위험은 거래 상대방이 금융상품이나 고객계약에 따른 의무를 이행하지 못하여 재정적 손실을 초래할 수 있는 위험입니다. 연결실체는 영업활동(주로 매출 채권)과 은행 및 금융기관 예금, 외환 거래 및 기타 금융 상품을 포함한 금융활동으로부터 신용 위험에 노출되어 있습니다.&cr;</SPAN>
<SPAN USERMARK=" !B"></SPAN>
</P>

<P>
<SPAN>매출채권 및 계약자산&cr;고객신용위험은 고객신용위험 관리와 관련된 연결실체의 확립 된 정책, 절차 및 통제를 조건으로 하여 각 사업단위에 의해 관리됩니다. 고객의 신용도는 광범위한 신용등급평점표를 기준으로 평가되며 개별 신용한도는 이 평가에 따라 정의됩니다. &cr;손상보고는 예상되는 신용 손실을 측정하기 위해 충당금을 사용하여 보고기간종료일에 수행됩니다. 충당금율은 유사한 손실 패턴(즉, 고객 유형 및 등급, 신용장 또는 다른 형태의 신용 보험 적용 범위)에 따라 다양한 고객 세그먼트를 그룹화하여 만기일을 기준으로합니다. 이 계산은 확률 가중 결과, 시간 가치 및 미래의 경제 상황에 대한 과거 사건, 현재 상황 및 예측에 대해보고 일에 합리적이고 지원 가능한 정보를 반영합니다. &cr;&cr;금융상품 및 현금 예금&cr;은행 및 금융기관과의 잔액에 대한 신용위험은 당사의 재무 정책에 따라 재무부서가 관리합니다. 연결실체는 은행 및 금융기관의 경우, 독립적인 신용등급기관으로부터의 신용등급이 최소 A이상인 경우에 한하여 거래를 하고있습니다. &cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>금융자산의 장부금액은 신용위험에 대한 최대노출정도를 나타냅니다. 보고기간종료일 현재 연결실체의 신용위험에 대한 최대 노출정도는 다음과 같으며, 매출채권 및 기타채권의 연령은 주석7에서 설명하고 있습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="621" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">72,114,590 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">31,770,159 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">매출채권</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">137,409,378 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">183,521,850 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">기타채권</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">31,257,135 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">38,526,617 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">단기금융자산</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">104,820,752 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">장기매출채권</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">800,018 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">278,881 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">장기기타채권</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">4,309,303 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">5,866,552 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">장기금융자산</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">79,548 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">689,548 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">350,790,724 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">358,390,569 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>다. 유동성위험 &cr;신중한 유동성위험 관리는 충분한 현금 및 시장성 있는 유가증권의 유지, 적절하게 약정된 신용한도금액으로부터의 자금 여력 및 시장포지션을 결제할 수 있는 능력 등을 포함하고 있습니다. 활발한 영업활동을 통해 연결실체의 재무팀은 신용한도 내에서 자금여력을 탄력적으로 유지하고 있습니다. &cr;</P>
<P>당기말 현재 비파생금융부채의 잔존계약만기에 따른 만기분석은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="645" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="645" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="145" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">1년 이하</TH>
<TH WIDTH="147" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">1년 초과</TH>
<TH WIDTH="146" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">차입금 및 사채</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30">147,052,620 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">291,524,819 </TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">438,577,439 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">매입채무 및 기타채무</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30">132,747,743 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">10,172,469 </TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">142,920,212 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">리스부채</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30">1,194,921 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">10,363,667 </TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">11,558,588 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30">280,995,284 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">312,060,955 </TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">593,056,239 </TD>
</TR>
</TBODY>
</TABLE>
<P>상기 만기분석은 할인하지 않은 현금흐름을 기초로 연결실체가 지급하여야 하는 가장 빠른 만기일에 근거하여 작성되었습니다.&cr;</P>
<P>(2) 자본 위험 관리&cr;연결실체의 자본관리 목적은 계속기업으로서 주주 및 이해당사자들에게 이익을 지속적으로 제공할 수 있는 능력을 보호하고 자본비용을 절감하기 위해 최적 자본구조를 유지하는 것입니다. 자본구조의 유지 또는 조정을 위하여 연결실체는 주주에게 지급되는 배당을 조정하거나 주주에 자본금을 반환하며, 부채감소를 위한 신주 발행 및 자산 매각 등을 실시하고 있습니다. </P>
<P></P>
<P>연결실체는 자본조달비율에 기초하여 자본을 관리하고 있습니다. 자본조달비율은 순차입금을 총자본으로 나누어 산출하고 있습니다. 순차입금은 차입금총계(연결재무상태표에 표시된 것)에서 현금및현금성자산을 차감한 금액이며, 총자본은 연결재무상태표의 '자본'에 순차입금을 가산한 금액입니다. </P>
<P></P>
<P>당기말과 전기말 현재 자본조달비율은 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="625" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">차입금총계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">438,577,439 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">389,414,842 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">차감: 현금및현금성자산</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(72,299,250)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(32,094,194)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">순차입금(A)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">366,278,189 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">357,320,648 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">자본총계(B)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">695,248,617 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">635,920,094 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">총자본(C = A + B)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,061,526,806 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">993,240,742 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">자본조달비율(A / C)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">34.50%</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">35.98%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 재무활동에서 생기는 부채의 변동&cr;연결실체의 당기 중 재무활동에서 생기는 부채의 변동은 아래와 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="795" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규리스</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무활동&cr;현금흐름</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화환산</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">9,414,842 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">139,289,950 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(127,353)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">148,577,439 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">379,117,453 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(90,000,000)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">448,965 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">289,566,418 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">리스부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,398,141 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,634,414 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(1,701,811)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">213,460 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">2,412 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">7,546,616 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">392,930,436 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,634,414 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">47,588,139 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">662,425 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(124,941)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">445,690,473 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="795" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규리스</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무활동&cr;현금흐름</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화환산</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">7,498,978 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">1,856,700 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">59,164 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">9,414,842 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">379,350,662 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(233,209)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">379,117,453 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">리스부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">5,610,412 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(1,324,334)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">90,644 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">21,419 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">4,398,141 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">386,849,640 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">5,610,412 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">532,366 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(142,565)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">80,583 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">392,930,436 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">6. 파생상품 등 풋백옵션 등 거래현황&cr;</SPAN>
<SPAN USERMARK="F-14 B"></SPAN>&cr;- 해당사항 없음&cr;
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK="F-14 0XFF0000 B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">7. 경영상의 주요계약 등</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">◆ (주)대웅제약&cr;&cr;</SPAN>
<SPAN USERMARK=" B">가. 나보타 글로벌 계약</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE BORDER="1" WIDTH="671" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="185"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="161"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>품목</P>
</TH>

<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>계약상대방</P>
</TH>

<TH WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>대상지역</P>
</TH>

<TH WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>계약체결일</P>
</TH>

<TH WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>총계약규모</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>나보타</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Evolus</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>US, EU, Australia, Canada, Russia, CIS, South Africa</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2013-09-30</P>
</TD>

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>289,792,500 USD</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>나보타 </P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Probiomed</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Mexico</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2015-03-06</P>
</TD>

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>10,010,000 USD</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>나보타 </P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Moksha8</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Brazil</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018-01-31</P>
</TD>

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>16,794,500 USD</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>*계약규모 등을 고려하여 주요 계약 위주로 기재하였습니다. &cr;</P>
<P>(1) 품목 : 나보타 (계약상대방 : Evolus)</P>

<TABLE BORDER="1" WIDTH="656" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="526"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>Evolus</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약내용</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>나보타에 대한 허가, 수입, 판매, 마케팅, 상업화에 관련된 독점 권리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>US, EU, Australia, Canada, Russia, CIS, South Africa</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2013-09-30</P>
<P>계약기간 : 제품 출시 후 5년 (자동연장 O)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>총계약금액</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>289,792,500 USD</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약조건</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>비공개</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>대상기술</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>Prabotulinumtoxin A (Botulinum toxin type A, 900kDa)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="76">
<P>개발진행경과</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="76">US, 캐나다 :  발매&cr;
<SPAN></SPAN>
<SPAN>EU : 품목허가 승인완료&cr;</SPAN>이외국가 : 허가중
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>기타사항</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P> (2) 품목 : 나보타 (계약상대방 : Probiomed)</P>

<TABLE BORDER="1" WIDTH="656" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="526"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>Probiomed</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약내용</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>나보타에 대한 허가, 수입, 판매, 마케팅, 상업화에 관련된 독점 권리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>Mexico</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2015-03-06</P>
<P>계약기간 : 제품 출시 후 5년 (자동연장 O)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>총계약금액</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>10,010,000 USD</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약조건</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>비공개</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>대상기술</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>Prabotulinumtoxin A (Botulinum toxin type A, 900kDa)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>개발진행경과</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>판매중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>기타사항</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"> </P>
<P>(3) 품목 : 나보타 (계약상대방 : Moksha 8)</P>

<TABLE BORDER="1" WIDTH="656" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="526"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>Moksha 8</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약내용</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>나보타에 대한 허가, 수입, 판매, 마케팅, 상업화에 관련된 독점 권리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>Brazil</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2018-01-31</P>
<P>계약기간 : 가격 등재 후 5년 (자동연장 O)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>총계약금액</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>16,794,500 USD</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>계약조건</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>비공개</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>대상기술</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>Prabotulinumtoxin A (Botulinum toxin type A, 900kDa)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>개발진행경과</P>
</TD>
<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">판매중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">
<P>기타사항</P>
</TD>

<TD WIDTH="535" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF B"></SPAN>
<SPAN USERMARK=" B">나. 주요 공동개발</SPAN>
</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="781">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="296"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">품목</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">계약상대방</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="305" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대상지역</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">계약체결일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">진행단계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE">HL036</TD>
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="305" HEIGHT="53" VALIGN="MIDDLE">공동연구개발&cr;(전세계 사업권 공동 소유)</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE"> 2016.03</TD>
<TD WIDTH="140" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">미국 임상3-1상 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE">HL186/187</TD>
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="305" HEIGHT="53" VALIGN="MIDDLE">공동연구개발&cr;(연구개발결과물 및 지식재산권 공동 소유)</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2016.09</TD>
<TD WIDTH="140" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">후보물질도출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE">DWRX2003</TD>
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE">대웅테라퓨틱스</TD>
<TD WIDTH="305" HEIGHT="53" VALIGN="MIDDLE">공동연구개발</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2020.05</TD>
<TD WIDTH="140" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">임상1상 &cr;(한국, 인도, 호주)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(1) 품목: HL036 (성분명: tanfanercept)</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="614" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="506"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약상대방</TD>
<TD WIDTH="515" HEIGHT="30">한올바이오파마(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약내용</TD>
<TD WIDTH="515" HEIGHT="30">안구건조증치료 바이오신약 HL036의 전세계 사업권 공동소유</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="99">계약조건</TD>
<TD WIDTH="515" HEIGHT="99">1. 한국 임상1상 IND 승인 이후 투자되는 연구개발비를 50:50으로 부담&cr;2. 공동연구결과물에 대한 특허는 양사 공동 소유&cr;3. 제3자에게 라이센싱 아웃하여 받게되는 기술료 및 로열티 등의 수익은 양 당사자가 50:50으로 배분</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">대상기술</TD>
<TD WIDTH="515" HEIGHT="30">안구건조증치료 바이오신약 HL036</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="191">개발진행경과</TD>

<TD WIDTH="515" HEIGHT="191">
<P>- 2017년 9월: Harbour BioMed와 중국지역 라이선스 아웃 계약</P>
<P>- 2018년 10월: 임상2상 시험 결과 발표 (OIS학회, 미국 시카고)</P>
<P>- 2019년 4월: 임상2상 시험 결과 포스터발표 (ARVO 2019, 캐나다 벤쿠버)</P>
<P>- 2019년 10월: 임상2상 시험 결과 발표 (AAO 2019, 미국 샌프란시스코)</P>
<P>- 2019년 10월: 중국 임상 2상 완료</P>
<P>- 2019년 임상3-1상 진행 (미국)&cr;- 2020년 상반기: 임상3-1상 완료 (미국)&cr;- 2020년 11월: 안과학회(AAO 2020)에서 3-1상 결과 발표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" HEIGHT="30">
<P>향후계획</P>
</TD>

<TD WIDTH="515" HEIGHT="30">
<P>- 2021년 임상3-2상 개시</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" HEIGHT="30">
<P>시장규모</P>
</TD>

<TD WIDTH="515" HEIGHT="30">
<P>- 2018년 전세계 약 4조원 (출처: Research and Markets  2019)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" HEIGHT="30">
<P>기타사항</P>
</TD>
<TD WIDTH="515" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(2) 품목: HL186/187</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="506"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약상대방</TD>
<TD WIDTH="515" HEIGHT="30">한올바이오파마(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약내용</TD>
<TD WIDTH="515" HEIGHT="30">면역항암항체 신약개발 공동연구개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="145">계약조건</TD>

<TD WIDTH="515" HEIGHT="145">
<P>1. 공동연구개발과 관련된 모든 연구개발비를 50:50으로 부담&cr;2. 공동연구개발의 연구 개발 결과물(정보, 노하우, 기술, 물질 등 유무형 산물을 포함) 및 이에 대한 지식재산권(국내외, 해외출원 불문)은 양 당사자가 공동 소유&cr;3. 공동연구개발의 연구 개발 결과물 및 이에 대한 지식재산권으로 인한 수익은 양 당사자가 50:50으로 배분</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">대상기술</TD>
<TD WIDTH="515" HEIGHT="30">면역항암항체 바이오신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">개발진행경과</TD>
<TD WIDTH="515" HEIGHT="30">Candidate 항체 도출을 위한 동물 모델 효능평가 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" HEIGHT="30">
<P>향후계획</P>
</TD>

<TD WIDTH="515" HEIGHT="30">
<P>2021년 상반기 Candidate 항체 도출 후 전임상 착수</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" HEIGHT="30">
<P>시장규모</P>
</TD>

<TD WIDTH="515" HEIGHT="30">
<P>2015년 전세계 20조원 시장 (출처: GBI리서치)  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" HEIGHT="30">
<P>기타사항</P>
</TD>
<TD WIDTH="515" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN>(3) 품목: DWRX</SPAN>
<SPAN>2003</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="506"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약상대방</TD>
<TD WIDTH="515" HEIGHT="30">대웅테라퓨틱스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약내용</TD>
<TD WIDTH="515" HEIGHT="30">COVID19 치료제 공동연구개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="99">계약조건</TD>
<TD WIDTH="515" HEIGHT="99">1. 공동연구개발과 관련된 모든 연구개발비를 50:50으로 부담&cr; 2. 공동연구결과물에 대한 특허는 양사 공동 소유&cr; 3. 제3자에게 라이센싱 아웃하여 받게 되는 기술료 및 로열티 등의 수익은 양 당사자가 50:50으로 배분</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="53">대상기술</TD>
<TD WIDTH="515" HEIGHT="53">Main 기전을 통한 COVID19 바이러스의 저해 외에 추가 기전을 통한 COVID19 증상개선도 가능, one shot으로 치료 가능한 depot 제제 COVID19 치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">개발진행경과</TD>
<TD WIDTH="515" HEIGHT="30">임상1상 진행중 (인도, 한국, 호주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">기타사항</TD>
<TD WIDTH="515" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" 0X1814FF B"></SPAN>
</P>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK=" 0X1814FF B"></SPAN>
<SPAN USERMARK=" B">다. 주요 라이선스인 (License-in) 계약</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="661">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제품명</TH>
<TH WIDTH="108" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제품유형</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">질환분야</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">개발단계</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대상기관명</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계약시점</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="76">DWP305401</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="108" HEIGHT="76">펩타이드 신약</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="109" HEIGHT="76">궤양성 대장염</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="102" HEIGHT="76">임상 2상</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="138" HEIGHT="76">브릿지바이오테라퓨틱스주식회사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="84" HEIGHT="76">2018.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="53">Enavogliflozin</TD>

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="108" HEIGHT="53">
<P>합성 신약</P>
</TD>

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="109" HEIGHT="53">
<P>제2형 당뇨병</P>
</TD>

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="102" HEIGHT="53">
<P>임상 3상</P>
</TD>

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="138" HEIGHT="53">
<P>㈜녹십자</P>
</TD>

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="84" HEIGHT="53">
<P>2016.05</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>(1) 품목 : DWP305401</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="500"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">계약상대방</TD>
<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">브릿지바이오타레퓨틱스(주) (한국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="53">계약내용</TD>
<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="53">대웅제약은 한국, 중국, 일본과 동남아시아를 포함한 총 22개 지역에서 BBT-401의 허가 및 사업권리와 함께 전세계 독점 생산/공급권을 확보함.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">대상지역</TD>
<TD VALIGN="MIDDLE" WIDTH="509" HEIGHT="30">한국, 중국, 일본 및 동남아시아 포함 총 22개 지역</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="53">계약기간</TD>
<TD VALIGN="MIDDLE" WIDTH="509" HEIGHT="53">계약체결일: 2018. 12. 18.&cr;계약종료일: 비공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">총계약금액</TD>
<TD VALIGN="MIDDLE" WIDTH="509" HEIGHT="30">미화 4천만 달러</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">지급금액</TD>
<TD VALIGN="MIDDLE" WIDTH="509" HEIGHT="30">양사 합의에 의해 계약규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">계약조건</TD>
<TD VALIGN="MIDDLE" WIDTH="509" HEIGHT="30">양사 합의에 의해 계약규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">회계처리방법</TD>
<TD VALIGN="MIDDLE" WIDTH="509" HEIGHT="30">무형자산(독점판매권)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="99">대상기술</TD>
<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="99">DWP305401은 인체의 면역기능에 관여하는 단백질 '펠리노-1 (Pellino-1)'의 기능을 조절하는 최초의 펠리노-1 저해제로서, 계열 최초 신약 (First-in-Class) 후보물질로 주목받고 있으며, 2018년 10월 미국 임상 1상을 성공적으로 완료, 임상 2상시험을 수행중임.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">개발진행경과</TD>
<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">현재 미국 임상 2상 진행 중, 중국 임상 1상 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">기타사항</TD>
<TD VALIGN="MIDDLE" WIDTH="509" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN>(2) 품목 : Enavogliflozin</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="506"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">계약상대방</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">㈜녹십자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="53" VALIGN="MIDDLE">계약내용</TD>
<TD WIDTH="515" HEIGHT="53" VALIGN="MIDDLE">대웅제약은 전세계를 대상으로 SGLT-2 inhibitor 에 대한 전용실시권을 확보함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">대상지역</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">전세계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">계약기간</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">비공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">총계약금액</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">양사 합의에 의해 계약규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">지급금액</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">양사 합의에 의해 계약규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">계약조건</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">양사 합의에 의해 계약규모 미공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">회계처리방법</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">대상기술</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">SGLT-2 inhibitor 에 대한 전용실시권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">개발진행경과</TD>
<TD WIDTH="515" HEIGHT="30" VALIGN="MIDDLE">임상 3상 단독, 병용 승인 (한국, 2020.09)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="53" VALIGN="MIDDLE">기타사항</TD>
<TD WIDTH="515" HEIGHT="53" VALIGN="MIDDLE">2020 ICDM(2020 International Congress of Diabetes and Metabolism) 임상 2상 결과 발표</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">라. </SPAN>
<SPAN USERMARK=" B">주요 공</SPAN>
<SPAN USERMARK=" B">급계약</SPAN>
</P>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="86"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="159"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제품명</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약상대방</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대상지역</TH>
<TH WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약규모</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약시점</TH>
<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약의 목적 및 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">Fexuprazan</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">Moksha8</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">멕시코</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">$50,000,000 </TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.01</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">현지 허가권, 판매권리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">Fexuprazan</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EMS</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">브라질</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">$73,000,000 </TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.08</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">현지 허가권, 판매권리</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(1) 품목 : Fexuprazan</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="137"></COL>
<COL WIDTH="474"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">품목명</TD>
<TD WIDTH="483" VALIGN="MIDDLE" HEIGHT="30">Fexuprazan</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="146" HEIGHT="30">계약상대방</TD>
<TD WIDTH="483" VALIGN="MIDDLE" HEIGHT="30">Moksha8 (멕시코)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="146" HEIGHT="30">대상지역</TD>
<TD VALIGN="MIDDLE" WIDTH="483" HEIGHT="30">멕시코</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="146" HEIGHT="30">계약체결일자</TD>
<TD VALIGN="MIDDLE" WIDTH="483" HEIGHT="30">2020.01.22</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="146" HEIGHT="30">계약종료일</TD>
<TD VALIGN="MIDDLE" WIDTH="483" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="146" HEIGHT="30">계약금액</TD>
<TD VALIGN="MIDDLE" WIDTH="483" HEIGHT="30">$50,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="146" HEIGHT="30">계약의 목적 및 내용</TD>
<TD VALIGN="MIDDLE" WIDTH="483" HEIGHT="30">현지 허가권, 판매권리</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(2) 품목 : Fexuprazan</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="472"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="148" VALIGN="MIDDLE" HEIGHT="30">품목명</TD>
<TD WIDTH="481" VALIGN="MIDDLE" HEIGHT="30">Fexuprazan</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="148" HEIGHT="30">계약상대방</TD>
<TD WIDTH="481" VALIGN="MIDDLE" HEIGHT="30">EMS (브라질)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="148" HEIGHT="30">대상지역</TD>
<TD VALIGN="MIDDLE" WIDTH="481" HEIGHT="30">브라질</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="148" HEIGHT="30">계약체결일자</TD>
<TD VALIGN="MIDDLE" WIDTH="481" HEIGHT="30">2020.08.14</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="148" HEIGHT="30">계약종료일</TD>
<TD VALIGN="MIDDLE" WIDTH="481" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="148" HEIGHT="30">계약금액</TD>
<TD VALIGN="MIDDLE" WIDTH="481" HEIGHT="30">$73,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="148" HEIGHT="30">계약의 목적 및 내용</TD>
<TD VALIGN="MIDDLE" WIDTH="481" HEIGHT="30">현지 허가권, 판매권리</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">마. 주요 판매계약</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="867">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="333"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="61"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">품목</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">계약처</TH>
<TH WIDTH="342" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">계약내용</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">대상지역</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">계약일</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="28" VALIGN="MIDDLE" WIDTH="93" HEIGHT="776" ALIGN="CENTER" USERMARK="F-9">라이선스</TD>
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">티로파</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Rotta</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">티로파 독점 라이센스 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1986.01.02</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">스멕타</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Ipsen</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">스멕타 라이센스</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1990.09.24</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">타나칸</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Ipsen</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">타나칸 라이센스</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1990.09.24</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">에어탈</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Almirall</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">에어탈 반독점 라이센스 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1993.05.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">엘도스</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Recipharm</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">엘도스 허가, 생산, 판매에 관한 독점권 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1994.03.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">아리셉트</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Eisai</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">아리셉트정 및 아리셉트 에비스정의 위수탁 생산(5,10mg)</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1999.03.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">가스모틴</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">SDP</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">가스모틴 독점 원료 및 제조 권한 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1999.04.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">올메텍/플러스</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">DS</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">올메텍/올메텍플러스 독점 license-in</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2002.09.02</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">아사콜, 엔토코트</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Tillotts</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">아사콜 / 엔토코트 독점적 수입, 판매, 배급권 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2003.09.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">마트리펜</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Takeda</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">마트리펜 공급 유통 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2006.12.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">피블라스트</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Kaken</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">피블라스트 스프레이 국내 허가 및 판매 독점권 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2006.12.26</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="47" USERMARK="F-9">아리셉트</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="47" USERMARK="F-9">Eisai</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="47" USERMARK="F-9">아리셉트정 및 아리셉트 에비스정의 위수탁 생산&cr;(에비스 5, 10mg 추가)</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2007.12.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">T-UDCA</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Bruschettini</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">T-UDCA 독점 라이센스 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2008.03.24</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">스카센스</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Biomed Sciences</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">스카센스 한국 내 독점적 라이센스&공급 유통 권리 부여 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2008.07.09</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">에플리가</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Supernus</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">에플리가 독점 라이센스 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2009.11.25</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">Lamaston</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Sato</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">Lamaston MX2 Gel & Liquid 독점 라이센스 (기술 도입) </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2010.02.02</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">Purastat</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">3D Matrix</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">Purastat 국내 독점 유통, 마케팅 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2010.09.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">아리셉트</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Eisai</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">아리셉트정 및 아리셉트 에비스정의 위수탁 생산(23mg 추가)</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2010.11.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">리필펜</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Ethypharm </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">리필펜캡슐의 국내 독점 라이센스 계약 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2010.12.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">Glufosfamide</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Eleison</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">Glufosfamide 국내 독점 & 개발 라이선스</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2011.10.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">에클리라/듀어클리어</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Astrazeneca</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">에클리라/듀어클리어 독점 & 개발 라이선스</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2011.12.13</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">안트롤</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Antares </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">Anturol 독점 라이센스 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2012.01.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">인스타닐</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Takeda</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">인스타닐 공급 유통 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2012.07.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">엘리델</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">한국메나리니 </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">엘리델크림 국내 독점 판매 및 유통 계약 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2014.03.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">시타빅</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">ONXEO</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">Sitavig의 한국 독점 라이센스 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2014.03.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">Linezolid</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Synthon </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">Linezolid의 중국, 한국 독점 라이센스 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국, 중국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2014.12.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">Purastat</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">3D Matrix</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">Purastat 동남아시아 판매권</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">동남아시아</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2015.07.10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">BBT-401(DWP305401)</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">브릿지바이오(주)</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">BBT-401 아시아 독점 라이선스</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">아시아</TD>
<TD VALIGN="MIDDLE" WIDTH="70" HEIGHT="27" USERMARK="F-9">2018.12.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="25" VALIGN="MIDDLE" WIDTH="93" HEIGHT="675" ALIGN="CENTER" USERMARK="F-9">코프로모션</TD>
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">다이아벡스/XR, 글루리아드</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">Merck Sante </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">다이아벡스, 다이아벡스XR, 글루리아드 코마케팅 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2002.12.02</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">올메텍/플러스</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">DSKR</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">올메텍/올메텍 플러스 코프로모션</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2008.07.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">에포시스</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">보령제약 </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">에포시스 코프로모션 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2008.08.20</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">세비카</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">DSKR</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">세비카 공동판촉 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2009.06.10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">에스디올하프</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">명문제약 </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">에스디올하프 국내독점 판권 계약 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2011.06.27</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">슈펙트</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">일양약품 </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">슈펙트 국내공급 계약 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2012.10.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">세비카HCT</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">DSKR</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">세비카HCT 공동판촉 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2013.02.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">올로스타</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">DSKR</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">올로스타 국내 co-promotion</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2014.04.11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">루피어</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">정주앤유(CSO)</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">루피어 Co-promotion</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2014.06.25</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">릭시아나</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">DSKR</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">릭시아나 국내 co-promotion</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2015.12.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">넥시움</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">한국 AstraZeneca</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">넥시움 3rd party promotion 및 유통 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2016.01.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">제미글로+제미메트</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">엘지화학</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">제미글로 공동 프로모션 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2020.09.07</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">크레스토</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">한국 AstraZeneca</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">크레스토 3rd party promotion 및 유통 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2016.04.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">알레락</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">한국쿄와하코기린 </TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">알레락 국내 판매 독점권 계약 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2016.12.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">루피어</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">와이비(CSO)</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">루피어 Co-promotion </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2017.05.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">루피어</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">효바이오텍(CSO)</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">루피어 Co-promotion</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2017.10.16</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">삼페넷</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">삼성바이오에피스</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">삼페넷 국내 독점 판매 및 유통 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2017.12.13</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">포시가, 직듀오</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">한국 AstraZeneca</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">포시가 및 직듀오 공동 프로모션 및 유통 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2018.03.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">아셀렉스</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">크리스탈지노믹스</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">아셀렉스 국내 판매 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2018.03.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">올로맥스</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">DSKR</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">올로맥스 국내 co-promotion</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2019.05.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">에빅사</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">한국룬드벡</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">에빅사 국내 co-promotion</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2019.08.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">콩코르</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">한국머크</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">콩코르 독점 판매 및 유통계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2019.11.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">프리스타일리브레</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">한국애보트</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">프리스타일 리브레 국내 약국 독점 유통, 병의원 독점 판촉 </TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2020.01.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">얼리텍</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">지노믹트리</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">얼리텍 국내 사업 제휴</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2020.04.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">위드풀</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">로하스메디</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">위드풀 공동판매 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2020.07.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ALIGN="CENTER" USERMARK="F-9">자체품목</TD>
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="30" USERMARK="F-9">졸레드론산</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" USERMARK="F-9">노바티스</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="30" USERMARK="F-9">졸레드론산 자산 구매 계약 (판권인수)</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="30" USERMARK="F-9">2017.08.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="74" ROWSPAN="2" ALIGN="CENTER" USERMARK="F-9">독점판권</TD>
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="27" USERMARK="F-9">모비케어</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="27" USERMARK="F-9">씨어스테크놀로지</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="27" USERMARK="F-9">MobiCARE-MC100 국내 독점 유통 및 판매 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="27" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">2020.07.10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="47" USERMARK="F-9">MIUchon</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="47" USERMARK="F-9">입셀(구 씨스템)</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="47" USERMARK="F-9">MIUchon 독점 유통 및 판매 계약</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">한국 및 &cr;아시아 5개국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020.09.07</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ALIGN="CENTER" USERMARK="F-9">자체품목&cr;판권계약</TD>
<TD VALIGN="MIDDLE" WIDTH="164" HEIGHT="53" USERMARK="F-9">리코발라민</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="53" USERMARK="F-9">휴온스</TD>
<TD VALIGN="MIDDLE" WIDTH="342" HEIGHT="53" USERMARK="F-9">리코발라민 상품공급 계약서</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" USERMARK="F-9">한국</TD>
<TD WIDTH="70" VALIGN="MIDDLE" HEIGHT="53" USERMARK="F-9">2020.04.20</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">한올바이오파마(주)&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">가. 라이선스아웃 (License-out) 계약&cr;</SPAN>
<SPAN>1) 공시서류 작성기준일 현재 당사가 체결 중인 주요 라이선스아웃 (License-out)계약의 현황은 다음과 같습니다.&cr;</SPAN>
</P>

<P>
<SPAN><라이선스아웃 계약 총괄표></SPAN>
<SPAN>&cr;                                                                                                 [단위: 백만원]</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="1116" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="51"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="211"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" USERMARK=" BC0XD7D7D7">품목</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="201" HEIGHT="30" USERMARK=" BC0XD7D7D7">계약상대방</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" USERMARK=" BC0XD7D7D7">대상지역</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" USERMARK=" BC0XD7D7D7">계약체결일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" USERMARK=" BC0XD7D7D7">계약종료일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" USERMARK=" BC0XD7D7D7">총 계약금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">수취금액</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">진행단계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="60" HEIGHT="145">HL036&cr;HL161</TD>
<TD VALIGN="MIDDLE" WIDTH="201" HEIGHT="145">하버바이오메드&cr;(HarbourBioMed, 중국)</TD>
<TD VALIGN="MIDDLE" WIDTH="220" HEIGHT="145">중국(대만, 홍콩, 마카오 포함)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="145">2017.09.12</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="145">관련 특허만료일 &cr;또는 중국 최초발매 후&cr;15년 중 나중에&cr;도달하는 시간까지</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="145">88,128&cr;(US$81,000,000)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="145">양사 합의에 의해 비공개&cr;(반환의무 없는 &cr;계약금 &cr;US$4,000,000) </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="145"><HL036>&cr;중국 임상2상&cr;<HL161>&cr;중국 임상1상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="60" HEIGHT="145">HL161</TD>
<TD VALIGN="MIDDLE" WIDTH="201" HEIGHT="145">로이반트 사이언스&cr;(Roivant Sciences, 스위스)</TD>
<TD VALIGN="MIDDLE" WIDTH="220" HEIGHT="145">미국 포함 북미와 중남미,&cr;EU국가, 영국,스위스, 중동,&cr;북아프리카 지역</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="145">2017.12.19</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="145">제품 출시 후 11년, 마지막 특허 만료일, 허가독점권 만료 중 가장 늦은 시점까지</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="145">546,720&cr;(US$502,500,000)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="145">양사 합의에 의해 비공개&cr;(반환의무 없는 &cr;계약금 &cr;US$30,000,000) </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="145">북미 임상2상</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>※ 외화금액은 공시서류 작성기준일 (2020.12.31) 환율로 환산 (1USD=1,088원)&cr;&cr;(1) 품목: HL036 (tanfanercept)/HL161 (batoclimab)</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="614" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="506"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약상대방</TD>
<TD WIDTH="515" HEIGHT="30">하버바이오메드 (HarbourBioMed, 중국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="53">계약내용</TD>
<TD WIDTH="515" HEIGHT="53">안구건조증치료 바이오신약 HL036, 자가면역질환치료 항체신약 HL161의 독점적 개발 및 사업권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">대상지역</TD>
<TD WIDTH="515" HEIGHT="30">중국 (대만, 홍콩, 마카오 포함)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약기간</TD>
<TD WIDTH="515" HEIGHT="30">계약체결일: 2017년 9월 12일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">총 계약금액</TD>
<TD WIDTH="515" HEIGHT="30">US$81,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="53">수취금액</TD>
<TD WIDTH="515" HEIGHT="53">양사 합의에 의해 비공개&cr;(반환의무 없는 계약금 US$4,000,000) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="122">계약조건</TD>
<TD WIDTH="515" HEIGHT="122">1. 계약금: US$4,000,000 (반환의무없는 계약금) &cr;2. 단계별 마일스톤: US$77,000,000&cr;3. 상업화에 따른 판매액 대비 일정 금액 로열티 별도 &cr;임상, 허가, 상업화 미실현시 본 계약은 종료될 수 있으며, 계약 종료에 따른&cr;당사의 위약금 지급의무는 없음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">회계처리방법</TD>
<TD WIDTH="515" HEIGHT="30">계약금 및 마일스톤 수취액 일시 수익 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">대상기술</TD>
<TD WIDTH="515" HEIGHT="30">안구건조증치료 바이오베터 HL036, 자가면역질환치료 항체신약 HL161</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="99">개발진행경과</TD>

<TD WIDTH="515" HEIGHT="99">
<P><HL036>&cr;2019년 10월 안구건조증 임상2상 완료 (중국)</P>
<P><HL161>&cr;2020년4월 시신경척수염 임상1b/2a 개시 (중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">기타사항</TD>
<TD WIDTH="515" HEIGHT="30">HL036은 대웅제약과 공동연구개발하여 비용과 수익을 5:5로 배분함.</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(2) 품목: HL161 (batoclimab)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="506"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약상대방</TD>
<TD WIDTH="515" HEIGHT="30">로이반트 사이언스 (Roivant Sciences, 스위스)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="53">계약내용</TD>
<TD WIDTH="515" HEIGHT="53">자가면역질환치료 항체신약 HL161의 독점적 권리를 갖고 임상개발, 생산, 품목허가 및 판매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">대상지역</TD>
<TD WIDTH="515" HEIGHT="30">미국 포함 북미와 중남미, EU국가, 영국, 스위스, 중동, 북아프리카 지역</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">계약기간</TD>
<TD WIDTH="515" HEIGHT="30">계약체결일: 2017년 12월 19일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">총 계약금액</TD>
<TD WIDTH="515" HEIGHT="30">US$502,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="53">수취금액</TD>
<TD WIDTH="515" HEIGHT="53">양사 합의에 의해 비공개&cr;(반환의무 없는 계약금 US$30,000,000) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="145">계약조건</TD>
<TD WIDTH="515" HEIGHT="145">1. 계약금: US$30,000,000 (반환의무없는 계약금) &cr;2. 연구비: US$20,000,000 (5년에 걸쳐 분할 수령)&cr;3. 단계별 마일스톤: US$452,500,000&cr;4. 상업화에 따른 판매액 대비 일정 금액 로열티 별도 &cr;임상, 허가, 상업화 미실현시 본 계약은 종료될 수 있으며, 계약 종료에 따른&cr;당사의 위약금 지급의무는 없음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="53">회계처리방법</TD>
<TD WIDTH="515" HEIGHT="53">계약금 (2017년 12월부터 64개월동안 분할하여 수익 인식)&cr;마일스톤 수취액 (수취일부터 64개월동안 분할하여 수익 인식)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">대상기술</TD>
<TD WIDTH="515" HEIGHT="30">자가면역질환치료 항체신약 HL161</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="122">개발진행경과</TD>

<TD WIDTH="515" HEIGHT="122">
<P>- 2019년: 임상1상 완료 (캐나다, 호주)&cr;- 2019년: MG, GO, WAIHA 임상2상 개시 (북미, 유럽)&cr;- 2020년 3월: GO (or TED) 임상2a 결과발표</P>
<P>- 2020년4월: NMOSD (시신경척수염) 임상1b/2a 개시(중국)&cr;- 2020년8월: MG (중증근무력증) 임상2상 결과발표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30">기타사항</TD>
<TD WIDTH="515" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">나. 라이센스인 (License-in) 계약&cr;</SPAN>
<SPAN>당사는 보고서 작성일 기준 현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" B">다. 공동연구개발계약&cr;</SPAN>
<SPAN>1) 공시서류 작성기준일 현재 당사가 체결 중인 주요 공동연구개발계약의 현황은 다음과 같습니다.&cr;<공동연구개발계약 총괄표></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="983">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="296"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">품목</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">계약상대방</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="305" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대상지역</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">계약체결일</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">계약 종료일</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">금액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">진행단계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" HEIGHT="53" VALIGN="MIDDLE">HL036</TD>
<TD WIDTH="105" HEIGHT="53" VALIGN="MIDDLE">(주)대웅제약</TD>
<TD WIDTH="305" HEIGHT="53" VALIGN="MIDDLE">공동연구개발&cr;(전세계 사업권 공동 소유)</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE"> 2016.03</TD>
<TD WIDTH="98" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="163" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">양사 합의하에 비공개</TD>
<TD WIDTH="129" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">임상3-1상(미국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" HEIGHT="53" VALIGN="MIDDLE">HL186/187</TD>
<TD WIDTH="105" HEIGHT="53" VALIGN="MIDDLE">(주)대웅제약</TD>
<TD WIDTH="305" HEIGHT="53" VALIGN="MIDDLE">공동연구개발&cr;(연구개발결과물 및 지식재산권 공동 소유)</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2016.09</TD>
<TD WIDTH="98" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="163" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">양사 합의하에 비공개</TD>
<TD WIDTH="129" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">물질탐색</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" 0X1814FF B"></SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK="F-14 0XFF0000 B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">8. 연구개발활동</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-14 B"></SPAN>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">◆(주)대웅제약</SPAN>&cr;&cr;
<SPAN USERMARK=" B">가.연구개발활동의 개요 </SPAN>&cr;당사는 케미컬 합성신약으로 위식도역류질환치료제, 당뇨병치료제, 폐섬유증치료제,통증치료제, 자가면역치료제 등을 연구하고 있으며, 개량신약으로 세계 최초 올메살탄+로수바스타틴 복합제 올로스타, 도네페질 패치제 및 데포주사제를 연구하고 있습니다. C&D센터를 통한 connected collaboration & developmnet 강화로 미래 신규사업 진출을 도모하고 있습니다.    &cr;
<SPAN USERMARK=" B">&cr;나.연구개발 담당조직   </SPAN>&cr;      &cr;
<SPAN USERMARK=" B">(1)연구개발 조직 개요  </SPAN>&cr;당사의 연구조직은 케미컬 기반 신약센터, 제제연구의 신제품센터, C&D센터로 구성되어 있습니다.&cr;      &cr; <연구개발 조직 구성>      
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="498">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연구소</TH>
<TH WIDTH="304" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">팀</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="194" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER">신약센터</TD>
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">소화기.항암신약팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">내분비신약팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">섬유증신약팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">자가면역신약팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="194" VALIGN="MIDDLE" HEIGHT="150" ALIGN="CENTER">신제품센터</TD>
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">신기술TF</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">신약제제팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">차별화제품팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">데포사업화팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">의약분석팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">세포치료센터</TD>
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">세포치료품질팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연구본부</TD>
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">연구지원팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER">C&D센터</TD>
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">C&D이노베이션TF</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">C&D전략팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="330" ROWSPAN="11" ALIGN="CENTER">개발본부</TD>
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">사업개발BD팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">시판연구팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">신제품기획팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">개발팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">대외협력실(MA팀)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30"> IP팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">신약기획팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">임상개발팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">임상분석팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">임상연구팀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">PV팀</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;<조직도></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="71" ALIGN="CENTER" HSPACE="0">연구개발 조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">연구개발 조직도</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B">(2) 연구개발 인력 현황 </SPAN>&cr;당사는 박사급 35명, 석사급 137명 등 총 231명의 연구인력을 보유하고 있습니다.&cr;     &cr;
<SPAN USERMARK=" B">(3) 핵심 연구인력    &cr;</SPAN>당사의 핵심 연구인력은 다음과 같습니다.&cr; &cr;<핵심 연구인력 현황>    
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="368"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">직 위</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">성 명</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">담당업무</TH>
<TH WIDTH="377" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">주요 경력</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="122" ALIGN="CENTER">센터장</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="122" ALIGN="CENTER">박준석</TD>
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="122" ALIGN="CENTER">신약센터 총괄</TD>
<TD WIDTH="377" VALIGN="MIDDLE" HEIGHT="122">서울대학교 약학 박사 (2007)&cr; 대웅제약 신약연구실 Project Leader (2004-2015)&cr; 대웅제약 이중표적사업팀 팀장 (2015~2016)&cr; 대웅제약 신약탐색팀 팀장 (2017-2018)&cr; 대웅제약 신약센터 센터장 (2018~)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="145" ALIGN="CENTER">센터장</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="145" ALIGN="CENTER">김관영</TD>
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="145" ALIGN="CENTER">신제품센터 총괄</TD>
<TD WIDTH="377" VALIGN="MIDDLE" HEIGHT="145">서울대학교 약학 학사 (2003) &cr; 서울대학교 약학 석사 (2005)&cr; 동아제약 제품연구소 과장 (2005-2011)&cr; SK케미칼 제제팀 경구 Project Leader  (2011-2017)&cr; 대웅제약 신제품센터 특화제제제팀 팀장 (2017-2018)&cr; 대웅제약 신제품센터 센터장 (2018~)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;다. 연구개발실적  </SPAN>&cr;       &cr;
<SPAN USERMARK=" B">(1)연구개발 진행 현황 및 향후계획      </SPAN>&cr;       &cr;공시서류 작성기준일 현재 당사가 연구개발 진행 중인 신약[개량신약, 복제약(시밀러) 등 포함]의 현황은 다음과 같습니다.        &cr;       &cr;<연구개발 진행 총괄표>       
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="919">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ROWSPAN="2" WIDTH="177" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구 분</TH>
<TH ROWSPAN="2" WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">품 목</TH>
<TH ROWSPAN="2" WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">적응증</TH>
<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">연구시작일</TH>
<TH COLSPAN="2" WIDTH="185" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">현재 진행단계</TH>
<TH ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">단계(국가)</TH>
<TH WIDTH="65" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">승인일</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="15" WIDTH="48" VALIGN="MIDDLE" HEIGHT="519" ALIGN="CENTER">화학&cr;합성</TD>
<TD ROWSPAN="12" WIDTH="129" VALIGN="MIDDLE" HEIGHT="406" ALIGN="CENTER">신약</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">Fexuprazan</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">위식도역류질환</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2007년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">NDA신청(한국)</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWP305401</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">궤양성대장염</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2018년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">임상 2상(미국)</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">2018년</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">공동개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">Enavogliflozin</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">제2형당뇨병</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2016년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">임상 3상(한국)</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">2020년</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">라이선스인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWN12088</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">특발성 폐섬유증</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2013년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">임상 1상(호주)</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">2019년</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">공동연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWP306001</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">비만</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2020년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">전임상</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWP212525</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">자가면역질환</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2015년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">전임상</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWP213388</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">자가면역질환</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2015년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">전임상</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWP218</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">자가면역질환 (CNS 관련)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2020년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">물질탐색</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWJ816S002</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">항암제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2019년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">물질탐색</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWJ816S003</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">항암제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2019년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">물질탐색</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53">DWRX2003</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="53">COVID19 치료제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">2020년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="53">임상1상(인도, 한국, 호주)</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="53">2020년</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="53">공동연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53">DWJ1248</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="53">COVID19 치료제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">2020년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="53">임상2상(한국, 멕시코)</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="53">2020년</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="53">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="129" VALIGN="MIDDLE" HEIGHT="113" ALIGN="CENTER">개량신약/제네릭</TD>
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">DWJ1451</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">고혈압고지혈 </TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2018년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">임상 3상(한국)</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">2019년</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30">디팻콜린주</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">지방분해</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">2016년</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">임상 3상</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="30">2019년</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53">장기지속형주사제</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="53">전립선암, 자궁근종, 성조숙증</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53">2013</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="53">스케일업</TD>
<TD WIDTH="65" VALIGN="MIDDLE" HEIGHT="53">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="53">글로벌향과제&cr; (미국/일본)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">1) 품목 :  Fexuprazan</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">합성신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">위식도역류질환, 위식도역류질환의 유지요법, NSAIDs로 인한 궤양 예방 등</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">APA (Acid Pump Antagonist)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">제품의특성</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">PPI 약물 대비 빠른 onset time, 긴 반감기로 야간까지 우수한 산분비 억제력 발휘, 복용편의성 확보</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">한국 품목허가(NDA) 신청 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">경쟁제품</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">Tegoprazane (CJ, 2019년 2월 발매), Vonoprazan (Takeda, 2019년 4월 시판허가)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">관련논문등</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">APNM 2018 임상결과 발표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">시장규모</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">2021년 위궤양 치료제 시장 규모는 $40B 예상 (GBI Research)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">정부보조금</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">범부처전주기신약개발사업단으로부터 임상 2상 마일스톤으로 정부출연금 약 19억원을 지원 받음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">수출: 멕시코(1월, 5,000만$), 브라질(8월, 7,300만$)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;2) 품목 : DWP305401</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="505"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">펩타이드 신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">궤양성 대장염</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">Pellino-1 inhibitor</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">제품의특성</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="53">세계 최초의 fellino-1 저해제, 체내에 대장에만 한정적으로 분포하는 우수한 안전성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">임상2a 중간결과 발표 (4월, 미국)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">2021년 임상 2상 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">경쟁제품</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">5-ASA(1차 약제), 스테로이드(2차 약제), 엔브렐, 휴미라, 스텔라라</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">관련논문등</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">2019 Crohn's & Colitis Congress 임상 1상 결과 발표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">시장규모</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">2022년 궤양성대장염 치료제 시장 규모는 $3.6B 예상(Decision Resources)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">대웅제약-브릿지바이오테라퓨틱스 공동 개발</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;3) 품목 : Enavogliflozin</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="506"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="30">합성신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="30">제2형 당뇨병</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="30">SGLT2 inhibitor</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">제품의특성</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="53">경쟁물질 대비 적은 유효용량, 우월한 혈당강하효과, 효과 지속능 및 낮은 감염 부작용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="30">임상 3상 단독, 병용 승인 (한국, 2020.09)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="30">2023년 국내 발매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">경쟁제품</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="53">Dapagliflozin (BMS/AZN, 출시), Canagliflozin (J&J/MTPC, 출시), Empagliflozin (Boehringer/Eli Lilly, 출시)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">관련논문등</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="53">2020 ICDM(2020 International Congress of Diabetes and Metabolism) 임상 2상 결과 발표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">시장규모</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="30">2022년 당뇨병 치료제 시장 규모는 $31.5B 예상 (Datamonitor)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="515" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;4) 품목 : DWN12088</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="503"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">합성신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">특발성 폐섬유증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">PRS inhibitor</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">제품의특성</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="53">First-in class target, 선택적인 PRS 억제를 통한 콜라겐 생성 억제로 넓은 안전역 확보, SoC 약물과의 탁월한 병용효과 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">호주 임상 1상 투약 완료, 미국 FDA 희귀의약품지정 (ODD)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">2021년 임상 2상 IND 승인 (글로벌)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">경쟁제품</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">Pirfenidone, Nintedanib</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">관련논문등</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="53">2019 IPF Summit 포스터 발표, 2018 ACR/ARHR 포스터 발표, 2017 미국심장학회 구두발표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">시장규모</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">2025년 특발성 폐섬유증 시장 규모는 $3.2B 예상 (GlobalData)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">정부보조금</TD>
<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">범부처전주기신약개발사업단으로부터 전임상 및 해외 임상 1상 비용 지원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;5) 품목 : DWP213388</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">합성신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">자가면역질환 (SLE, CSU, 쇼그렌증후군, GVHD, RA, Psoriasis)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">ITK/BTK dual inhibitor</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">제품의특성</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">ITK/BTK 동시에 저해하여 약효 시너지, 넓은 안전역 확보, 선택성 확보로 부작용 최소화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">전임상 (임상 1상 허가용 전임상 시험 (GLP-Tox) 투여 완료) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">2021년 임상1상 개시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">경쟁제품</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">Ibrutinib (Abbivie, 출시), Ruxolitinib (Incyte, 임상 3상), Itacitinib (Incyte, 임상 3상)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">관련논문등</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">2018년 ACR 포스터 발표&cr; 2019 미국혈액학회 (ASH) 포스터 발표 (12월)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">시장규모</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">2018년 GVHD 시장 규모는 $406.9M (global data)&cr;2015년 RA 시장 규모는 $19.6B (global dara)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;6) 품목 : DWP212525</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">합성신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">자가면역질환 (천포창, 아토피 피부염, RA, IBD)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">JAK3/TFK dual inhibitor</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">제품의특성</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">이중표적 억제기전으로 강력한 치료효과, 선택성 확보로 기전 기반 부작용 최소화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">전임상 (전임상 시험용(GLP-Tox) 시험물질 생산 완료)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">2021년 임상1상 IND 준비 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">경쟁제품</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">Rilzabrutinib (Principia Biopharma, 임상3상)&cr; Ritlecitinib (Pfizer, 임상3상)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">관련논문등</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">2019 미국류마티스 학회 (ACR/ARHR) 포스터 발표 (11월)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="99">시장규모</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="99">희귀 피부질환 치료제 시장 규모는 2017년 13억 달러 (1조 3천억원), 2024년 60억 달러 예상&cr;천포창(Pemphigus vulgaris) 치료제 시장 규모는 2017년 1천 5백만 달러 (150억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;7) 품목 : DWJ816S002</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="501"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">합성신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">항암제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">표적 치료제 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">제품의특성</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">First-in-class 타겟</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">물질 탐색 단계 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">2022년 후보물질 도출, 2023년 임상1상 IND 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">경쟁제품</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">관련논문등</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">시장규모</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;8) 품목 : DWJ816S003</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="501"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">합성신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">항암제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">면역항암 치료제 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">제품의특성</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">First-in-class 타겟</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">물질 탐색 단계 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">2022년 후보물질 도출, 2024년 임상1상 IND 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">경쟁제품</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">관련논문등</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">시장규모</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">정부보조금</TD>
<TD WIDTH="510" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">9) 품목 : DWRX2003</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">약물재창출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">COVID19 치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="76">작용기전</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="76">SKP2 저해를 통한 세포의 자가포식 작용 활성화(추가 기전 : TMEM16A Antagonist으로서 호흡곤란 개선, STAT3 인산화 저해 통한 염증성 폐합병증 개선)  </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">제품의특성</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">Main 기전을 통한 COVID19 바이러스의 저해 외에 추가 기전을 통한 COVID19 증상개선도 가능, one shot으로 치료 가능한 depot 제제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">진행경과</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">인도 임상1상 진행, 한국 임상2상 IND 신청, 호주 임상1상 IND 신청, 추가 비임상시험 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">21년 임상 2상 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">경쟁제품</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">치료제 : Remdesivior, nafamostat, camostat, 백신 : DNA, RNA, 단백질 백신</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="99">관련논문등</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="99">Meehyun Ko, Sangeun Jeon, Wang-Shick Ryu, Seungtaek Kim. Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate. 2020.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">시장규모</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">글로벌 COVID19 감염자 수 1,300만명(2020.07), 1조원 시장(Peak Sales 1,760억/년 예측) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">기타사항</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">코로나19 치료제 생산장비 구축지원 대상 과제 예비선정 (최대 19억원, 한국보건산업진흥원)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">10) 품목 : DWJ1248</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">약물재창출</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">COVID19 치료제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="76">작용기전</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="76">spike protein의 priming을 촉진시키는 역할을 하는 것으로 알려진 세포 표면의 수용체 단백질인 TMPRSS2의 활성을 억제해서 COVID-19 바이러스를 효과적으로 차단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">제품의특성</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">COVID19 바이러스의 저해제로 기 허가 제품의 허가 용량에서의 적용으로 안전성이 확보되어 2상 임상시험부터 진행되며, 빠른 허가 가능</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">한국 단독 임상2/3상 및 병용 임상3상 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">21년 코로나19 치료제 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">경쟁제품</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">치료제 : Remdesivior, nafamostat, niclosamide, 백신 : DNA, RNA, 단백질 백신 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="76">관련논문등</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="76">Markus Hoffmann. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271-280. 2020</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53">시장규모</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">글로벌 COVID19 감염자 수 1,300만명(2020.07), 1조원 시장(Peak Sales 1,760억/년 예측) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">11) 품목 : DWJ1451</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">개량신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">고혈압 및 고지혈 동반질환 치료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">ARB 및 Stain 등의 순환기 기존 치료 기전의 조합</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">제품의특성</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">복합제 특허 기술</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">임상연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">2022년 발매 목표</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">경쟁제품</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">올로스타, 올로맥스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">관련논문등</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">시장규모</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">12) 품목 : 디팻콜린주사</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">구 분</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">개량신약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">적응증</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">지방분해</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">작용기전</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">지방세포 영구적으로 파괴, 자연적인 치유로 새로운 콜라겐 형성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">제품의특성</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">주사제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">진행경과</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">임상 3상 진행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">향후계획</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">2021년 발매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">경쟁제품</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">벨카이라주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">관련논문등</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">시장규모</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">기타사항</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;(2)연구개발 완료 실적      &cr;</SPAN>
<SPAN></SPAN>
<SPAN>공시서류 작성기준일 현재 개발이 완료된 신약{개량신약, 복제약(시밀러) 등 포함}의 현황은 다음과 같습니다.    </SPAN>
<SPAN USERMARK=" B"> &cr;      &cr;<연구개발 완료 실적>      </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="822">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="209"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">품 목</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">적응증</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">개발완료일*</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">현재 현황</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="48" VALIGN="MIDDLE" HEIGHT="270" ALIGN="CENTER">화학&cr;합성</TD>
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" HEIGHT="90" ALIGN="CENTER">개량신약</TD>
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">올로스타정</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">고혈압/고지혈</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2015년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국 판매중</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">해외진출 위해 정부과제 지원 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">가스모틴CR</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2018년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국 판매중</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">올로맥스</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2019년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국 판매중</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">2020년 신규 함량 추가 발매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="78" VALIGN="MIDDLE" HEIGHT="180" ALIGN="CENTER">제네릭</TD>
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">타다라필 3용량</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2015년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국 판매중</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">엔테카비르정 2용량</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2015년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국 판매중</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" HEIGHT="30">타미빅트3용량</TD>
<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="100" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2017년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국 판매중</TD>
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">도네페질 제네릭</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ALIGN="CENTER">2018년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국 판매중</TD>
<TD VALIGN="MIDDLE" WIDTH="218" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">테노포비르</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">간염</TD>
<TD VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ALIGN="CENTER">2018년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">한국 판매중</TD>
<TD VALIGN="MIDDLE" WIDTH="218" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">토파시티닙 속방정</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ALIGN="CENTER">2020년</TD>
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">품목허가 완료</TD>
<TD VALIGN="MIDDLE" WIDTH="218" HEIGHT="30">　</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>&cr;
<SPAN USERMARK=" B">라.연구개발비용&cr;</SPAN>
<SPAN>당사의 최근 3년간 연구개발비용은 다음과 같습니다. &cr;당사는 연구 단계에 대한 지출은 발생시점에서 비용으로 인식하며, 요건을 충족한 일부 비용에 대해서 연구개발비로 자산화하고 있습니다.</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE WIDTH="622" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="613"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="622" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(단위 :천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="251" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">구 분</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제19기</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제18기</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="8" WIDTH="98" HEIGHT="240">비용의&cr;성격별 분류</TD>
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">원재료비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">22,277,297</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30"> 29,536,899 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30"> 15,328,996 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">위탁용역비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">44,315,639</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">  29,686,839 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30"> 30,292,265 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">인건비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">21,159,843</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30"> 20,426,186 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">  20,683,073 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">감가상각비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">9,454,154</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">    8,827,025 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">    10,364,973 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">기타</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">47,331,438</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">     52,092,424 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30"> 46,442,816 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">연구개발비용 합계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">144,538,371</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">  140,569,373 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">   123,112,123 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">(정부보조금)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">-1,051,164</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">-3,142,123 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">-1,954,473 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">보조금 차감 후 금액</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">143,487,207</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">137,427,250 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30"> 121,157,650 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="4" WIDTH="98" HEIGHT="120">회계처리&cr;내역</TD>
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">판매비와 관리비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">104,973,664</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">  99,725,680 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">  99,836,240 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">제조경비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">20,165,457</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">17,889,979 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">   21,321,410 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">개발비(무형자산)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">18,348,086</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">  19,811,591 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">   - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30">회계처리금액 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="30">143,487,207</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="30">  137,427,250 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30"> 121,157,650 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="251" HEIGHT="53">연구개발비 / 매출액 비율&cr;
<SPAN USERMARK="F-10">[연구개발비용합계÷당기매출액×100]</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="132" HEIGHT="53">15.30%</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="122" HEIGHT="53">13.98%</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="53">13.05%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주1) 연구개발비/매출액 비율은 정부보조금을 포함한 금액을 기준으로 하여 계산된 비율입니다.&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B">한올바이오파마(주)&cr;</SPAN>
</P>

<P>
<SPAN USERMARK=" B">가. 연구개발활동의 개요 &cr;</SPAN>당사는 합성의약품과 바이오의약품의 연구개발 및 자가면역질환, 안구건조증, 면역항암 치료제 등의 바이오신약 개발을 주로 진행하고 있습니다.&cr;&cr;
<SPAN USERMARK=" B">나. 연구개발 담당조직</SPAN>&cr;(1) 연구개발 조직 개요&cr;당사의 연구개발조직은 서울연구소, 전략기획센터 (서울 소재), 바이오연구소, 신규항체팀 (경기 수원 소재), 중앙연구소 (대전 소재), HPI (미국)로 구성되어 있습니다. &cr;&cr;                                            <연구개발 조직 구성>
</P>

<TABLE ACLASS="NORMAL" WIDTH="598" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="373"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">연구소</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">팀</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="382" HEIGHT="30" USERMARK=" BC0XD7D7D7">주요업무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="175">서울연구소</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">개발팀</TD>
<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="76">- 신제품 개발&cr;- 해외 제품 제휴 및 도입품목 관리&cr;- 기존 제품 사후 관리</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="99">임상팀</TD>
<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="99">- 국내 허가용 임상(생동)시험 관리&cr;- 글로벌 임상시험 지원(HL project)&cr;- 연구자임상 관리&cr;- 신규제품기획 임상부분 검토 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">전략기획센터</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">특허팀</TD>
<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="76">- 지재권관리&cr;- 제품관련 IP(특허/상표)조사, 선행기술조사&cr;- IP(특허/상표) 심판 소송업무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="152">바이오연구소</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="99">단백질의약팀</TD>
<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="99">- 바이오의약품 생산공정 개발&cr;- 비임상 연구&cr;- 제형 및 제품화 연구&cr;- 바이오의약품 임상 허가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">바이오신약팀</TD>
<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="53">- 바이오베터/바이오신약 후보도출&cr;- 약효 및 독성 연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">신규항체팀</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">신규항체팀</TD>
<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="76">- 면역항암항체 후보물질 도출&cr;- 항체 평가법 개발 및 작용기전 연구&cr;- 항체 생산 및 특성분석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="198">중앙연구소</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">분석팀</TD>
<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="76">- 신규 분석법 개발 및 밸리데이션 수행 &cr;- 품목 허가자료 작성 및 분석법 기술이전&cr;- 제제 품질평가 및 안정성 시험 진행 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="122">제제팀</TD>

<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="122">
<P>- 신제품 Formulation 연구 및 물성평가&cr;- 공정 최적화 및 생산 기술이전 연구</P>
<P>- 품목허가 자료작성 및 식약처 보완대응&cr;- 제품 발매 조력&cr;- 외부과제 위탁연구 수행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">HPI</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">HPI</TD>
<TD VALIGN="MIDDLE" WIDTH="382" HEIGHT="30">- 신약의 해외임상 진행 및 라이선스 아웃 업무</TD>
</TR>
</TBODY>
</TABLE>
<P><조직도>&cr;Ⅱ. 사업의 내용중 나. 회사의 현황  3)조직도 참조&cr;</P>
<P>(2) 연구개발 인력 현황&cr;공시서류 작성기준일 현재 당사는 박사급 4명, 석사급 23명 등 총 37명의 연구인력을 보유하고 있으며 그 현황은 다음과 같습니다.&cr;당사의 연구인력 개선전략은 조직 Slim化 및 Extream team 구축을 통해 핵심인력을 육성하고 자율과 책임 문화를 정착하여 R&D 생산성을 제고하는 것입니다.&cr;'최고가 되든지 최고와 손 잡든지'라는 모토 아래 Open innovation & Global outstanding 전략을 적극적으로 추진하고 있습니다.&cr;&cr;                                      <연구개발 인력 현황>&cr;                                                                                       [단위 : 명]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="516">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="63"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구분</TD>
<TD COLSPAN="4" WIDTH="288" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">인원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="72" HEIGHT="30" USERMARK=" BC0XD7D7D7">박사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="72" HEIGHT="30" USERMARK=" BC0XD7D7D7">석사</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="72" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="72" HEIGHT="30" USERMARK=" BC0XD7D7D7">합계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" COLSPAN="2" WIDTH="228" HEIGHT="30">임원실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" VALIGN="MIDDLE" WIDTH="114" HEIGHT="90">서울연구소</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">서울연구소장</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">개발팀</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">4</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">4</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">8</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">임상팀</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">전략기획센터</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">특허팀</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" VALIGN="MIDDLE" WIDTH="114" HEIGHT="90">바이오연구소</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">바이오연구소장</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">단백질의약팀</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">2</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">바이오신약팀</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">2</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="114" HEIGHT="60">중앙연구소</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">제제팀</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">4</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">5</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">분석팀</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">4</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">신규항체TFT</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">2</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">3</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">5</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">HPI</TD>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">담당임원</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">2</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30">합계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">4</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">23</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">10</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="72" HEIGHT="30">37</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 핵심 연구인력&cr;당사의 핵심 연구인력은 자가면역질환, 안구건조증 개발 총괄 바이오연구소 안혜경 센터장, 해외 임상시험 및 라이선스 아웃 업무 총괄 HPI 김영주 센터장이 있습니다.&cr;&cr;<핵심 연구인력 현황></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1119">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="315"></COL>
<COL WIDTH="467"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">직위</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">성명</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="163" HEIGHT="30" VALIGN="MIDDLE">담당업무</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="324" HEIGHT="30" VALIGN="MIDDLE">주요 경력</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="476" HEIGHT="30" VALIGN="MIDDLE">주요 연구실적</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="237" VALIGN="MIDDLE">센터장</TD>
<TD WIDTH="63" HEIGHT="237" VALIGN="MIDDLE">안혜경</TD>
<TD WIDTH="163" HEIGHT="237" VALIGN="MIDDLE">바이오신약 연구 총괄</TD>
<TD WIDTH="324" HEIGHT="237" VALIGN="MIDDLE">중앙대학교 생물학 졸업 ('90~'94)&cr;서울대학교 유전학 석사 ('94~'95)&cr;대웅제약 바이오연구소 연구원 ('96~'07)&cr;한올바이오파마 바이오연구소 ('10~현재)</TD>
<TD WIDTH="476" HEIGHT="237" VALIGN="MIDDLE">[논문]&cr;1. Neutralization of Ocular Surface TNF-a Reduces Ocular Surface and Lacrimal Gland Inflammation Induced by In Vivo Dry Eye&cr;('13년, IOVS 학술지)&cr;2. Efficacy of HL036 versus cyclosporine A in the treatment of naturally occurring canine keratoconjunctivitis sicca&cr;('18년, Current eye research 학술지)&cr;[학회발표]&cr;1. HL036337 Ophthalmic Solution: Topical TNF Blocker for Dry Eye Disease ('14년, PEGS 학회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="168" VALIGN="MIDDLE">센터장</TD>
<TD WIDTH="63" HEIGHT="168" VALIGN="MIDDLE">김영주</TD>
<TD WIDTH="163" HEIGHT="168" VALIGN="MIDDLE">해외임상시험 총괄</TD>

<TD WIDTH="324" HEIGHT="168" VALIGN="MIDDLE">
<P>부산대학교 자연과학대학 미생물학 졸업 ('94~'99)</P>
<P>부산대학교 미생물학 석사 ('99~'00)&cr;대웅제약 바이오연구소 연구원('00~'09)&cr;한올바이오파마 바이오연구소 ('10~'19)&cr;한올바이오파마 HPI 미국 ('19~현재)</P>
</TD>

<TD WIDTH="476" HEIGHT="168" VALIGN="MIDDLE">
<P>[논문]&cr;Efficacy of HL036 versus cyclosporine A in the treatment of naturally occurring canine keratoconjunctivitis sicca&cr;('18년, Current eye research 학술지)</P>
<P>[학회발표]&cr;1. HL036337 Ophthalmic Solution: Topical TNF Blocker for Dry Eye Disease ('14년, PEGS 학회)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">다. 연구개발비용</SPAN>&cr;당사의 최근 3년간 연구개발비용은 다음과 같습니다.&cr;&cr;<연구개발비용현황(연결재무제표기준)>
</P>

<TABLE WIDTH="592" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="583"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="592" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">과       목</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-10">제48기</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제47기</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제46기</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">원  재  료  비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,877,768</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">528,718</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">383,438</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">인    건    비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,809,897</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,855,438</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,768,384</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감 가 상 각 비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">565,377</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">408,778</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">142,510</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">위 탁 용 역 비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,188,668</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,270,801</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,368,546</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기            타</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,688,894</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,653,224</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,881,854</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구개발비용 계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,130,604</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,716,959</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,544,732</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">( 정 부 보 조 금 )</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">회계처리</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">판매비와 관리비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,316,282</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,050,611</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,544,732</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제조경비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">개발비(무형자산)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,814,322</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,666,348</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구개발비 / 매출액 비율&cr;[연구개발비용계÷당기매출액×100]</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">15.95%</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">16.34%</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">11.48%</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;<연구개발비용현황(별도재무제표기준)></P>

<TABLE WIDTH="594" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="585"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="594" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">과       목</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK="F-10">제48기</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제47기</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제46기</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">원  재  료  비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,877,768</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">528,718</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">383,438</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">인    건    비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,809,897</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,855,438</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,768,384</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감 가 상 각 비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">490,559</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">339,866</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">142,510</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">위 탁 용 역 비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,188,668</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,512,745</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,368,546</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기            타</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,686,103</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,655,781</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,849,296</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연구개발비용 계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,052,995</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,892,548</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,512,174</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">( 정 부 보 조 금 )</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">회계처리</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">판매비와 관리비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,238,673</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,226,200</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,512,174</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제조경비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">개발비(무형자산)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,814,322</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,666,348</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구개발비 / 매출액 비율&cr;[연구개발비용계÷당기매출액×100]</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">15.86%</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">16.50%</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">11.45%</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">라. 연구개발실적</SPAN>
</P>
<P>(1) 연구개발 진행 현황 및 향후 계획&cr;공시서류 작성기준일 현재 당사가 연구개발 진행 중인 신약의 현황은 다음과 같습니다.&cr;</P>

<P>
<SPAN><연구개발 진행 총괄표></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="819">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="2" WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구 분</P>
</TD>

<TD ROWSPAN="2" WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>품 목</P>
</TD>

<TD ROWSPAN="2" WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD ROWSPAN="2" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>연구</P>
<P>시작일</P>
</TD>

<TD COLSPAN="2" WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>현재 진행단계</P>
</TD>

<TD ROWSPAN="2" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>비 고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>단계(국가)</P>
</TD>

<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>승인일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="189">
<P>바이오</P>
</TD>

<TD ROWSPAN="4" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="189">
<P>신약</P>
</TD>

<TD WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>HL036</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>안구건조증</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2010년</P>
</TD>

<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="53">
<P>임상 3-1상(미국)</P>
<P>임상 3상(중국)</P>
</TD>

<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019년</P>
<P>2020년</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53">
<P>대웅제약 공동개발</P>
<P>라이센스아웃(중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>HL161</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>다수 자가면역질환</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2010년</P>
</TD>

<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="53">
<P>임상 2상&cr;북미, 유럽, 중국 등)</P>
</TD>

<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019년</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53">
<P>라이센스아웃</P>
<P>(북미, 유럽, 중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>HL186/</P>
<P>HL187</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>암 (확정 전)</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017년</P>
</TD>

<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="53">
<P>물질탐색</P>
</TD>

<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P> -</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="53">
<P>대웅제약 공동개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HL189</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>포도막염</P>
</TD>

<TD WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019년</P>
</TD>

<TD WIDTH="154" VALIGN="MIDDLE" HEIGHT="30">
<P>전임상</P>
</TD>

<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> -</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="30">
<P> -</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(가) HL036 (성분명: tanfanercept)</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="485"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>구분</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 바이오신약 (단백질 의약품)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>적응증</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 안구건조증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>작용기전</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="53">
<P>- 안구에서 염증을 유발하는TNFα를 억제 (tanfanercept가 TNFα와 binding)하여 안구건조증을 치료하는Mechanism of Action</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>제품의 특성</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="168">
<P>- Efficacy: TNFα를 효과적으로 억제해 징후 (Sign)와 증상 Symptom) 모두에서 개선 효과 나타남 (임상2, 3상 결과)</P>
<P>- Safety: 바이오의약품으로써 기존 허가 받아 판매되고 있는 합성의약품들과 비교해 우월한 안전성 보유</P>
<P>- Rapid onset of action: 기존 치료제가 약효를 발휘하는데 걸리는 시간 (12주 이상)이 긴데 반해 HL036은 4주 이내 효능 나타남 (임상3상 sign지표인 각막중앙부염색지수 결과)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>진행경과</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="214">
<P>- 2017년 9월: Harbour BioMed와 중국지역 라이선스 아웃 계약</P>
<P>- 2018년 10월: 임상2상 시험 결과 발표 (OIS학회, 미국 시카고)</P>
<P>- 2019년 4월: 임상2상 시험 결과 포스터발표 (ARVO 2019, 캐나다 벤쿠버)</P>
<P>- 2019년 10월: 임상2상 시험 결과 발표 (AAO 2019, 미국 샌프란시스코)</P>
<P>- 2019년 10월: 중국 임상 2상 완료</P>
<P>- 2019년 임상3-1상 진행 (미국)&cr;- 2020년 상반기: 임상3-1상 완료 (미국)&cr;- 2020년 11월: 안과학회(AAO 2020)에서 3-1상 결과 발표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>향후계획</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 2021년 임상3-2상 개시</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>경쟁제품</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="53">
<P>- Restasis (Allergan): 2002년 FDA 허가</P>
<P>- Xiidra (Shire): 2016년 FDA 허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>관련논문 등</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="99">
<P>- Gillian M. Keating. Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease. Drugs 2017;77(2):201-208</P>
<P>- ME Stern, CS Schaumburg, et al. Autoimmunity at the ocular surface: pathogenesis and regulation. MucosalImmunology 2010;3(5):425-442</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>시장규모</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 2018년 전세계 약 4조원 (출처: Research and Markets  2019)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타사항</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 대웅제약과 공동개발</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>(나) HL161 (성분명: batoclimab)</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="485"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>구분</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 바이오신약 (항체의약품)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>적응증</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="53">
<P>- MG (중증근무력증), TED (갑상선 안병증), WAIHA (온난항체 용혈성빈혈), NMOSD (시신경척수염), ITP (혈소판감소증)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>작용기전</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="99">
<P>- 자가면역질환을 유발하는 병원성 IgG를 감소시켜 질환치료</P>
<P>- HL161 항체가 혈액 내 IgG의 반감기를 늘려주는 FcRn과 binding하여 그 기능을 억제함으로써 체내 병원성 IgG를 빠르게 제거하는 효과를 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>제품의 특성</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="122">
<P>- Efficacy: IgG 최대 78%감소 (임상1상 결과), 경쟁 우위에 있음</P>
<P>- Safety: Human antibody (완전인간항체)를 이용하여 면역원성 (Immunogenicity) 우려가 낮고 높은 안전성 특징임</P>
<P>- Convenience: 경쟁제품들이 대부분 IV (정맥주입) 타입인데 반해 HL161은 자가투여가 가능한 SC (피하주사) 타입으로 편의성 높음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>진행경과</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="168">
<P>- 2017년 9월: Harbour BioMed와 중국지역 라이선스 아웃 계약</P>
<P>- 2017년 12월: Roivant Sciences와 글로벌 라이선스 아웃 계약</P>
<P>- 2019년: 임상1상 완료 (캐나다, 호주)&cr;- 2019년: MG, GO, WAIHA 임상2상 개시(북미, 유럽)&cr;- 2020년 3월: GO (or TED) 임상2a 결과발표</P>
<P>- 2020년 4월: NMOSD (시신경척수염) 임상1b/2a 개시(중국)&cr;- 2020년8월: MG (중증근무력증) 임상2상 결과발표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>향후계획</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="76">
<P>- 2021년 2분기: WAIHA 임상 2상 결과 도출</P>
<P>- 2021년 3분기: TED 임상 2b 결과 도출</P>
<P>- 2021년 상반기: MG 글로벌 임상3상 개시</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>경쟁제품</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="53">
<P>- 기존 치료제: IVIG 혈액제재 (Shire 등)</P>
<P>- 개발 진행 제품: efgartigimod (Argenx), rozanolixizumab (UCB) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>관련논문 등</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="168">
<P>- Peter Ulrichts, Antonio Guglietta, et al. Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans. J Clin Invest. 2018;128(10):4372-4386</P>
<P>- Bryan Smith, Andrea Kiessling, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. Mabs 2018;10(7):1111-1130</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>시장규모</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 전세계 60조원 전망 (출처: Chardan Capital)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타사항</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(다) HL186/187 </P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="485"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>구분</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 바이오신약 (항체의약품)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>적응증</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 항암치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>작용기전</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="53">
<P>- 면역세포의 기능을 약화시키는 면역관문억제제의 작용을 억제하여 면역세포의 항암 활성을 높임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품의 특성</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 새로운 타깃을 통한 병용 면역항암항체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>진행경과</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- Candidate 항체 도출을 위한 동물 모델 효능평가 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>향후계획</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 2021년 상반기 Candidate 항체 도출 후 전임상 착수</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>경쟁제품</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="53">
<P>- HL186: MGB453 (Novartis), BMS-986258 (BMS) 등 개발 중</P>
<P>- HL187: MTIG7192A (Genetech), MK-7684 (Merck) 등 개발 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>관련논문 등</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="145">
<P>- Benjamin L. Solomon, Ignacio Garrido-Laguna. TIGIT: a novel immunotherapy target moving from bench to bedside. Cancer Immunol Immunother. 2018 Nov;67(11):1659-1667</P>
<P>- Marin-Acevedo JA, Dholaria B et al., Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018 Mar 15;11(1):39</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>시장규모</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 2015년 전세계 20조원 시장 (출처: GBI리서치)  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타사항</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 대웅제약과 공동개발</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(라) HL189 (성분명: tanfanercept)</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="485"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>구분</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 바이오신약 (단백질의약품)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>적응증</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 포도막염</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>작용기전</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="53">
<P>- 안구에서 염증을 유발하는 TNFα를 억제 (tanfanercept가TNFα와binding)하여 포도막염을 치료하는 Mechanism of Action</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>제품의 특성</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="99">
<P>- 국소질환 최적화: Humira, Remicade 등 TNF저해제가 전신투여가 되어 국소질환에 비효과적인데 반해 HL189는 분자크기를 19kDa으로 최적화하여 조직에 효과적으로 침투 가능</P>
<P>- 안전성: 전신 노출이 극소량으로 높은 안전성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>진행경과</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 전임상 동물 모델 효력 확인 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>향후계획</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 효력 확인 후 독성시험 착수</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>경쟁제품</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 면역억제제, anti-TNF 항체 제품 (Humira 등)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>관련논문 등</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="122">
<P>- Suhler EB, Adan A, et al. Safety and Efficacy Patients with</P>
<P>Noninfectious of Adalimumab in Ongoing Open-Label Study: Uveitis in an VISUAL III. Ophthalmology. 2018;125(7):1075-1087</P>
<P>- Shahab MA, Mir TA, et al. Optimising drug therapy for non-infectious uveitis. 2018 doi: 10.1007/s10792-018-0984-1. [Epub ahead of print]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>시장규모</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>- 2016년 전세계 1조원 (출처: Variant Market Research)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타사항</P>
</TD>

<TD WIDTH="494" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> &cr;(2) 연구개발 완료 실적&cr;해당사항 없음.</P>
<P>&cr;(3) 연구개발활동 및 판매 중단 현황&cr;해당사항 없음.&cr;&cr;(4) 특허등록현황</P>

<TABLE BORDER="1" WIDTH="353" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="109"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="118" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">등록건수</TH>
<TH WIDTH="147" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">국내특허소계</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">33</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">한국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="31" WIDTH="118" HEIGHT="930" VALIGN="MIDDLE" ALIGN="CENTER">해외특허</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">24</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">남아프리카공화국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">싱가포르</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">5</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">호주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">11</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">9</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">프랑스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">러시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">11</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">일본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">9</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">독일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">11</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">영국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">네덜란드</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">말레이시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">스웨덴</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">스위스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">스페인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">캐나다</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">터키</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">이탈리아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">4</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">인도네시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">베트남</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">이스라엘</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">폴란드</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">벨기에</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">핀란드</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">덴마크</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">4</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">인도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">뉴질랜드</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">대만</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">마카오</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">홍콩</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">사우디아라비아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">해외특허 소계</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">120</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">    합 계</TD>
<TD WIDTH="88" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">153</TD>
<TD WIDTH="147" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>*한올바이오파마의 특허보유 현황은 한올바이오파마의 사업보고서를 참조하시기 바랍니다.</P>

<P>&cr;
<SPAN USERMARK="F-16 0XFF0000 B">&cr;9. 그 밖에 투자의사 결정에 필요한 사항&cr;</SPAN>
<SPAN USERMARK="F-14 B">&cr;</SPAN>
<SPAN USERMARK=" B">◆(주)대웅제약</SPAN>&cr;&cr;
<SPAN></SPAN>
<SPAN USERMARK=" B"> 가. 지적재산권 보유현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1061">

<COLGROUP>
<COL WIDTH="29"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="411"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="38" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="47" USERMARK="F-9">구분</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="47" USERMARK="F-9">종 류</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="47" USERMARK="F-9">취득일</TH>
<TH WIDTH="420" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="47" USERMARK="F-9">제  목</TH>
<TH WIDTH="163" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="47" USERMARK="F-9">독점적 사용기간</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="47" USERMARK="F-9">제품화여부&cr;  및 연구단계</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="47" USERMARK="F-9">제품의 명칭</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="47" USERMARK="F-9">출원인</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-01</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">신규한 헤테로 고리 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(러시아)&cr; 2020-10-01~2038-02-07</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-01</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">신규한 헤테로 고리 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(호주)&cr; 2020-10-01~2038-02-07</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-07</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">위장질환 치료용 의약 조성물</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(멕시코)&cr; 2020-10-07~2036-01-28</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">제품화</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">알비스</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">국문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-14</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">리토바젯</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(한국)&cr; 2020-10-14~2030-10-14</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-14</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">수산화알루미늄과 수산화마그네슘을 포함하는 현탁액 및 그 제조방법</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(인도)&cr; 2020-10-14~2038-04-12</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-15</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(칠레)&cr; 2020-10-15~2034-07-25</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">제품화</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">리피메트정</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">영문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-17</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">ABILICURE</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(한국)&cr; 2020-10-17~2030-10-17</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">영문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-19</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">LACFIDUS</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(태국)&cr; 2020-10-19~2027-06-12</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">제품화</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">영문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-19</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">OLODUO</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(과테말라)&cr; 2020-10-19~2030-10-19</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">영문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-19</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">SELAGUARD</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(태국)&cr; 2020-10-19~2027-06-13</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-21</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">피부 주입용 조성물</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(대만)&cr; 2020-10-21~2038-02-26</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">물질</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-22</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">소디움 채널 차단제</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(멕시코)&cr; 2020-10-22~2036-11-11</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">용기</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-26</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">용기 어셈블리</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(한국)&cr; 2020-10-26~2039-04-08</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">국문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-27</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">팻스필</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(한국)&cr; 2020-10-27~2030-10-27</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">영문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-29</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">SAYHEALTH</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(베트남)&cr; 2020-10-29~2027-12-04</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">영문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-10-30</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">CREZET</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(유럽)&cr; 2020-10-30~2030-06-25</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">제품화</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">크레젯</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-11-02</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">피부 주입용 조성물</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(일본)&cr; 2020-11-02~2038-02-27</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">물질</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-11-03</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">소디움 채널 차단제</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(도미니카공화국)&cr; 2020-11-03~2036-11-11</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-11-08</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(사우디)&cr; 2020-11-08~2036-04-27</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">제법</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-11-24</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">4-메톡시피롤 유도체의 중간체 제조 방법</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(일본)&cr; 2020-11-24~2038-06-21</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">제법</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-11-24</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">4-메톡시피롤 유도체의 중간체 제조 방법</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(일본)&cr; 2020-11-24~2038-05-31</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">영문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-11-24</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">BRINTELPIA</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(한국)&cr; 2020-11-24~2030-11-24</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">국문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-11-24</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">브린텔피아</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(한국)&cr; 2020-11-24~2030-11-24</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">제법</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-11-30</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">4-메톡시피롤 유도체의 중간체 제조 방법</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(러시아)&cr; 2020-11-30~2038-06-21</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">물질</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-12-01</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">카이네이즈 저해제로서의 피라졸로피리미딘 유도체</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(뉴질랜드)&cr; 2020-12-01~2037-06-30</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-12-04</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">SLIT-ROBO 시스템을 이용한 근감소증 예방 또는 치료용 조성물</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(일본)&cr; 2020-12-04~2037-06-08</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">상표</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">국문 및 영문상표(5류)</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-12-07</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">ALGIBIS 알지비스</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(한국)&cr; 2020-12-07~2030-12-07</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">물질</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-12-29</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">카이네이즈 저해제로서의 피롤로트리아진 유도체</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(콜롬비아)&cr; 2020-12-29~2038-03-19</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">제법</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-12-31</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">4-메톡시피롤 유도체의 중간체 제조 방법</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(카자흐스탄)&cr; 2020-12-31~2038-06-21</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">제법</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-12-31</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">4-메톡시피롤 유도체의 중간체 제조 방법</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(카자흐스탄)&cr; 2020-12-31~2038-05-31</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="67" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="67" USERMARK="F-9">조성물</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="67" USERMARK="F-9">2020-06-16</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="67" USERMARK="F-9">신규 약학 조성물</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="67" USERMARK="F-9">(중국)&cr; 2020-06-16~2036-01-14</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="67" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="67" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="67" USERMARK="F-9">(주) 대웅제약/(주)바이오시네틱스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="38" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">특허</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">제법</TD>
<TD WIDTH="74" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">2020-05-01</TD>
<TD WIDTH="420" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">다이페닐메탄 유도체의 제조방법</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(뉴질랜드)&cr; 2020-05-01~2037-06-15</TD>
<TD VALIGN="MIDDLE" WIDTH="93" HEIGHT="47" USERMARK="F-9">연구단계</TD>
<TD VALIGN="MIDDLE" WIDTH="84" HEIGHT="47" USERMARK="F-9">-</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="47" USERMARK="F-9">(주) 대웅제약/녹십자</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN> - 2020년 1월 1일~2020년 9월 30일 지적재산권 보유현황은 당사 제19기 정</SPAN>
<SPAN>기보고서의 </SPAN>
<SPAN>II. 사업의 내용 - 9. 그 밖에 투자의사 결정에 필요한 사항 - 지적재산권 보유현황을 참조하시기 바랍니다.  &cr;</SPAN>
<SPAN USERMARK=" 0X0000FF">&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B">한올바이오파마(주)&cr;</SPAN>
<SPAN USERMARK=" B">&cr;가. 특허보유현황&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>- 한올바이오파마(주)의 특허보유 현황은 한올바이오파마(주)의 사업보고서를 참조하시기 바랍니다.&cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『수주상황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_수주상황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>

<P>
<SPAN USERMARK=" B">&cr;※ </SPAN>
<SPAN USERMARK=" B">요약(연결)재무제표는 감사받은 (연결)재무제표입니다.</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">1) 요약 연결재무제표</SPAN>
</P>

<TABLE WIDTH="614" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="614" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="616" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">구 분</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 19기</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 18기</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[유동자산]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">528,351</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">526,256</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">515,666</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ현금및현금성 자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,299</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,094</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,334</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ매출채권 및 기타채권</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">148,887</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">205,736</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,888</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ단기금융자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,821</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,737</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ재고자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,971</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">177,609</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">189,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,374</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,080</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,366</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[비유동자산]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">838,557</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">719,412</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">692,180</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ유형자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">386,162</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">387,215</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">401,129</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ무형자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,742</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164,686</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149,574</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ투자부동산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,718</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">91,803</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">93,133</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">192,935</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,708</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,344</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">자산총계</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,366,908</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,245,668</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,207,846</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">326,750</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">262,080</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">367,401</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ매입채무및기타채무</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132,748</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">121,980</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,824</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ단기차입금</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">57,053</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,415</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,499</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">136,950</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">130,685</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">257,077</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">344,909</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">347,668</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">232,636</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ사채</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">199,640</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">289,196</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">179,486</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ퇴직급여채무</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,213</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ장기매입채무 및 기타채무</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,172</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,495</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135,096</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,977</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,636</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">부채총계</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">671,659</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">609,748</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">600,037</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[자본금]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[자기주식]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-29,236</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-44,916</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-44,916</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[기타불입자본]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,097</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,705</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,560</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[기타자본구성요소]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-2,635</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-6,857</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-9,362</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[이익잉여금]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">452,802</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">445,415</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">422,884</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[비지배지분]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">144,255</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">116,606</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">113,677</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">자본총계</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">695,249</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">635,920</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">607,809</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">매출액</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,055,424</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,113,426</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,031,427</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">영업이익</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,980</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,687</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,596</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">당기순이익</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,148</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,866</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-15,417</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[지배회사지분순이익]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,753</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,006</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-15,151</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[소수주주지분순이익]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,395</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,860</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">총포괄이익</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,506</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,360</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-14,082</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">주당순이익(원)</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,196</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,132</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-1,468</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">연결에 포함된 회사수</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">2) 요약 재무제표</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE WIDTH="615" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="616" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구 분</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 19기</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 18기</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">[유동자산]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">374,877</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">383,674</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">382,915</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ현금및현금성 자산</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,142</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">19,719</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">34,808</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ매출채권 및 기타채권</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">143,303</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">203,352</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">186,026</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ재고자산</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">141,453</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">146,053</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">154,709</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ단기금융자산</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,300</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">  8,050</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30"> 145</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,679</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">6,500</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">7,227</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">[비유동자산]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">811,858</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">716,308</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">693,394</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ유형자산</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">304,490</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">306,005</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">314,702</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ무형자산</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,906</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">92,107</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">71,529</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ투자부동산</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">82,561</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">93,680</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">95,046</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">321,901</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">224,516</TD>

<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">
<SPAN>212,11</SPAN>
<SPAN>8</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" ALIGN="CENTER" HEIGHT="30">자산총계</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,186,735</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">1,099,982</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">1,076,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">291,287</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">232,512</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">340,369</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ매입채무및기타부채</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">116,561</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">111,991</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">90,812</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">174,727</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">120,521</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">249,558</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">319,414</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">314,473</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">197,568</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ사채</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">199,640</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">289,196</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">179,486</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">ㆍ장기매입채무 및 기타채무</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,339</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">3,996</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">4,158</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">ㆍ기타</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">114,434</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">21,281</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">13,924</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">부채총계</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">610,702</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">546,985</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">537,937</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">[자본금]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">[자기주식]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-29,236</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">-44,916</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">-44,916</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">[기타불입자본]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">112,122</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">100,928</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">100,492</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">[이익잉여금]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">471,717</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">474,771</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">460,735</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">[기타자본구성요소]</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-7,535</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">-6,753</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">-6,907</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" ALIGN="CENTER" HEIGHT="30">자본총계</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">576,034</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">552,997</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">538,372</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="206" ALIGN="CENTER" HEIGHT="53">
<P>종속·관계·공동기업</P>
<P>투자주식의 평가방법</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">원가법</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">원가법</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">원가법　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">매출액</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">944,752</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">1,005,180</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">943,522</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">영업이익</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,626</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">31,447</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">33,795</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">당기순이익</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,139</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">20,228</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">1,481</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">총포괄이익</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,356</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">20,382</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">1,238</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30">주당순이익(원)</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">294</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">1,960</TD>
<TD WIDTH="136" ALIGN="RIGHT" HEIGHT="30">144</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<WARNING>※ 아래 『재무제표』단위서식을 클릭하여 해당사항을 선택하면,&cr;    2.연결재무제표 ~ 5.재무제표주석 항목을 삽입할 수 있습니다.</WARNING>
</SECTION-2>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『재무제표』 삽입</COMMENT>
<LIBRARYLIST>11011#*재무제표_*.*</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dslx:1629161712">제약연결_사업보고서 재무제표_2020.4q_별도,연결_20120315(단수조정).ixd</FILENAME>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>

<TABLE-GROUP ACLASS="{XBRL}BS" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">연결 재무상태표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 19 기          2020.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 18 기          2019.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기          2018.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 19 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 18 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 17 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>528,351,294,969</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>526,256,346,628</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>515,665,940,560</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>72,299,249,872</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>32,094,194,148</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>65,333,694,953</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　단기금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>104,820,752,359</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>97,736,962,094</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>67,042,664,110</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매출채권 및 기타채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>148,886,754,181</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>205,735,802,170</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>178,888,186,633</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>173,970,642,869</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>177,609,255,572</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>189,035,191,721</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　반환제품회수권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,764,043,800</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,282,361,981</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,889,161,469</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　당기법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>74,466,628</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>50,970,305</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>50,236,696</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,535,385,260</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,746,800,358</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>13,426,804,978</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>838,556,626,170</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>719,411,802,635</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>692,180,411,134</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>79,548,433</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>689,548,433</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>610,548,433</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기매도금융자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　당기손익-공정가치측정금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>75,342,100,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,000,020,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,072,604,290</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　　기타포괄손익-공정가치측정금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>58,573,590,692</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>20,908,223,880</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>7,923,052,670</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기매출채권 및 기타채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,738,348,201</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>5,733,900,726</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>7,405,470,590</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　관계기업투자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,880,980,123</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,235,949,046</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,127,635,048</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>386,161,986,677</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>387,214,960,894</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>401,129,322,098</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　사용권자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,528,467,364</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,493,091,884</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>80,718,109,172</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>91,802,587,643</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>93,133,376,262</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>178,741,886,162</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>164,685,811,529</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>149,573,573,685</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타투자자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,216,139,858</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,903,686,727</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,310,178,609</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이연법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>32,572,292,671</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,657,374,983</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,894,649,449</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　퇴직급여자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,176,817</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,086,646,890</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자산총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,366,907,921,139</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,245,668,149,263</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,207,846,351,694</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>326,750,097,396</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>262,080,185,563</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>367,400,664,611</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매입채무 및 기타채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>132,747,743,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>121,980,081,359</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>102,824,306,004</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　단기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>57,052,620,048</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,414,841,787</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,498,978,258</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유동성사채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>89,925,922,452</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>89,921,320,846</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>199,864,885,984</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유동성리스부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>984,156,852</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>993,720,142</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　당기법인세부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,660,343,070</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,910,348,466</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,946,300,566</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이연수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,157,582,412</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,092,448,422</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>43,379,311,618</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>36,702,290,551</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>38,173,745,377</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>344,909,207,138</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>347,667,869,229</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>232,636,237,152</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기매입채무 및 기타채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>10,172,468,872</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,494,944,622</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,300,805,655</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>91,524,818,966</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기차입부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>199,640,495,920</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>289,196,131,742</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>179,485,775,945</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　비유동리스부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,562,459,479</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,404,420,985</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　퇴직급여부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,213,217,417</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이연법인세부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,146,092,522</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,943,779,086</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,126,194,367</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>32,862,871,379</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>40,628,592,794</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>34,510,243,768</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>671,659,304,534</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>609,748,054,792</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>600,036,901,763</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자본</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　지배기업의 소유주에게 귀속되는 자본</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>550,993,579,785</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>519,314,539,733</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>494,132,577,022</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　자기주식</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(29,236,490,120)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타불입자본</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>101,097,023,147</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>96,705,421,479</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>96,559,941,491</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타자본구성요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,634,983,194)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,856,780,220)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,362,434,712)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이익잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>452,801,592,452</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>445,415,030,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>422,884,202,125</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비지배지분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>144,255,036,820</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>116,605,554,738</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>113,676,872,909</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>695,248,616,605</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>635,920,094,471</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>607,809,449,931</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자본과부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,366,907,921,139</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,245,668,149,263</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,207,846,351,694</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}IS1" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">연결 포괄손익계산서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 19 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 18 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 19 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 18 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 17 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,055,423,689,996</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,113,425,920,883</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,031,427,425,529</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>608,481,968,091</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>635,132,493,527</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>621,484,738,163</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출총이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>446,941,721,905</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>478,293,427,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>409,942,687,366</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>판매관리비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>314,744,407,100</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>324,165,830,437</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>269,385,493,680</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>경상연구개발비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>115,217,590,422</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>109,440,500,061</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>112,960,987,713</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>영업이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>16,979,724,383</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>44,687,096,858</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>27,596,205,973</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>영업외손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,420,391,546)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(21,365,423,631)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(28,218,728,319)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　지분법손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>529,964,809</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(27,483,863)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(127,270,325)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,062,013,492</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>11,109,049,119</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,419,497,122</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　금융원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(26,259,042,373)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(16,292,937,359)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(14,767,503,982)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　기타수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,811,940,785</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,098,695,263</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,238,959,803</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　기타비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(18,565,268,259)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(22,252,746,791)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(29,982,410,937)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>법인세비용차감전순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>13,559,332,837</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>23,321,673,227</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(622,522,346)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,588,732,825)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(5,543,932,617)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,794,722,172</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>24,148,065,662</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,865,605,844</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(15,417,244,518)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,358,102,337</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,493,998,684</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,334,827,158</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　후속적으로 손익으로 재분류되지 않는 항목</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>19,353,401,165</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>3,971,710,918</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>1,552,724,915</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　　기타포괄손익-공정가치측정 금융자산 평가손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>19,258,457,370</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>4,912,708,492</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>2,242,532,639</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　확정급여제도의 재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>94,943,795</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(940,997,574)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(689,807,724)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　당기손익으로 재분류될 수 있는 항목(세후기타포괄손익)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(995,298,828)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>522,287,766</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(217,897,757)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　　매도가능금융자산평가손익(세후기타포괄손익)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　　해외사업장환산외환차이(세후기타포괄손익)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(994,946,045)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>517,782,948</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(217,897,757)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　지분법자본변동</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(352,783)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,504,818</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>42,506,167,999</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>33,359,604,528</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(14,082,417,360)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)의 귀속</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　지배기업 소유주지분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>12,753,425,042</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>22,005,927,017</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(15,151,848,389)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비지배지분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>11,394,640,620</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,859,678,827</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(265,396,129)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총 포괄손익의 귀속</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　지배기업 소유주지분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>17,400,665,980</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>23,789,664,691</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(15,099,673,278)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비지배지분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>25,105,502,019</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,569,939,837</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,017,255,918</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주당이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　기본및희석주당이익 (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,196</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,132</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,468)</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
<P></P>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}EF" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1350" BORDER="0">

<COLGROUP>
<COL WIDTH="1341"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1350" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">연결 자본변동표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1350" HEIGHT="30" AUPDATECONT="N">
<P>제 19 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1350" HEIGHT="30" AUPDATECONT="N">
<P>제 18 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1350" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1350" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1350" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="136" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="3">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="1200" COLSPAN="8">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="900" COLSPAN="6">
<P>지배기업의 소유주에게 귀속되는 자본</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="106" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="2">
<P>비지배지분</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="106" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="2">
<P>자본  합계</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>자본금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>자기주식</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>기타불입자본</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>기타자본구성요소</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>이익잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>지배기업의 소유주에게 귀속되는 자본  합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2018.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>96,560,102,588</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,186,275,937)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>442,013,841,909</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>519,438,536,678</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>112,098,482,716</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>631,537,019,394</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,537,161,206)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,451,777,873</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(4,085,383,333)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(4,085,383,333)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(15,151,848,389)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(15,151,848,389)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(265,396,129)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(15,417,244,518)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 지분상품 평가손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>517,671,108</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>517,671,108</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>1,724,861,531</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>2,242,532,639</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>매도가능금융자산평가손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>확정급여제도의 재측정요소</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(237,047,268)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(237,047,268)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(452,760,456)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(689,807,724)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>지분법자본변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>해외사업환산손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(228,448,729)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(228,448,729)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,550,972</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(217,897,757)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>유상증자</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>71,780,052</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>71,780,052</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>561,272,971</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>633,053,023</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자기주식의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>연결범위의 변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(161,097)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(161,097)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(138,696)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(299,793)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>연결실체 내 자본거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2018.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>96,559,941,491</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,362,434,712)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>422,884,202,125</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>494,132,577,022</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>113,676,872,909</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>607,809,449,931</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2019.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>96,559,941,491</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,362,434,712)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>422,884,202,125</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>494,132,577,022</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>113,676,872,909</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>607,809,449,931</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,005,927,017</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,005,927,017</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,859,678,827</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,865,605,844</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 지분상품 평가손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>1,610,734,120</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>1,610,734,120</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>3,301,974,372</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>4,912,708,492</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>매도가능금융자산평가손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>확정급여제도의 재측정요소</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(286,378,226)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(286,378,226)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(654,619,348)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(940,997,574)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>지분법자본변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,504,818</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,504,818</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,504,818</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>해외사업환산손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>454,876,962</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>454,876,962</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>62,905,986</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>517,782,948</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>유상증자</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>238,982</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>238,982</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>109,617</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>348,599</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>435,538,592</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>435,538,592</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>507,674,821</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>943,213,413</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자기주식의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>연결범위의 변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>연결실체 내 자본거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>145,241,006</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>7,003,801,440</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>7,149,042,446</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(7,149,042,446)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2019.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>96,705,421,479</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,856,780,220)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>445,415,030,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>519,314,539,733</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>116,605,554,738</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>635,920,094,471</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2020.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>96,705,421,479</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,856,780,220)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>445,415,030,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>519,314,539,733</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>116,605,554,738</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>635,920,094,471</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>12,753,425,042</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>12,753,425,042</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>11,394,640,620</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>24,148,065,662</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 지분상품 평가손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>4,712,524,940</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>808,402,401</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>5,520,927,341</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>13,737,530,029</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>19,258,457,370</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>매도가능금융자산평가손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>확정급여제도의 재측정요소</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>17,256,053</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>17,256,053</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>77,687,742</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>94,943,795</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>지분법자본변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(352,783)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(352,783)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(352,783)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>해외사업환산손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(890,589,673)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(890,589,673)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(104,356,372)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(994,946,045)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,521,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,521,400)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,521,400)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>유상증자</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>67,774,770</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>67,774,770</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,792,227,880</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,860,002,650</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>400,214,542</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>400,214,542</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>794,302,173</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,194,516,715</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자기주식의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>15,679,079,262</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,793,848,888</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,472,928,150</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,472,928,150</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>연결범위의 변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>327,599,998</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>327,599,998</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>연결실체 내 자본거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,470,021,990)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,470,021,990)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,370,149,988)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,840,171,978)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2020.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(29,236,490,120)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>101,097,023,147</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,634,983,194)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>452,801,592,452</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>550,993,579,785</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>144,255,036,820</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>695,248,616,605</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}CF" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">연결 현금흐름표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 19 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 18 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 19 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 18 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 17 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>영업에서창출된현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,981,257,110</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>57,600,275,948</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>47,499,563,366</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>24,148,065,662</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,865,605,844</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(15,417,244,518)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　당기순이익조정을 위한 가감</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>60,196,904,719</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>73,757,436,699</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>117,830,898,365</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　퇴직급여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,121,272,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,744,250,342</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,173,378,647</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기종업원급여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>848,329,974</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>514,330,313</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>15,227,629</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　주식보상비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,194,516,715</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>943,213,414</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>633,053,021</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　감가상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>29,521,139,474</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>29,094,903,425</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>40,859,740,990</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,340,194,547</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,316,261,089</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,316,546,877</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,389,513,030</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,448,890,324</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,124,187,089</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　사용권자산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,630,860,235</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,335,313,053</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　대손상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,595,766,885</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,443,196,964</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,436,995,291</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>274,562,746</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,261,629,032</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　외화환산손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,975,648,981</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,235,459,979</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>618,004,521</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>57,149,867</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>339,388,737</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>7,972,678,874</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>278,466,508</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>14,527,530</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산평가손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>306,628,758</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>88,352,571</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산폐기손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>458,252,121</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>74,020,819</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,095,181,497</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산감모손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,443,459,107</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>6,367,057,383</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,967,556,925</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산손상차손</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,103,470,038</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>9,321,907,261</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>15,109,199,778</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이자비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,609,839,567</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,088,046,056</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,595,931,673</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매도가능금융자산손상차손</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　　당기손익-공정가치측정금융자산 평가손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>892,160,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　　당기손익-공정가치측정금융자산 평가이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(3,514,240,000)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,588,732,825)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(5,543,932,617)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,794,722,172</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　지분법손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>375,675,780</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>27,483,863</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>127,270,325</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　지분법이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(905,640,589)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　경상연구개발비</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>90,395,607</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　배당금수익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,863,336)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　대손충당금환입</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　잡손실</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,071,041,855</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　외화환산이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,617,329,599)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,949,026,786)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,090,431,297)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(69,495,354)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(396,112,094)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,081,394,553)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(632,705)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(8,069,639,855)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산평가손실환입</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　관계기업주식처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(11,782,988)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(5,323,110)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　관계기업주식손상차손</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>897,113,847</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　파생상품거래이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(10,915,817,753)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　리스해지이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(827,231)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이자수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,422,976,996)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,727,461,101)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,274,464,968)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　영업활동으로인한자산ㆍ부채의변동</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>27,954,268,879</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(14,903,589,538)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(39,485,517,560)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매출채권의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>44,176,341,183</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,733,084,514)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(8,440,175,425)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　미수금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>9,475,971,554</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(15,106,960,489)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,542,267,644)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　미수수익의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>286,165,733</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>210,672,264</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>107,943,092</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　단기보증금의증감</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>5,126,400</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,742,581,469)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>5,404,228,768</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(11,273,321,005)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　선급금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,124,814,067)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,020,240,923)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,846,171,069)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　선급비용의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(103,609,639)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(391,945,834)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,117,174,978</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　선급부가세의감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,131,180,568)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(622,690,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,245,958</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동자산의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(14,501,585,970)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>93,742,038</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,319,513,597)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기보증금의증감</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>236,221,459</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>367,788,807</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(738,246,263)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　반환제품회수권의증감</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>266,643,848</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(490,710,617)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>853,472,922</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기선급금의 감소(증가)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,393,836)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기선급비용의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,154,283,109</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(744,319,275)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(28,259,614)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동자산의증가(감소)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매입채무의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,865,323,720</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>12,600,131,210</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,513,227,769</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　미지급금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>7,461,743,705</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,252,989,654)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(7,349,029,608)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　미지급비용의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>273,806,637</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(60,573,949)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(79,914,145)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　선수금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(519,690,942)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>906,481,402</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(736,021,052)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　선수수익의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,756,539</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,437,916,051</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,421,006,560)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　예수금의감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(646,568,945)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>432,481,197</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>857,887</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　예수보증금의증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,084,578,123</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(258,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>775,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　부가세예수금의증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,205,585,564</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>208,804,011</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(73,040,313)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　이연수익의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(32,264,878)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,661,442,857</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,737,423,426</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,610,941,005)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,142,162,304)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타충당부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,201,103,974</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>728,958,469</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(907,272,162)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기미지급금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(46,146,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,020,348)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(354,499,097)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기예수보증금의증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,276,329,749)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(128,860,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(97,640,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기선수수익의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,504,388,039</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,474,320,715</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기이연수익의증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(7,893,068,271)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,531,217,857</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동부채의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(147,559,610)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>72,293,658</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,415,112,499</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타장기충당부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(443,556,149)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　퇴직급의지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,776,237,877)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,040,312,430)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,909,169,068)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　사외적립자산의감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(600,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(5,569,025,968)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,021,843,739)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이자수취(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,255,722,049</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,568,618,300</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,523,639,601</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이자지급(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,667,461,412)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,389,669,713)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,048,768,601)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　배당금수취(영업)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,129,725</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　법인세납부</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,906,309,837)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(22,299,469,454)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,913,573,646)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　법인세의 환급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>67,050</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,343,810</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>투자활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(127,151,664,625)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(85,605,118,333)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(68,619,492,620)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　단기금융상품의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>360,352,754,076</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,200,289</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>221,567,558,329</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　단기금융상품의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(367,292,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(219,165,374,446)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(233,541,729,614)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　당기손익-공정가치측정 금융자산의 감소</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>188,622,295,586</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　당기손익-공정가치측정 금융자산의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(78,165,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(1,000,020,000)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　장기금융상품의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(30,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(79,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(120,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　장기금융상품의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>640,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>256,185,338</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　대여금의 감소</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>200,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>207,666,666</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　대여금의 증가</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>174,275,951</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　장기대여금및수취채권의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,011,333,316</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>220,000,008</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　기타포괄손익-공정가치측정금융자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(3,239,896,643)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(5,608,502,872)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(339,100,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　기타포괄손익-공정가치측정금융자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>1,149,657,106</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>3,750</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>675,750,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　관계기업주식의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,000,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,125,970,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,600,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유형자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>130,151,078</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>139,873,205</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,242,020,994</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　무형자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,428,979,465</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,495,801,165</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>699,565,200</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　투자부동산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,570,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(26,486,239,341)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(22,314,486,678)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(56,989,379,371)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　무형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(33,210,070,366)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(27,792,271,648)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(72,306,121)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　투자부동산의 취득</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>재무활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>66,587,117,245</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(5,660,155,189)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,777,850,860)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　단기차입금의 차입</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>52,086,624,870</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,421,461,245</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,804,843,361</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　단기차입금의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,357,294,787)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,564,760,758)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,390,172,221)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　장기차입금의 차입</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>91,560,619,699</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　금융리스부채의 지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,701,811,154)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,324,333,676)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　배당금지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,521,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　사채의 증가</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>200,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>90,000,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　사채의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(90,000,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(200,000,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(90,000,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비지배지분의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,187,602,650</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자기주식의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>29,987,313,047</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비지배지분의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,000,030,680)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　종속기업주식의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>16,615,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>현금및현금성자산에 대한 환율변동효과</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(211,654,006)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>425,496,769</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>110,171,823</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>현금및현금성자산의순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>40,205,055,724</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(33,239,500,805)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(25,787,608,291)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기초현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>32,094,194,148</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>65,333,694,953</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>91,121,303,244</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기말현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>72,299,249,872</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>32,094,194,148</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>65,333,694,953</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P USERMARK="F-16 0XFF0000 B"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제19(당) 기 2020년 1월 1일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="53">제18(전) 기 2019년 1월 1일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">주식회사 대웅제약과 그 종속기업</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>1. 회사의 개요&cr;(1) 지배기업의 개요</P>

<P>주식회사 대웅제약(이하 "지배기업")은 2002년 10월 1일을 기준일로 주식회사 대웅  (분할 전 상호: 주식회사 대웅제약)이 사업부문을 인적분할하여 2002년 10월 2일자로 설립되었으며, 의약품 생산 및 판매를 주요 사업으로 영위하고 있습니다. 지배기업은 2002년 11월 1일자로 한국거래소(구, 한국증권선물거래소)가 개설한 유가증권 시장에 상장하였으며, 보고기간 종료일 현재 경기도 성남시와 화성군 향남공단 내에 정제의약품 생산 KGMP 기준에 부합하는 제조시설을 두고 있습니다.&cr;&cr;
<SPAN>지배기업은 그 동안 수차례의 증자를 거쳐 당기말 현재의 자본금은 </SPAN>
<SPAN>28,966백만원</SPAN>
<SPAN>이며, 주요 주주현황은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="638" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">주 주 명</TH>
<TH WIDTH="213" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">소유주식수</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">지 분 율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">(주)대웅</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">5,221,547 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">45.07%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">(재)대웅재단</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">998,453 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">8.62%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">자기주식</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">823,880 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">7.11%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">기타</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">4,542,695 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">39.20%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합         계</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">11,586,575 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;2020년 12월 31일로 종료하는 보고기간에 대한 연결재무제표는 지배기업과 지배기업의 종속기업(이하 "연결실체"라 함), 연결실체의 관계기업에 대한 지분으로 구성되어 있습니다. </P>
<PGBRK></PGBRK>
<P>(2) 종속기업 현황</P>
<P>당기말 현재 연결재무제표 작성대상 종속기업들의 현황은 다음과 같습니다.&cr;</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="998" BORDER="1">

<COLGROUP>
<COL WIDTH="332"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="223"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="341" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH ALIGN="CENTER" WIDTH="156" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">영업활동</TH>
<TH ALIGN="CENTER" WIDTH="232" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(*1)</TH>
<TH ALIGN="CENTER" WIDTH="80" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결산일</TH>
<TH ALIGN="CENTER" WIDTH="95" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">생활습관병 예방연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">75.97%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">12월 31일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">대한민국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">지주회사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">89.83%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">홍콩</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="53" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="53">의약품 제조 및 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="53">DAEWOONG PHARMACEUTICAL HONGKONG의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">89.83%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">인도네시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="53" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="53">의약품 제조 및 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="53">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">55.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">인도네시아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharma PHILIPPINES INC.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">필리핀</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical(Thailand)Co.,Ltd</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="53">의약품 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="53">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">태국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주) (*2)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">31.48%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">대한민국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">HPI,INC. (*2)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">FDA임상시험 진행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">한올바이오파마(주)의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">31.48%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">중국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical India Pvt.,Ltd.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">3월 31일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">인도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">Daewoong America, Inc.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">12월 31일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">미국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical(Japan)Co., Ltd.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 제조 및 판매</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">100.00%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">일본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">아피셀테라퓨틱스(*3)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">54.10%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">대한민국</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">아이엔테라퓨틱스(*3)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="30">의약품 연구</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="232" HEIGHT="30">지배기업의 종속기업</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">97.54%</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30">〃</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="30">대한민국</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0XBD6F00">
<SPAN USERMARK=" 0X000000">(*1) 연결실체가 보유한 소유지분율의 단순합계 입니다.&cr;</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">(*2) 사실상의 지배력이 있다고 판단하여 연결대상으로 포함하였습니다. &cr;(*3) 당기중 출자설립하여 연결대상으로 포함되었습니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>
<P>(3) 당기말 현재 연결대상 종속기업의 주요 재무정보는 다음과 같습니다.&cr;가. 재무상태 및 손익</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="970" BORDER="1">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" WIDTH="970" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">  (단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="344" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산총액</TH>
<TH ALIGN="CENTER" WIDTH="127" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채총액</TH>
<TH ALIGN="CENTER" WIDTH="127" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">순자산</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">31,160,612 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">20,612,773 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">10,547,839 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">6,144,535 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">(2,964,072)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">41,979,007 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">7,017 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">41,971,990 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">(14,814)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">32,712,153 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">3,596,034 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="127" HEIGHT="30">29,116,119 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">4,340,325 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">(1,901,628)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">2,386,331 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">1,528,245 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">858,086 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">497,152 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">(707,166)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">10,168,101 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">3,388,687 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">6,779,414 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">8,125,242 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">3,093,890 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharma PHILIPPINES INC.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">2,610,449 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">702,104 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">1,908,345 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">4,193,964 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">253,627 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical(Thailand)Co.,Ltd.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">3,542,105 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">4,393,930 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">(851,825)</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">7,231,142 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">727,562 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">219,483,648 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">38,322,293 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">181,161,355 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">88,602,270 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">19,863,538 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">HPI,INC.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">347,327 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">159,979 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">187,348 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">477,920 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">(99,039)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">4,193,618 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">3,594,245 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">599,373 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">2,103,549 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">734,568 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical India Pvt.,Ltd.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">849,678 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">159,725 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">689,953 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">1,272,950 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">225,637 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong America, Inc.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">97,103 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">2,362 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">94,741 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">259,611 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">84,033 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">Daewoong Japan, Inc.</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">7,671,647 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">7,426,644 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">245,003 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">19,488,952 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">659,692 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">아피셀테라퓨틱스</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">5,688,129 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">137,438 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">5,550,691 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">4,545 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">(1,174,712)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">아이엔테라퓨틱스</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">2,125,940 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">1,134,147 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">991,793 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">3,000 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">(2,566,132)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="344" HEIGHT="30" VALIGN="MIDDLE">합계</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">365,015,848 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">85,165,623 </TD>
<TD ALIGN="RIGHT" WIDTH="127" HEIGHT="30" VALIGN="MIDDLE">279,850,225 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">142,745,157 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">16,214,984 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>나. 현금흐름</SPAN>
</P>

<TABLE BORDER="1" WIDTH="970" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="333"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="970" VALIGN="MIDDLE" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30"> (단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="342" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">회사명</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">영업활동&cr;현금흐름</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">투자활동&cr;현금흐름</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">재무활동&cr;현금흐름</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">기타</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="54">현금및현금성자산의 순증감</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">(주)힐리언스</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,148,888)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(52,454)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,087,237 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(114,105)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,183)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,362)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(18,545)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">요녕대웅제약유한공사</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,126,697 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,872,014)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,560,620 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13,913)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">801,390 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">PT. Daewoong Pharmaceutical(Indonesia)Co.,Ltd.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(344,803)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(58,619)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">201 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(403,221)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">PT. DAEWOONG INFION</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,311,450 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(278,097)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,172,672)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,508)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(153,827)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,907 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,093)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,651)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,163 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical(Thailand)Co.,Ltd.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,408 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,330)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,886)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(43,306)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">192,886 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">한올바이오파마(주)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">976,174 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,528,489)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(446,479)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,322)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,002,116)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">HPI,INC.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(46,883)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(72,866)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,527)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(128,276)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">238,035 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,416 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">250,451 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical India Pvt.,Ltd.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">176,382 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,462 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,929)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">182,915 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong America, Inc.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,149 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,118)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">92,031 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">Daewoong Japan, Inc.</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,891,846 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">689 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(90,971)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(133,001)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,668,563 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">아피셀테라퓨틱스</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,267,524)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(549,548)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,713,011 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,895,939 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" HEIGHT="30">아이엔테라퓨틱스</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,654,215)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(12,711)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,924,252 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,257,326 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="342" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,644,552 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,338,204)</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,500,246 </TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(236,020)</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,570,574 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>&cr;상기 재무정보는 내부거래 상계전 금액입니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>다. 당기 중 연결대상 종속기업의 비지배지분에 대한 정보는 아래와 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="924">

<COLGROUP>
<COL WIDTH="331"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="924" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">  (단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="340" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">회사명</TH>
<TH WIDTH="158" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">비지배지분율(*)</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">비지배지분의&cr;장부금액</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">비지배지분의&cr;당기손익</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">비지배지분의&cr;총포괄손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">24.03%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,534,646 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(712,267)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(171,158)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10.17%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,268,551 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,507)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(252,856)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10.17%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,961,109 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(193,396)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,786 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">45.00%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,050,736 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,392,250 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">501,771 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">68.52%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">124,131,761 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,610,496 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,503,924 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">HPI,INC.</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">68.52%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">128,371 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(67,861)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(53,455)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">아피셀테라퓨틱스</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">45.90%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,547,767 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(539,193)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(247,489)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">아이엔테라퓨틱스</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2.46%</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,398 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(63,127)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,553)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="30" VALIGN="MIDDLE">연결조정</TD>
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,607,698 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,030,754)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,818,532 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="498" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">합           계</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">144,255,037 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,394,641 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,105,502 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 자기주식 등을 제외한 유효지분율 입니다.&cr;</P>

<P>
<SPAN>2. 재무제표 작성기준 및 중요한 회계정책&cr;연결실체는 '주식회사 등의 외부감사에 관한 법률'에 따라 제정된 한국채택국제회계기준에 따라 연결재무제표를 작성하였습니다.&cr;&cr;연결실체의 재무제표는</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"> </SPAN>
<SPAN>2</SPAN>
<SPAN>021년 3</SPAN>
<SPAN>월</SPAN>
<SPAN> </SPAN>
<SPAN>11</SPAN>
<SPAN>일자</SPAN>
<SPAN> 이사회</SPAN>
<SPAN>에서 </SPAN>
<SPAN>최종 승인될 </SPAN>
<SPAN>예</SPAN>
<SPAN>정</SPAN>
<SPAN>입니다&cr;&cr;2.1 재무제표 작성기준&cr;</SPAN>
<SPAN>연결재무제표는 아래에서 열거하고 있는 재무상태표의 주요 항목을 제외하고는 역사적원가를 기준으로 작성되었습니다.&cr;가. 공정가치로 측정되는 채무 및 지분의 금융자산&cr;나. 확정급여채무의 현재가치에서 사외적립자산의 공정가치를 차감한 확정급여부채&cr;</SPAN>
</P>
<P>(2) 기능통화와 표시통화&cr;연결실체 내 개별기업의 재무제표는 각 개별기업의 영업활동이 이루어지는 주된 경제환경의 통화(기능통화)로 작성되고 있습니다. 연결실체의 연결재무제표는 보고기업인 지배기업의 기능통화 및 표시통화인 원화로 작성하여 보고하고 있습니다.&cr;</P>
<P>(3) 추정과 판단&cr;한국채택국제회계기준에서는 재무제표를 작성함에 있어서 회계정책의 적용이나 보고기간말 현재 자산, 부채 및 수익, 비용의 보고금액에 영향을 미치는 사항에 대하여 경영진의 최선의 판단을 기준으로 한 추정치와 가정의 사용을 요구하고 있습니다. 보고기간말 현재 경영진의 최선의 판단을 기준으로 한 추정치와 가정이 실제 환경과 다를 경우 이러한 추정치와 실제결과는 다를 수 있습니다.&cr;</P>

<P>
<SPAN>현재의 상황과 미래</SPAN>에 대한 가정은 시장의 변화나 연결실체의 통제에서 벗어난 상황으로 인해 변화할 수 있습니다. 그러한 변화가 발생시 이를 가정에 반영하고 있습니다. 연결재무제표 작성시 사용된 중요한 회계추정 및 가정은 전기 연결재무제표의 작성시 적용된 회계추정 및 가정과 동일합니다.&cr;
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>가. 경영진의 판단&cr;
<SPAN>재무제표에 인식된 금액에 유의한 영향을 미치는 회계정책의 적용과 관련된 주요한 경영진의 판단에 대한 정보는 다음의 주석사항에 포함되어 있습니다. </SPAN>
</P>
<P>- 주석 1: 연결범위 - 사실상의 지배력&cr;- 주석 13: 투자부동산의 분류</P>

<P>
<SPAN>&cr;나. 가정과 추정의 불확실성&cr;다</SPAN>
<SPAN>음 </SPAN>
<SPAN>보고기간</SPAN>
<SPAN> 이내에 중요한 조정이 발생할 수 있는 유의한 위험이 있는 가정과 추정의 불확실성에 대한 </SPAN>
<SPAN>정보는 다음의 주석사항에 포함되어 있습니다.&cr;</SPAN>
<SPAN>- 주석 18: 계약부채의 측정&cr;- 주석 19: 확정급여채무의 측정&cr;- 주석 28: 이연법인세의 측정&cr;</SPAN>
<SPAN></SPAN>
</P>
<P>다. 공정가치 측정&cr;연결실체의 회계정책과 공시사항은 다수의 금융 및 비금융자산과 부채에 대해 공정가치 측정을 요구하고 있는 바, 연결실체는 공정가치평가 정책과 절차를 수립하고 있습니다. 동 정책과 절차에는 공정가치 서열체계에서 수준 3으로 분류되는 공정가치를 포함한 모든 유의적인 공정가치 측정의 검토를 책임지는 평가부서의 운영을 포함하고 있으며, 그 결과는 재무담당임원에게 직접 보고되고 있습니다.&cr;&cr;평가부서는 정기적으로 관측가능하지 않은 유의적인 투입변수와 평가 조정을 검토하고 있습니다. 공정가치 측정에서 중개인 가격이나 평가기관과 같은 제3자 정보를 사용하는 경우, 평가부서에서 제3자로부터 입수한 정보에 근거한 평가가 공정가치 서열체계 내 수준별 분류를 포함하고 있으며 해당 기준서의 요구사항을 충족한다고 결론을 내릴 수 있는지 여부를 판단하고 있습니다.&cr;</P>
<P>자산이나 부채의 공정가치를 측정하는 경우, 연결실체는 최대한 시장에서 관측가능한 투입변수를 사용하고 있습니다. 공정가치는 다음과 같이 가치평가기법에 사용된 투입변수에 기초하여 공정가치 서열체계 내에서 분류됩니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="671"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="680" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">투입변수의 유의성</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER">수준 1</TD>
<TD WIDTH="680" HEIGHT="30">측정일에 동일한 자산이나 부채에 대한 접근 가능한 활성시장의 조정되지 않은 공시가격</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER">수준 2</TD>
<TD WIDTH="680" HEIGHT="30">수준 1 의 공시가격 이외에 자산이나 부채에 대해 직접적으로 또는 간접적으로 관측가능한 투입변수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER">수준 3</TD>
<TD WIDTH="680" HEIGHT="30">자산이나 부채에 대한 관측가능하지 않은 투입변수</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;자산이나 부채의 공정가치를 측정하기 위해 사용되는 여러 투입변수가 공정가치 서열체계 내에서 다른 수준으로 분류되는 경우, 연결실체는 측정치 전체에 유의적인 공정가치 서열체계에서 가장 낮은 수준의 투입변수와 동일한 수준으로 공정가치 측정치 전체를 분류하고 있으며, 변동이 발생한 보고기간 말에 공정가치 서열체계의 수준간 이동을 인식하고 있습니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>라. 연장 및 종료선택권이 있는 계약의 리스기간 산정 - 리스이용자로서의 판단</SPAN>
</P>
<P>연결실체는 리스기간을 리스의 해지불능기간과 리스 연장선택권을 행사할 것이 상당히 확실한 경우에 그 선택권의 대상기간 또는 리스 종료선택권을 행사하지 않을 것이상당히 확실한 경우에 그 선택권의 대상기간을 포함하여 산정합니다</P>
<P></P>
<P>연결실체는 연장선택권을 포함하는 리스 계약들을 가지고 있습니다. 연결실체는 리스를 연장 또는 종료하기 위한 선택권을 행사할지 여부가 상당히 확실한지를 평가할 때 판단을 적용합니다. 즉, 연장선택권을 행사할 경제적 유인이 생기게 하는 관련되는 사실 및 상황을 모두 고려합니다. 개시일 이후, 연결실체는 연결실체의 통제 하에 있는 상황에서 유의적인 사건이나 변화가 있고, 연장선택권을 행사할지에 대한 능력에 영향을 미치는 경우 리스기간을 재평가합니다. </P>

<P>
<SPAN></SPAN>
</P>
<P>마. 부동산 리스의 분류 - 리스제공자로서의 판단</P>
<P>연결실체는 투자부동산 포트폴리오에 대한 상업용 부동산 리스계약을 체결하였습니다. 연결실체는 상업용 부동산 경제적 내용연수의 상당 부분을 차지하지 않는 리스기간 및 상업용 부동산 공정가치의 대부분에 해당하지 않는 리스료의 현재가치와 같은 약정의 조건에 대한 평가에 근거하여 해당 부동산의 소유에 따른 위험과 보상의 대부분을 보유하고 있고 이러한 계약을 운용리스로 회계처리 하기로 결정하였습니다. </P>

<P>
<SPAN></SPAN>
</P>
<P>바. 리스 - 증분차입이자율의 산정</P>

<P>
<SPAN>연결실체는 리스의 내재이자율을 쉽게 산정할 수 없으므로, 리스부채를 측정하기 위해 증분차입이자율을 사용합니다. 증분차입이자율은 연결실체가 비슷한 경제적 환경에서 비슷한 기간에 걸쳐 비슷한 담보로 사용권자산과 가치가 비슷한 자산 획득에 필요한 자금을 차입한다면 지급해야 하는 이자율입니다. 따라서 증분차입이자율은 관측가능한 요율이 없거나 리스 조건을 반영하기 위하여 조정되어야 하는 경우에 측정이 요구되는 연결실체가 '지불해야 하는' 사항을 반영합니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(4) 회계정책의 변경&cr;</SPAN>
<SPAN>아래에서 설명하고 있는 2020년 1월 1일부터 최초로 적용되는 제ㆍ개정 기준서의 적용을</SPAN>
<SPAN></SPAN>
<SPAN> 제외하고 </SPAN>
<SPAN>연결실체는 당기 및 비교 표시된 전기 재무제표에 동일한 회계정책을 </SPAN>
<SPAN>적용하고</SPAN>
<SPAN> 있습니다. 동 개정으로 인해 연결실체의 연결재무제표에 미치는 영향은 유의적이지 않다고 판단하고 있습니다.&cr;&cr;</SPAN>
<SPAN>가. 기업회계기준서 제1103호 '사업결합' (개정) - 사업의 정의&cr;</SPAN>
<SPAN>기</SPAN>
<SPAN>업회계기준서 제1103호의 개정사항은 활동과 자산의 집합이 사업의 정의를 충족하기 위해서는 적어도 산출물의 창출에 함께 유의적으로 기여할 수 있는 능력을 가진 투입물과 실질적인 과정을 반드시 포함해야 한다는 것을 명확히 하였습니다. 또한 산출물을 창출하는 데 필요한 모든 투입물과 과정을 포함하지 않더라도 사업이 존재할 수 있다는 것을 명확히 하였습니다. 이 개정사항이 연결재무제표에 미치는 영향은 없으나, 향후 에 사업결합이 발생할 경우 영향을 미칠 수 있습니다&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>나. 기업회계기준서 제1107호 '금융상품: 공시', 제1109호 '금융상품' 및 제1039호 '금융상품: 인식과 측정' (개정) - 이자율 지표 개혁&cr;</SPAN>
<SPAN>기</SPAN>
<SPAN>업회계기준서 제1109호와 제1039호 '금융상품: 인식과 측정' 개정은 이자율지표 개혁의 직접적인 영향을 받는 모든 위험회피관계에 적용되는 많은 완화 규정을 제공합니다. 위험회피관계는 이자율 지표 개혁이 위험회피대상항목이나 위험회피수단의 이자율지표에 근거한 현금흐름의 시기 또는 금액에 대한 불확실성을 야기하는 경우에 영향을 받습니다. 연결실체의 연결재무제표에는 어떠한 이자율위험회피관계도 없기 때문에 동 개정사항이 미치는 영향은 없습니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>다. 기업회계기준서 제1001호 '재무제표 표시'와 제1008호 '회계정책, 회계추정의 변경 및 오류' (개정) - 중요성의 정의&cr;</SPAN>
<SPAN>기업회계기준서 제1001호와 제1008호 개정사항은 '특정 보고기업에 대한 재무정보를 제공하는 일반목적재무제표에 정보를 누락하거나 잘못 기재하거나 불분명하게 하여, 이를 기초로 내리는 주요 이용자의 의사결정에 영향을 줄 것으로 합리적으로 예상할 수 있다면 그 정보는 중요'하다는 중요성의 새로운 정의를 제공합니다. 동 개정사항은 중요성이 개별적으로 또는 다른 정보와 결합하여 재무제표에서의 정보의 성격 또는 규모에 의존한다는 것을 명확히 하였습니다. 만약 주요 재무정보이용자의 결정에 영향을 줄 것이라는 합리적으로 예상 가능하다면 해당 정보의 오류는 중요합니다. 동 개정사항이 연결실체의 연결재무제표 및 향후에 미치는 영향은 없을 것으로 예상합니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>라. 재무보고를 위한 개념체계(2018 개정)&cr;</SPAN>
<SPAN>개</SPAN>
<SPAN>념체계는 회계기준이 아니며, 개념체계의 어떠한 내용도 회계기준이나 그 요구사항에 우선하지 않습니다. 개념체계의 목적은 회계기준위원회가 한국채택국제회계기준을 제ㆍ개정하는 데 도움을 주며, 적용할 회계기준이 없는 경우에 재무제표 작성자가 일관된 회계정책을 개발하는 데 도움을 줍니다. 또한 모든 이해관계자가 회계기준을 이해하고 해석하는 데 도움을 줍니다. 이 개념체계 개정은 일부 새로운 개념을 포함하고 있으며, 자산과 부채의 정의와 인식기준의 변경을 제시하고, 일부 중요한 개념을 명확히 합니다. 동 개정이 연결실체의 연결재무제표에 미치는 영향은 없습니다.</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>3. 유의적인 회계정책&cr;연결실체가 한국채택국제회계기준에 따른 연결재무제표 작성에 적용한 유의적인 회계정책은 아래 기술되어 있으며, 주석 2에서 설명하고 있는 회계정책의 변경을 제외하고, 당기 및 비교표시된 전기의 연결재무제표는 동일한 회계정책을 적용하여 작성되었습니다.&cr;&cr;(1) 연결</P>

<P>
<SPAN>가. 사업결합&cr;사업결합은 동일지배 하에 있는 기업실체나 사업에 대한 결합을 제외하고 취득법을 적용하여 회계처리하고 있습니다.&cr;&cr;이전대가는 일반적으로 식별가능한 취득 순자산을 공정가치로 측정하는 것과 동일하게 공정가치로 측정하고 있습니다. 사업결합의 결과 영업권이 발생되면 매년 손상검사를 수행하고 있으며, 염가매수차익이 발생되면 즉시 당기손익으로 인식하고 있습니다. 취득관련원가는 기업회계기준서 제1032호와 기업회계기준서 제1039호에 따라 인식하는 채무증권과 지분증권의 발행원가를 제외하고, 원가가 발생하고 용역을 제</SPAN>공받은 기간에 비용으로 회계처리하고 있습니다.&cr;&cr;이전대가는 기존관계의 정산과 관련된 금액을 포함하고 있지 않으며, 기존관계의 정산금액은 일반적으로 당기손익으로 인식하고 있습니다.&cr;&cr;조건부대가는 취득일에 공정가치로 측정되고 있습니다. 자본으로 분류되는 조건부대가는 재측정하지 않으며, 그 후속 정산은 자본 내에서 회계처리하고 있습니다. 조건부대가가 자본으로 분류되지 않는 경우, 후속적으로 조건부대가의 공정가치 변동을 인식하여 당기손익으로 처리하고 있습니다.&cr;&cr;피취득자의 종업원이 보유하고 있는 보상과 교환된 취득자의 주식기준보상의 경우, 취득자의 대체보상에 대한 시장기준 측정치의 전부 또는 일부는 사업결합의 이전대가 측정에 포함되고 있습니다. 피취득자에 대한 이전대가의 일부인 대체보상 부분과 사업결합 후 근무용역에 대한 보수 부분은 피취득자의 보상에 대한 시장기준측정치와 사업결합 전 근무용역에 대한 대체 보상액을 비교하여 결정되고 있습니다.&cr;&cr;나. 비지배지분&cr;비지배지분은 취득일에 피취득자의 식별가능한 순자산에 대해 인식한 금액 중 현재의 지분상품의 비례적 몫으로 측정하고 있습니다.&cr;&cr;지배력을 상실하지 않는 종속기업에 대한 지배기업의 소유지분 변동은 자본거래로 회계처리하고 있습니다.&cr;&cr;다. 종속기업
</P>
<P>종속기업은 연결실체에 의해 지배되는 기업입니다. 연결실체는 피투자기업에 대한 관여로 변동이익에 노출되거나 변동이익에 대한 권리가 있고 피투자기업에 대하여 자신의 힘으로 그러한 이익에 영향을 미치는 능력이 있을 때 피투자기업을 지배합니다. 종속기업의 재무제표는 지배기업이 종속기업에 대한 지배력을 획득하는 날부터 지배력을 상실할 때까지 연결재무제표에 포함됩니다.&cr;</P>
<P>연결실체를 구성하는 기업이 유사한 상황에서 발생한 동일한 거래와 사건에 대하여 연결재무제표에서 채택한 회계정책과 다른 회계정책을 사용한 경우에는 그 재무제표를 적절히 수정하여 연결재무제표를 작성하고 있습니다.&cr;</P>
<P>라. 지배력의 상실&cr;지배기업이 종속기업에 대한 지배력을 상실한다면, 연결재무상태표에서 종전의 종속기업에 대한 자산과 부채를 제거하고 종전의 지배지분에 귀속되는 지배력 상실 관련 손익을 인식합니다. 종속기업에 대한 잔존 투자는 지배력을 상실한 때의 공정가치로 인식합니다.&cr;</P>
<PGBRK></PGBRK>
<P>마. 관계기업&cr;관계기업은 연결실체가 재무정책 및 영업정책에 대한 유의적인 영향력을 보유하고 있으나, 지배하거나 공동지배하지 않는 기업이며, 일반적으로 연결실체가 피투자기업 의결권의 20%에서 50%를 소유하고 있다면 유의적인 영향력이 있는 것으로 판단하고 있습니다.&cr;&cr;관계기업 투자지분은 최초에 취득원가로 인식하고, 취득후에는 지분법을 사용하여 회계처리하고 있습니다. 즉, 취득일 이후에 발생한 피투자자의 당기순손익 및 자본변동분 중 연결실체의 지분에 해당하는 금액을 장부금액에 가감하고, 피투자자에게 받은 분배액은 투자지분의 장부금액에서 차감하고 있습니다. 연결실체와 관계기업간의내부거래에서 발생한 미실현이익은 연결실체지분만큼 제거하고 있습니다. 미실현손실 또한 거래가 이전된 자산에 대한 손상의 증거를 제공하지 않는 한 제거하고 있습니다. </P>
<P></P>
<P>관계기업이 유사한 상황에서 발생한 동일한 거래와 사건에 대하여 다른 회계정책을 사용한 경우에는 관계기업의 재무제표를 적절히 조정하고 있습니다.  </P>
<P></P>
<P>투자지분의 장부금액이 영("0")으로 감소된 이후 추가 손실분에 대하여 법적의무 또는 의제의무가 있거나 피투자자를 대신하여 지불하여야 하는 경우를 제외하고는 손실을 인식하지 않고 있습니다. </P>
<P>&cr;바. 내부거래제거&cr;연결실체 내의 거래, 이와 관련된 잔액, 수익과 비용, 미실현손익은 연결재무제표 작성시 모두 제거하고 있습니다. 한편, 연결실체는 관계기업과의 거래에서 발생한 미실현이익 중 연결실체의 몫은 제거하고 있으며, 미실현손실은 자산손상의 증거가 없다면 미실현이익과 동일한 방식으로 제거하고 있습니다.</P>
<PGBRK></PGBRK>
<P>(2) 현금 및 현금성자산&cr;연결실체는 취득일로부터 만기일이 3개월 이내인 투자자산을 현금 및 현금성자산으로 분류하고 있습니다. 지분상품은 현금성자산에서 제외되나, 상환일이 정해져 있고 취득일로부터 상환일까지의 기간이 단기인 우선주와 같이 실질적인 현금성자산인 경우에는 현금성자산에 포함됩니다.&cr;&cr;(3) 재고자산&cr;재고자산의 단위원가는 제품, 상품은 총평균법, 원료, 포장재료 및 저장품은 이동평균법, 재공품 및 미착품은 개별법에 의해 산정된 단가와 연중 계속기록법에 의한 수량을 이용하여 계산되며 매 회계연도의 결산기에 실지재고조사를 실시하여 그 기록을 조정하고 있습니다. 취득원가는 매입원가, 전환원가 및 재고자산을 이용가능한 상태로 준비하는데 필요한 기타 원가를 포함하고 있습니다. &cr;&cr;재고자산은 취득원가와 순실현가능가치 중 낮은 금액으로 측정하고 있습니다. 재고자산을 순실현가능가치로 감액한 평가손실과 모든 감모손실은 감액이나 감모가 발생한 기간에 비용으로 인식하고 있으며, 재고자산의 순실현가능가치의 상승으로 인한 재고자산평가손실의 환입은 환입이 발생한 기간의 비용으로 인식된 재고자산의 매출원가에서 차감하고 있습니다.&cr;</P>
<P>(4) 금융상품: 최초인식과 후속측정&cr;&cr;금융상품은 거래당사자 어느 한쪽에게는 금융자산이 생기게 하고 거래상대방에게 금융부채나 지분상품이 생기게 하는 모든 계약입니다.&cr;&cr;1) 금융자산&cr;&cr;최초인식 및 측정 </P>
<P>금융자산은 최초 인식 시점에 후속적으로 상각후원가로 측정되는 금융자산, 기타포괄손익-공정가치 측정 금융자산, 그리고 당기손익-공정가치 측정 금융자산으로 분류됩니다.</P>
<P></P>
<P>최초 인식 시점에 금융자산의 분류는 금융자산의 계약상 현금흐름 특성과 금융자산을 관리하기 위한 연결실체의 사업모형에 따라 달라집니다. 유의적인 금융요소가 포함되지 않거나 실무적 간편법을 적용하는 매출채권을 제외하고는, 연결실체는 금융자산을 최초에 공정가치로 측정하며, 당기손익-공정가치로 측정하는 금융자산의 경우가 아니라면 거래원가를 가감합니다. 유의적인 금융요소가 포함되지 않거나 실무적 간편법을 적용하는 매출채권은 기업회계기준서 제1115호에 따라 결정된 거래가격으로 측정합니다.&cr; </P>
<P>금융자산을 상각후원가 또는 기타포괄손익-공정가치로 측정하기 위해서는 현금흐름이 원리금만으로 구성(SPPI)되어야 합니다. 이 평가는 SPPI 테스트라고 하며, 개별 상품 수준에서 수행됩니다.</P>
<P></P>
<P>금융자산의 관리를 위한 연결실체의 사업모형은 현금흐름을 발생시키기 위해 금융자산을 관리하는 방법과 관련됩니다. 사업모형은 현금흐름의 원천이 금융자산의 계약상 현금흐름의 수취인지, 매도인지 또는 둘 다 인지를 결정합니다.</P>
<P></P>
<P>시장의 합의나 규제에 의해 설정된 기간 프레임 내에서 금융자산을 이전하는 것이 요구되는 금융자산의 매입 또는 매도(정형화된 거래)는 거래일에 인식됩니다. 즉, 연결실체가 금융자산을 매입하거나 매도하기로 약정한 날을 의미합니다.</P>
<P></P>
<P>후속측정&cr;후속 측정을 위해 금융자산은 아래 네 가지의 범주로 분류됩니다.&cr;ㆍ상각후원가 측정 금융자산 (채무상품)&cr;ㆍ누적 손익을 당기손익으로 재순환하는 기타포괄손익-공정가치 측정 금융자산 (채무상품)&cr;ㆍ제거시 누적 손익을 당기손익으로 재순환하지 않는 기타포괄손익-공정가치 측정 금융자산 (지분상품)&cr;ㆍ당기손익-공정가치 측정 금융자산&cr;</P>
<P>상각후원가 측정 금융자산 (채무상품)</P>
<P>연결실체는 아래 조건을 모두 만족하는 경우 금융자산을 상각후원가로 측정합니다.&cr;ㆍ계약상 현금흐름을 수취하기 위해 보유하는 것이 목적인 사업모형 하에서 금융자산을 보유&cr;ㆍ금융자산의 계약 조건에 따라 특정일에 원금과 원금잔액에 대한 이자 지급만으로 구성되어 있는 현금흐름이 발생&cr;</P>
<P>상각후원가 측정 금융자산은 후속적으로 유효이자율(EIR)법을 사용하여 측정되며, 손상을 인식합니다. 자산의 제거, 변경 또는 손상에서 발생하는 이익과 손실은 당기손익으로 인식됩니다.</P>
<P>&cr;기타포괄손익-공정가치 측정 금융자산 (채무상품)</P>
<P>연결실체는 아래의 조건을 모두 충족하는 채무상품을 기타포괄손익-공정가치 금융자산으로 측정합니다.&cr;ㆍ계약상 현금흐름의 수취와 금융자산의 매도 둘 다를 통해 목적을 이루는 사업모형 하에서 금융자산을 보유&cr;ㆍ금융자산의 계약 조건에 따라 특정일에 원리금 지급만으로 구성되어 있는 현금흐름이 발생&cr;&cr;기타포괄손익-공정가치 측정 채무상품에서 이자수익, 외화환산손익, 그리고 손상 또는 환입은 상각후원가 측정 금융자산과 동일한 방법으로 계산되어 당기손익으로 인식됩니다. 나머지 공정가치 변동부분은 기타포괄손익으로 인식됩니다. 금융자산의 제거 시 기타포괄손익으로 인식한 공정가치 누적 변동분은 당기손익으로 재순환됩니다.</P>
<P></P>
<P>연결실체의 기타포괄손익-공정가치 측정 채무상품은 비유동자산으로 분류되는 채무상품에 포함됩니다.</P>
<P></P>
<P>기타포괄손익-공정가치 측정 금융자산 (지분상품)</P>
<P>최초 인식 시점에, 연결실체는 기업회계기준서 제1032호 '금융상품 표시'에서의 지분의 정의를 충족하고 투자 목적으로 보유하고 있지 않은 지분상품을 기타포괄손익-공정가치로 측정하도록 하는 취소 불가능한 선택을 할 수 있습니다.</P>
<P></P>
<P>이러한 금융자산에서 발생하는 손익은 당기손익으로 재순환되지 않습니다. 배당은 연결기업이 금융자산의 원가 중 일부를 회수하여 이익을 얻는 경우에는 기타포괄손익으로 처리되며, 이를 제외하고는 받을 권리가 확정되었을 때 손익계산서상 기타수익으로 인식됩니다. 기타포괄손익-공정가치 측정 지분상품은 손상을 인식하지 않습니다.&cr;</P>
<P>연결실체는 비상장지분상품에 대해서도 취소불가능한 선택을 할 수 있습니다.</P>
<P></P>
<P>당기손익-공정가치 측정 금융자산</P>
<P>당기손익-공정가치 측정 금융자산은 단기매매항목, 최초 인식 시에 당기손익-공정가치로 측정하도록 지정된 금융자산 또는 공정가치로 측정하도록 요구되는 금융자산을 포함합니다. 단기간 내에 매도하거나 재구매할 목적으로 취득한 금융자산은 단기매매항목으로 분류됩니다. 분리된 내재파생상품을 포함한 파생상품은 효과적인 위험회피수단으로 지정되지 않았다면 단기매매항목으로 분류됩니다. 현금흐름이 원리금 지급만으로 구성되지 않은 금융자산은 사업모형에 관계없이 당기손익-공정가치 측정 금융자산으로 분류 및 측정됩니다. 상기 문단에서 서술된 것과 같이 채무상품이 상각후원가 또는 기타포괄손익-공정가치 측정 금융자산으로 분류됨에도 불구하고 회계 불일치를 제거하거나 유의적으로 감소시킬 수 있다면 채무상품을 당기손익-공정가치로 측정하도록 지정할 수 있습니다.</P>
<P></P>
<P>당기손익-공정가치 측정 금융자산은 재무상태표에 공정가치로 표시되며, 공정가치의 순변동은 손익계산서에서 당기손익으로 인식됩니다.</P>
<P></P>
<P>이 범주는 파생상품과 공정가치의 변동을 기타포괄손익으로 처리하는 취소불가능한 선택을 하지 않은 상장 지분 상품을 포함합니다. 상장 지분 상품에 대한 배당은 권리가 확정된 시점에 당기손익으로 인식합니다.</P>
<P></P>
<P>복합계약에 내재된 파생상품은 경제적인 특성과 위험이 주계약에 밀접하게 관련되지않고, 내재파생상품과 동일한 조건인 별도의 상품이 파생상품의 정의를 충족하며, 복합계약이 당기손익-공정가치로 측정되지 않는다면 주계약으로부터 분리하여 별도의파생상품으로 회계처리합니다. 내재파생상품은 공정가치로 측정하고 공정가치의 변동을 당기손익으로 인식합니다. 현금흐름을 유의적으로 변경시키는 계약 조건의 변경이 있거나 당기손익-공정가치 측정 범주에 해당하지 않게 되는 경우에만 재평가가발생합니다.</P>
<P></P>
<P>주계약이 금융자산인 복합계약에서 내재파생상품은 분리하여 회계처리하지 않습니다. 주계약인 금융자산과 내재파생상품은 상품 전체를 당기손익-공정가치 측정 금융자산으로 분류합니다.</P>
<P></P>
<P>제거</P>
<P>금융자산 (또는, 금융자산의 일부 또는 비슷한 금융자산의 집합의 일부)는 다음과 같은 상황에서 우선적으로 제거됩니다.&cr;ㆍ금융자산의 현금흐름을 수취할 권리가 소멸&cr;ㆍ연결실체는 금융자산의 현금흐름을 수취할 권리를 양도하거나 양도(pass-through)계약에 따라 수취한 현금흐름 전체를 중요한 지체 없이 제3자에게 지급할 의무가 있는 경우에 연결실체는 금융자산의 보유에 따른 위험과 보상의 대부분을 이전하거나 금융자산의 보유에 따른 위험과 보상의 대부분을 이전하지도 보유하지도 않으나 자산에 대한 통제를 이전&cr;</P>
<P>연결실체는 금융자산의 현금흐름을 수취할 권리를 이전하거나 양도(pass-through) 계약을 체결할 때, 자산을 소유함에 따른 위험과 보상을 유지하는지를 평가합니다. 연결실체가 금융자산의 위험과 보상의 대부분을 보유하지도 이전하지도 않았다면, 해당 금융자산에 지속적으로 관여하는 정도까지 그 금융자산을 계속 인식합니다. 이 경우에, 연결실체는 관련된 부채를 인식하고 있습니다. 양도된 자산과 관련된 부채는연결실체가 보유한 권리와 의무를 반영하여 측정합니다.</P>
<P>보증을 제공하는 형태인 지속적 관여는 양도된 자산의 장부금액과 수취한 대가 중 상환을 요구받을 수 있는 최대 금액 중 낮은 금액으로 측정됩니다.</P>
<P></P>
<P>2) 금융자산의 손상&cr;</P>
<P>금융자산의 손상과 관련된 자세한 공시 사항은 아래 주석에 제공됩니다.&cr;ㆍ유의적인 가정에 대한 공시&cr;ㆍ기타포괄손익-공정가치로 측정되는 채무상품&cr;ㆍ계약자산을 포함한 매출채권&cr;&cr;연결실체는 당기손익-공정가치 항목을 제외한 모든 채무상품에 대하여 기대신용손실(ECL)에 대한 충당금을 인식합니다. 기대신용손실은 계약상 수취하기로 한 현금흐름과 연결실체가 수취할 것으로 예상하는 모든 현금흐름의 차이를 최초의 유효이자율로 할인하여 추정합니다. 예상되는 현금흐름은 보유한 담보를 처분하거나 계약의 필수 조건인 그 밖의 신용 보강으로부터 발생하는 현금흐름을 포함합니다.</P>
<P></P>

<P>기대신용손실은 두 개의 단계로 인식합니다. 최초 인식 이후 신용위험의 유의적인 증가가 없는 신용 익스포저에 대하여 기대신용손실은 향후 12개월 내에 발생할 가능성이 있는 채무불이행 사건으로부터 발생하는 신용손실(12개월 기대신용손실)을 반영합니다. 최초 인식 이후 신용위험의 유의적인 증가가 있는 신용 익스포저에 대하여 손실충당금은 채무불이행 사건이 발생하는 시기와 무관하게 익스포저의 남은 존속기
<SPAN>간에 대한 기대신용손실(전체기간 기대신용손실)을 측정하도록 요구됩니다.</SPAN>
</P>
<P></P>
<P>매출채권과 계약자산에 대하여, 연결실체는 기대신용손실 계산에 간편법을 적용할 수 있습니다. 따라서, 연결실체는 신용위험의 변동을 추적하지 않는 대신에, 각 결산일에 전체기간 기대신용손실에 해당하는 금액으로 손실충당금을 인식합니다. 연결실체는 특정 채무자에 대한 미래전망정보와 경제적 환경을 반영하여 조정된 과거 신용손실 경험에 근거하여 충당금 설정률표를 설정합니다.</P>
<P> </P>
<P>기타포괄손익-공정가치 측정 채무상품에 대하여, 연결실체는 낮은 신용위험 간편법을 적용합니다. 매 결산일에, 연결실체는 과도한 원가나 노력 없이 이용할 수 있는 합리적이고 뒷받침될 수 있는 모든 정보를 사용하여 채무상품이 낮은 신용위험을 가지고 있다고 고려되는지를 평가합니다. 이러한 평가를 위해서, 연결실체는 채무상품의 내부 신용 등급을 재평가합니다. 또한, 연결실체는 계약상의 지급일을 초과하였을 때신용위험의 유의적인 증가가 있는지를 고려합니다.</P>
<P>&cr;연결실체의 기타포괄손익-공정가치 측정 채무상품이 최상위 투자등급에 해당하는 상장 채권만으로 구성되어 있다면 낮은 신용 위험 투자자산으로 평가됩니다. 연결실체의 정책은 이러한 상품을 12개월 기대신용손실로 측정하는 것입니다. 그러나, 최초 인식 이후에 신용위험의 유의적인 증가가 있다면 손실충당금은 전체기간 기대신용손실에 근거하여 산출됩니다. 연결실체는 채무상품의 신용위험이 유의적으로 증가했는지를 결정하고 기대신용손실을 측정하기 위해 신용평가기관의 등급을 사용합니다.</P>
<P> </P>
<P>연결실체는 계약상 지급일을 초과하여 연체되는 경우에 채무불이행이 발생한 것으로봅니다. 그러나, 특정 상황에서, 연결실체는 내부 또는 외부 정보가 연결실체에 의한 모든신용보강을 고려하기 전에는 연결실체가 계약상의 원금 전체를 수취하지 못할 것을 나타내는 경우에 금융자산에 채무불이행 사건이 발생했다고 볼 수 있습니다. 금융자산은 계약상 현금흐름을 회수하는 데에 합리적인 기대가 없을 때 제거됩니다.</P>
<P USERMARK=" 0X0000FF">  </P>
<P>3) 금융부채&cr;</P>
<P>최초 인식과 측정</P>
<P>금융부채는 최초 인식 시점에 당기손익-공정가치 측정 금융부채, 대출과 차입, 미지급금 또는 효과적인 위험회피 수단으로 지정된 파생상품으로 적절하게 분류됩니다.</P>
<P></P>
<P>모든 금융부채는 최초에 공정가치로 인식되고, 대여금, 차입금 및 미지급금의 경우에는 직접 관련된 거래원가를 차감합니다.</P>
<P></P>
<P>연결실체의 금융부채는 매입채무와 기타 미지급금, 당좌차월을 포함한 대여 및 차입을 포함합니다.</P>
<P></P>
<P>후속 측정</P>
<P>금융부채의 측정은 아래에서 언급된 분류에 따릅니다.</P>
<P></P>
<P>당기손익-공정가치 측정 금융부채</P>
<P>당기손익-공정가치 측정 금융부채는 단기매매금융부채와 최초 인식 시점에 당기손익-공정가치로 측정하도록 지정된 금융부채를 포함합니다.</P>
<P></P>
<P>금융부채가 단기간 내에 재매입되는 경우에는 단기매매항목으로 분류됩니다. 이 범주는 또한 기업회계기준서 제1109호에서 정의된 위험회피관계에 있는 위험회피수단으로 지정되지 않은 파생상품을 포함합니다. 또한 분리된 내재파생상품은 위험회피에 효과적인 수단으로 지정되지 않았다면 단기매매항목으로 분류됩니다.</P>
<P></P>
<P>단기매매항목인 금융부채에서 발생하는 손익은 당기손익으로 인식됩니다.&cr;&cr;당기손익-공정가치 항목으로 지정된 금융부채는 기업회계기준서 제1109호의 기준을 충족하는 경우에 최초 인식 시점에만 지정됩니다.&cr;</P>
<P>대여금 및 차입금</P>
<P>최초 인식 이후에, 이자부 대여금과 차입금은 후속적으로 유효이자율법을 사용하여 상각후원가로 측정됩니다. 부채가 제거되거나 유효이자율 상각 절차에 따라 발생하는 손익은 당기손익으로 인식됩니다.</P>
<P></P>
<P>상각후원가는 유효이자율의 필수적인 부분인 수수료나 원가에 대한 할인이나 할증액을 고려하여 계산됩니다. 이 범주는 일반적으로 이자부 대여나 차입에 적용합니다. </P>
<P></P>
<P>제거</P>
<P>금융부채는 지급 의무의 이행, 취소, 또는 만료된 경우에 제거됩니다. 기존 금융부채가 대여자는 동일하지만 조건이 실질적으로 다른 금융부채에 의해 교환되거나, 기존 부채의 조건이 실질적으로 변경된 경우에, 이러한 교환이나 변경은 최초의 부채를 제거하고 새로운 부채를 인식하게 합니다. 각 장부금액의 차이는 당기손익으로 인식하고 있습니다.</P>
<P>&cr;4) 금융상품의 상계&cr;</P>
<P>금융자산과 금융부채는 인식한 자산과 부채에 대해 법적으로 집행 가능한 상계 권리를 현재 가지고 있거나, 차액으로 결제하거나 자산을 실현하는 동시에 부채를 결제할의도가 있는 경우에 재무상태표에서 상계하여 순액으로 표시됩니다.</P>
<P>&cr;(5) 유형자산&cr;유형자산은 최초에 원가로 측정하여 인식하고 있습니다. 유형자산의 원가에는 경영진이 의도하는 방식으로 자산을 가동하는데 필요한 장소와 상태에 이르게 하는데 직접 관련되는 원가 및 자산을 해체, 제거하거나 부지를 복구하는데 소요될 것으로 추정되는 원가가 포함됩니다.&cr;&cr;유형자산은 최초 인식 후에 원가에서 감가상각누계액과 손상차손누계액을 차감한 금액을 장부금액으로 하고 있습니다.&cr;&cr;유형자산 중 토지는 감가상각을 하지 않으며, 그 외 유형자산은 자산의 취득원가에서잔존가치를 차감한 금액에 대하여 아래에 제시된 내용연수에 걸쳐 해당 자산에 내재되어 있는 미래 경제적 효익의 예상 소비 형태를 가장 잘 반영한 정액법으로 상각하고 있습니다. 유형자산을 구성하는 일부의 원가가 당해 유형자산의 전체 원가와 비교하여 유의적이라면, 해당 유형자산을 감가상각할 때, 그 부분은 별도로 구분하여 감가상각하고 있습니다.&cr;</P>
<P>유형자산의 제거로 인하여 발생하는 손익은 순매각금액과 장부금액의 차이로 결정되고 그 차액은 당기손익으로 인식하고 있습니다.&cr;&cr;당기 및 전기의 추정 내용연수는 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="641" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="312"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="321" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="320" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">건         물</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">28 년 ~ 60 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구   축   물</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2 년 ~ 35 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기 계 장 치</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2 년 ~ 10 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차량운반구</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2 년 ~ 6 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공구와기구</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">집 기 비 품</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3년 ~ 16년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타의유형자산</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4 년 ~ 7 년</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;연결실체는 매 보고기간말에 자산의 잔존가치와 내용연수 및 감가상각방법을 재검토하고 재검토 결과 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 처리하고 있습니다.&cr;</P>
<P>(6) 무형자산&cr;무형자산은 최초 인식할 때 원가로 측정하며, 최초 인식 후에 원가에서 상각누계액과손상차손누계액을 차감한 금액을 장부금액으로 인식하고 있습니다.&cr;&cr;무형자산은 사용 가능한 시점부터 잔존가치를 영("0")으로 하여 아래의 내용연수 동안 정액법으로 상각하고 있습니다. 다만, 일부 무형자산에 대해서는 이를 이용할 수 있을 것으로 기대되는 기간이 예측가능하지 않아 당해 무형자산의 내용연수가 비한정인 것으로 평가하고 상각하지 아니하고 있습니다.</P>

<TABLE BORDER="1" WIDTH="635" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="309"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="318" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="317" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">산  업  재  산  권</TD>
<TD WIDTH="317" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5 년 ~ 15 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">개       발      비</TD>
<TD WIDTH="317" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타의무형자산</TD>
<TD WIDTH="317" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5 년 ~ 15 년</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>내용연수가 유한한 무형자산의 상각기간과 상각방법은 매 보고기간말에 재검토하고 내용연수가 비한정인 무형자산에 대해서는 그 자산의 내용연수가 비한정이라는 평가가 계속하여 정당한 지를 매 보고기간말에 재검토하며, 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 처리하고 있습니다.&cr;&cr;가. 연구 및 개발&cr;연구 또는 내부프로젝트의 연구단계에 대한 지출은 발생시점에 비용으로 인식하고 있습니다. 개발단계의 지출은 자산을 완성할 수 있는 기술적 실현가능성, 자산을 완성하여 사용하거나 판매하려는 기업의 의도와 능력 및 필요한 자원의 입수가능성, 무형자산의 미래 경제적 효익을 모두 제시할 수 있고, 관련 지출을 신뢰성 있게 측정할 수 있는 경우에 무형자산으로 인식하고 있으며, 기타 개발관련 지출은 발생시점에 비용으로 인식하고 있습니다.&cr;&cr;신규개발 프로젝트는 신약후보물질발굴, 전임상, 임상1상, 임상2상, 임상3상, 정부승인 신청, 정부승인완료, 제품 판매시작 등의 단계로 진행됩니다. 연결실체는 관련 프로젝트의 임상 3단계시점부터 발생한 지출을 무형자산으로 인식하고, 이전 단계에서발생한 지출은 연구개발비로 보아 당기 비용처리하고 있습니다.&cr;&cr;나. 후속지출&cr;후속지출은 관련되는 특정자산에 속하는 미래의 경제적 효익이 증가하는 경우에 한하여 자본화하며, 내부적으로 창출한 영업권 및 상표명 등을 포함한 다른 지출은 발생 즉시 비용화하고 있습니다.&cr;&cr;(7) 차입원가&cr;적격자산의 취득, 건설 또는 제조와 직접 관련된 차입원가는 당해 자산 원가의 일부로 자본화하고 있으며, 기타차입원가는 발생기간에 비용으로 인식하고 있습니다. 적격자산이란 의도된 용도로 사용하거나 판매가능한 상태가 될 때까지 상당한 기간을 필요로 하는 자산을 말하며, 금융자산과 단기간 내에 제조되거나 다른 방법으로 생산되는 재고자산은 적격자산에 해당되지 아니하며, 취득시점에 의도된 용도로 사용할 수 있거나 판매가능한 상태에 있는 자산인 경우에도 적격자산에 해당되지 아니합니다.&cr;</P>
<P>적격자산을 취득하기 위한 목적으로 특정하여 차입한 자금에 한하여, 보고기간 동안 그 차입금으로부터 실제 발생한 차입원가에서 당해 차입금의 일시적 운용에서 생긴 투자수익을 차감한 금액을 자본화가능차입원가로 결정하며, 일반적인 목적으로 자금을 차입하고 이를 적격자산의 취득을 위해 사용하는 경우에 한하여 당해 자산 관련 지출액에 자본화이자율을 적용하는 방식으로 자본화가능차입원가를 결정하고 있습니다. 자본화이자율은 보고기간동안 차입한 자금(적격자산을 취득하기 위해 특정 목적으로 차입한 자금 제외)으로부터 발생된 차입원가를 가중평균하여 산정하고 있습니다. 보고기간 동안 자본화한 차입원가는 당해 기간 동안 실제 발생한 차입원가를 초과할 수 없습니다.&cr;&cr;(8) 정부보조금&cr;정부보조금은 연결실체가 정부보조금에 부수되는 조건을 준수하고 그 보조금을 수취하는 것에 대해 합리적인 확신이 있을 경우에만 인식하고 있습니다.&cr;&cr;연결실체는 비유동자산을 취득 또는 건설하는데 사용해야 한다는 기본조건이 부과된정부보조금을 수령하고 있으며, 보조금을 이연수익으로 인식하여 자산의 내용연수에걸쳐 당기손익으로 인식하고 있습니다.&cr;&cr;연결실체는 정부보조금을 정부보조금으로 보전하려 하는 관련원가가 비용으로 인식되는 기간에 걸쳐 관련비용에서 차감하는 방법으로 인식하고 있습니다.&cr;&cr;(9) 투자부동산&cr;임대수익이나 시세차익 또는 두 가지 모두를 얻기 위하여 보유하고 있는 부동산은 투자부동산으로 분류하고 있습니다. 투자부동산은 취득시 발생한 거래원가를 포함하여최초 인식시점에 원가로 측정하며, 최초 인식 후에 원가에서 감가상각누계액과 손상차손누계액을 차감한 금액을 장부금액으로 표시하고 있습니다.&cr;</P>
<P>후속원가는 자산으로부터 발생하는 미래 경제적 효익이 유입될 가능성이 높으며, 그 원가를 신뢰성 있게 측정할 수 있는 경우에 한하여 자산의 장부금액에 포함하거나 적절한 경우 별도의 자산으로 인식하고 있으며, 후속지출에 의해 대체된 부분의 장부금액은 제거하고 있습니다. 한편, 일상적인 수선ㆍ유지와 관련하여 발생하는 원가는 발생시점에 당기손익으로 인식하고 있습니다.</P>
<P>&cr;투자부동산 중 토지에 대해서는 감가상각을 하지 않으며, 토지를 제외한 투자부동산은 경제적 내용연수(건물: 내용연수 20~56년)에 따라 정액법으로 상각하고 있습니 다. 투자부동산의 감가상각방법, 잔존가치 및 내용연수는 매 보고기간말에 재검토하고 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 회계처리하고 있습니다.&cr;&cr;(10) 비금융자산의 손상&cr;건설계약에서 발생한 자산, 종업원급여에서 발생한 자산, 재고자산, 이연법인세자산을 제외한 모든 비금융자산에 대해서는 매 보고기간말마다 자산손상을 시사하는 징후가 있는지를 검토하며, 만약 그러한 징후가 있다면 당해 자산의 회수가능액을 추정하고 있습니다. 단, 내용연수가 비한정인 무형자산, 아직 사용할 수 없는 무형자산에대해서는 자산손상을 시사하는 징후와 관계없이 매년 회수가능액과 장부금액을 비교하여 손상검사를 하고 있습니다.</P>
<P>&cr;회수가능액은 개별 자산별로, 또는 개별 자산의 회수가능액을 추정할 수 없다면 그 자산이 속하는 현금창출단위별로 회수가능액을 추정하고 있습니다. 회수가능액은 사용가치와 순공정가치 중 큰 금액으로 결정하고 있습니다. 사용가치는 자산이나 현금창출단위에서 창출될 것으로 기대되는 미래현금흐름을 화폐의 시간가치 및 미래현금흐름을 추정할 때 조정되지 아니한 자산의 특유위험에 대한 현행 시장의 평가를 반영한 적절한 할인율로 할인하여 추정합니다.&cr;&cr;자산이나 현금창출단위의 회수가능액이 장부금액에 미달하는 경우 자산의 장부금액을 감소시키며 즉시 당기손익으로 인식하고 있습니다.&cr;</P>
<P>사업결합으로 취득한 영업권은 사업결합으로 인한 시너지효과의 혜택을 받게 될 것으로 기대되는 각 현금창출단위에 배분합니다. 현금창출단위에 대한 손상차손은 현금창출단위에 배분된 영업권의 장부금액을 우선 감소시키고, 그 다음 현금창출단위에 속하는 다른 자산 각각의 장부금액에 비례하여 자산의 장부금액을 감소시키고 있습니다. 영업권에 대해 인식한 손상차손은 후속기간에 환입할 수 없습니다. 매 보고기간말에 영업권을 제외한 자산에 대해 과거기간에 인식한 손상차손이 더 이상 존재하지 않거나 감소된 것을 시사하는 징후가 있는지를 검토하고 직전 손상차손의 인식시점 이후 회수가능액을 결정하는 데 사용된 추정치에 변화가 있는 경우에만 환입합니다. 손상차손환입으로 증가된 장부금액은 과거에 손상차손을 인식하기 전 장부금액의 감가상각 또는 상각 후 잔액을 초과할 수 없습니다.&cr;&cr;(11) 종업원급여&cr;가. 단기종업원급여&cr;종업원이 관련 근무용역을 제공한 보고기간말부터 12개월 이내에 결제될 단기종업원급여는 근무용역과 교환하여 지급이 예상되는 금액을 근무용역이 제공된 때에 당기손익으로 인식하고 있습니다. 단기종업원급여는 할인하지 않은 금액으로 측정하고있습니다.&cr;&cr;나. 기타장기종업원급여&cr;종업원이 관련 근무용역을 제공한 보고기간말부터 12개월 이내에 지급되지 않을 기타장기종업원급여는 당기와 과거기간에 제공한 근무용역의 대가로 획득한 미래의 급여액을 현재가치로 할인하고 있습니다. 재측정에 따른 변동은 발생한 기간에 당기손익으로 인식하고 있습니다.&cr;&cr;다 퇴직급여: 확정기여제도&cr;확정기여제도와 관련하여 일정기간 종업원이 근무용역을 제공하였을 때에는 그 근무용역과 교환하여 확정기여제도에 납부해야 할 기여금에 대하여 자산의 원가에 포함되는 경우를 제외하고는 당기손익으로 인식하고 있습니다. 납부해야 할 기여금은 이미 납부한 기여금을 차감한 후 부채(미지급비용)로 인식하고 있습니다. 또한, 이미 납부한 기여금이 보고기간말 이전에 제공된 근무용역에 대해 납부하여야 하는 기여금을 초과하는 경우에는 초과 기여금 때문에 미래 지급액이 감소하거나 현금이 환급되는 만큼을 자산(선급비용)으로 인식하고 있습니다.&cr;</P>
<PGBRK></PGBRK>
<P>라. 퇴직급여: 확정급여제도&cr;보고기간 말 현재 확정급여제도와 관련된 확정급여부채는 확정급여채무의 현재가치에서 사외적립자산의 공정가치를 차감하여 인식하고 있습니다.&cr;&cr;확정급여부채는 매년 독립적인 계리사에 의해 예측단위적립방식으로 계산되고 있습니다. 확정급여채무의 현재가치에서 사외적립자산의 공정가치를 차감하여 산출된 순액이 자산일 경우, 제도로부터 환급받거나 제도에 대한 미래기여금이 절감되는 방식으로 이용가능한 경제적 효익의 현재가치를 한도로 자산을 인식하고 있습니다.&cr;</P>
<P>순확정급여부채의 재측정요소는 보험수리적손익, 순확정급여부채의 순이자에 포함된 금액을 제외한 사외적립자산의 수익 및 순확정급여부채의 순이자에 포함된 금액을 제외한 자산인식상한효과의 변동으로 구성되어 있으며, 즉시 기타포괄손익으로 인식됩니다. 연결실체는 순확정급여부채(자산)의 순이자를 순확정급여부채(자산)에 연차보고기간 초에 결정된 할인율을 곱하여 결정되며 보고기간 동안 기여금 납부와 급여지급으로 인한 순확정급여부채(자산)의 변동을 고려하여 결정하고 있습니다. 확정급여제도와 관련된 순이자비용과 기타비용은 당기손익으로 인식됩니다.&cr;&cr;제도의 개정이나 축소가 발생하는 경우, 과거근무에 대한 효익의 변동이나 축소에 따른 손익은 즉시 당기손익으로 인식하고 있습니다. 연결실체는 확정급여제도의 정산이 일어나는 때에 정산으로 인한 손익을 인식하고 있습니다.&cr;&cr;(12) 충당부채&cr;충당부채는 과거사건의 결과로 존재하는 현재의무(법적의무 또는 의제의무)로서, 당해 의무를 이행하기 위하여 경제적효익을 갖는 자원이 유출될 가능성이 높으며 그  의무의 이행에 소요되는 금액을 신뢰성 있게 추정할 수 있는 경우에 인식하고 있습니다.&cr;&cr;충당부채로 인식하는 금액은 관련된 사건과 상황에 대한 불가피한 위험과 불확실성을 고려하여 현재의무를 보고기간말에 이행하기 위하여 소요되는 지출에 대한 최선의 추정치입니다. 화폐의 시간가치 효과가 중요한 경우 충당부채는 의무를 이행하기 위하여 예상되는 지출액의 현재가치로 평가하고 있습니다.&cr;&cr;충당부채를 결제하기 위해 필요한 지출액의 일부 또는 전부를 제 3자가 변제할 것이 예상되는 경우 이행한다면 변제를 받을 것이 거의 확실하게 되는 때에 한하여 변제금액을 인식하고 별도의 자산으로 회계처리하고 있습니다.&cr;&cr;매 보고기간말마다 충당부채의 잔액을 검토하고, 보고기간말 현재 최선의 추정치를 반영하여 조정하고 있습니다. 의무이행을 위하여 경제적효익이 내재된 자원이 유출될 가능성이 더 이상 높지 아니한 경우에는 관련 충당부채를 환입하고 있습니다.&cr;&cr;충당부채는 최초 인식과 관련 있는 지출에만 사용하고 있습니다.</P>

<P>
<SPAN>&cr;(13) 외화&cr;가. 외화거래&cr;</SPAN>
<SPAN>연결실체를 구성하는 개별기업들의 재무제표 작성에 있어서 그 기업의 기능통화 외의 통화(외화)로 이루어진 거래는 거래일의 환율을 적용하여 기록하고 있습니다. 매 보고기간 말에 화폐성 외화항목은 보고기간 말의 마감환율로 환산하고 있습니다. 공정가치로 측정하는 비화폐성 외화항목은 공정가치가 결정된 날의 환율로 환산하고, 역사적원가로 측정하는 비화폐성항목은 거래일의 환율로 환산하고 있습니다.&cr;&cr;화폐성항목의 결제시점에 생기는 외환차이와 화폐성항목의 환산으로 인해 발생한 외환차이는 모두 당기손익으로 인식하고 있습니다. 비화폐성항목에서 발생한 손익을 기타포괄손익으로 인식하는 경우에는 그 손익에 포함된 환율변동효과도 기타포괄손익으로 인식하고, 당기손익으로 인식하는 경우에는 환율변동효과도 당기손익으로 인식하고 있습니다. &cr;&cr;</SPAN>
<SPAN>나. 해외사업장&cr;해외사업장의 기능통화가 연결실체의 표시통화와 다른 경우 경영성과와 재무상태를 다음의 방법에 따라 표시통화로 환산하고 있습니다.&cr;&cr;해외사업장의 기능통화가 초인플레이션 경제의 통화가 아닌 경우 재무상태표(비교표시하는 재무상태표 포함)의 자산과 부채는 해당 보고기간말의 마감환율로 환산하고, 포괄손익계산서(비교표시하는 포괄손익계산서 포함)의 수익과 비용은 평균환율로 환산하고, 환산에서 생기는 외환차이는 기타포괄손익으로 인식합니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>해외사업장의 취득으로 생기는 영업권과 자산ㆍ부채의 장부금액에 대한 공정가치 조정액은 해외사업장의 자산ㆍ부채로 보아 해외사업장의 기능통화로 표시하고, 해외사업장의 다른 자산ㆍ부채와 함께 마감환율을 적용하여 원화로 환산하고 있습니다.&cr;</SPAN>
</P>
<P>해외사업장을 처분하는 경우 기타포괄손익과 별도의 자본항목으로 인식한 해외사업장 관련 외환차이누계액은 해외사업장의 처분손익을 인식하는 시점에 자본에서 당기손익으로 재분류합니다. 해외사업장을 포함한 종속기업을 일부 처분 시 기타포괄손익에 인식된 외환차이의 누계액 중 비례적 지분을 그 해외사업장의 비지배지분으로 재귀속시키며, 이 외의 경우에는 해외사업장을 일부 처분한 때 기타포괄손익에 인식된 외환차이누계액 중 비례적 지분만을 당기손익으로 재분류하고 있습니다.&cr;&cr;다. 해외사업장에 대한 순투자의 환산&cr;해외사업장으로부터 수취하거나 해외사업장에 지급할 화폐성항목 중 예측할 수 있는미래에 결제할 계획이 없고 결제될 가능성이 낮은 항목은 그 해외사업장에 대한 순투자의 일부로 보아 연결재무제표에서 외환차이를 기타포괄손익으로 인식하고 관련 순투자의 처분 시점에 당기손익으로 재분류하고 있습니다.&cr;&cr;(14) 납입자본&cr;보통주는 자본으로 분류하며 자본거래와 직접 관련되어 발생하는 증분원가는 세금효과를 반영한 순액으로 자본에서 차감하고 있습니다.&cr;&cr;연결실체가 자기지분상품을 재취득하는 경우에 이러한 지분상품은 자기주식의 과목으로 자본에서 직접 차감하고 있습니다. 자기지분상품을 매입 또는 매도하거나 발행 또는 소각하는 경우의 손익은 당기손익으로 인식하지 아니합니다. 연결실체 또는 연결실체 내의 다른 기업이 자기주식을 취득하여 보유하는 경우 지급하거나 수취한 대가는 자본에서 직접 인식하고 있습니다.</P>

<P>
<SPAN></SPAN>
</P>
<P>(15) 주식기준보상거래 &cr;&cr;연결실체는 임직원의 근로용역에 대해 주식기준에 따른 보상을 제공하고 있는데 임직원에게 주식선택권을 부여하는 제도(주식결제형 주식기준보상거래)를 운영하고 있습니다.&cr;</P>
<P>주식결제형 주식기준보상원가는 적절한 가치평가모델을 사용하여 부여일의 공정가치로 측정됩니다. </P>
<P> </P>
<P>주식기준보상원가는 용역제공조건(또는 성과조건)이 충족되는 기간(이하 '가득기간')에 걸쳐 종업원급여로 인식하고, 그에 상응한 자본의 증가를 인식합니다. 매 보고기간말에 누적 보상원가의 측정에는 가득기간의 완료 여부와 최종적으로 부여될 지분상품의 수량에 대한 추정이 반영됩니다. 보고기간 초와 보고기간 말의 누적 보상원가의 변동분은 당기 손익계산서에 가감됩니다.</P>
<P> </P>
<P>용역제공조건 및 비시장조건은 부여일 현재 주식선택권의 공정가치를 추정할 때 고려하지 아니하나 궁극적으로 가득되는 지분상품의 수량에 대한 추정 시 반영되고, 시장조건은 부여일 현재 공정가치 측정시 반영됩니다. 주식기준보상에 부여된 다른 조건(관련 용역조건이 없는 경우)은 비가득조건으로 간주됩니다. 비가득조건은 주식기준보상원가 공정가치 측정 시 반영되며 용역제공조건 (또는 성과조건)이 없는 경우에는 즉시 비용으로 인식합니다. </P>
<P> </P>

<P>궁극적으로
<SPAN USERMARK="F-8"> </SPAN>가득되지
<SPAN USERMARK="F-8"> </SPAN>않는
<SPAN USERMARK="F-8"> </SPAN>주식기준보상에
<SPAN USERMARK="F-8"> </SPAN>대해서는
<SPAN USERMARK="F-8"> </SPAN>비용을
<SPAN USERMARK="F-8"> </SPAN>인식하지
<SPAN USERMARK="F-8"> </SPAN>않고
<SPAN USERMARK="F-8"> </SPAN>있습니다.다만 시장조건이나 비가득조건이 있는 주식결제형 거래로서 다른 모든 성과조건이나용역 조건을 충족한다면 시장조건이나 비가득조건의 충족여부와 관계없이 가득된것으로 회계처리하고 있습니다.
</P>
<P> </P>
<P>주식결제형주식기준보상의 조건이 변경될 경우 지정된 가득조건이 충족되지 않아 지분상품이 가득되지 못하는 경우를 제외하고는 조건이 변경되지 않았을 경우에 인식하였어야 할 원가를 최소한으로 하여 인식하고 있습니다. 주식기준보상약정의 총공정가치를 증가시키거나 종업원에게 유리하게 조건을 변경하는 경우에는 추가로 조건변경의 효과를 인식하고 있습니다. 주식결제형보상이 취소될 경우 취소일에 가득된 것으로 보고 인식되지 않은 보상원가는 즉시 인식하고 있습니다. </P>
<P> </P>
<P>발행된 옵션의 희석효과는 희석주당이익을 계산할 때 희석주식으로 반영하고 있습니다.</P>
<P>&cr;(16) 고객과의 계약에서 생기는 수익&cr;</P>
<P>가. 변동대가&cr;연결실체는 주로 의약품을 제조 및 판매하는 사업을 영위하고 있으며 재화의 판매에 따른수익은 재화가 구매자에게 인도되는 시점에 인식하고 있습니다. 연결실체는 고객에게 지급할 대가인 변동대가와 관련하여 불확실성이 나중에 해소 될 때, 이미 인식한 누적 수익 금액 중 유의적인 부분을 되돌리지 않을 가능성이 매우 높은 정도까지만 변동대가를 거래가격에 포함하여 수익으로 인식합니다.&cr; </P>
<P>특정 계약은 일정한 기간 이내에 재화를 반품할 권리를 고객에게 제공합니다. 연결실체는 반품되지 않을 재화의 추정방법으로 연결실체가 받을 권리를 갖게 될 대가를 더잘 예측할 것으로 예상되는 기댓값을 사용합니다. 기업회계기준서 제1115호의 요구사항 중 변동대가 추정의 제약은 거래가격에 포함되는 변동대가(금액)를 결정하는 경우에도 적용됩니다. 연결실체는 반품이 예상되는 재화에 대해서는 수익으로 인식하지 않고 환불부채로 인식합니다. 반품 재화에 대한 권리(와 이에 상응하는 매출원가 조정)를 인식합니다.</P>
<P></P>
<P>나. 수행의무의 식별&cr;연결실체는 신약개발과 관련된 기술이전으로 인한 수익이 발생하고 있습니다. 기술이전으로 인한 수익은 통상 계약체결시점에 수령하는 계약금(Upfront payment), 일정요건 달성시점에 수령하는 마일스톤 금액(Milestone payment), 및 매출액의 일정비율로 수령하는 로열티로 구성되어 있습니다. 계약금(Upfront payment)은 반환의무가 없고, 기술이전 시점 이후에 수행할 추가적인 의무가 없는 경우 일시에 수익으로 인식하고 있습니다. 특정 임상실험의 완료 등 추가적인 의무가 있다면, 의무가 종료될 것으로 예상되는 기간 동안 안분하여 수익으로 인식하고 있습니다. 마일스톤 금액(Milestone payment)은 특정 임상실험의 착수 및 종료, 규제당국의 승인 등 계약에서 규정된 일정요건이 만족되는 시점에 수익으로 인식하고 있습니다. 로열티(Royalty)는 관련된 계약의 경제적 실질을 반영하여 발생기준에 따라 인식하고 있습니다. 연결실체는 과거에 체결했던 라이선스 계약 중 수행의무를 이행한 때 또는 기간에 걸쳐이행하는지에 따라 수익을 인식합니다.</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>다. 계약부채&cr;계약부채는 연결실체가 고객에게서 이미 받은 대가(또는 지급기일이 된 대가)에 상응하여고객에게 재화나 용역을 이전하여야 하는 기업의 의무입니다. 만약 연결실체가 재화나 용역을 고객에 이전하기 전에 고객이 대가를 지불한다면, 지급이 되었거나 지급기일 중 이른 시점에 계약부채를 인식합니다. 계약부채는 </SPAN>
<SPAN>연결실체가 계약에 따라 수행의무를 이행할 때 수익으로 인식합니다</SPAN>
</P>
<P>&cr;(17) 리스</P>
<P>연결실체는 계약에서 대가와 교환하여, 식별되는 자산의 사용 통제권을 일정기간 이전하게 하는지를 고려하여 계약의 약정시점에, 계약자체가 리스인지, 계약이 리스를 포함하는지를 판단합니다.</P>
<P> </P>
<P>ㆍ리스이용자로서의 회계정책&cr;연결실체는 단기리스와 소액 기초자산 리스를 제외한 모든 리스에 대하여 하나의 인식과 측정 접근법을 적용합니다. 연결실체는 리스료 지급의무를 나타내는 리스부채와 기초자산의 사용권을 나타내는 사용권자산을 인식합니다.</P>
<P> </P>
<P>가. 사용권자산</P>
<P>연결실체는 리스개시일(즉, 기초자산이 사용가능한 시점)에 사용권자산을 인식합니다. 사용권자산은 원가로 측정하고, 감가상각누계액과 손상차손누계액을 차감하고, 리스부채의 재측정에 따라 조정합니다. 사용권자산의 원가는 인식된 리스부채 금액, 최초 직접원가, 그리고 받은 리스 인센티브를 차감한 리스개시일이나 그 전에 지급한 리스료를 포함합니다. 사용권자산은 리스기간과 다음과 같은 자산의 추정된 내용연수 중 짧은 기간에 걸쳐 정액기준으로 감가상각됩니다.</P>
<P USERMARK=" 0X1814FF"> </P>
<P>- 건물 1~5년</P>
<P>- 차량운반구 및 기타설비 1~5년 &cr;- 토지 5년~38년</P>
<P USERMARK=" 0X1814FF"> </P>
<P>리스기간 종료시점에 연결실체에 기초자산의 소유권이 이전되는 경우나 사용권자산의 원가에 연결실체가 매수선택권을 행사할 것임이 반영되는 경우, 감가상각은 자산의 기초자산의 추정된 내용연수를 사용하여 계산됩니다.</P>
<P>&cr;사용권자산도 손상의 대상이 됩니다. 비금융자산의 손상 부분의 회계정책을 참조합니다.</P>
<P>&cr;나. 리스부채</P>
<P>리스 개시일에, 연결실체는 리스기간에 걸쳐 지급될 리스료의 현재가치로 측정된 리스부채를 인식합니다. 리스료는 받을 리스 인센티브는 차감한 고정리스료(실질적인 고정리스료를 포함), 지수나 요율에 따라 달라지는 변동리스료 및 잔존가치보증에 따라 지급될 것으로 예상되는 금액을 포함합니다. 리스료는 또한 연결실체가 매수선택권을 행사할 것이 상당히 확실한 경우에 그 매수선택권의 행사가격과 리스기간이 연결실체의 종료선택권 행사를 반영하는 경우에 그 리스를 종료하기 위하여 부담하는 금액을 포함합니다.</P>
<P>지수나 요율에 따라 달라지지 않는 변동리스료는 (재고자산을 생산하는데 발생된 것이 아니라면) 리스료 발생을 유발하는 사건 또는 조건이 발생한 기간의 비용으로 인식합니다.</P>
<P> </P>
<P>연결실체는 리스료의 현재가치를 계산할 때, 리스의 내재이자율을 쉽게 산정할 수 없기 때문에 리스개시일의 증분차입이자율을 사용합니다. 리스개시일 이후 리스부채 금액은 이자부담을 반영하여 증가하고 리스료 지급으로 감소합니다. 또한, 리스부채의 장부금액은 리스기간의 변경, 리스료의 변경(예를 들어, 리스료를 산정할 때 사용한 지수나 요율의 변동으로 생기는 미래 리스료의 변동) 또는 기초자산을 매수하는 선택권 평가에 변동이 있는 경우 재측정됩니다.</P>
<P> </P>
<P>연결실체의 리스부채는 이자부 차입금에 포함됩니다.</P>
<P> </P>
<P>다. 단기리스와 소액 기초자산 리스</P>
<P>연결실체는 기계장치와 설비의 리스에 단기리스(즉, 이러한 리스는 리스기간이 리스개시일로부터 12개월 이하이고 매수선택권을 포함하지 않음)에 대한 인식 면제 규정을 적용합니다. 또한 연결실체는 소액자산으로 간주되는 사무용품의 리스에 소액자산 리스에 대한 인식 면제 규정을 적용합니다. 단기리스와 소액자산 리스에 대한 리스료는 리스기간에 걸쳐 정액기준으로 비용으로 인식합니다.</P>
<P> </P>
<P>ㆍ리스제공자로서의 회계정책&cr; 연결실체는 기초자산의 소유에 따른 위험과 보상의 대부분을 이전하지 않는 리스는 운용리스로 분류합니다. 리스료 수익은 리스기간에 걸쳐 정액 기준으로 인식하며, 영업 성격에 따라 손익계산서에서 영업외수익에 포함됩니다. 운용리스 체결과정에서 부담하는 리스개설 직접원가를 기초자산의 장부금액에 더하고 리스료 수익과 같은 기준으로 리스기간에 걸쳐 비용으로 인식합니다. 조건부 임대료는 임대료를 수취하는 시점에 매출로 인식합니다.</P>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>
<P>(18) 법인세&cr;법인세비용은 당기법인세와 이연법인세로 구성되어 있으며, 기타포괄손익이나 자본에 직접 인식되는 거래나 사건에서 발생하는 세액을 제외하고는 당기손익으로 인식하고 있습니다.&cr;&cr;가. 당기법인세&cr;당기법인세는 당기의 과세소득을 기초로 산정하고 있습니다. 과세소득은 포괄손익계산서상의 법인세비용차감전순이익에서 다른 과세기간에 가산되거나 차감될 손익 및 비과세항목이나 손금불인정항목을 제외하므로 포괄손익계산서상 손익과 차이가 있습니다. 연결실체의 당기법인세와 관련된 미지급법인세는 제정되었거나 실질적으로 제정된 세율을 사용하여 계산하고 있습니다.&cr;&cr;나. 이연법인세&cr;이연법인세자산과 이연법인세부채를 측정할 때에는 보고기간말에 연결실체가 관련 자산과 부채의 장부금액을 회수하거나 결제할 것으로 예상되는 방식에 따른 세효과를 반영하고 있습니다. 종속기업, 관계기업 및 공동기업 투자지분에 관한 가산할 일시적차이에 대해서는 연결실체가 일시적차이의 소멸시점을 통제할 수 있으며, 예측가능한 미래에 일시적차이가 소멸하지 않을 가능성이 높은 경우를 제외하고는 모두 이연법인세부채를 인식하고 있습니다. 또한, 차감할 일시적차이로 인하여 발생하는 이연법인세자산은 일시적차이가 예측가능한 미래에 소멸할 가능성이 높고, 일시적차이가 사용될 수 있는 기간에 과세소득이 발생할 가능성이 높은 경우에 인식하고 있습니다.&cr;&cr;이연법인세자산의 장부금액은 매 보고기간말에 검토하고, 이연법인세자산으로 인한 혜택이 사용되기에 충분한 과세소득이 발생할 가능성이 더 이상 높지 않은 경우 이연법인세자산의 장부금액을 감소시키고 있습니다.&cr;&cr;이연법인세자산과 부채는 보고기간말 제정되었거나 실질적으로 제정된 세법에 근거하여 당해 자산이 실현되거나 부채가 지급될 보고기간에 적용될 것으로 기대되는 세율을 사용하여 측정하고 있습니다. </P>
<P>&cr;이연법인세자산과 부채는 동일 과세당국이 부과하는 법인세이고, 연결실체가 인식된금액을 상계할 수 있는 법적 권한을 가지고 있으며 당기 법인세부채와 자산을 순액으로 결제할 의도가 있는 경우에만 상계하고 있습니다. 배당금 지급에 따라 추가적으로발생하는 법인세비용이 있다면 배당금 지급과 관련한 부채가 인식되는 시점에 인식하고 있습니다.&cr;&cr;(19) 주당이익&cr;연결실체는 보통주 기본주당이익과 희석주당이익을 계속영업손익과 당기순손익에 대하여 계산하고 포괄손익계산서에 표시하고 있습니다. 기본주당이익은 보통주에 귀속되는 당기순손익을 보고기간 동안에 유통된 보통주식수를 가중평균한 주식수로 나누어 계산하고 있습니다. 희석주당이익은 전환사채와 종업원에게 부여한 주식기준보상 등 모든 희석화 효과가 있는 잠재적 보통주의 영향을 고려하여 보통주에 귀속되는당기순손익 및 가중평균유통보통주식수를 조정하여 계산하고 있습니다.&cr;</P>
<PGBRK></PGBRK>

<P>(20)
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>미적용 제ㆍ개정 기준서</SPAN>&cr;
</P>
<P>연결실체의 재무제표 발행승인일 현재 공표되었으나 아직 시행되지 않아 연결실체가채택하지 않은 한국채택국제회계기준의 기준서 및 해석서의 제ㆍ개정내역은 다음과 같습니다. </P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>가. 기업회계기준서 제1001호 '재무제표 표시' 개정 - 부채의 유동ㆍ비유동 분류</SPAN>
<SPAN>&cr;기업회계기준서 제1001호 문단 69~76에 대한 개정사항은 부채의 유동ㆍ비유동 분류에 대한 다음의 요구사항을 명확히 합니다.&cr;ㆍ결제를 연기할 수 있는 권리의 의미&cr;ㆍ연기할 수 있는 권리가 보고기간종료일 현재 존재해야 함&cr;ㆍ기업이 연기할 수 있는 권리를 행사할 가능성은 유동성 분류에 영향을 미치지 않음&cr;ㆍ전환가능부채의 내재파생상품 자체가 지분상품일 경우에만 부채의 조건이 유동성    분류에 영향을 미치지 않음&cr;동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 적용하며 소급 적용합니다. 연결실체는 개정사항이 현행 실무에 미칠 영향과 기존의 대출 약정에 재협상이 필요한지를 평가하고 있습니다.&cr;&cr;</SPAN>
<SPAN>나. 기업회계기준서 제1103호 '사업결합' 개정 - 재무보고를 위한 개념체계 참조</SPAN>
<SPAN>&cr;동 개정사항의 목적은 1989년에 발표된 '재무제표의 작성과 표시를 위한 개념체계'를 2018년 3월에 발표된 '재무보고를 위한 개념체계'의 참조로 변경시, 유의적인 요구사항의 변경이 없도록 하는데 있습니다. 기업회계기준서 제1037호 '충당부채, 우발부채, 우발자산' 또는 기업회계기준해석서 제2121호 '부담금'의 범위인 부채와 우발부채에서 day 2 손익이 발생하지 않도록, 기업회계기준서 제1103호의 인식 원칙에 예외를 추가하였습니다. 아울러 재무보고를 위한 개념체계 변경의 영향이 없도록,기업회계기준서 제1103호의 우발자산 관련 지침을 명확히 하였습니다. 동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도부터 적용하며, 전진 적용합니다.&cr;&cr;</SPAN>
<SPAN>다. 기업회계기준서 제1016호 '유형자산' 개정 - 의도한 사용전의 매각금액&cr;</SPAN>
<SPAN>동 개정사항의 목적은 경영진이 의도하는 방식으로 자산을 가동하는 데 필요한 장소와 상태에 이르게 하는 동안 발생하는 재화의 순매각가액을 원가에서 차감하지 않도록 하는데 있습니다. 대신에, 기업은 그러한 품목을 판매하여 얻은 수익과 품목을 생산하는데 드는 원가를 각각 당기손익으로 인식합니다. &cr;동 개정사항은 2022년 1월 1일 이후 시작되는 회계연도부터 적용하며, 비교 표시되는 가장 이른 기간이나 그 후에 경영진이 의도하는 방식으로 가동될 수 있는 장소와 상태에 이르는 유형자산에 대해서 소급 적용하여야 합니다. 해당 개정사항은 연결실체에 중요한 영향을 미치지 않을 것으로 예상됩니다.&cr;&cr;</SPAN>
<SPAN>라. 기업회계기준서 제1037호 '충당부채, 우발부채, 우발자산' 개정 - 손실부담계약의 의무이행 원가</SPAN>
<SPAN>&cr;동 개정사항은 계약이 손실부담계약인지 또는 손실을 발생시키는 계약인지 평가할 때 기업이 포함해야할 원가를 명확하게 하였습니다.&cr;개정 기준서는 "직접 관련된 원가 접근법"을 적용합니다. 재화나 용역을 제공하는 계약에 직접적으로 관련되는 원가는 증분원가와 계약 활동에 직접적으로 관련되는 원가 배분액을 모두 포함합니다. 일반 관리 원가는 계약에 직접적으로 관련되지 않으며계약에 따라 거래상대방에게 명시적으로 부과될 수 없다면 제외됩니다.&cr;동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도에 적용됩니다. 연결실체는 이 개정 기준서를 최초로 적용하는 연차 보고기간 초에 모든 의무를 아직 이행하지 않은 계약에 적용할 것입니다.&cr;&cr;</SPAN>
<SPAN>마. 한국채택국제회계기준 2018-2020 연차개선</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>① </SPAN>
<SPAN></SPAN>
<SPAN>기업회계기준서 제1101호 '한국채택국제회계기준의 최초채택' -  최초채택기업인종속기업&cr;</SPAN>
<SPAN>개정 기준서는 종속기업이 기업회계기준서 제1101호 한국채택국제회계기준의 최초채택 문단 D16(1)을 적용하기로 선택한 경우 종속기업이 지배기업의 한국채택국제회계기준 전환일에 기초하여 지배기업이 보고한 금액을 사용하여 누적환산차이를 측정할 수 있도록 허용합니다. 이 개정사항은 동 기준서 문단 D16(1)을 적용하기로 선택한 관계기업 또는 조인트 벤처에도 적용됩니다.&cr;동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도에 적용하며 조기적용이 허용됩니다.&cr;&cr;</SPAN>
<SPAN>②</SPAN>
<SPAN></SPAN>
<SPAN> 기업회계기준서 제1109호 '금융상품' - 금융부채 제거 목적의 10% 테스트 관련 수수료&cr;</SPAN>
<SPAN>동 개정사항은 새로운 금융부채나 변경된 금융부채의 조건이 기존의 금융부채의 조건과 실질적으로 다른지를 평가할 때 기업이 포함하는 수수료를 명확히 합니다. 이러한 수수료에는 채권자와 채무자 간에 지급하거나 수취한 수수료와 채권자와 채무자가 서로를 대신하여 지급하거나 수취한 수수료만 포함됩니다. 기업은 동 개정사항을 최초로 적용하는 회계연도 이후에 변경되거나 교환되는 금융부채에 동 개정사항을 적용합니다.&cr;동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도부터 적용하며 조기 적용이 허용됩니다. 연결실체는 시행일 이후 최초로 시작되는 회계연도 이후에 변경되거나 교환되는 금융부채에 동 개정사항을 적용할 것입니다. &cr;동 개정사항은 연결실체에 중요한 영향을 미치지 않을 것으로 예상됩니다.&cr;&cr;</SPAN>
<SPAN>③</SPAN>
<SPAN> </SPAN>
<SPAN>기업회계기준서 제1041호 '농림어업' - 공정가치 측정</SPAN>
<SPAN>&cr;개정 기준서는 동 기준서의 적용 범위에 포함되는 자산의 공정가치를 측정할 때 세금관련 현금흐름을 포함하지 않는 문단 22의 요구사항을 제거했습니다.&cr;동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도부터 전진적으로 적용하며 조기 적용이 허용됩니다.&cr;동 개정사항은 연결실체에 중요한 영향을 미치지 않을 것으로 예상합니다.</SPAN>
</P>
<P></P>

<P>
<SPAN>바. 기업회계기준서 제1116호 '리스' (개정) - 코로나바이러스감염증-19 관련 임차료 할인 등&cr;</SPAN>
<SPAN>동 개정사항은 코로나19 세계적 유행의 직접적인 결과로 발생한 임차료 할인 등에 대한 리스이용자의 기업회계기준서 제 1116호 '리스'의 리스변경 회계처리 적용을 완화하였습니다. 실무적 간편법으로, 리스이용자는 코로나19와 관련하여 발생한 임차료 할인 등이 리스변경에 해당하는지 평가하지 않을 수 있습니다. 이러한 선택을 한 리스이용자는 임차료 할인 등으로 인한 리스료 변동을 그러한 변동이 리스변경이 아닐 경우에 이 기준서가 규정하는 방식과 일관되게 회계처리하여야 합니다. 동 개정사항은 2020년 6월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 가능합니다. 동 개정사항이 연결실체의 연결재무제표에 미치는 영향은 없습니다.</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
</P>
<PGBRK></PGBRK>
<P>4. 영업부문&cr;(1) 영업부문에 대한 일반정보&cr;연결실체의 영업부문은 총 3개의 사업부문으로 구성되어 있으며, 각 사업부문의 주요 재화 및 용역유형에 따라 다음과 같이 분류할 수 있습니다.</P>

<TABLE BORDER="1" WIDTH="643" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="211"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="220" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">분류 기준</TH>
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주요 재화 및 용역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">의약품 제조 및 판매</TD>
<TD WIDTH="220" ALIGN="CENTER" HEIGHT="30">재화 및 용역제공 유형별 분류</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">원료 및 완성의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">용역제공</TD>
<TD WIDTH="220" ALIGN="CENTER" HEIGHT="30">〃</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">생활습관병 예방연구 용역</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">기타</TD>
<TD WIDTH="220" ALIGN="CENTER" HEIGHT="30">〃</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">기타 서비스</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 영업부문의 재무현황&cr;가. 당기와 전기 중 영업부문의 손익은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="716">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="716" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="141" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="288" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="287" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문매출</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문영업이익(손실)</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문매출</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부문영업이익(손실)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">의약품제조및판매</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,079,812,107 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">22,848,285 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,154,926,024 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">49,440,696 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">용역제공</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,144,535 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(2,489,876)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">8,123,496 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(1,536,706)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">기타</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,540,106 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(3,419,557)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,310,794 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(7,394)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,087,496,748 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">16,938,852 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,164,360,314 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">47,896,596 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER">연결조정</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(32,073,058)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">40,872 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(50,934,393)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(3,209,499)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER">조정후금액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,055,423,690 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">16,979,724 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,113,425,921 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">44,687,097 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 당기말과 전기말 현재 영업부문의 자산 및 부채는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="714">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="714" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="286" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="286" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30">의약품제조및판매</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,469,853,957 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">673,816,849 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,363,097,534 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">633,794,673 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30">용역제공</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">31,160,612 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">20,612,773 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">32,848,339 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">19,308,034 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30">기타</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">50,739,856 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,440,689 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">45,039,213 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">25,724 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,551,754,425 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">695,870,311 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,440,985,086 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">653,128,431 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER">연결조정</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(184,846,504)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(24,211,006)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(195,316,937)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(43,380,376)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER">조정후금액</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,366,907,921 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">671,659,305 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,245,668,149 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">609,748,055 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>다. 당기와 전기 중 영업부문의 기타부문정보는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="830">

<COLGROUP>
<COL WIDTH="156"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="830" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="165" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="332" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각비</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동자산 취득(*)</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각비</TH>
<TH WIDTH="166" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동자산 취득(*)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">의약품제조및판매</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">37,307,654 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">59,078,532 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">37,936,036 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">49,866,437 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">용역제공</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">1,370,029 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">52,689 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">1,381,948 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">198,695 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30">기타</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">70,446 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">565,089 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">48,772 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">41,626 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">38,748,129 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">59,696,310 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">39,366,756 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">50,106,758 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30" ALIGN="CENTER">연결조정</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">548,022 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">828,612 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="165" HEIGHT="30" ALIGN="CENTER">조정후금액</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">39,296,151 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">59,696,310 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">40,195,368 </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">50,106,758 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 유형자산, 투자부동산 및 무형자산의 현금 취득금액입니다.&cr;</P>
<P>(3) 지역에 대한 정보  &cr;지역부문에 대한 일반정보는 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="642" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="431"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="440" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주요 재화 및 용역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30">대한민국</TD>
<TD WIDTH="440" HEIGHT="30">의약품 제조 및 판매, 생활습관병 예방연구 용역</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30">아시아(대한민국 제외)</TD>
<TD WIDTH="440" HEIGHT="30">의약품 제조 및 판매</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;제조설비는 주로 대한민국을 포함한 아시아 지역에 위치하고 있으며, 매출의 대부분도 대한민국을 포함한 아시아 지역에 위치한 고객으로부터 발생합니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
</P>
<P>5. 현금및현금성자산 및 단기금융자산&cr;(1) 당기말과 전기말 현재 현금및현금성자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="723">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="229"></COL>
<COL WIDTH="228"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="723" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="248" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="238" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="237" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" HEIGHT="30">현금</TD>
<TD WIDTH="238" ALIGN="RIGHT" HEIGHT="30">184,660 </TD>
<TD WIDTH="237" ALIGN="RIGHT" HEIGHT="30">324,035 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" HEIGHT="30">예적금</TD>
<TD WIDTH="238" ALIGN="RIGHT" HEIGHT="30">72,114,590 </TD>
<TD WIDTH="237" ALIGN="RIGHT" HEIGHT="30">31,770,159 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="238" ALIGN="RIGHT" HEIGHT="30">72,299,250 </TD>
<TD WIDTH="237" ALIGN="RIGHT" HEIGHT="30">32,094,194 </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(2) 당기말과 전기말 현재 단기금융자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="723">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="215"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="723" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="274" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="225" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="224" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30">정기적금 등</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="RIGHT">15,438 </TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30">당기손익-공정가치측정금융자산</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="RIGHT">104,805,315 </TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT">97,736,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="RIGHT">104,820,753 </TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT">97,736,962 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>6. 금융상품의 범주별 분류&cr;(1) 당기말과 전기말 현재 금융자산의 범주별 분류내역은 다음과 같습니다.</P>
<P>가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="991">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="173"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="991" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" VALIGN="MIDDLE" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">구분</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">상각후원가로&cr; 측정하는 금융자산</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">당기손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">기타포괄손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">72,299,250 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">72,299,250 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">단기금융자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">15,438 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">104,805,315 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">104,820,753 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">매출채권및기타채권</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">148,886,754 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">148,886,754 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">장기금융자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">79,548 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">79,548 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">장기매출채권및기타채권</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">4,738,348 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">4,738,348 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">58,573,591 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">58,573,591 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">당기손익-공정가치측정금융자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">226,019,338 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">180,147,415 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">58,573,591 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">464,740,344 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="991">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="173"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="991" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" VALIGN="MIDDLE" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">구분</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">상각후원가로&cr; 측정하는 금융자산</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">당기손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">기타포괄손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">32,094,194 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">32,094,194 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">단기금융자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">매출채권및기타채권</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">205,735,802 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">205,735,802 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">장기금융자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">689,548 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">689,548 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">장기매출채권및기타채권</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">5,733,901 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">5,733,901 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">20,908,224 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">20,908,224 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">당기손익-공정가치측정금융자산</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">244,253,445 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">98,736,982 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">20,908,224 </TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">363,898,651 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(2) 당기말과 전기말 현재 금융부채의 범주별 분류내역은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="666">

<COLGROUP>
<COL WIDTH="324"></COL>
<COL WIDTH="324"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="666" HEIGHT="30" COLSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="333" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="333" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가로 측정하는 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">매입채무 및 기타채무</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">132,747,743 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">단기차입금</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">57,052,620 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">유동성사채</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">89,925,922 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">유동성리스부채</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">984,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">장기매입채무 및 기타채무</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">10,172,469 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">장기차입금</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">91,524,819 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">사채</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">199,640,496 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">리스부채</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">6,562,459 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">588,610,685 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="666">

<COLGROUP>
<COL WIDTH="324"></COL>
<COL WIDTH="324"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="666" HEIGHT="30" COLSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="333" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="333" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가로 측정하는 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">매입채무 및 기타채무</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">121,980,081 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">단기차입금</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">9,414,842 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">유동성사채</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">89,921,321 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">유동성리스부채</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">993,720 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">장기매입채무 및 기타채무</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">11,494,944 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">사채</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">289,196,132 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30">리스부채</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">3,404,421 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="333" HEIGHT="30" ALIGN="RIGHT">526,405,461 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(3) 당기와 전기 중 자산의 범주별 금융손익의 내역은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="972">

<COLGROUP>
<COL WIDTH="227"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="175"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="972" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="236" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="184" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가로&cr;측정하는 금융자산/부채</TH>
<TH WIDTH="184" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="184" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="184" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 합      계 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="972" HEIGHT="30" COLSPAN="5">Ⅰ. 금융수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">  이자수익</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">487,739 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">2,935,237 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">3,422,976 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">  외환차익</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">5,591,649 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">5,591,649 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">  외화환산이익</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">2,617,330 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">2,617,330 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">  파생상품 거래이익</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">10,915,818 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">10,915,818 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30"> 공정가치측정금융자산평가이익</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">3,514,240 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">3,514,240 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">금융수익 소계</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">8,696,718 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">17,365,295 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">26,062,013 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="972" HEIGHT="30" COLSPAN="5">Ⅱ. 금융원가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">  이자비용</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(10,609,840)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(10,609,840)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">  외환차손</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(4,781,394)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(4,781,394)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">  외화환산손실</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(3,530,649)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(6,445,000)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(9,975,649)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">  공정가치측정금융자산평가손실</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(892,160)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(892,160)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">금융원가 소계</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(18,921,883)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(7,337,160)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(26,259,043)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">Ⅲ. 순금융수익(원가)(Ⅰ+Ⅱ)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(10,225,165)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">10,028,135 </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(197,030)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="972" HEIGHT="30" COLSPAN="5">Ⅳ. 판매관리비</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="236" HEIGHT="30">   대손상각비</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(3,595,767)</TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="184" HEIGHT="30" ALIGN="RIGHT">(3,595,767)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="972" HEIGHT="30" COLSPAN="5">Ⅴ. 기타포괄손익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" 0X0000FF" WIDTH="236" HEIGHT="53">
<SPAN USERMARK=" 0X000000">  기타포괄손익-공정가치</SPAN>
<SPAN USERMARK=" 0X000000">&cr;    지분상품 평가손익</SPAN>
</TD>
<TD WIDTH="184" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="184" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="184" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">19,258,457 </TD>
<TD WIDTH="184" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">19,258,457 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="972">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="178"></COL>
<COL WIDTH="178"></COL>
<COL WIDTH="178"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="972" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="188" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가로&cr;측정하는 금융자산/부채</TH>
<TH WIDTH="187" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="187" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="187" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 합      계 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="972" HEIGHT="30" COLSPAN="5">Ⅰ. 금융수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">  이자수익</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">529,871 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">2,197,590 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">2,727,461 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">  외환차익</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">6,432,561 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">6,432,561 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">  외화환산이익</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">1,949,027 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">1,949,027 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">금융수익 소계</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">8,911,459 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">2,197,590 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">11,109,049 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="972" HEIGHT="30" COLSPAN="5">Ⅱ. 금융원가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">  이자비용</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">(10,088,046)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">　- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(10,088,046)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">  외환차손</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">(4,969,431)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">　- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(4,969,431)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">  외화환산손실</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">(1,235,460)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">　- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(1,235,460)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">금융원가 소계</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">(16,292,937)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(16,292,937)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">Ⅲ. 순금융수익(원가)(Ⅰ+Ⅱ)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">(7,381,478)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">2,197,590 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(5,183,888)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="972" HEIGHT="30" COLSPAN="5">Ⅳ. 판매관리비</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">   대손상각비</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">(1,443,197)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(1,443,197)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="972" HEIGHT="30" COLSPAN="5">Ⅴ. 기타포괄손익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" 0X0000FF" WIDTH="223" HEIGHT="53">
<SPAN USERMARK=" 0X000000">  기타포괄손익-공정가치</SPAN>
<SPAN USERMARK=" 0X000000">&cr;    지분상품 평가손익</SPAN>
</TD>
<TD WIDTH="188" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="187" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="187" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">4,912,708 </TD>
<TD WIDTH="187" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">4,912,708 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(4) 당기말과 전기말 현재 사용제한예금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="689">

<COLGROUP>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="689" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">금융기관</TH>
<TH WIDTH="133" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="133" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
<TH WIDTH="155" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제한내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30">장기금융자산</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)우리은행 외 3</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">21,548 </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">21,548 </TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당좌개설보증금</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(5) 금융자산 양도&cr;</SPAN>
<SPAN>당기말 현재 연결실체는 매출채</SPAN>
<SPAN>권 </SPAN>
<SPAN>2,016,970천원(전기말: 4,355,409천원</SPAN>
<SPAN>)을</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>(</SPAN>
<SPAN USERMARK="F-8"></SPAN>
<SPAN>주)신한은행 외 1</SPAN>
<SPAN>에 양도하고 해당 채권의 예상 손실액에 대하여 신용보증을 제공하였습니다. 따라서 연결실체는 동 채권의 장부금액 전액을 계속하여 인식하였</SPAN>
<SPAN>으며, 양도시 수령한 현금을 담보차입으로 인식하였습니다(</SPAN>
<SPAN>주석16 참조</SPAN>
<SPAN>).</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>&cr;</SPAN>&cr;7. 매출채권 및 기타채권&cr;(1) 당기말과 전기말 현재 매출채권 및 기타채권의 내역은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="709">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="709" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="276" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="275" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="138" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
<TH WIDTH="138" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="137" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">매출채권</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">137,409,378 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">800,018 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">183,521,850 </TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">278,881 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">대손충당금</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">(19,054,133)</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">(277,169)</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">(15,604,964)</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">(278,881)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미수금</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">29,002,265 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">38,473,748 </TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">대손충당금</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">(722,490)</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">(707,701)</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미수수익</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">942,625 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">52,869 </TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">대여금</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">보증금</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">1,309,109 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">3,215,499 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">4,733,901 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">148,886,754 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">4,738,348 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">205,735,802 </TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">5,733,901 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;연결실체는 상기 매출채권 및 기타채권의 일부에 대해서 담보 혹은 지급보증을 제공받고 있습니다. 또한, 매출채권 및 기타채권의 공정가치는 장부금액과 중요한 차이가없습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>(2) 당기말과 전기말</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>현재</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>매출채권 및 기타채권의</SPAN>
<SPAN USERMARK="F-8"></SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>연령별</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>금액은</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="710">

<COLGROUP>
<COL WIDTH="266"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="5" WIDTH="710" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="275" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH COLSPAN="2" WIDTH="217" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="218" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　매출채권</TH>
<TH WIDTH="109" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채권</TH>
<TH WIDTH="109" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　매출채권</TH>
<TH WIDTH="109" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채권</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" HEIGHT="30">Ⅰ. 손상되지 않은 금융자산</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" HEIGHT="30"> 6개월 이하</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30">112,878,729 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">30,673,279 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">166,990,976 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">43,552,817 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" HEIGHT="30"> 6개월 초과 ~ 1년 이하</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30">2,171,812 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">3,086,008 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">925,910 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" HEIGHT="30"> 1년 초과</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30">3,827,553 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">987,721 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소      계</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30">118,878,094 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">34,747,008 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">167,916,886 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">43,552,817 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" HEIGHT="30">Ⅱ. 손상된 금융자산</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" HEIGHT="30"> 집합적으로 손상된 금융자산</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30">5,493,221 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">15,419 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">6,781,924 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">629 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" HEIGHT="30"> 개별적으로 손상된 금융자산</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30">13,838,081 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">707,071 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">9,101,921 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">707,072 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소      계</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30">19,331,302 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">722,490 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">15,883,845 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">707,701 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="275" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합      계</TD>
<TD WIDTH="108" ALIGN="RIGHT" HEIGHT="30">138,209,396 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">35,469,498 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">183,800,731 </TD>
<TD WIDTH="109" ALIGN="RIGHT" HEIGHT="30">44,260,518 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" IU">&cr;</SPAN>
<SPAN USERMARK=" !B">(3) 당기와 전기 중 매출채권 및 기타채권의 대손충당금 변동내역은 다음과 같습니 다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="704" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="226"></COL>
<COL WIDTH="226"></COL>
<COL WIDTH="225"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="704" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="235" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="235" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="234" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30">기초금액</TD>
<TD WIDTH="235" ALIGN="RIGHT" HEIGHT="30">16,591,546 </TD>
<TD WIDTH="234" ALIGN="RIGHT" HEIGHT="30">15,268,909 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30">대손상각비</TD>
<TD WIDTH="235" ALIGN="RIGHT" HEIGHT="30">3,595,767 </TD>
<TD WIDTH="234" ALIGN="RIGHT" HEIGHT="30">1,443,197 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30">연중제각 및 회수</TD>
<TD WIDTH="235" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="234" ALIGN="RIGHT" HEIGHT="30">(376,449)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30">기타</TD>
<TD WIDTH="235" ALIGN="RIGHT" HEIGHT="30">(133,521)</TD>
<TD WIDTH="234" ALIGN="RIGHT" HEIGHT="30">255,889 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30">기말금액</TD>
<TD WIDTH="235" ALIGN="RIGHT" HEIGHT="30">20,053,792 </TD>
<TD WIDTH="234" ALIGN="RIGHT" HEIGHT="30">16,591,546 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B"></SPAN>
<SPAN USERMARK=" !B"></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK=" B">
<SPAN USERMARK=" !B">8. 재고자산&cr;</SPAN>
<SPAN USERMARK=" !B">(1) 당기말과 전기말 현재 재고자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="710">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="710" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="7" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="102" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="83">구분</TH>
<TH COLSPAN="3" WIDTH="305" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH COLSPAN="3" WIDTH="303" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="102" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">취득원가</TH>
<TH WIDTH="102" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">평가손실&cr;충당금</TH>
<TH WIDTH="101" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">장부금액</TH>
<TH WIDTH="101" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">취득원가</TH>
<TH WIDTH="101" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">평가손실&cr;충당금</TH>
<TH WIDTH="101" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30">상품</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">53,485,516 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">(1,077,659)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">52,407,857 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">52,686,496 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(803,163)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">51,883,333 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30">제품</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">68,641,703 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">(5,968,943)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">62,672,760 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">55,387,599 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(2,156,896)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">53,230,703 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30">재공품</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">19,648,981 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">(1,656,110)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">17,992,871 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">35,473,248 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(1,539,051)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">33,934,197 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30">원재료</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">32,938,557 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">(385,503)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">32,553,054 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">29,812,002 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(259,702)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">29,552,300 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30">포장재료</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">6,733,464 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">(109,763)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">6,623,701 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">5,788,157 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(164,494)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">5,623,663 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30">미착품</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">1,720,400 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">1,720,400 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">3,385,060 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">3,385,060 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">183,168,621 </TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">(9,197,978)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">173,970,643 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">182,532,562 </TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(4,923,306)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">177,609,256 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(2) 당기말 현재 담보로 제공된 재고자산은 없습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>
<P>9. 기타자산&cr;당기말과 전기말 현재 기타자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="704">

<COLGROUP>
<COL WIDTH="186"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="704" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="195" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="255" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">제 19(당) 기</TH>
<TH WIDTH="254" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="127" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
<TH WIDTH="127" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="127" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="31">선급금</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="31">18,389,133 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="31">161,731 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="31">5,683,793 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="31">180,867 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30">대손충당금</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">(82,000)</TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">(82,000)</TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30">선급비용</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">4,452,434 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">3,054,409 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">2,675,985 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">4,722,820 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30">부가세대급금</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">3,761,577 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">2,467,505 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30">기타</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">14,241 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">1,517 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">26,535,385 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">3,216,140 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">10,746,800 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">4,903,687 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B"></SPAN>
<SPAN USERMARK=" !B"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>10. </SPAN>
<SPAN>공정가치측정금융자산</SPAN>
</P>
<P>(1) 당기말과 전기말 현재 공정가치측정금융자산의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="663" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="212"></COL>
<COL WIDTH="212"></COL>
<COL WIDTH="212"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="663" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="221" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구     분</TH>
<TH WIDTH="221" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="221" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="663" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">기타포괄손익-공정가치측정 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30"> 시장성 있는 금융자산</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">48,184,012 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">13,817,172 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30"> 시장성 없는 금융자산</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">10,389,579 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">7,091,052 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소      계</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">58,573,591 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">20,908,224 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="663" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">당기손익-공정가치측정 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30"> 시장성 없는 금융자산</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소      계</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합      계</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">133,915,691 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">21,908,244 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(2) 당기와 전기 중</SPAN>
<SPAN> 공정가치 측정 금융자산의</SPAN>
<SPAN> 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="670">

<COLGROUP>
<COL WIDTH="215"></COL>
<COL WIDTH="214"></COL>
<COL WIDTH="214"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="670" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="224" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구     분</TH>
<TH WIDTH="223" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="223" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기초금액</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">21,908,244 </TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">        7,923,053 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">취득 및 대체</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">81,402,986 </TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">       7,681,127 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">처분</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">(1,149,657)</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">(4)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">거래손익</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">10,915,818 </TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">                   - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">평가손익(법인세효과 차감 전)</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">20,838,300 </TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">         6,304,068 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기말금액</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">133,915,691 </TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">       21,908,244 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">차감: 유동항목</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">비유동항목</TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30">133,915,691 </TD>
<TD WIDTH="223" ALIGN="RIGHT" HEIGHT="30"> 21,908,244 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>
<P></P>
<PGBRK></PGBRK>
<P>11. 관계기업투자 및 공동기업투자&cr;(1) 당기말과 전기말 현재 관계기업투자의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="905">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="905" HEIGHT="30" COLSPAN="9" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="152" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계기업명</TH>
<TH WIDTH="186" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요영업활동</TH>
<TH WIDTH="77" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">영업&cr;소재지</TH>
<TH WIDTH="72" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결산월</TH>
<TH WIDTH="74" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율</TH>
<TH WIDTH="172" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="172" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="28" USERMARK="F-10">(주)엠디웰아이앤씨(*2)</TD>
<TD WIDTH="186" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">건강기능식품 생산 판매</TD>
<TD WIDTH="77" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">대한민국</TD>
<TD WIDTH="72" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">12월</TD>
<TD WIDTH="74" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">50.00% </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">500,000 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,130,506 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">500,000 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,295,895 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="28" USERMARK="F-10">(주)이피피미디어</TD>
<TD WIDTH="186" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">광고대행업</TD>
<TD WIDTH="77" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">대한민국</TD>
<TD WIDTH="72" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">12월</TD>
<TD WIDTH="74" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">20.00% </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,000,000 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,000,000 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="28" USERMARK="F-10">(주)바이오시네틱스(*1)</TD>
<TD WIDTH="186" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">의약원료 제조 및 판매</TD>
<TD WIDTH="77" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">대한민국</TD>
<TD WIDTH="72" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">12월</TD>
<TD WIDTH="74" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">18.04% </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,999,500 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">277,793 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,999,500 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">531,861 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="28" USERMARK="F-10">건강한삶기술창업벤처</TD>
<TD WIDTH="186" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">사모펀드</TD>
<TD WIDTH="77" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">대한민국</TD>
<TD WIDTH="72" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">12월</TD>
<TD WIDTH="74" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">49.50% </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,500,000 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,303,388 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,500,000 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,375,648 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" HEIGHT="28" USERMARK="F-10">다나아데이터
<SPAN>(*2)</SPAN>
</TD>
<TD WIDTH="186" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">응용소프트웨어 개발및 판매</TD>
<TD WIDTH="77" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">대한민국</TD>
<TD WIDTH="72" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">12월</TD>
<TD WIDTH="74" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">51.00% </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,100,000 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,163,953 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,100,000 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,092,923 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="28" USERMARK="F-10">Immplacate, Inc.</TD>
<TD WIDTH="186" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">줄기세포치료제 연구 및 개발</TD>
<TD WIDTH="77" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">미국</TD>
<TD WIDTH="72" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">12월</TD>
<TD WIDTH="74" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">20.00% </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,125,970 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,340 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,125,970 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">939,622 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="561" HEIGHT="28" COLSPAN="5" ALIGN="CENTER" USERMARK="F-10">합계</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">12,225,470 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">10,880,980 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">11,225,470 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">10,235,949 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B"></SPAN>
<SPAN USERMARK=" !B">(*1) 의결권 있는 지분율은 20%미만이나 유의적인 영향력이 있다고 판단하여 관계</SPAN>
<SPAN USERMARK=" !B">기</SPAN>
<SPAN USERMARK=" !B">업투자주식으로 분류하였습니다.</SPAN>
<SPAN USERMARK=" !B">&cr;</SPAN>
<SPAN USERMARK=" !B"></SPAN>
<SPAN USERMARK=" !B">(*2) </SPAN>
<SPAN USERMARK="F-8 !B"></SPAN>
<SPAN USERMARK=" !B">공동기업투자주식입니다.</SPAN>
<SPAN USERMARK=" 0XBD6F00 !B">&cr;</SPAN>
<SPAN USERMARK=" 0XBD6F00">&cr;</SPAN>
<SPAN USERMARK=" !B">2) 당기와 전기 중 관계기업투자의 장부금액 변동내역은 다음과 같습니다.&cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="974">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="974" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="7" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">관계기업명</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">기초</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">취득 및 처분</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">지분법손익</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">지분법자본변동</TH>
<TH WIDTH="133" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">손상</TH>
<TH WIDTH="133" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">(주)엠디웰아이앤씨</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">2,295,895 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">834,611 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">3,130,506 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">(주)이피피미디어(*)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">(주)바이오시네틱스</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">531,861 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">11,783 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">(265,883)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">32 </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">277,793 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">건강한삶기술창업벤처</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">1,375,648 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">(72,261)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">2,303,387 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">다나아데이터</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">5,092,923 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">71,030 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">5,163,953 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">Immplacate, Inc.</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">939,622 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">(37,532)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">365 </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">(897,114)</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">5,341 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">10,235,949 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">1,011,783 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">529,965 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">397 </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">(897,114)</TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">10,880,980 </TD>
</TR>
</TBODY>
</TABLE>

<P>(*) (주)이피피미디어는 순자산가액이 '0' 이하로 하락하여 지분법 적용을 중단하였습니다.&cr;
<SPAN>&cr;나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="841">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="841" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">관계기업명</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">기초</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">취득 및 처분</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">지분법손익</TH>
<TH WIDTH="134" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">지분법자본변동</TH>
<TH WIDTH="133" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">(주)엠디웰아이앤씨</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">1,865,498 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">430,397 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">2,295,895 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">(주)이피피미디어(*)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">(주)바이오시네틱스</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">759,744 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">5,323 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">(233,206)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">531,861 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">건강한삶기술창업벤처</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">1,437,090 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">(61,442)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">1,375,648 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">다나아데이터</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">5,065,303 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">27,620 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">5,092,923 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">Immplacate, Inc.</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">1,125,970 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">(190,853)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">4,505 </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">939,622 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">9,127,635 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">1,131,293 </TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">(27,484)</TD>
<TD WIDTH="134" ALIGN="RIGHT" HEIGHT="30">4,505 </TD>
<TD WIDTH="133" ALIGN="RIGHT" HEIGHT="30">10,235,949 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) (주)이피피미디어는 순자산가액이 '0' 이하로 하락하여 지분법 적용을 중단하였습니다.</P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr;(3) 당기말과 전기말 현재 지분법중단으로 인해 인식하지 못한 관계기업의 손실 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="851">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="851" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="194" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60">관계기업명</TH>
<TH WIDTH="329" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="328" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2" HEIGHT="30">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="165" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30">당기분</TH>
<TH WIDTH="164" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">누적</TH>
<TH WIDTH="164" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기분</TH>
<TH WIDTH="164" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">누적</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30">(주)이피피미디어</TD>
<TD WIDTH="165" ALIGN="RIGHT" HEIGHT="30">(59,394)</TD>
<TD WIDTH="164" ALIGN="RIGHT" HEIGHT="30">(2,432,070)</TD>
<TD WIDTH="164" ALIGN="RIGHT" HEIGHT="30">(280,384)</TD>
<TD WIDTH="164" ALIGN="RIGHT" HEIGHT="30">(2,372,676)</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B"></SPAN>
</P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">(4) 당기말 현재 관계기업의 요약 재무정보는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="854">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="178"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="854" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">관계기업명</TH>
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출</TH>
<TH WIDTH="187" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">(주)엠디웰아이앤씨</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">9,829,663 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">3,568,651 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">16,182,266 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">1,669,222 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">(주)이피피미디어</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">6,815,780 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">18,976,130 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(296,971)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">(주)바이오시네틱스</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">2,139,099 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">599,534 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">229,187 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(1,473,558)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">건강한삶기술창업벤처</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">4,658,995 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">7,810 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">1,734 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(145,967)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">다나아데이터</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">10,127,138 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">1,741 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">139,274 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30">Immplacate, Inc.</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">26,949 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">246 </TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">3,540 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">(187,662)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(5) 당기말 현재 관계기업의 순자산과 관계기업투자와의 조정내역은 다음과 같</SPAN>
<SPAN>습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="682">

<COLGROUP>
<COL WIDTH="155"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="682" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="164" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계기업명</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">순자산</TH>
<TH WIDTH="100" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">지분상당액</TH>
<TH WIDTH="103" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">투자차액잔액</TH>
<TH WIDTH="111" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">미인식손실&cr;누적액</TH>
<TH WIDTH="99" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="30">(주)엠디웰아이앤씨</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">6,261,012 </TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">3,130,506 </TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">3,130,506 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="30">(주)이피피미디어</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">(12,160,350)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">(2,432,070)</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">2,432,070 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="30">(주)바이오시네틱스</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">1,539,565 </TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">277,793 </TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">277,793 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="30">건강한삶기술창업벤처</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">4,651,185 </TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">2,302,567 </TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT">821 </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">2,303,388 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="30">다나아데이터</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">10,125,397 </TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">5,163,953 </TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">5,163,953 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="30">Immplacate, Inc.</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">26,703 </TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">5,341 </TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">5,341 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>12. 유형자산&cr;(1) 당기말과 전기말 현재 유형자산의 내역은 다음과 같습니다.</P>

<TABLE WIDTH="988" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="107"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="9" WIDTH="988" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH COLSPAN="4" WIDTH="436" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH COLSPAN="4" WIDTH="436" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각&cr;누계액</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각&cr;누계액</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">토       지</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,813,793 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,813,793 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,784,516 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,784,516 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">건       물</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">211,687,189 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(52,638,729)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(79,196)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,969,264 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">209,161,527 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(46,963,005)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(81,401)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">162,117,121 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구  축  물</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,418,287 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,432,143)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(28,147)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,957,997 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,175,880 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(12,738,600)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(30,407)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,406,873 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기계장치</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">244,960,629 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(145,072,689)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,887,940 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,754,392 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(131,381,270)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">109,373,122 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차량운반구</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,475,146 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,250,942)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">224,204 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,494,712 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,117,606)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">377,106 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공구와기구</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,440,958 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,743,123)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,697,835 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,590,716 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,001,636)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,589,080 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">집기비품</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,022,726 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(47,512,759)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,509,967 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,940,371 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(45,782,609)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,157,762 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타의유형자산</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,596,566 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,534,275)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(7,609)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,054,682 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,958,941 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(7,040,453)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,752)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">906,736 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,046,305 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,046,305 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,502,645 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,502,645 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합       계</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">659,461,599 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(273,184,660)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(114,952)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">386,161,987 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">635,363,700 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(248,025,179)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(123,560)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">387,214,961 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기 중 유형자산의 변동내역은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE BORDER="1" WIDTH="1089" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="11" WIDTH="1089" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">토지</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구축물</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기계장치</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공구와기구</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">집기비품</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타&cr;유형자산</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건설중인&cr;자산</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">기초 장부금액</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,784,516 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">162,117,121 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,406,873 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">109,373,122 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">377,106 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,589,080 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,157,762 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">906,736 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,502,644 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">387,214,960 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">취득</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">202,147 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">777,070 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,495,876 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,694 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">854,933 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">459,640 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">322,958 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,912,323 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,053,641 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">처분</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(15,770)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(25,454)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(36,550)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(24,012)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,020)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(117,806)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">감가상각비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,846,282)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,702,342)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(17,370,091)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(156,470)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(744,696)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,145,458)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(555,800)</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(29,521,139)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,277 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,108 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,030 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(56,323)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,114)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,482)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,747)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(303)</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(35,467)</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,979 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">대체</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,409,940 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500,820 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,481,906 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,790 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,381,091 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,333,195)</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">497,352 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">연결범위의 변동</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">기말 장부금액</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,813,793 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,969,264 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,957,997 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,887,940 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">224,204 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,697,835 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,509,967 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,054,682 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,046,305 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">386,161,987 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>나. 제 18(전) 기
</P>

<TABLE BORDER="1" WIDTH="1089" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="11" WIDTH="1089" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">토지</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구축물</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기계장치</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공구와기구</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">집기비품</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타&cr;유형자산</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건설중인&cr;자산</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">기초 장부금액</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,202,926 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">155,816,166 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,251,894 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">92,011,148 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">547,870 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,909,682 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,065,707 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,067,194 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,256,735 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">401,129,322 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">취득</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">919,815 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135,645 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,895,206 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,227 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">165,021 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">495,889 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">163,095 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,027,540 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,820,438 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">처분</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(179)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(190,514)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">154,682 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(23,122)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(24,014)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3)</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(83,150)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">감가상각비</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,316,755)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,675,136)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,645,300)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(166,515)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(639,879)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,113,816)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(537,502)</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(29,094,903)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,512 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">221,308 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,401 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">122,005 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">646 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">126 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">938 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,909,139)</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,051 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,487,152)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">대체</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">510,078 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,476,766 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">883,583 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,835,381 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">154,130 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,733,058 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,091 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(52,785,681)</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,069,594)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">연결범위의 변동</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">기말 장부금액</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,784,516 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">162,117,121 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,406,873 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">109,373,122 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">377,106 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,589,080 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,157,762 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">906,736 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,502,645 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">387,214,961 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(3) </SPAN>
<SPAN>당기말 현</SPAN>
<SPAN>재 </SPAN>
<SPAN></SPAN>
<SPAN>토지</SPAN>
<SPAN>(</SPAN>
<SPAN>장부금</SPAN>
<SPAN>액</SPAN>
<SPAN> </SPAN>
<SPAN>2,765,833천</SPAN>
<SPAN>원</SPAN>
<SPAN>)는 </SPAN>
<SPAN>중소기업은행</SPAN>
<SPAN>의 원화</SPAN>
<SPAN>단기차입금에대한 담보로 제공되어 있습니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> (주석 32)&cr;&cr;</SPAN>13. 투자부동산
</P>
<P>(1) 당기말과 전기말 현재 투자부동산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="871">

<COLGROUP>
<COL WIDTH="109"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="7" WIDTH="871" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH COLSPAN="3" WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH COLSPAN="3" WIDTH="375" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각누계액</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각누계액</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">토       지</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,715,783 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,715,783 </TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,586,143 </TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,586,143 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">건       물</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,444,660 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,442,334)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,002,326 </TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,683,478 </TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,467,033)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,216,445 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합       계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">92,160,443 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,442,334)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,718,109 </TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,269,621 </TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,467,033)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">91,802,588 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기와 전기 중 투자부동산의 변동내역은 다음과 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE BORDER="1" WIDTH="871" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="208"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="4" WIDTH="871" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">토지</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">기초 장부금액</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,586,143 </TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,216,445 </TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">91,802,588 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">처분</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,870,360)</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(908,467)</TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,778,827)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">투자부동산감가상각비</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,340,195)</TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,340,195)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">대체</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,543 </TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,543 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">기말 장부금액</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,715,783 </TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,002,326 </TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,718,109 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 제 18(전) 기</P>

<TABLE BORDER="1" WIDTH="871" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="208"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="4" WIDTH="871" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">토지</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">기초 장부금액</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,586,143 </TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,547,233 </TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">93,133,376 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">처분</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,527)</TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(14,527)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">투자부동산감가상각비</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,316,261)</TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,316,261)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30">기말 장부금액</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,586,143 </TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,216,445 </TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">91,802,588 </TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(3) 당기와 전기 중 투자부동산과 관련하여 인식한 임대수익 및 임대비용은 다음과&cr;같습니다.</SPAN>
</P>

<TABLE WIDTH="866" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="280"></COL>
<COL WIDTH="280"></COL>
<COL WIDTH="279"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="866" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="289" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="288" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="30">임대수익</TD>
<TD WIDTH="289" ALIGN="RIGHT" HEIGHT="30">2,804,872 </TD>
<TD WIDTH="288" ALIGN="RIGHT" HEIGHT="30">2,649,827 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="30">임대비용(*)</TD>
<TD WIDTH="289" ALIGN="RIGHT" HEIGHT="30">(3,443,213)</TD>
<TD WIDTH="288" ALIGN="RIGHT" HEIGHT="30">(3,484,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="30">임대손익</TD>
<TD WIDTH="289" ALIGN="RIGHT" HEIGHT="30">(638,341)</TD>
<TD WIDTH="288" ALIGN="RIGHT" HEIGHT="30">(834,386)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(*) 감가상각비 및 세금과공과 등으로 구성되어 있습니다.&cr;&cr;(4) 리스제공자&cr;가. 연결실체는 특정 토지 및 건물로 구성된 투자부동산 포트폴리오에 대한 운용리스계약을 체결하였</SPAN>
<SPAN>으며 이 리스들의 기간은 </SPAN>
<SPAN>1년에서 3년 사이</SPAN>
<SPAN>입니</SPAN>
<SPAN>다.&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>
</P>
<P>나. 해지불능 운용리스 하에서 미래 최소 임대료 채권</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="620" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" HEIGHT="30">
<P>1년 이내</P>
</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,778,926 </TD>
<TD WIDTH="206" ALIGN="RIGHT" HEIGHT="30">1,370,094 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" HEIGHT="30">
<P>1년 초과 5년 이하</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,100,291 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,809,329 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" HEIGHT="30">
<P>5년 초과</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,879,217 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,179,423 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(5) 당기말 현재 차입금에 대한 담보로 제공되어 있는 투자부동산은 없습니다. </SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(6)</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> 당기말 현재 투자부동산 토지의 공시지가는 </SPAN>
<SPAN></SPAN>
<SPAN>55,163,990천원(전기말: 58,597,838천원) 입니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>
<P>14. 무형자산&cr;(1) 당기말과 전기말 현재 무형자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="855">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="7" WIDTH="855" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH COLSPAN="3" WIDTH="349" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH COLSPAN="3" WIDTH="348" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액 및 &cr;손상차손누계액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액 및 &cr;손상차손누계액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">영업권</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,848,079 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,848,079 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,848,079 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,848,079 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">산업재산권</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,502,380 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,686,468)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,815,912 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,526,735 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,156,549)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,370,186 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">개발비</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,807,700 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,020,043)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,787,657 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,610,196 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,780,494)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,829,702 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회원권</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,893,945 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,893,945 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,620,748 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,620,748 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타의무형자산</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,690,086 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(48,293,793)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,396,293 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">93,612,066 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(38,594,969)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,017,097 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합    계</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">235,742,190 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(57,000,304)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,741,886 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">230,217,824 </TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(65,532,012)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164,685,812 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기와 전기 중 무형자산의 변동내역은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE BORDER="1" WIDTH="968" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="7" WIDTH="968" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">영업권</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">산업재산권</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개발비</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회원권</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타의무형자산</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">기초 장부금액</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,848,079 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,370,186 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,829,702 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,620,748 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,017,097 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164,685,812 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">취득</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">745,799 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,162,409 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,359,260 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,261,550 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,529,018 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">처분</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,347)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,694,563)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,702,910)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,273,307)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(230,782)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,885,424)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,389,513)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">무형자산손상</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,132,000)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,973,672)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(391,500)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,845,478)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,342,650)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">대체</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,113,772 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">849,196 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,962,968 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(191)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(648)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(839)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">기말 장부금액</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,848,079 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,815,912 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,787,657 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,893,945 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,396,293 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,741,886 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE BORDER="1" WIDTH="968" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="7" WIDTH="968" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">영업권</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">산업재산권</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개발비</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회원권</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타의무형자산</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">기초 장부금액</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,848,079 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,862,310 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,035,359 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,598,748 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,229,078 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149,573,574 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">취득</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,185,773 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,089,740 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,022,000 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,740,927 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,038,440 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">처분</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,075)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,494,726)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,495,801)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,260,377)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(216,045)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,972,468)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,448,890)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">무형자산손상</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,601,926)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,163,132)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(556,850)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,321,908)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">대체</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">201,409 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,386,799 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,070,996 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,659,204 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,015,928)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,303,018)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">139 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,318,807)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">기말 장부금액</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,848,079 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,370,186 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,829,703 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,620,748 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,017,096 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164,685,812 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(3) 연결실체의 개발비 자산화 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1093">

<COLGROUP>
<COL WIDTH="49"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="331"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1093" HEIGHT="28" COLSPAN="10" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="58" HEIGHT="77" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">단  계</TH>
<TH WIDTH="68" HEIGHT="77" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">구  분</TH>
<TH WIDTH="340" HEIGHT="77" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">개별&cr;자산명</TH>
<TH WIDTH="246" HEIGHT="28" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">제 19(당) 기</TH>
<TH WIDTH="245" HEIGHT="28" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">제 18(전) 기</TH>
<TH WIDTH="136" HEIGHT="77" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">잔여&cr;상각기간</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="82" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">취득가액</TH>
<TH WIDTH="82" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">상각 및&cr;손상누계액</TH>
<TH WIDTH="82" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">장부금액</TH>
<TH WIDTH="82" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">취득가액</TH>
<TH WIDTH="82" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">상각 및&cr;손상누계액</TH>
<TH WIDTH="81" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWP14012302(NERD)(*1)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,456,808 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(3,456,808)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,268,201 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,268,201 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 계획 변경</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWP14012301(GERD)(*2)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">4,049,146 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">4,049,146 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,303,649 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,303,649 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DW_UDCA005우루사(*3)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">380,525 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(126,023)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">254,502 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">374,381 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(49,916)</TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">324,465 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3년 4개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWJ1351003(O+A+R3제복합제)(*4)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">235,126 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(82,294)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">152,832 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">235,126 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(35,269)</TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">199,857 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3년 3개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWJ211301(국소지방분해주사제)(*5)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,172,929 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,172,929 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">879,904 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">879,904 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">HL036(*6)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">24,961,341 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">24,961,341 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">15,332,696 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">15,332,696 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">1상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWP14012101(APA)BE_1상(BE)(*7)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">581,796 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">581,796 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">457,231 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">457,231 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">1상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWJ1351005(OAR추가용량BE)(*8)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">538,579 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(71,811)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">466,768 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">536,512 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">536,512 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">4년 4개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">생동</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제네릭</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWJ1410(도네페질23mgBE)(*9)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">251,988 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(251,988)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">245,194 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">245,194 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">중단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제네릭</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWP450007(나보타안검경련)_3상(*10)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">142,972 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(45,274)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">97,698 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">142,972 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(16,681)</TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">126,291 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3년 5개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">생동</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제네릭</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWJ1421(토파시티닙염변경5mgBE)생동(*11)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">299,719 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">299,719 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">219,088 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">219,088 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">생동</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제네릭</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWJ1255(엔테카비르1mg 태국)BE(*12)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">111,223 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(111,223)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">111,223 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">111,223 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">중단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 3상 </TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 제네릭</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> DW_DWP450301 나보타 사각턱 3상(*13) </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,203,112 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,203,112 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 3상 </TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 신약 </TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 레바미피드서방정_공동연구(*14) </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,237,845 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,237,845 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3상</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">DWJ1451301(OARE4제)_3상(*15)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,268,187 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,268,187 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">637,791 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">637,791 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 3상 </TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 신약 </TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> DWP14012303 Fexuprazan ERD 유지요법 3상(*16) </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">4,929,345 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">4,929,345 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 3상 </TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 신약 </TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> DWP14012305_20mg(위염)(*17) </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,581,305 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,581,305 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 3상 </TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 신약 </TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> DWP16001301Enavogliflozin 3상 단독요법(*18) </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">997,336 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">997,336 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 3상 </TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> 신약 </TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"> DWP16001302Enavogliflozin 3상 2제요법(*18) </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">459,215 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">459,215 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">
<SPAN>1상</SPAN>
</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">신약</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">기타 신약임상(*19)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">82,605 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(53,618)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">28,987 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">81,589 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(46,371)</TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">35,218 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">4년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">생동</TD>
<TD WIDTH="68" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">제네릭</TD>
<TD WIDTH="340" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">기타 제네릭임상(*20)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">199,246 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(153,652)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">45,594 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">152,382 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">152,382 </TD>
<TD WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="466" HEIGHT="28" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">합계</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">49,140,348 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(4,352,691)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">44,787,657 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">25,977,939 </TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(148,237)</TD>
<TD WIDTH="81" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">25,829,702 </TD>
<TD USERMARK="F-10" WIDTH="136" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) Best-in Class 항궤양제 신약 개발 프로젝트이며 후속 적응증(비미란성 위식도 역류질환)을 득하기 위한 임상3상 진행하였으나, 최근 임상 전략이 변경되어 글로벌 개발 계획 등을 반영하여 재추진할 계획입니다.&cr;(*2) Best-in Class 항궤양제 신약 개발 프로젝트이며 현재 최초 적응증 GERD에 대한 허가 단계로 2022년 중 발매를 목표로 하고 있습니다.&cr;(*3) 우루사 제품의 적응증 추가(위암 수술 후 담석 예방)를 위한 임상시험으로 2019년 5월 적응증 추가하였습니다. &cr;(*4) 고혈압/고지혈증의 3제 복합제로 2019년 2월 판매 승인 후 2019년 5월 발매하였습니다.&cr;(*5) 국소지방분해 미용시장 진출을 위한 DWJ211 주사제 개발 임상시험으로 2021년 3분기 허가를 목표로 하고 있습니다.&cr;(*6) 안구건조증 치료제(점안액)로 한올바이오파마와 공동개발건으로 현재 미국 임상 3상 단계로 2023년 발매를 목표로 하고 있습니다.&cr;(*7) 허가 진행중인 DWP14012의 허가자료로 활용할 예정이며, 최종발매제형에 대한 임상1상 PK시험입니다.&cr;(*8) 2019년 2월 품목허가를 취득한 올로맥스정(고혈압/고지혈증 3제 복합제)의 추가용량에 대한 1상 임상시험으로 2020년 5월 발매 하였습니다.&cr;(*9) 동등성 확보하였으나, 시장 니즈 감소에 따라 미발매 결정 되었습니다.&cr;(*10) 본태성 눈꺼풀경련 적응증을 추가하였습니다.&cr;(*11) 류마티스관절염치료제로 2025년 4분기 발매를 목표로 하고 있습니다.&cr;(*12) 동등성 확보하였으나 시장성 저하로 사업 중단 결정하였습니다.&cr;(*13) 양성교근비대증(사각턱) 적응증 추가를 위한 3상 임상시험으로 2022년 2분기 허가적응증 추가 획득을 목표로 하고 있습니다.&cr;(*14) 유한양행과 공동개발로 20년 7월까지 3상 수행 후 허가 신청 완료하였으며 2021년 2분기 발매 계획입니다.&cr;(*15) 고혈압/고지혈증의 4제 복합제로 2022년 허가를 목표로 하고 있습니다.&cr;(*16) Best-in Class 항궤양제 신약 개발 프로젝트이며 현재 적응증 추가를 위한 ERD 유지요법에 대한 임상3상 단계로 2022년 3분기 허가를 목표로 하고 있습니다.&cr;(*17) Best-in Class 항궤양제 신약 개발 프로젝트이며 현재 적응증 추가를 위한 급성 또는 만성위염에 대한 임상3상 단계로 2022년 3분기 허가를 목표로 하고 있습니다.&cr;(*18) Best-in Class SGL2Ti 신약 개발 프로젝트이며 현재 임상 단계로 2023년 중 발매를 목표로 하고 있습니다.&cr;(*19) 개발비 자산화 요건을 충족한 기타 신약임상으로 구성되어 있으며, 발매가 완료된 건은 상각을 진행하고 있습니다.&cr; </SPAN>
<SPAN>(*20) 개발비 자산화 요건을 충족한 기타 제네릭임상으로 구성되어 있습니다.&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF">&cr;</SPAN>
<SPAN USERMARK=" 0X0000FF"></SPAN>(4) 비한정 내용연수의 무형자산인 회원권의 손상검사&cr;당사는 회원권의 시장가치 하락 등 손상 징후를 발견시 합리적으로 추정하여 손상을 반영합니다. 회원권의 회수가능액은 순공정가치와 사용가치 중에서 큰 금액이며 순공정가치가 존재한다면 이를 사용하고, 존재하지 않는다면 사용가치를 합리적으로 산정하여 회수가능액을 결정하였습니다.&cr;
<SPAN USERMARK=" 0X0000FF"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>(5) </SPAN>
<SPAN>연결실체의</SPAN>
<SPAN></SPAN>
<SPAN> 무형자산 중 </SPAN>
<SPAN>독점판매권 취득 등으로 인해 외부에 지급된 금액의 주요 내역은 아래와 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1000">

<COLGROUP>
<COL WIDTH="244"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1000" HEIGHT="30" COLSPAN="8" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="253" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구분</TH>
<TH WIDTH="317" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">제 19(당) 기</TH>
<TH WIDTH="317" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">제 18(전) 기</TH>
<TH WIDTH="113" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">잔여 상각기간</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="97" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="123" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각 및&cr;손상차손누계액</TH>
<TH WIDTH="97" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="97" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="123" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각 및&cr;손상차손누계액</TH>
<TH WIDTH="97" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30" VALIGN="MIDDLE">제품개발완료(*1)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">66,828,988 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(25,743,888)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">41,085,100 </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">57,767,156 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(15,891,829)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">41,875,327 </TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8개월~17년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30" VALIGN="MIDDLE">신규 의약품, 의료기기 개발</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,737,825 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,000)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,728,825 </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,729,828 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,729,828 </TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30" VALIGN="MIDDLE">글로벌 신규 의약품, 의료기기 개발</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,686,053 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,686,053 </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,286,053 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,286,053 </TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">77,252,866 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(25,752,888)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">51,499,978 </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">63,783,037 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(15,891,829)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,891,208 </TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>(*1) 당기 중 독점판매권 3,693,479천원에 대해서 손상차손을 인식하였습니다.</SPAN>
</P>
<P>&cr;15. 매입채무 및 기타채무&cr;당기말과 전기말 현재 매입채무 및 기타채무의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="790">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="790" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" VALIGN="MIDDLE" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="316" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="316" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">매입채무</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">78,784,863 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">76,702,821 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미지급금</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">44,442,602 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">914,963 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">37,735,306 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">961,109 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미지급비용</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">3,709,476 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">3,815,730 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">예수보증금</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">5,802,817 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">9,257,506 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">3,718,239 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">10,533,836 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30">미지급배당금</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">7,985 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">7,985 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">132,747,743 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">10,172,469 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">121,980,081 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">11,494,945 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;16. 차입금 등&cr;(1) 당기말과 전기말 현재 차입금의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="783" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="783" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="316" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="316" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30">차입금</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">57,052,620 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">91,524,819 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">9,414,842 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30">사채</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">89,925,923 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">199,640,496 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">89,921,321 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">289,196,132 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">146,978,543 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">291,165,315 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">99,336,163 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">289,196,132 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(2) 당기말과 전기말 현재 차입금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="738">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="738" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="225" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" VALIGN="MIDDLE">원화장기차입금</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">케이비그레이트베어제일차(유)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2.27%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">          90,000,000 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30">외화장기차입금</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">국민은행</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EURIBOR+1.35%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">            1,524,819 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">원화단기차입금</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">수출입은행</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">1.72%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">            50,000,000 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">중소기업은행</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">2.83%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">            2,000,000 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">4.17%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">400,000 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">400,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30">수출채권 할인(*)</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">㈜신한은행 외</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">0.81%~5.80%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">2,016,970 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">4,355,409 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">외화단기차입금</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">Local Bank</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">2.30%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">1,933 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">일본신한은행</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">1.20%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">2,635,650 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,657,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="487" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">         148,577,439 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">9,414,842 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="487" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감 : 단기차입금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">         (57,052,620)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(9,414,842)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="487" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">91,524,819 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) L/C조건의 외화매출채권 중 할인 후 만기가 도래하지 않은 금액입니다.&cr;</P>
<P>(3) 당기말과 전기말 현재 사채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="777">

<COLGROUP>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="777" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만기일</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">표면이자율</TH>
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">제11회 무보증사채</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">2020.10.27</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">2.83%</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">90,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">제12회 무보증사채</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">2021.07.23</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">2.57%</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">90,000,000 </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">90,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">제13회 무보증사채</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">2022.04.25</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">2.05%</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">제14회 무보증사채</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">2022.10.30</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">2.06%</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="431" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감: 사채할인발행차금</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(433,582)</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(882,547)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="431" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감: 유동성사채</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(89,925,922)</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(89,921,321)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="431" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차  감  계</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">199,640,496 </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">289,196,132 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(4</SPAN>
<SPAN>) 당기말 현재 </SPAN>
<SPAN>중소기업은행</SPAN>
<SPAN>에 원화단기차입금과 관련하여</SPAN>
<SPAN> </SPAN>
<SPAN>토지</SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>장부금</SPAN>
<SPAN>액 </SPAN>
<SPAN>2,765,833천</SPAN>
<SPAN>원</SPAN>
<SPAN>)</SPAN>
<SPAN>를</SPAN>
<SPAN> </SPAN>
<SPAN>담보로 제공하고 있습니</SPAN>
<SPAN>다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>
<P>17. 이연수익</P>
<P>당기말과 전기말 현재 이연수익의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="665" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="213"></COL>
<COL WIDTH="213"></COL>
<COL WIDTH="212"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="665" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="222" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분 </TH>
<TH WIDTH="222" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="221" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" HEIGHT="30">정부보조금 관련 이연수익</TD>
<TD WIDTH="222" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">1,157,582 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;이연수익은 경상연구개발비 정부보조금으로 경상연구개발비에 대응하여 상계 되었습니다.&cr;</P>
<P>18. 기타부채&cr;(1) 당기말과 전기말 현재 기타부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="871">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="871" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="175" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="348" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">제 19(당) 기</TH>
<TH WIDTH="348" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="2">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="174" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="174" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
<TH WIDTH="174" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="174" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">선수금</TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">605,627 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">1,087,965 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">예수금</TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">6,192,399 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">7,253,286 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">종업원급여</TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">11,276,535 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">2,712,474 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">9,921,729 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">2,008,175 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">부가세예수금</TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">6,944,754 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">2,130,446 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">계약부채</TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">16,259,997 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">30,150,397 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">16,308,865 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">38,620,418 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">기타충당부채</TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">2,100,000 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">43,379,312 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">32,862,871 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">36,702,291 </TD>
<TD WIDTH="174" ALIGN="RIGHT" HEIGHT="30">40,628,593 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(2) 계약부채&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>1) </SPAN>
<SPAN> </SPAN>
<SPAN>유동 계약부채 중 8,748,522천원 및 비유동 계약부채 30,150,397천원은 UpfrontFee</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>수취금액이며,</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN></SPAN>
<SPAN>보고기간에</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>인식한</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>수익은 8,117,158천원(전기:11,137,683 천원) 입니다</SPAN>
<SPAN>(주석31참조)</SPAN>
<SPAN>.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>2) 반품관련 계약부채</SPAN>
</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="615" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="205" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구      분</TH>
<TH WIDTH="205" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="205" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3"> 계약부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기   초   잔   액</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">8,778,777 </TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">8,147,329 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당  기  설 정 액</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">4,574,361 </TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">6,467,144 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당  기  사 용 액</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">(6,172,556)</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">(5,835,696)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기   말   잔   액</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">7,180,582 </TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">8,778,777 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3"> 반환제품회수권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기   초   잔   액</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">2,282,362 </TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">1,889,161 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당  기  설 정 액</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">1,625,167 </TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">2,333,697 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당  기  사 용 액</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">(2,143,485)</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">(1,940,496)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기   말   잔   액</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">1,764,044 </TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">2,282,362 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>
<P>19. 퇴직급여&cr;연결실체는 종업원을 위한 퇴직급여제도로서 확정급여제도와 확정기여제도를 운영하고 있습니다.&cr;&cr;(1) 당기와 전기 중 퇴직급여부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="699">

<COLGROUP>
<COL WIDTH="281"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="195"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="699" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="290" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="699" HEIGHT="30">연결재무상태표상 구성항목:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="290" HEIGHT="30">  확정급여채무의 현재가치</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">18,111,144 </TD>
<TD WIDTH="204" ALIGN="RIGHT" HEIGHT="30">16,600,996 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="290" VALIGN="MIDDLE" HEIGHT="30">  사외적립자산의 공정가치</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">(18,114,321)</TD>
<TD WIDTH="204" ALIGN="RIGHT" HEIGHT="30">(17,687,643)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="290" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="205" ALIGN="RIGHT" HEIGHT="30">(3,177)</TD>
<TD WIDTH="204" ALIGN="RIGHT" HEIGHT="30">(1,086,647)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<P>(2) 당기와 전기 중 확정급여제도와 관련하여 당기손익으로 인식한 비용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="699">

<COLGROUP>
<COL WIDTH="283"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="699" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="292" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="203" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">당기근무원가</TD>
<TD WIDTH="204" ALIGN="RIGHT" HEIGHT="30">1,894,923 </TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">1,820,994 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">이자비용</TD>
<TD WIDTH="204" ALIGN="RIGHT" HEIGHT="30">317,668 </TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">329,848 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">사외적립자산의 기대수익</TD>
<TD WIDTH="204" ALIGN="RIGHT" HEIGHT="30">(340,895)</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">(278,419)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="30">종업원 급여에 포함된 총 비용</TD>
<TD WIDTH="204" ALIGN="RIGHT" HEIGHT="30">1,871,696 </TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">1,872,423 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<P>(3) 당기와 전기 중 확정급여채무의 현재가치 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="698">

<COLGROUP>
<COL WIDTH="286"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="698" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="295" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">기초금액</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">16,600,996 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">14,074,914 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">퇴직급여 지급액</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">(619,311)</TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">(810,728)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">당기근무원가</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">1,894,923 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">1,820,994 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">이자원가</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">317,668 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">329,848 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">계열사간 전출입효과</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">(1,757)</TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">확정급여제도의 재측정요소:</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">(78,535)</TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">1,185,968 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">  인구통계학적가정의 변동</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">406,508 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">(260,609)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">  재무적가정의 변동</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(634,185)</TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">685,670 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">  경험조정</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">149,142 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">760,907 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">기타증감</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(2,840)</TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="295" HEIGHT="30">기말금액</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">18,111,144 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">16,600,996 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<P>(4) 당기와 전기 중 사외적립자산의 공정가치 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="697">

<COLGROUP>
<COL WIDTH="289"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="697" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="298" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="199" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30">기초금액</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">17,687,643 </TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">11,861,697 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30">기여금 납입액</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">600,000 </TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6,200,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30">사외적립자산 퇴직급여 지급액</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(565,414)</TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(630,974)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30">사외적립자산의 기대수익</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">340,895 </TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">278,419 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30">확정급여제도의 재측정요소:</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">51,197 </TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(21,499)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30">  사외적립자산의 수익</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">51,197 </TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(21,499)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="298" HEIGHT="30">기말금액</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">18,114,321 </TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">17,687,643 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>연결실체는 당기말 현재 퇴직금 총추계액의</SPAN>
<SPAN></SPAN>
<SPAN> 약</SPAN>
<SPAN> </SPAN>
<SPAN>100.02</SPAN>
<SPAN>%에</SPAN>
<SPAN> 상당하는 금액에 대하여 미래에셋대우 등에 수익자인 종업원의 퇴직금수급권을 보장하는 퇴직연금에 가입하고 있습니다. </SPAN>
</P>

<P>
<SPAN USERMARK=" 0X1814FF">&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>(5) 당기와 전기 중 기타포괄손익으로 인식된 보험수리적손실의 변동액은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="688" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="341"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="688" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="350" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구       분</TH>
<TH WIDTH="169" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="169" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="30">법인세효과 차감전 확정급여제도의 재측정요소</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30">(129,732)</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30">1,207,468 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="30">법인세효과</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30">34,788 </TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30">(266,470)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="30">법인세효과 차감후 확정급여제도의 재측정요소</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30">(94,944)</TD>
<TD WIDTH="169" ALIGN="RIGHT" HEIGHT="30">940,998 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">(6) 당기말 현재 주요 보험수리적 가정 변동에 따른 연결실체의 확정급여채무 관련 민감도 효과는 다음과 같습니다.&cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="681">

<COLGROUP>
<COL WIDTH="218"></COL>
<COL WIDTH="218"></COL>
<COL WIDTH="218"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="681" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="227" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH WIDTH="454" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">확정급여채무에 대한 영향 </TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="227" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 증가</TH>
<TH WIDTH="227" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30">할인율변동</TD>
<TD WIDTH="227" HEIGHT="30" ALIGN="RIGHT">(1,610,253)</TD>
<TD WIDTH="227" HEIGHT="30" ALIGN="RIGHT">1,855,922 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30">임금상승률변동</TD>
<TD WIDTH="227" HEIGHT="30" ALIGN="RIGHT">1,851,804 </TD>
<TD WIDTH="227" HEIGHT="30" ALIGN="RIGHT">(1,636,810)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;나. 제 18(전) 기
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="681">

<COLGROUP>
<COL WIDTH="218"></COL>
<COL WIDTH="218"></COL>
<COL WIDTH="218"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="681" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="227" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH WIDTH="454" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">확정급여채무에 대한 영향 </TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="227" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 증가</TH>
<TH WIDTH="227" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30">할인율변동</TD>
<TD WIDTH="227" HEIGHT="30" ALIGN="RIGHT">(1,257,818)</TD>
<TD WIDTH="227" HEIGHT="30" ALIGN="RIGHT">1,430,765 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="227" HEIGHT="30">임금상승률변동</TD>
<TD WIDTH="227" HEIGHT="30" ALIGN="RIGHT">1,414,014 </TD>
<TD WIDTH="227" HEIGHT="30" ALIGN="RIGHT">(1,267,681)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;민감도분석은 제도에서 발생할 것으로 기대되는 모든 현금흐름의 분산을 고려하지는않았으나, 사용된 가정에 대한 민감도의 근사치를 제공하고 있습니다.</P>
<PGBRK></PGBRK>

<P>
<SPAN>(7) 당기말과 전기말 현재 보험수리적평가를 위하여 사용된 주요 가정은 다음과 같습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>가. 할인율 등</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="678">

<COLGROUP>
<COL WIDTH="217"></COL>
<COL WIDTH="217"></COL>
<COL WIDTH="217"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="226" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="226" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="226" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30">할인율</TD>
<TD WIDTH="226" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">1.94% ~ 2.17%</TD>
<TD WIDTH="226" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">2.01% ~ 2.17%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30">임금상승율(물가상승률 포함)</TD>
<TD WIDTH="226" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">1.21% ~ 2.30%</TD>
<TD WIDTH="226" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">1.21% ~ 2.3%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>나. 사망률 &cr;사망률은 보험업법에 의한 보험요율산출기관(보험개발원)이 산출하여 발표한 퇴직연금 생존사망률을 사용하였습니다. &cr;&cr;당기말 현재 연결실체의 사외적립자산의 공정가치는 독립된 평가인이 수행한 평가에근거하여 결정되었습니다. &cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>

<P>
<SPAN>(8</SPAN>
<SPAN>) 당</SPAN>
<SPAN>기말과 전기말 현재 사외적립자산의 공정가치 구성요소는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="666">

<COLGROUP>
<COL WIDTH="213"></COL>
<COL WIDTH="213"></COL>
<COL WIDTH="213"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="666" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="222" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="222" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="222" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">채무상품</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,635,740 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,974,353 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">예적금 등</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,478,581 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,713,290 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,114,321 </TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,687,643 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(9) 당기와 전기 중 확정기여제도와 관련하여 비용으로 인식한 금액은 다음과 같습니</SPAN>
<SPAN>다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="629" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT">8,249,576 </TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">7,488,578 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>
<P>20. 자본금&cr;당기말과 전기말 현재 지배기업의 자본금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="659">

<COLGROUP>
<COL WIDTH="211"></COL>
<COL WIDTH="211"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="659" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="220" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="220" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="219" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">발행할 주식의 총수</TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">32,000,000 주</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">32,000,000 주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">1주당 액면금액</TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">2,500 </TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">2,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">발행한 주식의 수</TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">11,586,575 주</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">11,586,575 주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">자본금</TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">28,966,437,500 </TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">28,966,437,500 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">&cr;21. 자기주식&cr;</SPAN>
<SPAN USERMARK=" !B">당기말 현재 지배기업이 주가안정 등의 목적으로 보유하고 있는 </SPAN>
<SPAN USERMARK=" !B">자기주식수는 </SPAN>
<SPAN USERMARK=" !B">823,880주이며, 장부금액은 29,236,490천</SPAN>
<SPAN USERMARK=" !B">원</SPAN>
<SPAN USERMARK=" !B">입니다. 상법상의 규정에 따라 당기말 현재 지배기업이 보유 중인 자기주식의 의결권은 제한되어 있으며, 동 자기주식은 주식시장의 여건을 고려하여 매각될 예정입니다.&cr;</SPAN>
<SPAN USERMARK=" !B">&cr;&cr;22. 기타불입자본 및 기타자본구성요소&cr;(1) 당기말과 전기말 현재 기타불입자본의 내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="689">

<COLGROUP>
<COL WIDTH="243"></COL>
<COL WIDTH="210"></COL>
<COL WIDTH="209"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="689" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="252" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분 </TH>
<TH WIDTH="219" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="218" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="252" HEIGHT="30">주식발행초과금</TD>
<TD WIDTH="219" HEIGHT="30" ALIGN="RIGHT">100,357,854 </TD>
<TD WIDTH="218" HEIGHT="30" ALIGN="RIGHT">100,357,854 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="252" HEIGHT="30">기타자본잉여금</TD>
<TD WIDTH="219" HEIGHT="30" ALIGN="RIGHT">(10,054,680)</TD>
<TD WIDTH="218" HEIGHT="30" ALIGN="RIGHT">(3,652,433)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="252" HEIGHT="30">자기주식처분이익</TD>
<TD WIDTH="219" HEIGHT="30" ALIGN="RIGHT">10,793,849 </TD>
<TD WIDTH="218" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="252" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="219" HEIGHT="30" ALIGN="RIGHT">101,097,023 </TD>
<TD WIDTH="218" HEIGHT="30" ALIGN="RIGHT">96,705,421 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기말과 전기말 현재 기타자본구성요소의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="317"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="620" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="326" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구      분</TH>
<TH WIDTH="147" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="147" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30">기타포괄손익-공정가치측정금융자산평가손익</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">192,512 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(4,520,013)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30">지분법자본변동</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,152 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,505 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30">해외사업환산손익</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">(3,739,180)</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">(2,848,591)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30">주식선택권</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">907,533 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">507,319 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" ALIGN="CENTER" HEIGHT="30">합      계</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">(2,634,983)</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">(6,856,780)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 당기말 현재 지배기업의 주식기준 보상약정은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="675">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="178"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="300" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구           분</TH>
<TH WIDTH="188" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차</TH>
<TH WIDTH="187" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1차</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">부여일</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2019.03.06</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2018.09.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">부여주식의 총수</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,257 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,752 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">철회 및 소멸수량</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,148)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,912)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">기대소멸율</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.0%</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">행사수량</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">                          - </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">                              - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">당기말 수량</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,109 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,840 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">공정가치</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,535 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,156 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">행사가격(단위 : 원)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">195,020 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">194,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">무위험이자율</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.85%</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2.07%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">행사가능기간</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2022.03.06~2023.03.06</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2021.09.21~2022.09.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">만기</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4년</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">기대존속기간</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.5년</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">가득조건</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">용역제공조건:3년</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">용역제공조건:3년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">총보상원가(단위 : 천원)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">683,592 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">646,699 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">잔여보상원가(단위 : 천원)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">267,574 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">155,184 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(4) 당기말 현재 지배기업이 부여하고 있는 주식선택권의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="670">

<COLGROUP>
<COL WIDTH="215"></COL>
<COL WIDTH="214"></COL>
<COL WIDTH="214"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="670" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 개)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="224" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구           분</TH>
<TH WIDTH="223" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="223" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기초</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,539 </TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">                  10,752 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">부여</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,257 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">상실</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,590)</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,470)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">행사</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">                           - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기말</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,949 </TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,539 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기말 현재 행사가능수량</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">                           - </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(5) 당기 중 발생한 보상원가의 내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="667">

<COLGROUP>
<COL WIDTH="276"></COL>
<COL WIDTH="182"></COL>
<COL WIDTH="182"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="667" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="285" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">292,432 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">308,259 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30">경상연구비</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">55,790 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">                67,442 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30">제조원가</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">51,993 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">                 59,838 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">400,215 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">435,539 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>한</SPAN>
<SPAN>편, 연결실체 내 한올바이오파마(주)는 일부 임직원을 대상으로 주식선택권을 부여하고 있습니다. 부여되는 주식결제형 주식보상거래에 대하여 제공받는 재화나 용역의 공정</SPAN>
<SPAN>가치를 측정하고, 그 금액을 가득기간 동안에 종업원급여 (당기비용)와 자본(비지배지분)으로 인식하여 회계처리하고 있으</SPAN>
<SPAN>며, </SPAN>
<SPAN>당기 중 발생한 보상원가는 794,302천원(전기 </SPAN>
<SPAN>507,674</SPAN>
<SPAN>천원)입니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>23. 이익잉여금&cr;당기말과 전기말 현재 이익잉여금의 내역은 다음과 같습니다.
</P>

<TABLE BORDER="1" WIDTH="693" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="242"></COL>
<COL WIDTH="212"></COL>
<COL WIDTH="212"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="693" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="251" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="221" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="221" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30">이익준비금</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">12,336,721 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">11,717,469 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30">임의적립금</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">455,050,000 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">441,650,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30">미처분이익잉여금</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">(14,585,129)</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">(7,952,439)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">452,801,592 </TD>
<TD WIDTH="221" ALIGN="RIGHT" HEIGHT="30">445,415,030 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
</P>
<PGBRK></PGBRK>
<P>24. 배당금&cr;당기와 전기 배당금의 지급내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="687">

<COLGROUP>
<COL WIDTH="220"></COL>
<COL WIDTH="220"></COL>
<COL WIDTH="220"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="687" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="229" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="229" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="229" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="30">보통주 배당금</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT">6,192,522 </TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT">6,192,522 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
</P>
<P>25. 판매관리비 및 경상연구개발비&cr;(1) 당기와 전기 중 판매관리비의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="622" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" BC0XD7D7D7" HEIGHT="30">제 19(당) 기</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" BC0XD7D7D7" HEIGHT="30">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">급여</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">71,157,633 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">74,200,948 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">5,653,152 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">5,621,942 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">복리후생비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">12,505,727 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">12,426,337 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">접대비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">219,237 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">321,086 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">감가상각비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">3,519,193 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">3,247,787 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,350,828 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">3,503,930 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">사용권자산상각비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,436,984 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,335,313 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">세금과공과</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">3,530,561 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">3,471,304 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">광고선전비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">46,326,615 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">68,179,048 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">지급수수료</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">129,417,914 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">108,538,453 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">교육훈련비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">648,908 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,828,088 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">보험료</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">701,472 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,466,746 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">해외시장개척비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">3,084,912 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">3,963,776 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">회의비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">602,147 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,382,682 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">수도광열비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">976,072 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,020,901 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">운반비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">6,846,558 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">6,669,762 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">판매촉진비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,780,349 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,698,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">견본비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">20,609 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">121,101 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">여비교통비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">11,659,508 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">12,506,613 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">통신비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">220,485 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">186,292 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">소모품비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,827,549 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,255,018 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">도서인쇄비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">704,786 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,069,335 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">문헌제작비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">735,787 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">468,863 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">수선비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">738,057 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">593,789 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">차량유지비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">214,971 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">266,085 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">외주용역비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,377,089 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,669,063 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">임차료</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,873,038 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,364,383 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">수출제비용</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">358,108 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">375,094 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">시장조사비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">161,320 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">418,330 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">대손상각비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">3,595,767 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,443,197 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">420,663 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">446,956 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">잡비</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">78,408 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">105,408 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">314,744,407 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">324,165,830 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기 중 연구개발활동과 관련하여 지출된 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="623" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="623" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">13,342,317 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">12,613,443 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,226,322 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,038,579 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">복리후생비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,516,054 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">983,825 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">지급수수료</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">25,580,058 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">28,658,961 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">재료비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">15,102,278 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">25,063,731 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">기타시험연구비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">43,266,314 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">23,567,281 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">기타</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">15,184,247 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">17,514,680 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">115,217,590 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">109,440,500 </TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN></SPAN>
<SPAN>26. 비용의 성격별 분류&cr;(1) 당기와 전기 중 발생한 비용을 성격별로 분류한 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">제품과 재공품의 변동</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">129,826,949 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(10,581,756)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">원재료와 저장품의 사용액</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">9,848,978 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">173,951,213 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">상품의 판매</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">338,004,972 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">336,216,485 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">종업원급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">129,895,490 </TD>

<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">
<SPAN>133,747,005 </SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">지급수수료</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">173,278,391 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">144,865,738 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">광고비 및 판매촉진비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">48,148,228 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">70,204,594 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">복리후생비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">18,282,989 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">15,784,682 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">감가상각비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">39,296,151 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">38,617,349 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">외주가공비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">19,699,670 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">27,680,566 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">여비교통비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">12,014,495 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">12,930,966 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">120,147,653 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">125,321,982 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,038,443,966 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,068,738,824 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000 U"></SPAN>
</P>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">(2) 당기와 전기 중 발생한 종업원급여의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" VALIGN="MIDDLE" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">급여 및 상여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">118,579,701 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">123,442,791 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">10,121,272 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">9,361,001 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">주식보상비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,194,517 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">943,213 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">129,895,490 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">133,747,005 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>27. 기타수익비용&cr;(1) 당기와 전기 중 기타수익 및 기타비용의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="622" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="622" HEIGHT="30">Ⅰ. 기타수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">임대수익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,804,872 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,673,325 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">용역수익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">907,683 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,026,101 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">수수료수익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">247,568 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">640,818 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">유형자산처분이익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">69,495 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">396,112 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">무형자산처분이익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">633 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">투자부동산처분이익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">8,069,640 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">관계기업주식처분이익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">11,783 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">5,323 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">리스해지이익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">827 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">잡이익</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,699,440 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,357,016 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">기타수익 소계</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">14,811,941 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">6,098,695 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="622" VALIGN="MIDDLE" HEIGHT="30">Ⅱ. 기타비용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">임대비용</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(3,443,213)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(3,484,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">재고자산폐기손실</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(458,252)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(74,021)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">유형자산처분손실</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(57,150)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(339,389)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">투자부동산처분손실</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(278,467)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(14,528)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">무형자산처분손실</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(274,563)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">무형자산손상차손</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(8,103,470)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(9,321,907)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">관계기업주식손상차손</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(897,114)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">기타비용</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(1,724,849)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">용역비용</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(1,466,398)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">기부금</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(1,064,348)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(1,874,650)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">잡손실</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(2,522,293)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(5,419,190)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">기타비용 소계</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(18,565,268)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(22,252,747)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">Ⅲ. 기타손익(Ⅰ+Ⅱ)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(3,753,327)</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">(16,154,052)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" BIU">&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>28. 법인세비용&cr;(1) 당기와 전기 중 법인세비용의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="328"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="625" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="337" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="144" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="144" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30">법인세부담액</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">4,135,203 </TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">4,422,093 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30">일시적차이 증감으로 인한 이연법인세 변동액</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">(4,481,079)</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">(8,973,381)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30">자본에 직접 가감되는 당기법인세</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">(9,744,829)</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">(1,124,889)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30">과거기간 법인세와 관련되어 인식한 당기 조정액</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">(498,028)</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">132,244 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30">법인세비용(수익)</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">(10,588,733)</TD>
<TD WIDTH="144" ALIGN="RIGHT" HEIGHT="30">(5,543,933)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF BIU"></SPAN>
</P>
<P>(2) 당기와 전기 중 자본에 반영된 법인세비용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="328"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="625" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="337" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　구분</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="625" HEIGHT="30" COLSPAN="3">자본에 직접 반영된 이연법인세:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30">확정급여제도의 재측정요소</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(34,788)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">266,470 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30"> 기타포괄손익-공정가치측정 금융자산평가손익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(5,402,763)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(1,391,359)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30"> 해외사업환산손익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(935,387)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30"> 자기주식처분이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(3,459,475)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30"> 지분법자본변동</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(750)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30"> 주식매수선택권</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">88,334 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="337" HEIGHT="30">자본에 직접 반영된 법인세비용</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(9,744,829)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(1,124,889)</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X1814FF BIU"></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X1814FF BIU"></SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">(3) 당기와 전기의 법인세비용차감전순이익과 법인세비용간의 관계는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="329"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="626" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="338" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="144" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="144" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30">법인세비용 차감 전 순이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">13,559,333 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">23,321,673 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30">적용세율에 따른 부담액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">5,148,589 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">7,531,517 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="626" HEIGHT="30" COLSPAN="3">조정사항:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30"> 비공제비용</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,530,410 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,342,538 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30"> 세액공제</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(8,486,409)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(8,531,638)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30"> 이월세액공제의 이연법인세효과</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(6,502,735)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(4,513,434)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30"> 이연법인세미인식효과의 변동</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(3,409,928)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(4,607,199)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30"> 기타</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">131,340 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,234,283 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30">법인세비용(수익)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(10,588,733)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(5,543,933)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="338" HEIGHT="30">유효세율</TD>

<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" USERMARK=" BI">
<SPAN USERMARK=" !B!I">- </SPAN>
</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(4) 당기와 전기 중 연결실체의 일시적 차이 및 이연법인세자산(부채)의 증감내역과 상계전 총액기준 이연법인세자산(부채)의 증감내역은 다음과 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1002">

<COLGROUP>
<COL WIDTH="215"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1002" HEIGHT="30" COLSPAN="8" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="224" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="457" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일시적차이</TH>

<TH WIDTH="321" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>인식한 이연법인세자산(부채)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="109" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1002" HEIGHT="30" COLSPAN="8"><차감할 일시적차이></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">재고자산평가충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">4,594,299 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,562,566 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(4,594,299)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">8,562,566 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,111,820 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">960,321 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,072,141 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">퇴직급여충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">16,078,941 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,134,056 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(621,067)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">17,591,930 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,489,735 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">316,927 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,806,662 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">대손충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,772,175 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">15,887,180 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(11,772,174)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">15,887,181 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,823,039 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">997,097 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,820,136 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">반품충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">6,496,415 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">6,076,343 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(7,156,220)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">5,416,538 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,522,020 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(251,572)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,270,448 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">감가상각비</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">14,170,414 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,244,557 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(1,794,189)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">13,620,782 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,168,448 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(121,294)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,047,154 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">미지급연월차</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,053,197 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">14,044,143 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(11,715,857)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">13,381,483 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,640,991 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">495,965 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,136,956 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기타장기종업원급여</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,512,512 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,353,402 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(1,512,512)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">2,353,402 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">366,028 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">169,586 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">535,614 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="53" VALIGN="MIDDLE">기타포괄손익-공정가치측정 &cr;금융자산</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">6,201,415 </TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">931,434 </TD>
<TD WIDTH="109" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">651,704 </TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">7,784,553 </TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,500,742 </TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">249,760 </TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,750,502 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="53">기타포괄손익-공정가치측정 &cr;금융자산 평가 손익</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(9,351,411)</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="109" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(614,274)</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(9,965,685)</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(2,057,310)</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(5,424,512)</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(7,481,822)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">외화평가</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">(766,497)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">7,941,719 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">766,497 </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">7,941,719 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(185,492)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,053,072 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,867,580 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">선수수익</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">47,401,389 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">31,098,699 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(29,237,115)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">49,262,973 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,472,481 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(82,082)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,390,399 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,128,825 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,714,692 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(1,975,695)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,867,822 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,247,427 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(442,069)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">805,358 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">이월결손금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,165,350 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(11,122,938)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">42,412 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="224" HEIGHT="53" VALIGN="MIDDLE">
<SPAN>당기손익-공정가치측정 &cr;금융자산 평가 손익</SPAN>
</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">892,160 </TD>
<TD WIDTH="109" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(3,514,240)</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(2,622,080)</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(634,543)</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(634,543)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소계</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">121,457,024 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">93,880,951 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(84,212,379)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">131,125,596 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">24,099,929 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(1,713,344)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">22,386,585 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1002" HEIGHT="30" COLSPAN="8" VALIGN="MIDDLE"><가산할 일시적차이></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">수수료매출</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">16,752,440 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">17,394,752 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(16,527,994)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">17,619,198 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">4,054,090 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">155,440 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">4,209,530 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">압축기장충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">7,677,300 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">224,445 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">7,901,745 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,857,907 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,857,907 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">연구인력개발준비금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,752 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">7,609 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">19,361 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,585 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(911)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,674 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">퇴직보험예치금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">15,862,432 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(340,969)</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">2,005,991 </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">17,527,454 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,489,735 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">316,927 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,806,662 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">건물재평가</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,368,575 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,868 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,370,443 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">331,195 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(29,087)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">302,108 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">8,025,461 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">8,025,461 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,765,601 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,765,601 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">무형자산</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">7,925,911 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(22,063,438)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">(14,137,527)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,754,999 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(365,582)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,389,417 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소계</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">57,623,871 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">17,287,705 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(36,585,441)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">38,326,135 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">13,256,112 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">76,787 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">13,332,899 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">연구인력개발비 세액공제 등</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">12,869,779 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">6,502,735 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">19,372,514 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">12,869,779 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">6,502,735 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">19,372,514 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">합계(순액)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">76,702,932 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">114,794,055 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">23,713,596 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">4,712,604 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">28,426,200 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">이연법인세자산</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">26,657,375 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">5,914,918 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">32,572,293 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">이연법인세부채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(2,943,779)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(1,202,314)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(4,146,093)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1002">

<COLGROUP>
<COL WIDTH="215"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1002" HEIGHT="30" COLSPAN="8" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="224" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="457" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일시적차이</TH>

<TH WIDTH="321" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>인식한 이연법인세자산(부채)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="109" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1002" HEIGHT="30" COLSPAN="8"><차감할 일시적차이></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">재고자산평가충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">3,226,584 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,367,715 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">4,594,299 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">780,833 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">330,987 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,111,820 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">퇴직급여충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">13,338,248 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,740,693 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">16,078,941 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">3,489,735 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,489,735 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">대손충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,105,203 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">930,907 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(263,935)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,772,175 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,339,489 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">483,550 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,823,039 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">반품충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">6,811,417 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">137,025 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(452,027)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">6,496,415 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">987,734 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">534,286 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,522,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">감가상각비</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">21,635,944 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,551,182 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(9,016,712)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">14,170,414 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,519,567 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(351,119)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,168,448 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">미지급연월차</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">10,292,940 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">760,257 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,053,197 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,301,158 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">339,833 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,640,991 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기타장기종업원급여</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,067,923 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">444,589 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,512,512 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">292,346 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">73,682 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">366,028 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="53" VALIGN="MIDDLE">기타포괄손익-공정가치측정 &cr;금융자산</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">5,853,268 </TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">551,074 </TD>
<TD WIDTH="109" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(202,927)</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">6,201,415 </TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,416,491 </TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">84,251 </TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,500,742 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="53">기타포괄손익-공정가치측정 &cr;금융자산 평가 손익</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">551,074 </TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="109" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(9,902,485)</TD>
<TD WIDTH="119" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(9,351,411)</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">133,360 </TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(2,190,670)</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(2,057,310)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">외화평가</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">(911,301)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">224,445 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(79,641)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">(766,497)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(166,219)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(19,273)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(185,492)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">선수수익</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">29,273,023 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">22,314,347 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(4,185,981)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">47,401,389 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">6,311,821 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,160,660 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,472,481 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">6,226,708 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">670,276 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(5,768,159)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,128,825 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,105,199 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(857,772)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,247,427 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">이월결손금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">22,288,288 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(11,122,938)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,165,350 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소계</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">130,759,319 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">31,692,510 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(40,994,805)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">121,457,024 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">20,021,779 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">4,078,150 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">24,099,929 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1002" HEIGHT="30" COLSPAN="8" VALIGN="MIDDLE"><가산할 일시적차이></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">수수료매출</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">20,607,884 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(3,855,444)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">16,752,440 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">5,041,424 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(987,334)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">4,054,090 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">압축기장충당금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">7,452,855 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">224,445 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">7,677,300 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,857,907 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,857,907 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">연구인력개발준비금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">11,752 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">11,752 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,585 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,585 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">퇴직보험예치금</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">8,548,640 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">7,313,792 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">15,862,432 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">3,489,735 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">3,489,735 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">건물재평가</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,246,514 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">122,061 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">1,368,575 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">355,972 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(24,777)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">331,195 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">8,025,461 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">8,025,461 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,765,601 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,765,601 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE">무형자산</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">29,989,349 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(22,063,438)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">7,925,911 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">6,608,955 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(4,853,956)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,754,999 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소계</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">75,870,703 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">7,672,050 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(25,918,882)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">57,623,871 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">15,629,859 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(2,373,747)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">13,256,112 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">연구인력개발비 세액공제 등</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">7,434,840 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">5,434,939 </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">12,869,779 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">5,529,493 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">7,340,286 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">12,869,779 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">합계(순액)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">62,323,456 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">76,702,932 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">9,921,413 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">13,792,183 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">23,713,596 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">이연법인세자산</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">17,894,649 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">8,762,726 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">26,657,375 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">이연법인세부채</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(5,126,194)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,182,415 </TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(2,943,779)</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" BI">
<SPAN USERMARK=" !BU">&cr;</SPAN>
<SPAN USERMARK=" !B!I">(5) 미인식 이연법인세자산ㆍ부채&cr;연결실체는 당기말 현재 일시적차이의 소멸시점을 통제할 수 있으며, 예측가능한 미래에 일시적차이가 소멸하지 않을 가능성이 높을 것으로 판단한 선수수익, 종속기업 및 관계기업 투자지분 등의 일시적차이에 대하여 이연법인세자산을 인식하지 않았습니다.&cr;</SPAN>
<SPAN USERMARK=" !BU"></SPAN>
</P>
<PGBRK></PGBRK>
<P>29. 주당이익&cr;주당이익은 보통주 1주에 대한 이익(기본주당이익) 또는 보통주 및 희석성 잠재적보통주 1주에 대한 이익(희석주당이익)을 계산한 것으로 그 내역은 다음과 같습니다.&cr;&cr;(1) 기본주당이익</P>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="312"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="321" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="152" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="151" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">지배기업 소유주지분에 귀속되는 당기순이익</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">12,753,425,042 </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">22,005,927,017 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">가중평균유통보통주식수(*)</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">10,662,499 주</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">10,320,870 주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">기본주당이익</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30">1,196 </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">2,132 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 가중평균유통보통주식수는 발행한 주식수에서 지배기업이 보유하고 있는 자기주식을 차감하여 가중평균해서 산정하였습니다.&cr;&cr;(2) 희석주당이익은 희석효과가 발생하지 않아 기본주당이익과 동일합니다.</P>

<P USERMARK=" B">
<SPAN USERMARK=" !B"></SPAN>
</P>

<P>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN>30. 특수관계자 거래&cr;(1) 당기말과 전기말 현재 연결실체의 특수관계자 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="817">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="221"></COL>
<COL WIDTH="221"></COL>
<COL WIDTH="220"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">제 19(당) 기</TD>
<TD WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">제 18(전) 기</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">최상위 지배기업</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)대웅</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)대웅</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="186">관계기업</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)이피피미디어</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)이피피미디어</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)엠디웰아이앤씨</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)엠디웰아이앤씨</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)바이오시네틱스</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)바이오시네틱스</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">건강한삶기술창업벤처</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">건강한삶기술창업벤처</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">㈜다나아데이터</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">㈜다나아데이터</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">Immplacate, Inc.</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">Immplacate, Inc.</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="24" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="743">기타특수관계자</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">대웅바이오㈜</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">대웅바이오㈜</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">사천대웅생물기술유한공사</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">사천대웅생물기술유한공사</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">대웅바이오(주)의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)HR그룹</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)HR그룹</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)아이디에스앤트러스트</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)아이디에스앤트러스트</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)대웅경영개발원</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)대웅경영개발원</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)대웅생명과학</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)대웅생명과학</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)디엔컴퍼니</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)디엔컴퍼니</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">대웅엔지니어링(주)</TD>
<TD WIDTH="230" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">대웅엔지니어링(주)</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)산웅개발</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)산웅개발</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)알피코프</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)알피코프</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)알피바이오</TD>
<TD WIDTH="230" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">(주)알피바이오</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)알피스페이스</TD>
<TD WIDTH="230" VALIGN="MIDDLE" HEIGHT="31" ALIGN="CENTER">(주)알피스페이스</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)디톤</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)디톤</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)이지메디컴</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)이지메디컴</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">- (*)</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)인성정보</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)대웅개발</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)대웅개발</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)팜팩</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)팜팩</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">- (*)</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)인성디지탈</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">- (*)</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)아이넷뱅크</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)시지바이오</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)시지바이오</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">STH이솔루션</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">STH이솔루션</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">(주)대웅의 종속기업　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">- (*)</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">(주)벤치비 등</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">PT.DAEWOONG-BIO INDONESIA</TD>
<TD WIDTH="230" HEIGHT="31" ALIGN="CENTER">PT.DAEWOONG-BIO INDONESIA</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">대웅바이오(주)의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="230" HEIGHT="30" ALIGN="CENTER">(주)엠서클 등</TD>

<TD WIDTH="230" HEIGHT="30" ALIGN="CENTER">
<SPAN>(주)엠서클 등</SPAN>
</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*)당기 중 기타 특수관계자에서 제외되었습니다. &cr;</SPAN>
</P>

<P>
<SPAN>(</SPAN>
<SPAN>2) 당기와 전기 중 연결실체와 특수관계자간의 수익ㆍ비용거래 내역은 다음과 같습니다.&cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1018">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1018" HEIGHT="28" COLSPAN="11" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="86" HEIGHT="77" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" USERMARK="F-10">구분</TH>
<TH WIDTH="166" HEIGHT="77" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" USERMARK="F-10">회사명</TH>
<TH WIDTH="341" HEIGHT="28" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4" USERMARK="F-10">수익 등</TH>
<TH WIDTH="425" HEIGHT="28" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" USERMARK="F-10">비용 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="86" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">제품/상품&cr;매출</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">용역/&cr;서비스 제공</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">임대수익</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">기타</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">재고자산&cr;매입</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">고정자산매입</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">용역/&cr;서비스 비용</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">연구비용</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">기타</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" HEIGHT="49" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">최상위&cr;지배기업</TD>
<TD WIDTH="166" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">(주)대웅 (*1)</TD>
<TD WIDTH="86" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">28,223 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">43,404 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">589,869 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">108,360 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">33,077,686 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">15,322,510 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">28,241 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" HEIGHT="28" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">관계기업</TD>
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)엠디웰아이앤씨</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">15,568 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,027 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">13,962 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">698 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">214,819 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">57,223 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" HEIGHT="420" ROWSPAN="15" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">기타&cr;특수관계자</TD>
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">대웅바이오㈜</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">14,586,615 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">65,618 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">178,114 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">45,084,168 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">8,681,877 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">115,214 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,990 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)아이디에스앤트러스트</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,155 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">12,785 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">65,594 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">78,868 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">786,458 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">657,637 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">16,655 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)대웅경영개발원</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,691 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">472,997 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,358 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,747 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,126,186 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">354,119 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)대웅생명과학</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">332 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,135 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,014 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">454,364 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)시지바이오</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,904,239 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">29,092 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">53,760 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,985 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">6,095,738 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">712,196 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">36,787 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)디엔컴퍼니</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,399,865 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">17,767 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">136,510 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">8,107 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">450,846 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">10,094,859 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,589 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,700,989 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">대웅엔지니어링㈜</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">250 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">17,284 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,674 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,174,474 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)산웅개발</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">207 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">9,018 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">22,231 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">128,411 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,231,459 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">49,644 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)알피바이오</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,729 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">255 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">4,492,604 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)이지메디컴</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">420,736 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">45,215 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,604 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">951,234 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">868 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,422,473 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)인성정보</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">17,252 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,378,910 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,680 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)대웅개발</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">674,339 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">690,607 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)팜팩 </TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,411 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">25,257 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">792 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,905,855 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">(주)엠서클</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">101,883 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">25,644 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">78,106 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">13,197 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">150,712 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">9,120,393 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">23 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,507,763 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="28" USERMARK="F-10">기타</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,222,524 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">18,145 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">42,592 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,348 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,807,341 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,328,188 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,503,975 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,651,179 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="252" HEIGHT="28" COLSPAN="2" ALIGN="CENTER" USERMARK="F-10">합계</TD>
<TD WIDTH="86" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">19,687,096 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">311,843 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,153,426 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">399,416 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">68,098,231 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">67,452,005 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">19,070,365 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">12,978,714 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) 대웅바이오㈜와의 거래에서 발생하는 연구비를 131,502천원 차감 처리하였습니다.&cr;</SPAN>
<SPAN USERMARK=" BIU"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" BIU"></SPAN>
<SPAN>나. 제 18(전) 기</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1016">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1016" HEIGHT="28" COLSPAN="11" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="86" HEIGHT="77" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" USERMARK="F-10">구분</TH>
<TH WIDTH="167" HEIGHT="77" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" USERMARK="F-10">회사명</TH>
<TH WIDTH="340" HEIGHT="28" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4" USERMARK="F-10">수익 등</TH>
<TH WIDTH="423" HEIGHT="28" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" USERMARK="F-10">비용 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">제품/상품&cr;매출</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">용역/&cr;서비스 제공</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">임대수익</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">기타</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">재고자산&cr;매입</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">고정자산매입</TH>
<TH WIDTH="85" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">용역/&cr;서비스 비용</TH>
<TH WIDTH="84" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">연구비용</TH>
<TH WIDTH="84" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">기타</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" HEIGHT="49" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">최상위&cr;지배기업</TD>
<TD WIDTH="167" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">(주)대웅</TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">35,478 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">114,535 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">458,837 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">554,524 </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">29,942,917 </TD>
<TD WIDTH="84" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">14,469,818 </TD>
<TD WIDTH="84" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">307,562 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" HEIGHT="28" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">관계기업</TD>
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)엠디웰아이앤씨</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">14,338 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,670 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,858 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">235,417 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">31,319 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" HEIGHT="420" ROWSPAN="15" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">기타&cr;특수관계자</TD>
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">대웅바이오㈜(*1)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">14,000,975 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">57,271 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">45,296 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">79,687,412 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">505,372 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">6,170,525 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">224,943 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">20,249 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)아이디에스앤트러스트</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,708 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">26,892 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">68,463 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">62,135 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">50 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">614,162 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">67 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">15,736 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)대웅경영개발원</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,427 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">477,797 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">28,928 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">28,343 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,299,826 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">617,486 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)대웅생명과학</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,657 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,636 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">9,892 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">936 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">462,701 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)시지바이오</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,366,107 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">51,258 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">61,198 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">20,552 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,626,603 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,163,864 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">25,077 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)디엔컴퍼니</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,052,940 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">47,061 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">117,928 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">67,309 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,104,779 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,928,895 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">9,287 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,625,882 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">대웅엔지니어링㈜</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">19,644 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,555 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,195,274 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)산웅개발</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,473 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">11,369 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,455 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">125,348 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,273,575 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">273 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">48,805 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)알피바이오</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,403,693 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">19,666 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">10,000 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">4,183,239 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">91 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">126,237 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)이지메디컴</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">84,654 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">52,362 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">334,502 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">837,591 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">3,062,445 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)인성정보</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,368 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,367,868 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">58,010 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)대웅개발</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">618,500 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">458,282 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)팜팩 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,879 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">28,097 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">563 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">7,223,802 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">(주)엠서클</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">399,878 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">151,181 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">58,793 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">80,877 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">154,672 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">6,549,292 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">5,100 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">4,293,293 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="28" USERMARK="F-10">기타</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">6,291 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">29,258 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">50,685 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">31,439 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,284,846 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">- </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">316,565 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">819,767 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">2,554,710 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="253" HEIGHT="28" COLSPAN="2" ALIGN="CENTER" USERMARK="F-10">합계</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">23,375,841 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">604,552 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,936,688 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">1,206,583 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">103,626,213 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">505,372 </TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">55,429,105 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">16,830,017 </TD>
<TD WIDTH="84" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">14,707,794 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" BI">
<SPAN USERMARK=" !B!I">(*1) 대웅바이오(주)와 원재료 구매단가를 인하하기로 약정하였으며, 전기 중 정산된 원재료 매입액 378,146천원을 매출원가에서 차감 처리하였습니다.&cr;</SPAN>
</P>
<P>(3) 당기말과 전기말 현재 연결실체와 특수관계자간의 거래에서 발생한 채권ㆍ채무 잔액은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1096">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1096" HEIGHT="30" COLSPAN="9" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="199" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="460" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권 등</TH>
<TH WIDTH="344" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출채권</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대여금</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임차보증금</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채권</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입채무</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임대보증금</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">최상위&cr;지배기업</TD>
<TD WIDTH="199" HEIGHT="53" VALIGN="MIDDLE">(주)대웅</TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">52,528 </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">703,164 </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,968,268 </TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">19,211,367 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="199" HEIGHT="30">(주)엠디웰아이앤씨</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,518 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,242 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,838 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,635 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="420" ROWSPAN="14" VALIGN="MIDDLE" ALIGN="CENTER">기타&cr;특수관계자</TD>
<TD WIDTH="199" HEIGHT="30">대웅바이오(주)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,424,184 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,933 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,798,228 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">983,400 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,735,127 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)아이디에스앤트러스트</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,170 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,822 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">314,337 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">250,275 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)대웅경영개발원</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">362,537 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">655,600 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,575 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)대웅생명과학</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">155,121 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,301 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)시지바이오</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">288,449 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">31,172 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">883,275 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,200,000 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">960,786 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)디엔컴퍼니</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">512,121 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,213 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">98,023 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">654,971 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,547,212 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">대웅엔지니어링(주)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,360 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,960 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)산웅개발</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">975 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">95,623 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,935 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)알피바이오</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">194,968 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,750 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">602,045 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)이지메디컴</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">63,334 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">157,014 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,851 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">655,600 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">335,419 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">777,935 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">96,256 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)팜팩</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,450 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)엠서클</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">646 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,063 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,026,133 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,543,046 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기타</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">417,731 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,694 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">154,513 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">78,221 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">851,406 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">합계</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,118,745 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">877,935 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,346,058 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,548,935 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,715,401 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,753,340 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" BI">
<SPAN USERMARK=" !BU">&cr;</SPAN>
<SPAN USERMARK=" !B!I">나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1096">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1096" HEIGHT="30" COLSPAN="9" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="199" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="460" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권 등</TH>
<TH WIDTH="344" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출채권</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대여금</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임차보증금</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채권</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입채무</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임대보증금</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">최상위&cr;지배기업</TD>
<TD WIDTH="199" HEIGHT="53" VALIGN="MIDDLE">(주)대웅</TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">13,903 </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">197,814 </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,025,023 </TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">12,911,584 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="199" HEIGHT="30">(주)엠디웰아이앤씨</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,061 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">628 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,723 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="450" ROWSPAN="15" VALIGN="MIDDLE" ALIGN="CENTER">기타&cr;특수관계자</TD>
<TD WIDTH="199" HEIGHT="30">대웅바이오(주)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,400,577 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">206,805 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,843,757 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">983,400 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">732,713 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)아이디에스앤트러스트</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,173 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,853 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">234,062 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,467 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)대웅경영개발원</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">130,187 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">655,600 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">88,673 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)대웅생명과학</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">155,121 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,210 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,000 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,097 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)시지바이오</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">239,662 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86,879 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,254,860 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,434 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">629,338 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)디엔컴퍼니</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">562,610 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">127,182 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">164,686 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,041,987 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">301,011 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">대웅엔지니어링(주)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">126,028 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,600 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)산웅개발</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">48,640 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">332,688 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)알피바이오</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">194,968 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,266 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">925,601 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,032 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)이지메디컴</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,181 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">366,235 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,459 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">655,600 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">231,764 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)인성정보</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">327,800 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">347,585 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">437,298 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,968 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)팜팩</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,907 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">140 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,680 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">313,079 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">(주)엠서클</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">200,077 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,655 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">195,018 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,507,734 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기타</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,851 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">118,493 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,622 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,678,775 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">173,764 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">합계</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,841,091 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">437,298 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,264,359 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,413,013 </TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,947,587 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,618,252 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" BI">
<SPAN USERMARK=" !B!I"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK=" BIU"></SPAN>
<SPAN>(4)</SPAN>
<SPAN> 당기와 전기 중 연결실체와 특수관계자와의 자금거래 내역은 다음과 같습니다.&cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="954">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="230"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="8" WIDTH="954" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="128" HEIGHT="60">구    분</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="239" HEIGHT="60">회사명</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="196" HEIGHT="30">자금대여 거래</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="196" HEIGHT="30">배당</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="195" HEIGHT="30">지분투자</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">대여</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">회수</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">지급</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">수령</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">증자 및 취득</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="97" HEIGHT="30">감자 및 처분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30">최상위 지배기업</TD>
<TD VALIGN="MIDDLE" WIDTH="239" HEIGHT="30">㈜대웅</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">2,867,833 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">29,918,985 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30">관계기업</TD>
<TD VALIGN="MIDDLE" WIDTH="239" HEIGHT="30">건강한삶기술창업벤처</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">1,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30">기타특수관계자</TD>
<TD VALIGN="MIDDLE" WIDTH="239" HEIGHT="30">PT.DAEWOONG-BIO INDONESIA</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">39,200 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" BIU">&cr;</SPAN>
<SPAN>나. 제 18(전) 기</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="952">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="228"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="8" WIDTH="952" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위:천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="128" HEIGHT="60">구    분</TH>
<TH ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="237" HEIGHT="60">회사명</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="196" HEIGHT="30">자금대여 거래</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="196" HEIGHT="30">배당</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="195" HEIGHT="30">지분투자</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">대여</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">회수</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">지급</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">수령</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="98" HEIGHT="30">증자 및 취득</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="97" HEIGHT="30">감자 및 처분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30">최상위 지배기업</TD>
<TD VALIGN="MIDDLE" WIDTH="237" HEIGHT="30">㈜대웅</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">2,831,527 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30">관계기업</TD>
<TD VALIGN="MIDDLE" WIDTH="237" HEIGHT="30">Immplacate, Inc.</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">1,125,970 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="90">기타특수관계자</TD>
<TD VALIGN="MIDDLE" WIDTH="237" HEIGHT="30">(주)아이넷뱅크</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">2,855 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="237" HEIGHT="30">(주)아이디에스앤트러스트</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">1,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="237" HEIGHT="30">(주)HR그룹</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">200,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" BI">
<SPAN USERMARK=" !BU">&cr;</SPAN>
<SPAN USERMARK=" !B!I">(5) 주요 경영진에 대한 보상금액&cr;연결실체는 등기이사 및 연결기업의 기업활동의 계획, 운영 및 통제에 대한 중요한 권한과 책임을 가진 임원을 주요 경영진에 포함하고 있으며, 당기와 전기 중 주요 경영진에 대한 보상금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="648">

<COLGROUP>
<COL WIDTH="276"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="172"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="648" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="285" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="182" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="181" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30">단기종업원급여</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">1,742,076 </TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">2,283,607 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">111,460 </TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">126,064 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30" VALIGN="MIDDLE">주식보상비용</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">128,231 </TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">138,697 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">1,981,767 </TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">2,548,368 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(6) 특수관계자간 주요 약정사항&cr;지배기업과 연결실체 내 한올바이오파마(주)는 대웅바이오(주) 및 기타 특수관계자간에 의약품, 의료기기 및 이와 유사한 품목 등에 대해 상호 판매대행계약을 체결하였습니다.&cr;&cr;</SPAN>
<SPAN>(7) 당기 중 특수관계자와의 리스 약정계약에 따라 지급한 금액과 연결재무제표에 인식한 리스관련 항목은 다음과 같습니다.&cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="817">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="817" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="131" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구  분</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사의 명칭</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">사용권자산</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">지급액</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기말&cr;리스부채</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기&cr;이자비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30">지배기업</TD>
<TD WIDTH="110" VALIGN="MIDDLE" HEIGHT="30">(주)대웅</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">293,394 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,003 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">297,647 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,992 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30">기타 특수관계자</TD>
<TD WIDTH="110" VALIGN="MIDDLE" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,370,944 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">527,011 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,410,868 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">122,052 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;나. 제 18(전) 기</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="814">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="814" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구  분</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사의 명칭</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">사용권자산</TH>
<TH WIDTH="143" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">지급액</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기말&cr;리스부채</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기&cr;이자비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" HEIGHT="30">기타 특수관계자</TD>
<TD WIDTH="112" VALIGN="MIDDLE" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">95,050 </TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,243 </TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,858 </TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,367 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN>31. 우발채무와 약정사항&cr;(1) 소송사건&cr;가. 메디톡스 영업비밀침해 소송</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="664">

<COLGROUP>
<COL WIDTH="131"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계류법원</P>
</TH>

<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>원고</P>
</TH>

<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>피고</P>
</TH>

<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사건내용</P>
</TH>

<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>진행상황</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="140" HEIGHT="76" ALIGN="CENTER">
<P>미국 무역위원회 &cr;(International Trade Commission)</P>
</TD>

<TD WIDTH="151" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>앨러간, 메디톡스</P>
</TD>

<TD WIDTH="104" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">

<P>대
<SPAN>웅제약 및&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN>에볼루스</SPAN>
</P>
</TD>

<TD WIDTH="168" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>영업비밀침해</P>
</TD>
<TD WIDTH="101" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">최종판결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="140" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>서울중앙지방법원</P>
</TD>

<TD WIDTH="151" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>메디톡스</P>
</TD>

<TD WIDTH="104" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대웅 및&cr;대웅제약</P>
</TD>

<TD WIDTH="168" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>영업비밀침해</P>
</TD>

<TD WIDTH="101" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1심 진행중</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>2019년 2월 4일 미국국제무역위원회에 제기되었던 영업비밀침해 소송에 대해서 2020년 12월 16일 미국국제무역위원회 행정판사는 최종판결에서 대웅제약의 보툴리늄 톡신 제제가 관세법 337조를 위반했다고 판결하고 21개월간의 미국 수입금지명령을 내렸으나 그 결과가 재무제표에 미치는 영향이 없다고 판단되어 기말 현재 충당부채로 인식한 금액은 없습니다. 또한, 2021년 2월 15일 지배기업은 미국국제무역위원회의 최종결정에 대해서 미국 연방순회항소법원(CAFC)에 항소하였고, 신속절차진행을 요청하였으며 법원은 미국국제무역위원회의 최종결정에 대해서 지배기업이 신청한 임시가처분 신청을 인용하였습니다.&cr;</SPAN>
<SPAN>&cr;나. 상기의 건 이외에 상기의 건 이외에 연결 실체가 피소되어 계류 중인 소송사건 1건이 있습니다. 연결실체의 경영진은 상기 소송사건 결과의 합리적인 예측이 불가능하고 자원의 유출금액 및 시기가 불확실하며 그 결과가 재무제표에 미치는 영향이 중요하지 않을 것으로 판단하고 있어 당기말 현재 충당부채로 인식한 금액은 없습니다.</SPAN>
<SPAN></SPAN>
</P>
<P>(2) 당기말 현재 연결실체가 금융기관 등과 체결한 주요 약정사항은 다음과 같습니 다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="667">

<COLGROUP>
<COL WIDTH="158"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="667" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(원화단위: 천원, 외화단위: USD,EUR,JPY)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정종류</TH>
<TH WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">한도금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">KEB하나은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구매론</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">2,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)우리은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당좌차월</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">13,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)현대카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신용카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">3,600,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)삼성카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신용카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">2,800,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)신한카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신용카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">2,500,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">산업은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당좌차월</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">27,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">(주)국민은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구매카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">9,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">외화지급보증</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> EUR </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">1,200,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">(주)신한은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">수입신용장</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> USD </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">11,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">수출매입외환</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> USD </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">5,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전자방식외담대</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">3,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">외화지급보증</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> JPY </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">250,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="120" COLSPAN="2" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합      계</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">62,900,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> USD </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">16,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> EUR </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">1,200,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> JPY </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">250,000,000 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(3) 당기말 현재 연결실체가 금융기관에 제공한 담보내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="661" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="133" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">금융기관명</TH>
<TH WIDTH="132" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">차입금 등의 내역</TH>
<TH WIDTH="132" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">담보제공자산</TH>
<TH WIDTH="132" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">장부금액</TH>
<TH WIDTH="132" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">채권최고액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">중소기업은행</TD>
<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">일반자금</TD>
<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">토지</TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">2,765,833 </TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">2,400,000 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>4) 당기말 현재 연결실체가 타인으로부터 제공받은 지급보증의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="651" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="208"></COL>
<COL WIDTH="208"></COL>
<COL WIDTH="208"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="651" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="217" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제공자</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보증금액</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보증내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" ALIGN="CENTER">서울보증보험(주)</TD>
<TD WIDTH="217" ALIGN="RIGHT" HEIGHT="30">1,041,173 </TD>
<TD WIDTH="217" HEIGHT="30" ALIGN="CENTER">계약이행보증 등</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(5) </SPAN>
<SPAN>연결실체가 체결한 주요 약정 내용은 다음과 같습니다.&cr;</SPAN>
<SPAN>&cr;가. 지배기업은 미국의 Evolus외 14개사와 계약을 체결하고 2020년까지 Upfront Fee USD 16,824,000를 수취하였습니다. 동 Upfront Fee는 향후 제품이 매출될 것으로 예상되는 기간동안 합리적으로 배분하여 수익으로 인식하고 있으며, 이와 관련하여 수취한 금액은 계약부채로 계상하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>나. 하버바이오메드사</P>
<P>연결실체 내 한올바이오파마(주)는 2017년 9월 12일자로 중국에 소재한 하버바이오메드사와 자가면역질환 치료항체신약 HL161BKN 물질과 항TNF 단백질 바이오베터 HL036 점안액에 대한 기술이전 계약을 각각 체결하였습니다. 동 계약으로 인하여 하버바이오메드사는 중국(대만, 홍콩, 마카오 포함)에서 HL161BKN과 HL036에 대한 임상개발, 생산, 품목허가 및 판매에 대한 독점적 권리를 확보하였습니다. 연결실체는 물질에 대해 반환조건 없는 계약금(Upfront payment) USD 4,000,000(각 계약별USD 2,000,000)을 전기 이전에 일시에 수령하였습니다. 기술이전 시점 이후에 수행할 추가적인 의무가 존재하지 않으므로 일시에 수익으로 인식하였습니다. 또한, 연결실체는 규제당국의 허가 및 상업화에 성공할 경우 최대 USD 77,000,000 규모의 마일스톤 금액(Milestone payment)을 수령할 수 있고, 전기에 USD 3,000,000, 당기에 USD 1,000,000을 수령하였습니다. HL036 점안액은 한올바이오파마(주)와 (주)대웅제약이 공동개발계약을 맺은 과제로 계약조건에 의해 관련 수익을 양사간 각각 50%씩 인식하고 있습니다.</P>
<P> </P>
<P>다. 로이반트사이언스사</P>
<P>연결실체 내 한올바이오파마(주)는 2017년 12월 19일자로 스위스에 소재한 로이반트사이언스사와 자가면역질환 치료 항체신약 HL161BKN 물질에 대한 기술이전 계약을 체결하였습니다. 동계약으로 인하여 로이반트사이언스사는 북미(미국 포함)와 중남미, EU국가, 영국, 스위스, 중동, 북아프리카 지역에서 HL161BKN에 대한 임상개발, 생산, 품목허가 및 판매에 대한 독점적 권리를 확보하였습니다. 연결실체는 반환조건 없는 계약금(Upfront payment) USD 30,000,000을 2017년 12월에 일시에 수령하였고, 계약과 관련된 의무가 종료되는 기간까지 분할하여 수익으로 인식하고 있습니다. 또한, 연결실체는 규제당국의 허가 및 상업화에 성공할 경우 최대 USD 452,500,000 규모의 마일스톤 금액(Milestone payment)을 수령할 수 있고, 2019년 6월에 USD 10,000,000 을 수령하였습니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>라. 기술이전계약과 관련된 불확실성 및 기타사항</SPAN>
</P>

<P>
<SPAN>연결실체 내 한올바이오파마(주)의 향후 마일스톤 및 로열티 수익은 임상시험, 관계당국의 허가 등 개발의 성공여부에 따라 달라질 수 있으므로 발생가능성에 불확실성이 내포되어 있습니다. 또한 상기 HL161BKN 물질에 대한 기술이전계약과 관련하여 리간드사에게 지적재산 실시계약에 따라 일정 수수료를 지급하기로 약정하고 있습니다.&cr;&cr;마. 2015년 8월 18일 및 2016년 1월 8일에 연결실체 내 한올바이오파마(주)가 지분을 보유하고 있는 ImmunoMET Therapeutics, Inc.에 특허권등을 양도하였으며, ImmunoMET Therapeutics, Inc.가 양도 받은 특허권 등을 활용하여 일으킨 순매출액의 8%를 판매개시일로부터 10년 또는 동 특허권의 존속기간 만료일 중 늦은 날까지 양도대가로 수취할 예정입니다. 또한, ImmunoMETTherapeutics, Inc.가 동 특허권을 바탕으로 제3자에게 기술이전계약을 체결하는 경우, 제3자로부터 받을 총 기술료의 일정비율을 양도대가로 수취할 예정입니다.&cr;</SPAN>
</P>
<P>(6) 연결실체 내 한올바이오파마(주)는 2019년 12월 19일 대전지방식품의약품안전청에서 실시한 정기약사감시에서 제조업무정지 3개월에 해당하는 위반사항이 지적되어, 2020년 5월 8일에 '2020년 5월 17일부터 3개월간 자사 허가품목(의약품 제조업) 제조업무정지 처분' 통지서를 수령하였습니다. 한올바이오파마(주)는 제조업무정지 행정처분에 대하여 대전지방법원에 집행정지 처분을 신청하였고, 2020년 5월 22일부로 행정처분 효력이 정지되어 의약품제조업무를 진행할 수 있습니다. 지적된 사항의 처분은 아직 확정되지 않은 상태이며, 이로 인하여 연결실체의 재무제표에 미칠 영향 여부를 현재로서는 예측할 수 없습니다.&cr;</P>
<P>(7) 2019년 9월 26일 식품의약품안전처는 발암물질 성분인 NDMA가 포함되어 국내 유통 중인 라니티딘 원료의약품(7종)과 이를 사용한 완제의약품(269품목) 전체에 대해 잠정적으로 제조ㆍ수입ㆍ판매 중지 및 회수 조치하고 처방을 제한하도록 하였으며, 해당 조치에는 지배기업의 완제의약품인 알비스정 및 알비스D정이 포함되었습니다. 식품의약품안전처는 전문가 자문을 거쳐 라니티딘 성분 의약품을 단기 복용한 경우 인체 위해우려는 크지 않다고 밝혔으나, 해당 의약품에 장기적으로 노출되었을 때 인체에 미치는 영향을 조사ㆍ평가 할 계획입니다. 동 조사를 토대로 한 식품의약품안전처의 후속 조치 결과가 당사의 재무제표에 미칠 영향은 현재로서는 예측할 수 없습니다.&cr;&cr;(8) 연결실체 내 한올바이오파마(주)가 주식을 보유중이던 Immunovant, Inc.가 2019년 12월 HSAC와 SPAC 합병을 통해 상장하면서 기존 Immunovant, Inc.주주에게 Earn-out Payment 조건을 부여하였습니다. 상장 후 Immunovant, Inc.의 주가가 20일 거래일 이상 $17.5, $31.5을 초과할 경우 각각 10,000,000주를 상장 이전 지분 비율에 따라 지급하는 조건이며,  당기 중 조건을 충족하여 한올바이오파마(주)는 보통주 302,590주를 수령하였고,수령한 주식의 공정가치에 해당하는 금액을 파생상품거래이익으로 인식하였습니다.</P>

<P>
<SPAN USERMARK=" 0XBD6F00"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>3</SPAN>
<SPAN>2. 현금흐름표&cr;(1) 당기와 전기의 투자활동 중 현금의 유입과 유출이 없는 중요한 거래내역은 다음과 같습니다. </SPAN>
</P>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="314"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="626" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="323" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="152" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="151" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="323" HEIGHT="30" VALIGN="MIDDLE">건설중인자산의 본계정 대체</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6,333,195 </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">52,785,681 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="323" HEIGHT="30" VALIGN="MIDDLE">유형자산 취득 관련 미지급금 변동</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,567,403 </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">505,952 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="323" HEIGHT="30" VALIGN="MIDDLE">무형자산 취득 관련 미지급금 변동</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,308,978 </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,510,793 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="323" HEIGHT="30" VALIGN="MIDDLE">무형자산 취득 관련 선급금 변동</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,362,729 </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">6,854,235 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="323" HEIGHT="30" VALIGN="MIDDLE">전환사채의 전환권 행사</TD>
<TD WIDTH="152" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,072,604 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기 중 영업에서 창출된 현금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="623" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위:천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" WIDTH="344" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전)기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">영업활동에서 창출된 현금흐름</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">112,299,239 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">87,719,453 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">1. 당기순이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">24,148,066 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">28,865,606 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">2. 현금의 유출이 없는 비용 등의 가산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">89,725,288 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">78,835,358 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   퇴직급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">10,121,272 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">9,744,250 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   장기종업원급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">848,330 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">514,330 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   주식보상비용</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">1,194,517 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">943,213 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   감가상각비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">29,521,139 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">29,094,903 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   투자부동산상각비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">1,340,195 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">1,316,261 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   무형자산상각비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">8,389,513 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">8,448,890 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   사용권자산상각비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">1,630,860 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">1,335,313 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   대손상각비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">3,595,767 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">1,443,197 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   무형자산처분손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">274,563 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   외화환산손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">9,975,648 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">1,235,460 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   유형자산처분손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">57,150 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">339,389 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   재고자산평가손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">306,629 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">-  </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   재고자산폐기손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">458,252 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">74,021 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   재고자산감모손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">11,443,459 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">6,367,057 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   무형자산손상차손</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">8,103,470 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">9,321,907 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   투자부동산처분손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">278,467 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">14,528 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   이자비용</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">10,609,840 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">10,088,046 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   관계기업주식손상차손</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">897,114 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   법인세비용</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(10,588,733)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(5,543,933)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   당기손익-공정가치측정금융자산 평가손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">892,160 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   지분법손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">375,676 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">27,484 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   잡손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">4,071,042 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">3. 현금의 유입이 없는 수익 등의 차감</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(29,528,385)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(5,077,923)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   무형자산처분이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(633)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   외화환산이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(2,617,331)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(1,949,027)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   유형자산처분이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(69,495)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(396,112)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   관계기업주식처분이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(11,783)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(5,323)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   투자부동산처분이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(8,069,640)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   이자수익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(3,422,977)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(2,727,461)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   당기손익-공정가치측정금융자산 평가이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(3,514,240)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   지분법이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(905,641)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   파생상품거래이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(10,915,818)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   리스해지이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(827)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">4. 영업활동으로인한 자산부채의 변동</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">27,954,270 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(14,903,588)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   매출채권</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">44,176,341 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(6,733,085)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   미수금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">9,475,972 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(15,106,960)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   기타유동자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(26,312,480)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">3,673,766 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   제품반환회수권</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">266,644 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(490,711)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   기타비유동자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">1,390,505 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(378,924)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   매입채무</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">1,865,324 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">12,600,131 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   미지급금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">7,461,744 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(1,252,989)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   기타유동부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">6,308,729 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">7,452,108 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   장기미지급급</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(46,146)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(1,020)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   기타비유동부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(8,256,125)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(56,566)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   퇴직급의 지급</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(7,776,238)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(9,040,312)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="344" HEIGHT="30">   사외적립자산 납입액</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="140" HEIGHT="30">(600,000)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">(5,569,026)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" BIU"></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>33. 위험관리&cr;(1) 금융위험관리 &cr;연결실체는 여러 활동으로 인하여 시장위험(외환위험, 가격위험, 현금흐름 및 공정가치 이자율 위험), 신용위험 및 유동성위험과 같은 다양한 금융위험에 노출되어 있습니다. 연결실체의 전반적인 위험관리는 연결실체의 재무성과에 잠재적으로 불리할 수 있는 효과를 최소화하는데 중점을 두고 있습니다. &cr;&cr;위험관리는 이사회에서 승인한 정책에 따라 중앙 자금부서(연결실체 재무팀)에 의해 이루어지고 있습니다. 연결실체의 재무팀은 영업부서들과 긴밀히 협력하여 금융위험을 식별, 평가 및 회피하고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN>가. 시장위험 &cr;</SPAN>
<SPAN>① 외환위험&cr;연결실체의 외환위험은 주로 인식된 자산과 부채의 환율변동과 관련하여 발생하고 있습니다. 연결실체의 영업거래 및 자본거래 상 외환위험에 대한 회피가 필요하다고 판단되는 경우 통화선도거래 등을 통해 외환위험을 관리하고 있습니다. 외환위험은 미래예상거래 및 인식된 자산ㆍ부채가 기능통화 외의 통화로 표시될 때 발생하고 있습니다. &cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>당기말과 전기말 현재 연결실체가 보유하고 있는 외화표시 화폐성자산 및 화폐성부채의 장부금액은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="669" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="176"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="669" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="185" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="242" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="242" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">자산</TH>
<TH WIDTH="121" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">부채</TH>
<TH WIDTH="121" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">자산</TH>
<TH WIDTH="121" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30">USD</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">102,307,565 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">9,098,372 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">47,769,894 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">12,114,640 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30">JPY</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">68,160 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">4,330,197 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">11,992,605 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">2,086,098 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" HEIGHT="30">기타통화</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">3,986,258 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">4,275,663 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">7,002,500 </TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">5,243,904 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>당기말과 전기말 현재 장부통화인 원화에 대한 환율이 10% 상승하는 경우 법인세비용 차감전 손익에 미치는 효과는 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="668" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="181"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="668" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="190" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="240" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="238" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10%상승시</TH>
<TH WIDTH="120" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10%하락시</TH>
<TH WIDTH="119" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10%상승시</TH>
<TH WIDTH="119" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10%하락시</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="30">USD </TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">9,320,919 </TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">(9,320,919)</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">3,565,525 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(3,565,525)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="30">JPY </TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">(426,204)</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">426,204 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">990,651 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(990,651)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="30">기타통화</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">(28,940)</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">28,940 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">175,860 </TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(175,860)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>② 가격위험&cr;연결실체는 기타포괄손익-공정가치측정 금융자산에서 발생하는 가격변동위험에 노출되어 있습니다. 당기말 현재 공정가치로 평가하는 기타포괄손익-공정가치측정 금융자산은</SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>58,573,590천</SPAN>
<SPAN>원으로, 다른 변수가 일정하고 지분상품의 가격이 10% 증가 및 감소할 경우 가</SPAN>
<SPAN>격변동이 자본에 미치는영향은</SPAN>
<SPAN> </SPAN>
<SPAN>4,439,878천원(</SPAN>
<SPAN>법인세효과 고려 후)입니다. 당기말 공정가치로 평가하는 당기손익-공정가치측정 금융상품은 </SPAN>
<SPAN>75,342,100</SPAN>
<SPAN>천원으로 다른 변수가 일정하고 지분상품의 가격이 10% 증가 및 감소할 경우 가격변동이 손익에 미치는 영향은 </SPAN>
<SPAN>5,710,931</SPAN>
<SPAN>천원(법인세효과 고려 후)입니다. &cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>③ 이자율 위험&cr;연결실체는 차입금과 관련하여 이자율변동위험에 노출되어 있습니다. 연결실체의 경영진은 시장이자율의 변동으로 인하여 금융상품의 공정가치 또는 미래현금흐름이 변동할 위험을 정기적으로 측정하고 있습니다. 한편, 당기말 현재 연결실체의 변동이자율을 적용받는 이자부부채의 규모를 고려할 때 이자율변동이 금융부채의 공정가치 또는 미래현금흐름에 미치는 영향은 중요하지 아니합니다.</P>
<P></P>
<PGBRK></PGBRK>

<P USERMARK=" B">
<SPAN USERMARK=" !B">나. 신용위험 &cr;신용위험은 거래 상대방이 금융상품이나 고객계약에 따른 의무를 이행하지 못하여 재정적 손실을 초래할 수 있는 위험입니다. 연결실체는 영업활동(주로 매출 채권)과 은행 및 금융기관 예금, 외환 거래 및 기타 금융 상품을 포함한 금융활동으로부터 신용 위험에 노출되어 있습니다.&cr;</SPAN>
<SPAN USERMARK=" !B"></SPAN>
</P>

<P>
<SPAN>매출채권 및 계약자산&cr;고객신용위험은 고객신용위험 관리와 관련된 연결실체의 확립 된 정책, 절차 및 통제를 조건으로 하여 각 사업단위에 의해 관리됩니다. 고객의 신용도는 광범위한 신용등급평점표를 기준으로 평가되며 개별 신용한도는 이 평가에 따라 정의됩니다. &cr;손상보고는 예상되는 신용 손실을 측정하기 위해 충당금을 사용하여 보고기간종료일에 수행됩니다. 충당금율은 유사한 손실 패턴(즉, 고객 유형 및 등급, 신용장 또는 다른 형태의 신용 보험 적용 범위)에 따라 다양한 고객 세그먼트를 그룹화하여 만기일을 기준으로합니다. 이 계산은 확률 가중 결과, 시간 가치 및 미래의 경제 상황에 대한 과거 사건, 현재 상황 및 예측에 대해보고 일에 합리적이고 지원 가능한 정보를 반영합니다. &cr;&cr;금융상품 및 현금 예금&cr;은행 및 금융기관과의 잔액에 대한 신용위험은 당사의 재무 정책에 따라 재무부서가 관리합니다. 연결실체는 은행 및 금융기관의 경우, 독립적인 신용등급기관으로부터의 신용등급이 최소 A이상인 경우에 한하여 거래를 하고있습니다. &cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>금융자산의 장부금액은 신용위험에 대한 최대노출정도를 나타냅니다. 보고기간종료일 현재 연결실체의 신용위험에 대한 최대 노출정도는 다음과 같으며, 매출채권 및 기타채권의 연령은 주석7에서 설명하고 있습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="621" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">72,114,590 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">31,770,159 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">매출채권</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">137,409,378 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">183,521,850 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">기타채권</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">31,257,135 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">38,526,617 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">단기금융자산</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">104,820,752 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">장기매출채권</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">800,018 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">278,881 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">장기기타채권</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">4,309,303 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">5,866,552 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">장기금융자산</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">79,548 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">689,548 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">350,790,724 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">358,390,569 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>다. 유동성위험 &cr;신중한 유동성위험 관리는 충분한 현금 및 시장성 있는 유가증권의 유지, 적절하게 약정된 신용한도금액으로부터의 자금 여력 및 시장포지션을 결제할 수 있는 능력 등을 포함하고 있습니다. 활발한 영업활동을 통해 연결실체의 재무팀은 신용한도 내에서 자금여력을 탄력적으로 유지하고 있습니다. &cr;</P>
<P>당기말 현재 비파생금융부채의 잔존계약만기에 따른 만기분석은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="645" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="645" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="145" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">1년 이하</TH>
<TH WIDTH="147" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">1년 초과</TH>
<TH WIDTH="146" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">차입금 및 사채</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30">147,052,620 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">291,524,819 </TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">438,577,439 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">매입채무 및 기타채무</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30">132,747,743 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">10,172,469 </TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">142,920,212 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">리스부채</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30">1,194,921 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">10,363,667 </TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">11,558,588 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="145" ALIGN="RIGHT" HEIGHT="30">280,995,284 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">312,060,955 </TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">593,056,239 </TD>
</TR>
</TBODY>
</TABLE>
<P>상기 만기분석은 할인하지 않은 현금흐름을 기초로 연결실체가 지급하여야 하는 가장 빠른 만기일에 근거하여 작성되었습니다.&cr;</P>
<P>(2) 자본 위험 관리&cr;연결실체의 자본관리 목적은 계속기업으로서 주주 및 이해당사자들에게 이익을 지속적으로 제공할 수 있는 능력을 보호하고 자본비용을 절감하기 위해 최적 자본구조를 유지하는 것입니다. 자본구조의 유지 또는 조정을 위하여 연결실체는 주주에게 지급되는 배당을 조정하거나 주주에 자본금을 반환하며, 부채감소를 위한 신주 발행 및 자산 매각 등을 실시하고 있습니다. </P>
<P></P>
<P>연결실체는 자본조달비율에 기초하여 자본을 관리하고 있습니다. 자본조달비율은 순차입금을 총자본으로 나누어 산출하고 있습니다. 순차입금은 차입금총계(연결재무상태표에 표시된 것)에서 현금및현금성자산을 차감한 금액이며, 총자본은 연결재무상태표의 '자본'에 순차입금을 가산한 금액입니다. </P>
<P></P>
<P>당기말과 전기말 현재 자본조달비율은 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="625" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">차입금총계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">438,577,439 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">389,414,842 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">차감: 현금및현금성자산</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(72,299,250)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(32,094,194)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">순차입금(A)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">366,278,189 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">357,320,648 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">자본총계(B)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">695,248,617 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">635,920,094 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">총자본(C = A + B)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,061,526,806 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">993,240,742 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">자본조달비율(A / C)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">34.50%</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">35.98%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 재무활동에서 생기는 부채의 변동&cr;연결실체의 당기 중 재무활동에서 생기는 부채의 변동은 아래와 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="795" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규리스</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무활동&cr;현금흐름</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화환산</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">9,414,842 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">139,289,950 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(127,353)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">148,577,439 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">379,117,453 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(90,000,000)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">448,965 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">289,566,418 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">리스부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,398,141 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,634,414 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(1,701,811)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">213,460 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">2,412 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">7,546,616 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">392,930,436 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,634,414 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">47,588,139 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">662,425 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(124,941)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">445,690,473 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="795" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규리스</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무활동&cr;현금흐름</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화환산</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">7,498,978 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">1,856,700 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">59,164 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">9,414,842 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">379,350,662 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(233,209)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">379,117,453 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">리스부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">5,610,412 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(1,324,334)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">90,644 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">21,419 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">4,398,141 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">386,849,640 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">5,610,412 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">532,366 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(142,565)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">80,583 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">392,930,436 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<PGBRK></PGBRK>
<P>34. 공정가치 서열체계&cr;(1) 금융상품의 공정가치</P>
<P>연결실체의 금융상품 중 상각후원가로 측정하는 금융자산 및 금융부재는 장부금액과 공정가치의 차이가 유의적이지 않으며, 기타 금융상품은 장부금액과 공정가치가 일치합니다. </P>
<P>&cr;(2) 공정가치 서열체계&cr;가. 공정가치 서열체계&cr;연결실체는 공정가치 측정에 사용된 투입변수의 유의성을 반영하는 공정가치 서열체계에따라 공정가치 측정치를 분류하고 있으며, 공정가치 서열체계의 수준은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="764" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="676"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="79" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="685" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">투입변수의 유의성</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수준 1</TD>
<TD WIDTH="685" HEIGHT="30">측정일에 동일한 자산이나 부채에 대한 접근 가능한 활성시장의 조정되지 않은 공시가격</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수준 2</TD>
<TD WIDTH="685" HEIGHT="30">수준 1 의 공시가격 이외에 자산이나 부채에 대해 직접적으로 또는 간접적으로 관측가능한 투입변수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수준 3</TD>
<TD WIDTH="685" HEIGHT="30">자산이나 부채에 대한 관측가능하지 않은 투입변수</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 당기말과 전기말 현재 금융상품의 수준별 공정가치 측정치는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="764">

<COLGROUP>
<COL WIDTH="275"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="764" VALIGN="MIDDLE" COLSPAN="5" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="284" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 1</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 2</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 3</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="764" HEIGHT="30" COLSPAN="5">제 19(당) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">  기타포괄손익-공정가치측정 금융자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,184,012 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,389,579 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,573,591 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">  당기손익-공정가치 측정 금융자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">  단기금융자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,805,315 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,805,315 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,184,012 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,805,315 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85,731,679 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">238,721,006 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="764" HEIGHT="30" COLSPAN="5">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">
<SPAN>  기타포괄손익-공정가치측정 금융자산</SPAN>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,817,172 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,091,052 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,908,224 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">
<SPAN>  당기손익-공정가치 측정 금융자산</SPAN>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">  단기금융자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,817,172 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,091,072 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">119,645,206 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>35.</SPAN>
<SPAN> 리스</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>(1) </SPAN>
<SPAN></SPAN>
<SPAN>사용권자산과 리스부채 변동내역</SPAN>
<SPAN>&cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="731">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="731" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구  분</TH>
<TH COLSPAN="4" WIDTH="457" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">사용권자산</TH>
<TH ROWSPAN="2" WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">리스부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">건물</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">차량운반구</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">토지</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">당기초</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,384,709 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">370,587 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,737,795 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,493,091 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,398,141 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">  증가</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,217,902 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,140 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,424,278 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,663,320 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,634,414 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">  감가상각</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,293,416)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(166,963)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(170,481)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,630,860)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">  기타조정</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,567 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">350 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,917 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,412 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">  이자비용</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">213,460 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">  지급</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,701,811)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">당기말</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,311,762 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">225,114 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,991,592 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,528,468 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,546,616 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">차감: 유동성리스부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="115" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(984,157)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">차  감  계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="115" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">6,562,459 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="732">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="732" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="161" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구  분</TH>
<TH COLSPAN="4" WIDTH="457" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">사용권자산</TH>
<TH ROWSPAN="2" WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">리스부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">건물</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">차량운반구</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">토지</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">당기초</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30"> 회계정책의 변경</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,455,805 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">528,938 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,824,648 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,809,391 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,651,613 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">  증가</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">925,623 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,269 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,579 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">997,471 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">958,799 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">  감가상각</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,018,099)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(212,782)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(104,432)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,335,313)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">  기타조정</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,380 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">162 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,542 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,419 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">  이자비용</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,644 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">  지급</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,324,334)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">당기말</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,384,709 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">370,587 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,737,795 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,493,091 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,398,141 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">차감: 유동성리스부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(993,720)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" VALIGN="MIDDLE" HEIGHT="30">차  감  계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="115" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="114" HEIGHT="30">3,404,421 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>(2) 사용권자산과 리스부채와 관련하여 손익계산서에 인식한 금액
<SPAN USERMARK=" 0X1814FF"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="320"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="624" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="329" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" VALIGN="MIDDLE" HEIGHT="30">사용권자산에 대한 감가상각비</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,630,860 </TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,335,313 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" VALIGN="MIDDLE" HEIGHT="30">리스부채에 대한 이자비용</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">213,460 </TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,644 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" VALIGN="MIDDLE" HEIGHT="30">단기리스료</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">77,066 </TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">338,109 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" VALIGN="MIDDLE" HEIGHT="30">단기리스가 아닌 소액자산 리스료</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">261,912 </TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">233,862 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" VALIGN="MIDDLE" HEIGHT="30">리스부채 측정치에 포함되지 않은 변동리스료</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" VALIGN="MIDDLE" HEIGHT="30">리스해지이익</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(827)</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN></SPAN>
<SPAN>(3) </SPAN>
<SPAN>리스기간에 포함되지 않은 행사되지 않을 것으로 예상되는 연장선택권의 할인되</SPAN>
<SPAN>지 않은 잠재적인 미래 리스료는 당기 </SPAN>
<SPAN>1,383,840천원(전기 1,064,500천원)입니다.&cr;&cr;36. COVID 19의 영향의 불확실성&cr;COVID19의 확산을 차단하기 위하여 전세계적으로 이동 제한을 포함한 다양한 예방및 통제가 시행되고 있으며, 그 결과 전세계 경제가 광범위한 영향을 받고 있습니다.또한, COVID19에 대처하기 위한 다양한 정부지원정책이 발표되고 있습니다. COVID-19의 영향을 받는 항목은 매출채권의 회수가능성, 재고자산 및 유ㆍ무형자산의 손상, 충당부채의 인식 등 입니다. 연결실체는 COVID19의 영향과 정부지원정책이 향후 연결실체에 미칠 영향을 보고기간말 현재 합리적으로 추정할 수 없었으며 이로 인한 영향은 연결재무제표에 반영되지 않았습니다. &cr;&cr;37. 보고기간 후 사건&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>미국국제무역위원회에 제기되었던 영업비밀침해 소송의 당사자인 에볼루스, 앨러간,매디톡스는 미국국제무역위원회 최종판결에 따라 2021년 2월 19일에 3자간 합의 계약을 완료하였습니다. 지배기업은 해당 합의의 당사자가 아니므로 이로 인한 연결재무제표에 미칠 영향을 알 수 없습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>또한, 지배기업은 2021년 3월 3일자로 공정거래위원회로부터 부당고객유인행위에 대한 과징금 2,146백만원을 부과 받아 이를 기타충당부채로 계상하였습니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>

<TABLE-GROUP ACLASS="{XBRL}BS_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">재무상태표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 19 기          2020.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 18 기          2019.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기          2018.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 19 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 18 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 17 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>374,877,424,433</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>383,673,677,063</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>382,914,743,226</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>52,142,241,479</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>19,718,513,562</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>34,808,238,832</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　단기금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,300,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,050,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>144,643,269</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매출채권 및 기타채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>143,302,761,085</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>203,352,194,472</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>186,026,004,756</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>141,453,027,804</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>146,053,182,690</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>154,709,225,575</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　반환제품회수권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,559,978,346</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,826,622,194</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,335,911,577</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,119,415,719</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,673,164,145</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,890,719,217</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>811,857,976,041</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>716,308,362,132</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>693,394,002,656</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,500,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,500,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,500,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기매출채권 및 기타채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>6,009,109,923</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,646,753,154</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>6,096,600,154</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　　기타포괄손익-공정가치 측정 금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>5,825,557,850</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>3,657,562,128</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>3,454,639,079</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　당기손익-공정가치 측정 금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>75,342,100,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,000,020,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　관계기업투자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,045,055,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,045,055,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,919,085,500</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　종속기업투자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>188,104,887,048</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>178,113,688,588</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>179,977,976,632</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>304,489,983,589</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>306,005,390,769</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>314,702,142,321</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>82,561,182,080</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>93,680,203,280</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>95,045,534,628</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>102,905,772,143</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>92,106,920,154</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>71,528,601,771</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　사용권자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,782,025,460</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,714,527,661</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>413,075,127</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>569,251,465</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이연법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>29,368,727,321</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>19,758,489,433</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,658,922,571</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자산총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,186,735,400,474</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,099,982,039,195</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,076,308,745,882</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>291,287,496,597</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>232,512,231,295</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>340,369,355,673</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매입채무 및 기타채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>116,560,719,252</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>111,991,297,411</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>90,811,610,299</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　단기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>52,016,970,048</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,355,408,787</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,564,760,758</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유동성사채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>89,925,922,452</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>89,921,320,846</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>199,864,885,984</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유동리스부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>551,320,897</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>474,050,190</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　당기법인세부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,842,112,945</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>672,746,638</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,815,992,750</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　단기이연수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,157,582,412</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,092,448,422</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>30,390,451,003</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>23,939,825,011</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,219,657,460</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>319,414,014,600</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>314,472,986,069</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>197,567,751,195</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기매입채무 및 기타채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>5,339,087,728</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,995,715,167</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,157,775,167</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>90,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기차입부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>199,640,495,920</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>289,196,131,742</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>179,485,775,945</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　비유동리스부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,236,651,291</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,139,801,566</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,197,779,661</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,141,337,594</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>13,924,200,083</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>610,701,511,197</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>546,985,217,364</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>537,937,106,868</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자본</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자기주식</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(29,236,490,120)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　기타불입자본</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>112,121,875,131</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>100,927,811,701</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>100,492,273,110</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　기타자본구성요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,535,377,559)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,753,073,107)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,906,891,620)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이익잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>471,717,444,325</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>474,771,215,119</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>460,735,389,406</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>576,033,889,277</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>552,996,821,831</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>538,371,639,014</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자본과부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,186,735,400,474</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,099,982,039,195</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,076,308,745,882</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}IS_S1" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">포괄손익계산서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 19 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 18 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 19 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 18 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 17 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>944,751,590,837</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,005,179,735,629</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>943,522,107,235</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>554,719,366,345</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>591,552,500,094</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>585,824,503,034</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출총이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>390,032,224,492</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>413,627,235,535</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>357,697,604,201</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>판매관리비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>272,432,198,794</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>282,454,282,069</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>224,916,727,780</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>경상연구개발비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>104,973,663,922</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>99,725,680,002</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>98,985,448,916</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>영업이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>12,626,361,776</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>31,447,273,464</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>33,795,427,505</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,266,343,506</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,540,977,140</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,640,031,937</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>금융원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,827,968,138</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>13,937,904,308</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,973,333,408</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>12,737,763,082</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,281,599,687</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,125,949,149</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>20,587,397,601</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>12,921,641,347</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,816,097,789</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>법인세비용차감전순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(7,784,897,375)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>16,410,304,636</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>15,771,977,394</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,923,647,981)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,818,043,077)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,290,706,068</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,138,750,606</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>20,228,347,713</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,481,271,326</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(782,304,452)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>153,818,513</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(243,381,948)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　후속적으로 손익으로 재분류되지 않는 항목</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(782,304,452)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>153,818,513</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(243,381,948)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　　기타포괄손익-공정가치측정금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(782,304,452)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>153,818,513</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(243,381,948)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,356,446,154</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>20,382,166,226</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,237,889,378</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주당이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　기본주당이익(손실) (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>294</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,960</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>144</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
<P></P>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}EF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1500" BORDER="0">

<COLGROUP>
<COL WIDTH="1491"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1500" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">자본변동표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1500" HEIGHT="30" AUPDATECONT="N">
<P>제 19 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1500" HEIGHT="30" AUPDATECONT="N">
<P>제 18 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1500" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1500" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1500" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="90" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="3">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="1350" COLSPAN="9">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="2">
<P>자본금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="2">
<P>자기주식</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="600" COLSPAN="4">
<P>기타불입자본</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="2">
<P>기타자본구성요소</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="2">
<P>이익잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="2">
<P>자본  합계</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>주식발행초과금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>주식선택권</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>기타자본잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>기타불입자본 합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2018.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,357,854,372</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>62,638,685</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,420,493,057</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(264,723,682)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>463,133,237,423</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>547,339,874,916</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,398,785,990)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,313,402,657</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(4,085,383,333)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,481,271,326</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,481,271,326</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 측정 금융자산 평가손익 적립금</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(243,381,948)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(243,381,948)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>71,780,053</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>71,780,053</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>71,780,053</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자기주식의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2018.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,357,854,372</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>71,780,053</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>62,638,685</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,492,273,110</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,906,891,620)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>460,735,389,406</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>538,371,639,014</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2019.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,357,854,372</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>71,780,053</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>62,638,685</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,492,273,110</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,906,891,620)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>460,735,389,406</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>538,371,639,014</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>20,228,347,713</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>20,228,347,713</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 측정 금융자산 평가손익 적립금</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>153,818,513</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>153,818,513</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>435,538,591</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>435,538,591</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>435,538,591</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자기주식의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2019.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,357,854,372</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>507,318,644</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>62,638,685</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,927,811,701</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,753,073,107)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>474,771,215,119</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>552,996,821,831</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2020.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(44,915,569,382)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,357,854,372</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>507,318,644</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>62,638,685</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,927,811,701</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,753,073,107)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>474,771,215,119</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>552,996,821,831</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>회계정책변경에 따른 증가(감소)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,138,750,606</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,138,750,606</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 측정 금융자산 평가손익 적립금</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(782,304,452)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(782,304,452)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,521,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,521,400)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>400,214,542</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>400,214,542</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>400,214,542</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자기주식의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>15,679,079,262</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,793,848,888</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,793,848,888</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,472,928,150</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2020.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>28,966,437,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(29,236,490,120)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>100,357,854,372</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>907,533,186</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>10,856,487,573</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>112,121,875,131</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(7,535,377,559)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>471,717,444,325</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>576,033,889,277</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}CF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">현금흐름표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 19 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 18 기 2019.01.01 부터 2019.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2018.01.01 부터 2018.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 19 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 18 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 17 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>영업에서창출된현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>98,363,539,706</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>37,986,056,546</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>53,761,450,987</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,138,750,606</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>20,228,347,713</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,481,271,326</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　당기순이익조정을 위한 가감</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>64,775,999,937</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>56,046,405,350</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>89,902,224,395</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　퇴직급여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,987,893,377</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,267,882,205</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,149,508,326</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기종업원급여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>848,329,974</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>514,330,313</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>15,227,619</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　감가상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>23,452,020,497</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,556,785,419</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>34,245,675,020</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산감가상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,340,194,547</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,350,803,818</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,351,089,606</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,244,208,731</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,049,410,150</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,643,710,660</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　사용권자산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>959,625,268</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>784,203,885</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　대손상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,712,124,325</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,150,558,513</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,233,491,874</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산감모손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,443,459,107</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>5,544,175,194</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,967,556,925</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산폐기손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,085,524,457</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,923,647,981)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,818,043,077)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,290,706,068</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이자비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,957,664,241</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,958,784,541</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,934,560,691</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>6,433,357</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>337,388,629</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>7,971,387,205</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(8,069,639,855)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　투자부동산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>278,466,508</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>14,527,530</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>274,562,746</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,261,629,032</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산손상차손</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>7,210,649,980</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>603,220,664</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>541,770,990</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　당기손익인식금융자산평가손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>892,160,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　당기손익인식금융자산평가이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,514,240,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　외화환산손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,242,360,822</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>875,396,420</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>303,158,776</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　주식보상비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>400,214,542</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>435,538,591</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>71,780,053</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　종속기업주식손상차손</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>5,087,941,873</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,296,678,663</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,408,264,289</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　이자수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,495,398,522)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(851,905,275)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(506,904,373)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　외화환산이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(525,086,723)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,641,893,828)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(990,014,997)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　리스변경이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(501,244)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(33,162,928)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(381,437,005)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,075,897,826)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(632,705)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　영업활동으로인한자산ㆍ부채의변동</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>41,070,394,619</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(8,431,831,071)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(22,194,626,383)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매출채권의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>48,552,900,669</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,835,070,704)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(20,887,922,678)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　미수금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>9,556,979,294</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(19,471,538,467)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,917,684,117)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,843,304,221)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,111,867,691</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>541,287,547</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　반환제품회수권의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>266,643,848</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(490,710,617)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,406,722,814</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동자산의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(14,487,818,258)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>94,950,289</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,325,099,643)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　보증금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>381,879,703</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>365,630,457</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(730,249,667)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동자산의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(368,163,676)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(569,251,465)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매입채무의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,207,775,038)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>12,330,489,164</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,368,262,777</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　미지급금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>12,916,956,601</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>5,795,865,984</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(3,708,169,960)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　예수보증금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(852,239,069)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(258,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>775,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　임대보증금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,341,526,060</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(162,060,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(97,640,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　금융보증부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(197,416)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>380,879</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,071,999</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기금융보증부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>12,058,213</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,934,458,660</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,983,205,644)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,498,260,377</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,504,388,039</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,474,320,715</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,630,774,001</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　퇴직금의 지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,490,339,180)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,625,638,770)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,491,163,277)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기종업원급여의 지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(147,559,610)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(209,860,583)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(265,076,556)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이자수취(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>219,699,531</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>572,757,949</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>613,892,254</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이자지급(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,127,783,560)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,227,834,495)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,554,414,132)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　법인세납부</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(713,521,427)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(20,201,788,900)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,486,896,473)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>투자활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(136,446,029,569)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(48,243,879,672)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(54,324,962,553)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　단기금융상품의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,050,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>144,643,269</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>88,540,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　단기금융상품의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(18,300,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(8,050,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　장기금융상품의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>256,185,338</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　단기대여금의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,477,240,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>200,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　단기대여금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,100,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(500,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,000,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　장기대여금의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,129,400,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>200,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　당기손익-공정가치측정금융자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(78,165,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(1,000,020,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　기타포괄손익-공정가치측정금융자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(3,200,059,644)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(339,100,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>　기타포괄손익-공정가치측정금융자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>3,750</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>675,750,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　관계기업주식의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,000,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,125,970,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(6,600,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　종속회사주식의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(14,467,830,680)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,066,732,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　종속회사주식의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>16,615,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유형자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>34,762,016</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>82,309,091</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,213,710,111</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(21,082,334,234)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(19,102,471,636)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(52,653,437,441)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　투자부동산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,570,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　무형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(28,360,561,492)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(21,598,683,311)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(66,175,761)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　무형자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,428,979,465</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,495,801,165</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>699,565,200</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>재무활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>70,438,580,168</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(5,098,489,061)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(7,012,270,689)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　단기차입금의 차입</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>52,086,624,870</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,421,461,245</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,570,423,532</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　단기차입금의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(4,355,408,787)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,564,760,758)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,390,172,221)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　장기차입금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>90,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　사채의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>200,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>90,000,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　사채의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(90,000,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(200,000,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(90,000,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　금융리스부채의 지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,019,099,962)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(762,667,548)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자기주식의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>29,918,985,447</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　배당금지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,521,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(6,192,522,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>환율변동효과 반영전 현금및현금성자산의 순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>32,356,090,305</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(15,356,312,187)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>(7,575,782,255)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>현금및현금성자산에 대한 환율변동효과</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>67,637,612</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>266,586,917</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>142,554,791</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>현금및현금성자산의순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>32,423,727,917</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(15,089,725,270)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(7,433,227,464)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기초현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>19,718,513,562</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>34,808,238,832</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>42,241,466,296</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기말현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>52,142,241,479</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>19,718,513,562</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>34,808,238,832</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P USERMARK="F-16 0XFF0000 B"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제19(당) 기 2020년 1월 1일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="53">제18(전) 기 2019년 1월 1일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">주식회사 대웅제약</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<P>1. 회사의 개요</P>

<P>
<SPAN>주식회사 대웅제약(이하 "당사"라 함)은 2002년 10월 1일을 기준일로 주식회사 대웅 (분할 전 상호: 주식회사 대웅제약)이 사업부문을 인적분할하여 2002년 10월 2일자로 설립되었으며, 의약품 생산 및 판매를 주요 사업으로 영위하고 있습니다. 당사는 2002년 11월 1일자로 한국거래소(구, 한국증권선물거래소)가 개설한 유가증권 시장에 상장하였으며, 보고기간 종료일 현재 화성군 향남공단과 충청북도청주시 오송생명과학단지 내에 정제의약품 생산 KGMP 기준에 부합하는 제조시설을 두고 있습니다.&cr;&cr;당사는 그 동안 수차례의 증자를 거쳐 당기말 현재의 자본금은</SPAN>
<SPAN> </SPAN>
<SPAN>28,966</SPAN>
<SPAN>백만원이며, 주요 주주현황은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="638" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">주 주 명</TH>
<TH WIDTH="213" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">소유주식수</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">지 분 율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">(주)대웅</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">5,221,547 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">45.07%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">(재)대웅재단</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">998,453 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">8.62%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">자기주식</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">823,880 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">7.11%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">기타</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">4,542,695 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">39.20%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합         계</TD>
<TD WIDTH="213" ALIGN="RIGHT" HEIGHT="30">11,586,575 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN>2. 재무제표 작성기준&cr;</SPAN>
<SPAN>당사의 재무제표는 '주식회사 등의 외부감사에 관한 법률'에 따라 제정된 한국채택국제회계기준에 따라 작성되었습니다.</SPAN>
<SPAN> </SPAN>
<SPAN>당사의 재무제표는 기업회계기준서 제1027호 '별도재무제표'에 따른 별도재무제표로서 지배기업, 관계기업의 투자자 또는 공동기업의 참여자가 투자자산을 피투자자의 보고된 성과와 순자산에 근거하지 않고 직접적인 지분 투자에 근거한 회계처리로 표시한 재무제표입니다.&cr;&cr;</SPAN>
<SPAN>당사의 재무제표는 </SPAN>
<SPAN>2021년 </SPAN>
<SPAN>03</SPAN>
<SPAN>월</SPAN>
<SPAN> </SPAN>
<SPAN>11</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>일자</SPAN>
<SPAN> </SPAN>
<SPAN>이</SPAN>
<SPAN></SPAN>
<SPAN>사회에서 최종 승인될 예정입니다.</SPAN>
<SPAN>&cr;&cr;(1) 측정기준&cr;당사의 재무제표는 공정가치로 측정되는 지분 금융상품을 제외하고는 역사적원가를 기준으로 작성되었습니다.&cr;&cr;(2) 기능통화와 표시통화&cr;</SPAN>
<SPAN>당사의 재무제표는 당사의 영업활동이 이루어지는 주된 경제환경의 통화(기능통화)로 작성</SPAN>
<SPAN>되고 있으며 기능통화 및 표시통화인 원화로 작성하여 보고하고 있습니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;(3) 추정과 판</SPAN>
<SPAN>단</SPAN>
</P>
<P>한국채택국제회계기준에서는 재무제표를 작성함에 있어서 회계정책의 적용이나 보고기간말 현재 자산, 부채 및 수익, 비용의 보고금액에 영향을 미치는 사항에 대하여 경영진의 최선의 판단을 기준으로 한 추정치와 가정의 사용을 요구하고 있습니다. 보고기간말 현재 경영진의 최선의 판단을 기준으로 한 추정치와 가정이 실제 환경과 다를 경우 이러한 추정치와 실제결과는 다를 수 있습니다.&cr;</P>

<P>
<SPAN>현재의 상황과 미래</SPAN>
<SPAN>에 대한 가정은 시장의 변화나 당사의 통제에서 벗어난 상황으로 인해 변화할 수 있습니다. 그러한 변화가 발생시 이를 가정에 반영하고 있습니다. 요약재무제표 작성시 사용된 중요한 회계추정 및 가정은 전기 재무제표의 작성시 적용된 회계추정 및 가정과 동일합니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>가. 경영진의 판단&cr;재무제표에 인식된 금액에 유의한 영향을 미치는 회계정책의 적용과 관련된 주요한 경</SPAN>
<SPAN>영진의 판단에 대한 정보는 다음의 주석사항에 포함되어 있습니다. </SPAN>
</P>
<P>- 주석 13: 투자부동산의 분류</P>

<P>
<SPAN>&cr;나. 가정과 추정의 불확실성&cr;다</SPAN>
<SPAN>음 </SPAN>
<SPAN>보고기간</SPAN>
<SPAN> 이내에 중요한 조정이 발생할 수 있는 유의한 위험이 있는 가정과 추정의 불확실성에 대한 </SPAN>
<SPAN>정보는 다음의 주석사항에 포함되어 있습니다.&cr;</SPAN>
<SPAN>- 주석 18: 계약부채의 측정&cr;- 주석 28: 이연법인세의 측정&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>다. 공정가치 측정&cr;당사의 회계정책과 공시사항은 다수의 금융 및 비금융자산과 부채에 대해 공정가치 측정을 요구하고 있는 바, 당사는 공정가치평가 정책과 절차를 수립하고 있습니다. 동 정책과 절차에는 공정가치 서열체계에서 수준 3으로 분류되는 공정가치를 포함한모든 유의적인 공정가치 측정의 검토를 책임지는 평가부서의 운영을 포함하고 있으며, 그 결과는 재무담당임원에게 직접 보고되고 있습니다.&cr;</SPAN>
</P>
<P>평가부서는 정기적으로 관측가능하지 않은 유의적인 투입변수와 평가 조정을 검토하고 있습니다. 공정가치측정에서 중개인 가격이나 평가기관과 같은 제3자 정보를 사용하는 경우, 평가부서에서 제3자로부터 입수한 정보에 근거한 평가가 공정가치 서열체계 내 수준별 분류를 포함하고 있으며 해당 기준서의 요구사항을 충족한다고 결론을 내릴 수 있는지 여부를 판단하고 있습니다.&cr;&cr;자산이나 부채의 공정가치를 측정하는 경우, 당사는 최대한 시장에서 관측가능한 투입변수를 사용하고 있습니다. 공정가치는 다음과 같이 가치평가기법에 사용된 투입변수에 기초하여 공정가치 서열체계 내에서 분류됩니다.</P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="671"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="680" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">투입변수의 유의성</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER">수준 1</TD>
<TD WIDTH="680" HEIGHT="30">측정일에 동일한 자산이나 부채에 대한 접근 가능한 활성시장의 조정되지 않은 공시가격</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER">수준 2</TD>
<TD WIDTH="680" HEIGHT="30">수준 1 의 공시가격 이외에 자산이나 부채에 대해 직접적으로 또는 간접적으로 관측가능한 투입변수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER">수준 3</TD>
<TD WIDTH="680" HEIGHT="30">자산이나 부채에 대한 관측가능하지 않은 투입변수</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">&cr;자산이나 부채의 공정가치를 측정하기 위해 사용되는 여러 투입변수가 공정가치 서열체계 내에서 다른 수준으로 분류되는 경우, 당사는 측정치 전체에 유의적인 공정가치 서열체계에서 가장 낮은 수준의 투입변수와 동일한 수준으로 공정가치 측정치 전체를 분류하고 있으며, 변동이 발생한 보고기간 말에 공정가치 서열체계의 수준간 이동을 인식하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK=" 0X000000">라. 연장 및 종료선택권이 있는 계약의 리스기간 산정 - 리스이용자로서의 판단</SPAN>
</P>
<P>당사는 리스기간을 리스의 해지불능기간과 리스 연장선택권을 행사할 것이 상당히 확실한 경우에 그 선택권의 대상기간 또는 리스 종료선택권을 행사하지 않을 것이 상당히 확실한 경우에 그 선택권의 대상기간을 포함하여 산정합니다.</P>
<P></P>
<P>당사는 연장선택권을 포함하는 리스 계약들을 가지고 있습니다. 당사는 리스를 연장 또는 종료하기 위한 선택권을 행사할지 여부가 상당히 확실한지를 평가할 때 판단을 적용합니다. 즉, 연장선택권을 행사할 경제적 유인이 생기게 하는 관련되는 사실 및 상황을 모두 고려합니다. 개시일 이후, 당사는 당사의 통제 하에 있는 상황에서 유의적인 사건이나 변화가 있고, 연장선택권을 행사할지에 대한 능력에 영향을 미치는 경우 리스기간을 재평가합니다. </P>

<P>
<SPAN></SPAN>
</P>
<P>마. 부동산 리스의 분류 - 리스제공자로서의 판단</P>
<P>당사는 투자부동산 포트폴리오에 대한 상업용 부동산 리스계약을 체결하였습니다. 당사는 상업용 부동산 경제적 내용연수의 상당 부분을 차지하지 않는 리스기간 및 상업용 부동산 공정가치의 대부분에 해당하지 않는 리스료의 현재가치와 같은 약정의 조건에 대한 평가에 근거하여 해당 부동산의 소유에 따른 위험과 보상의 대부분을 보유하고 있고 이러한 계약을 운용리스로 회계처리 하기로 결정하였습니다. </P>

<P>
<SPAN></SPAN>
</P>
<P>바. 리스 - 증분차입이자율의 산정</P>
<P>당사는 리스의 내재이자율을 쉽게 산정할 수 없으므로, 리스부채를 측정하기 위해 증분차입이자율을 사용합니다. 증분차입이자율은 당사가 비슷한 경제적 환경에서 비슷한 기간에 걸쳐 비슷한 담보로 사용권자산과 가치가 비슷한 자산 획득에 필요한 자금을 차입한다면 지급해야 하는 이자율입니다. 따라서 증분차입이자율은 관측가능한 요율이 없거나 리스 조건을 반영하기 위하여 조정되어야 하는 경우에 측정이 요구되는 당사가 '지불해야 하는' 사항을 반영합니다.&cr;</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(4) </SPAN>
<SPAN>회계정책의 변경&cr;</SPAN>
<SPAN>아래에서 설명하고 있는 2020년 1월 1일부터 최초로 적용되는 제ㆍ개정 기준서의 적용을</SPAN>
<SPAN></SPAN>
<SPAN> 제외하고 </SPAN>
<SPAN>당사</SPAN>
<SPAN>는 당기 및 비교 표시된 전기 재무제표에 동일한 회계정책을 적용하고</SPAN>
<SPAN> 있습니다. 동 개정으로 인해 당사의 재무제표에 미치는 영향은 유의적이지 않다고 판단하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>가. 기업회계기준서 제1103호 '사업결합' (개정) - 사업의 정의&cr;</SPAN>
<SPAN>기</SPAN>
<SPAN>업회계기준서 제1103호의 개정사항은 활동과 자산의 집합이 사업의 정의를 충족하기 위해서는 적어도 산출물의 창출에 함께 유의적으로 기여할 수 있는 능력을 가진 투입물과 실질적인 과정을 반드시 포함해야 한다는 것을 명확히 하였습니다. 또한 산출물을 창출하는 데 필요한 모든 투입물과 과정을 포함하지 않더라도 사업이 존재할 수 있다는 것을 명확히 하였습니다. 이 개정사항이 재무제표에 미치는 영향은 없으나, 향후 당사에 사업결합이 발생할 경우 영향을 미칠 수 있습니다&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>나. 기업회계기준서 제1107호 '금융상품: 공시', 제1109호 '금융상품' 및 제1039호 '금융상품: 인식과 측정' (개정) - 이자율 지표 개혁&cr;</SPAN>
<SPAN>기</SPAN>
<SPAN>업회계기준서 제1109호와 제1039호 '금융상품: 인식과 측정' 개정은 이자율지표 개혁의 직접적인 영향을 받는 모든 위험회피관계에 적용되는 많은 완화 규정을 제공합니다. 위험회피관계는 이자율 지표 개혁이 위험회피대상항목이나 위험회피수단의 이자율지표에 근거한 현금흐름의 시기 또는 금액에 대한 불확실성을 야기하는 경우에 영향을 받습니다. 당사의 재무제표에는 어떠한 이자율위험회피관계도 없기 때문에 동 개정사항이 미치는 영향은 없습니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>다. 기업회계기준서 제1001호 '재무제표 표시'와 제1008호 '회계정책, 회계추정의 변경 및 오류' (개정) - 중요성의 정의&cr;</SPAN>
<SPAN>기업회계기준서 제1001호와 제1008호 개정사항은 '특정 보고기업에 대한 재무정보를 제공하는 일반목적재무제표에 정보를 누락하거나 잘못 기재하거나 불분명하게 하여, 이를 기초로 내리는 주요 이용자의 의사결정에 영향을 줄 것으로 합리적으로 예상할 수 있다면 그 정보는 중요'하다는 중요성의 새로운 정의를 제공합니다. 동 개정사항은 중요성이 개별적으로 또는 다른 정보와 결합하여 재무제표에서의 정보의 성격 또는 규모에 의존한다는 것을 명확히 하였습니다. 만약 주요 재무정보이용자의 결정에 영향을 줄 것이라는 합리적으로 예상 가능하다면 해당 정보의 오류는 중요합니다. 동 개정사항이 당사의 재무제표 및 향후에 미치는 영향은 없을 것으로 예상합니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>라. 재무보고를 위한 개념체계(2018 개정)&cr;</SPAN>
<SPAN>개</SPAN>
<SPAN>념체계는 회계기준이 아니며, 개념체계의 어떠한 내용도 회계기준이나 그 요구사항에 우선하지 않습니다. 개념체계의 목적은 회계기준위원회가 한국채택국제회계기준을 제ㆍ개정하는 데 도움을 주며, 적용할 회계기준이 없는 경우에 재무제표 작성자가 일관된 회계정책을 개발하는 데 도움을 줍니다. 또한 모든 이해관계자가 회계기준을 이해하고 해석하는 데 도움을 줍니다. 이 개념체계 개정은 일부 새로운 개념을 포함하고 있으며, 자산과 부채의 정의와 인식기준의 변경을 제시하고, 일부 중요한 개념을 명확히 합니다. 동 개정이 당사의 재무제표에 미치는 영향은 없습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>3. 유의적인 회계정책&cr;당사가 한국채택국제회계기준에 따른 재무제표 작성에 적용한 유의적인 회계정책은 아래 기술되어 있으며, 주석 2에서 설명하고 있는 회계정책의 변경을 제외하고, 당기및 비교표시된 전기의 재무제표는 동일한 회계정책을 적용하여 작성되었습니다.&cr;&cr;(1) 종속기업 및 지분법피투자기업 지분&cr;당사의 재무제표는 기업회계기준서 제1027호 '별도재무제표'에 따른 별도재무제표로서 지배기업, 관계기업의 투자자 또는 공동기업의 참여자가 투자자산을 피투자자의 보고된 성과와 순자산에 근거하지 않고 직접적인 지분 투자에 근거한 회계처리로 표시한 재무제표입니다. 한편, 종속기업 및 관계기업으로부터 수취하는 배당금은 배당을 받을 권리가 확정되는 시점에 당기손익으로 인식하고 있습니다.&cr;&cr;(2) 현금 및 현금성자산&cr;당사는 취득일로부터 만기일이 3개월 이내인 투자자산을 현금 및 현금성자산으로 분류하고 있습니다. 지분상품은 현금성자산에서 제외되나, 상환일이 정해져 있고 취득일로부터 상환일까지의 기간이 단기인 우선주와 같이 실질적인 현금성자산인 경우에는 현금성자산에 포함됩니다.&cr;&cr;(3) 재고자산&cr;재고자산의 단위원가는 제품, 상품은 총평균법, 원료, 포장재료 및 저장품은 이동평균법, 재공품 및 미착품은</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>개별법</SPAN>
<SPAN>에 의해 산정된 단가와 연중 계속기록법에 의한 수량을 이용하여 계산되며 매 회계연도의 결산기에 실지재고조사를 실시하여 그 기록을 조정하고 있습니다. 취득원가는 매입원가, 전환원가 및 재고자산을 이용가능한 상태로 준비하는데 필요한 기타 원가를 포함하고 있습니다. &cr;&cr;재고자산은 취득원가와 순실현가능가치 중 낮은 금액으로 측정하고 있습니다. 재고자산을 순실현가능가치로 감액한 평가손실과 모든 감모손실은 감액이나 감모가 발생한 기간에 비용으로 인식하고 있으며, 재고자산의 순실현가능가치의 상승으로 인한 재고자산평가손실의 환입은 환입이 발생한 기간의 비용으로 인식된 재고자산의 매출원가에서 차감하고 있습니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>(4) </SPAN>
<SPAN>금융상품&cr;</SPAN>
<SPAN>금융상품은 거래당사자 어느 한쪽에게는 금융자산이 생기게 하고 거래상대방에게 금융부채나 지분상품이 생기게 하는 모든 계약입니다.</SPAN>
</P>
<P> </P>
<P>가. 금융자산</P>
<P> </P>
<P>최초 인식과 측정</P>
<P>금융자산은 최초 인식 시점에 후속적으로 상각후원가로 측정되는 금융자산, 기타포괄손익-공정가치 측정 금융자산, 그리고 당기손익-공정가치 측정 금융자산으로 분류됩니다.</P>
<P> </P>
<P>최초 인식 시점에 금융자산의 분류는 금융자산의 계약상 현금흐름 특성과 금융자산을 관리하기 위한 당사의 사업모형에 따라 달라집니다. 유의적인 금융요소가 포함되지 않거나 실무적 간편법을 적용하는 매출채권을 제외하고는, 당사는 금융자산을 최초에 공정가치로 측정하며, 당기손익-공정가치로 측정하는 금융자산의 경우가 아니라면 거래원가를 가감합니다. 유의적인 금융요소가 포함되지 않거나 실무적 간편법을 적용하는 매출채권은 기업회계기준서 제1115호에 따라 결정된 거래가격으로측정합니다.</P>
<P> </P>
<P>금융자산을 상각후원가 또는 기타포괄손익-공정가치로 측정하기 위해서는 현금흐름이 원리금만으로 구성(SPPI)되어야 합니다. 이 평가는 SPPI 테스트라고 하며, 개별 상품 수준에서 수행됩니다.</P>
<P> </P>
<P>금융자산의 관리를 위한 당사의 사업모형은 현금흐름을 발생시키기 위해 금융자산을 관리하는 방법과 관련됩니다. 사업모형은 현금흐름의 원천이 금융자산의 계약상 현금흐름의 수취인지, 매도인지 또는 둘 다 인지를 결정합니다.</P>
<P> </P>
<P>시장의 합의나 규제에 의해 설정된 기간 프레임 내에서 금융자산을 이전하는 것이 요구되는 금융자산의 매입 또는 매도(정형화된 거래)는 거래일에 인식됩니다. 즉, 당사가 금융자산을 매입하거나 매도하기로 약정한 날을 의미합니다.</P>
<P></P>
<PGBRK></PGBRK>
<P>후속 측정</P>
<P>후속 측정을 위해 금융자산은 아래 네 가지의 범주로 분류됩니다.</P>
<P>- 상각후원가 측정 금융자산 (채무상품)</P>
<P>- 누적 손익을 당기손익으로 재순환하는 기타포괄손익-공정가치 측정 금융자산 (채무상품)</P>
<P>- 제거시 누적 손익을 당기손익으로 재순환하지 않는 기타포괄손익-공정가치 측정 금융자산 (지분상품)</P>
<P>- 당기손익-공정가치 측정 금융자산</P>
<P>&cr;상각후원가 측정 금융자산 (채무상품)</P>
<P>당사는 아래 조건을 모두 만족하는 경우에 금융자산을 상각후원가로 측정합니다.</P>
<P>- 계약상 현금흐름을 수취하기 위해 보유하는 것이 목적인 사업모형 하에서 금융자산을 보유하고,</P>
<P>- 금융자산의 계약 조건에 따라 특정일에 원금과 원금잔액에 대한 이자 지급만으로 구성되어 있는 현금흐름이 발생합니다.</P>
<P>상각후원가 측정 금융자산은 후속적으로 유효이자율(EIR)법을 사용하여 측정되며, 손상을 인식합니다. 자산의 제거, 변경 또는 손상에서 발생하는 이익과 손실은 당기손익으로 인식됩니다.</P>
<P> </P>
<P>기타포괄손익-공정가치 측정 금융자산 (채무상품)</P>
<P>당사는 아래의 조건을 모두 충족하는 채무상품을 기타포괄손익-공정가치 금융자산으로 측정합니다.</P>
<P>- 계약상 현금흐름의 수취와 금융자산의 매도 둘 다를 통해 목적을 이루는 사업모형 하에서 금융자산을 보유하고,</P>
<P>- 금융자산의 계약 조건에 따라 특정일에 원리금 지급만으로 구성되어 있는 현금흐름이 발생</P>
<P>기타포괄손익-공정가치 측정 채무상품에서, 이자수익, 외화환산손익, 그리고 손상 또는 환입은 상각후원가 측정 금융자산과 동일한 방법으로 계산되어 당기손익으로 인식됩니다. 나머지 공정가치 변동부분은 기타포괄손익으로 인식됩니다. 금융자산의 제거 시, 기타포괄손익으로 인식한 공정가치 누적 변동분은 당기손익으로 재순환됩니다.</P>
<P> </P>
<P>당사의 기타포괄손익-공정가치 측정 채무상품은 비유동자산으로 분류되는 채무상품에 포함됩니다.</P>
<P> </P>
<P>기타포괄손익-공정가치 측정 금융자산 (지분상품)</P>
<P>최초 인식 시점에, 당사는 기업회계기준서 제1032호 '금융상품 표시'에서의 지분의 정의를 충족하고 투자 목적으로 보유하고 있지 않은 지분상품을 기타포괄손익-공정가치로 측정하도록 하는 취소 불가능한 선택을 할 수 있습니다.</P>
<P> </P>
<P>이러한 금융자산에서 발생하는 손익은 당기손익으로 재순환되지 않습니다. 배당은 당사가 금융자산의 원가 중 일부를 회수하여 이익을 얻는 경우를 제외하고는, 받을 권리가 확정되었을 때 손익계산서에 기타수익으로 인식되며, 기타포괄손익으로 처리됩니다. 기타포괄손익-공정가치 측정 지분상품은 손상을 인식하지 않습니다.</P>
<P> </P>
<P>당사는 비상장지분상품에 대해서도 취소불가능한 선택을 할 수 있습니다.</P>
<P> </P>
<P>당기손익-공정가치 측정 금융자산</P>
<P>당기손익-공정가치 측정 금융자산은 단기매매항목, 최초 인식 시에 당기손익-공정가치로 측정하도록 지정된 금융자산 또는 공정가치로 측정하도록 요구되는 금융자산을 포함합니다. 단기간 내에 매도하거나 재구매할 목적으로 취득한 금융자산은 단기매매항목으로 분류됩니다. 분리된 내재파생상품을 포함한 파생상품은 효과적인 위험회피수단으로 지정되지 않았다면 단기매매항목으로 분류됩니다. 현금흐름이 원리금 지급만으로 구성되지 않은 금융자산은 사업모형에 관계없이 당기손익-공정가치 측정 금융자산으로 분류 및 측정됩니다. 상기 문단에서 서술된 것과 같이 채무상품이 상각후원가 또는 기타포괄손익-공정가치 측정 금융자산으로 분류됨에도 불구하고 회계 불일치를 제거하거나 유의적으로 감소시킬 수 있다면 채무상품을 당기손익-공정가치로 측정하도록 지정할 수 있습니다.</P>
<P> </P>
<P>당기손익-공정가치 측정 금융자산은 재무상태표에 공정가치로 표시되며, 공정가치의 순변동은 손익계산서에서 당기손익으로 인식됩니다.</P>
<P> </P>
<P>이 범주는 파생상품과 공정가치의 변동을 기타포괄손익으로 처리하는 취소불가능한 선택을 하지않은 상장 지분 상품을 포함합니다. 상장 지분 상품에 대한 배당은 권리가 확정된 시점에 당기손익으로 인식합니다.</P>
<P> </P>
<P>복합계약에 내재된 파생상품은 경제적인 특성과 위험이 주계약에 밀접하게 관련되지 않고, 내재파생상품과 동일한 조건인 별도의 상품이 파생상품의 정의를 충족하며, 복합계약이 당기손익-공정가치로 측정되지 않는다면 주계약으로부터 분리하여 별도의 파생상품으로 회계처리합니다. 내재파생상품은 공정가치로 측정하고 공정가치의 변동을 당기손익으로 인식합니다. 현금흐름을 유의적으로 변경시키는 계약 조건의 변경이 있거나 당기손익-공정가치 측정 범주에 해당하지 않게 되는 경우에만 재평가가 발생합니다.</P>
<P> </P>
<P>주계약이 금융자산인 복합계약에서 내재파생상품은 분리하여 회계처리하지 않습니다. 주계약인 금융자산과 내재파생상품은 상품 전체를 당기손익-공정가치 측정 금융자산으로 분류합니다.</P>
<P> </P>
<P>제거</P>
<P>금융자산 (또는, 금융자산의 일부 또는 비슷한 금융자산의 집합의 일부)는 다음과 같은 상황에서 우선적으로 제거됩니다.</P>
<P>- 금융자산의 현금흐름을 수취할 권리가 소멸되거나</P>
<P>- 당사가 금융자산의 현금흐름을 수취할 권리를 양도하거나 양도(pass-through) 계약에 따라 수취한 현금흐름 전체를 중요한 지체 없이 제3자에게 지급할 의무가 있다. 이 경우에 당사는 금융자산의 보유에 따른 위험과 보상의 대부분을 이전하거나 금융자산의 보유에 따른 위험과 보상의 대부분을 이전하지도 보유하지도 않으나 자산에 대한 통제를 이전</P>
<P>&cr;당사가 금융자산의 현금흐름을 수취할 권리를 이전하거나 양도(pass-through) 계약을 체결할 때, 자산을 소유함에 따른 위험과 보상을 유지하는지를 평가합니다. 당사가 금융자산의 위험과 보상의 대부분을 보유하지도 이전하지도 않았다면, 해당 금융자산에 지속적으로 관여하는 정도까지 그 금융자산을 계속 인식합니다. 이 경우에, 당사는 관련된 부채를 인식합니다. 양도된 자산과 관련된 부채는 당사가 보유한 권리와 의무를 반영하여 측정합니다.</P>
<P> </P>
<P>보증을 제공하는 형태인 지속적 관여는, 양도된 자산의 장부금액과 수취한 대가 중 상환을 요구받을 수 있는 최대 금액 중 낮은 금액으로 측정됩니다.</P>
<P> </P>
<P>금융자산의 손상</P>
<P>금융자산의 손상과 관련된 자세한 공시 사항은 아래 주석에 제공됩니다.</P>
<P>- 유의적인 가정에 대한 공시</P>
<P>- 기타포괄손익-공정가치로 측정되는 채무상품</P>
<P>- 계약자산을 포함한 매출채권</P>
<P>&cr;당사는 당기손익-공정가치 항목을 제외한 모든 채무상품에 대하여 기대신용손실(ECL)에 대한 충당금을 인식합니다. 기대신용손실은 계약상 수취하기로 한 현금흐름과 당사가 수취할 것으로 예상하는 모든 현금흐름의 차이를 최초의 유효이자율로 할인하여 추정합니다. 예상되는 현금흐름은 보유한 담보를 처분하거나 계약의 필수 조건인 그 밖의 신용 보강으로부터 발생하는 현금흐름을 포함합니다.</P>
<P> </P>
<P>기대신용손실은 두 개의 stage로 인식합니다. 최초 인식 이후 신용위험의 유의적인 증가가 없는 신용 익스포저에 대하여, 기대신용손실은 향후 12개월 내에 발생할 가능성이 있는 채무불이행 사건으로부터 발생하는 신용손실(12개월 기대신용손실)을 반영합니다. 최초 인식 이후 신용위험의 유의적인 증가가 있는 신용 익스포저에 대하여, 손실충당금은 채무불이행 사건이 발생하는 시기와 무관하게 익스포저의 남은 존속기간에 대한 기대신용손실(전체기간 기대신용손실)을 측정하도록 요구됩니다.</P>
<P> </P>
<P>매출채권과 계약자산에 대하여, 당사는 기대신용손실 계산에 간편법을 적용할 수 있습니다. 따라서, 당사는 신용위험의 변동을 추적하지 않는 대신에, 각 결산일에 전체기간 기대신용손실에 해당하는 금액으로 손실충당금을 인식합니다. 당사는 특정 채무자에 대한 미래전망정보와 경제적 환경을 반영하여 조정된 과거 신용손실 경험에 근거하여 충당금 설정률표를 설정합니다.</P>
<P> </P>
<P>기타포괄손익-공정가치 측정 채무상품에 대하여, 당사는 낮은 신용위험 간편법을 적용합니다. 매 결산일에, 당사는 과도한 원가나 노력 없이 이용할 수 있는 합리적이고 뒷받침될 수 있는 모든 정보를 사용하여 채무상품이 낮은 신용위험을 가지고 있다고 고려되는지를 평가합니다. 이러한 평가를 위해서, 당사는 채무상품의 내부 신용 등급을 재평가합니다. 또한, 당사는 계약상의 지급일을 초과하였을 때 신용위험의 유의적인 증가가 있는지를 고려합니다.</P>
<P> </P>
<P>당사의 기타포괄손익-공정가치 측정 채무상품이 최상위 투자등급에 해당하는 상장 채권만으로 구성되어 있다면 낮은 신용 위험 투자자산으로 평가됩니다. 당사의 정책은 이러한 상품을 12개월 기대신용손실로 측정하는 것입니다. 그러나, 최초 인식 이후에 신용위험의 유의적인 증가가 있다면 손실충당금은 전체기간 기대신용손실에 근거하여 산출됩니다. 당사는 채무상품의 신용위험이 유의적으로 증가했는지를 결정하고 기대신용손실을 측정하기 위해 신용평가기관의 등급을 사용합니다.</P>
<P> </P>
<P>당사는 계약상 지급일을 초과하여 연체되는 경우에 채무불이행이 발생한 것으로 봅니다. 그러나, 특정 상황에서, 당사는 내부 또는 외부 정보가 당사에 의한 모든 신용보강을 고려하기 전에는 당사가 계약상의 원금 전체를 수취하지 못할 것을 나타내는 경우에 금융자산에 채무불이행 사건이 발생했다고 볼 수 있습니다. 금융자산은 계약상 현금흐름을 회수하는 데에 합리적인 기대가 없을 때 제거됩니다.</P>
<P> </P>
<P>나. 금융부채</P>
<P> </P>
<P>최초 인식과 측정</P>
<P>금융부채는 최초 인식 시점에 당기손익-공정가치 측정 금융부채, 대출과 차입, 미지급금 또는 효과적인 위험회피 수단으로 지정된 파생상품으로 적절하게 분류됩니다.</P>
<P> </P>
<P>모든 금융부채는 최초에 공정가치로 인식되고, 대여금, 차입금 및 미지급금의 경우에는 직접 관련된 거래원가를 차감합니다.</P>
<P> </P>
<P>당사의 금융부채는 매입부채와 기타 미지급금, 당좌차월을 포함한 대여 및 차입과 파생상품부채를 포함합니다.</P>
<P> </P>
<P>후속 측정</P>
<P>금융부채의 측정은 아래에서 언급된 분류에 따릅니다.</P>
<P> </P>
<P>당기손익-공정가치 측정 금융부채</P>
<P>당기손익-공정가치 측정 금융부채는 단기매매금융부채와 최초 인식 시점에 당기손익-공정가치로 측정하도록 지정된 금융부채를 포함합니다.</P>
<P> </P>
<P>금융부채가 단기간 내에 재매입되는 경우에는 단기매매항목으로 분류됩니다. 이 범주는 또한 기업회계기준서 제1109호에서 정의된 위험회피관계에 있는 위험회피수단으로 지정되지 않은 파생상품을 포함합니다. 또한 분리된 내재파생상품은 위험회피에 효과적인 수단으로 지정되지 않았다면 단기매매항목으로 분류됩니다.</P>
<P> </P>
<P>단기매매항목인 금융부채에서 발생하는 손익은 당기손익으로 인식됩니다.</P>
<P> </P>
<P>당기손익-공정가치 항목으로 지정된 금융부채는 기업회계기준서 제1109호의 기준을 충족하는 경우에 최초 인식 시점에만 지정됩니다. 당사는 어떤 금융부채도 당기손익-공정가치 항목으로 지정하지 않았습니다.</P>
<P> </P>
<P>대여금 및 차입금</P>
<P>최초 인식 이후에, 이자부 대여금과 차입금은 후속적으로 유효이자율법을 사용하여 상각후원가로 측정됩니다. 부채가 제거되거나 유효이자율 상각 절차에 따라 발생하는 손익은 당기손익으로 인식됩니다.</P>
<P> </P>
<P>상각후원가는 유효이자율의 필수적인 부분인 수수료나 원가에 대한 할인이나 할증액을 고려하여 계산됩니다. 이 범주는 일반적으로 이자부 대여나 차입에 적용합니다. </P>
<P> </P>
<P>제거</P>
<P>금융부채는 지급 의무의 이행, 취소, 또는 만료된 경우에 제거됩니다. 기존 금융부채가 대여자는 동일하지만 조건이 실질적으로 다른 금융부채에 의해 교환되거나, 기존 부채의 조건이 실질적으로 변경된 경우에, 이러한 교환이나 변경은 최초의 부채를 제거하고 새로운 부채를 인식하게 합니다. 각 장부금액의 차이는 당기손익으로 인식합니다.</P>

<P>
<SPAN> </SPAN>
<SPAN></SPAN>
</P>
<P>다. 금융상품의 상계&cr; 금융자산과 금융부채는 인식한 자산과 부채에 대해 법적으로 집행 가능한 상계 권리를 현재 가지고 있거나, 차액으로 결제하거나 자산을 실현하는 동시에 부채를 결제할 의도가 있는 경우에 재무상태표에서 상계하여 순액으로 표시됩니다.</P>
<PGBRK></PGBRK>

<P>
<SPAN>(5)</SPAN>
<SPAN> 유형자산&cr;유형자산은 최초에 원가로 측정하여 인식하고 있습니다. 유형자산의 원가에는 경영진이 의도하는 방식으로 자산을 가동하는데 필요한 장소와 상태에 이르게 하는데 직접 관련되는 원가 및 자산을 해체, 제거하거나 부지를 복구하는데 소요될 것으로 추정되는 원가가 포함됩니다.&cr;&cr;유형자산은 최초 인식 후에 원가에서 감가상각누계액과 손상차손누계액을 차감한 금액을 장부금액으로 하고 있습니다.&cr;&cr;유</SPAN>
<SPAN>형자산 중 토지는 감가상각을 하지 않으며, 그 외 유형자산은 자산의 취득원가에서잔존가치를 차감한 금액에 대하여 아래에 제시된 내용연수에 걸쳐 해당 자산에 내재되어 있는 미래 경제적 효익의 예상 소비 형태를 가장 잘 반영한 정액법으로 상각하고 있습니다. 유형자산을 구성하는 일부의 원가가 당해 유형자산의 전체 원가와 비교하여 유의적이라면, 해당 유형자산을 감가상각할 때, 그 부분은 별도로 구분하여 감가상각하고 있습니다.&cr;&cr;유형자산의 제거로 인하여 발생하는 손익은 순매각금액과 장부금액의 차이로 결정되고 그 차액은 당기손익으로 인식하고 있습니다.&cr;&cr;당기와 전기의 추정 내용연수는 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="641" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="312"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="321" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구         분</TH>
<TH WIDTH="320" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">건         물</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">20 년 ~ 56 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구   축   물</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6 년 ~ 31 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기 계 장 치</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2 년 ~ 10 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차량운반구</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2 년 ~ 5 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공구와기구</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">집 기 비 품</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3 년 ~ 16년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타의유형자산</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5 년</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;당사는 매 보고기간말에 자산의 잔존가치와 내용연수 및 감가상각방법을 재검토하고재검토 결과 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 처리하고 있습니다.</P>
<PGBRK></PGBRK>

<P>
<SPAN>(6)</SPAN>
<SPAN> 무형자산&cr;무형자산은 최초 인식할 때 원가로 측정하며, 최초 인식 후에 원가에서 상각누계액과손상차손누계액을 차감한 금액을 장부금액으로 인식하고 있습니다.&cr;&cr;무형자산은 사용 가능한 시점부터 잔존가치를 영("0")으로 하여 아래의 내용연수 동안 정액법으로 상각하고 있습니다. 다만, 일부 무형자산에 대해서는 이를 이용할 수 있을 것으로 기대되는 기간이 예측가능하지 않아 당해 무형자산의 내용연수가 비한정인 것으로 평가하고 상각하지 아니하고 있습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="635" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="309"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="318" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구         분</TH>
<TH WIDTH="317" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">산  업  재  산  권</TD>
<TD WIDTH="317" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5 년 ~ 15 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">개       발      비</TD>
<TD WIDTH="317" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5 년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타의무형자산</TD>
<TD WIDTH="317" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5 년 ~ 15 년</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;내용연수가 유한한 무형자산의 상각기간과 상각방법은 매 보고기간말에 재검토하고 내용연수가 비한정인 무형자산에 대해서는 그 자산의 내용연수가 비한정이라는 평가가 계속하여 정당한 지를 매 보고기간말에 재검토하며, 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 처리하고 있습니다.&cr;&cr;가. 연구 및 개발&cr;연구 또는 내부프로젝트의 연구단계에 대한 지출은 발생시점에 비용으로 인식하고 있습니다. 개발단계의 지출은 자산을 완성할 수 있는 기술적 실현가능성, 자산을 완성하여 사용하거나 판매하려는 기업의 의도와 능력 및 필요한 자원의 입수가능성, 무형자산의 미래 경제적 효익을 모두 제시할 수 있고, 관련 지출을 신뢰성 있게 측정할 수 있는 경우에 무형자산으로 인식하고 있으며, 기타 개발관련 지출은 발생시점에 비용으로 인식하고 있습니다.&cr;&cr;나. 후속지출&cr;후속지출은 관련되는 특정자산에 속하는 미래의 경제적 효익이 증가하는 경우에 한하여 자본화하며, 내부적으로 창출한 영업권 및 상표명 등을 포함한 다른 지출은 발생 즉시 비용화하고 있습니다.&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN>(7)</SPAN>
<SPAN> </SPAN>
<SPAN>차입원가&cr;적격자산의 취득, 건설 또는 제조와 직접 관련된 차입원가는 당해 자산 원가의 일부로 자본화하고 있으며, 기타차입원가는 발생기간에 비용으로 인식하고 있습니다. 적격자산이란 의도된 용도로 사용하거나 판매가능한 상태가 될 때까지 상당한 기간을 필요로 하는 자산을 말하며, 금융자산과 단기간 내에 제조되거나 다른 방법으로 생산되는 재고자산은 적격자산에 해당되지 아니하며, 취득시점에 의도된 용도로 사용할 수 있거나 판매가능한 상태에 있는 자산인 경우에도 적격자산에 해당되지 아니합니다.&cr;&cr;적격자산을 취득하기 위한 목적으로 특정하여 차입한 자금에 한하여, 보고기간 동안 그 차입금으로부터 실제 발생한 차입원가에서 당해 차입금의 일시적 운용에서 생긴 투자수익을 차감한 금액을 자본화가능차입원가로 결정하며, 일반적인 목적으로 자금을 차입하고 이를 적격자산의 취득을 위해 사용하는 경우에 한하여 당해 자산 관련 지출액에 자본화이자율을 적용하는 방식으로 자본화가능차입원가를 결정하고 있습니다. 자본화이자율은 보고기간동안 차입한 자금(적격자산을 취득하기 위해 특정 목적으로 차입한 자금 제외)으로부터 발생된 차입원가를 가중평균하여 산정하고 있습니다. 보고기간 동안 자본화한 차입원가는 당해 기간 동안 실제 발생한 차입원가를 초과할 수 없습니다.&cr;&cr;</SPAN>
<SPAN>(8)</SPAN>
<SPAN> </SPAN>
<SPAN>정부보조금&cr;정부보조금은 당사가 정부보조금에 부수되는 조건을 준수하고 그 보조금을 수취하는것에 대해 합리적인 확신이 있을 경우에만 인식하고 있습니다.&cr;&cr;당사는 비유동자산을 취득 또는 건설하는데 사용해야 한다는 기본조건이 부과된 정부보조금을 수령하고 있으며, 해당 자산의 장부금액을 계산할 때, 정부보조금을 차감하고 감가상각자산의 내용연수에 걸쳐 당기손익으로 인식하고 있습니다.&cr;&cr;당사는 정부보조금을 정부보조금으로 보전하려 하는 관련원가가 비용으로 인식되는 기간에 걸쳐 관련비용에서 차감하는 방법으로 인식하고 있습니다.&cr;&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>(9)</SPAN>
<SPAN> 투자부동산&cr;임대수익이나 시세차익 또는 두 가지 모두를 얻기 위하여 보유하고 있는 부동산은 투자부동산으로 분류하고 있습니다. 투자부동산은 취득시 발생한 거래원가를 포함하여최초 인식시점에 원가로 측정하며, 최초 인식 후에 원가에서 감가상각누계액과 손상차손누계액을 차감한 금액을 장부금액으로 표시하고 있습니다.&cr;</SPAN>
</P>
<P>후속원가는 자산으로부터 발생하는 미래 경제적 효익이 유입될 가능성이 높으며, 그 원가를 신뢰성 있게 측정할 수 있는 경우에 한하여 자산의 장부금액에 포함하거나 적절한 경우 별도의 자산으로 인식하고 있으며, 후속지출에 의해 대체된 부분의 장부금액은 제거하고 있습니다. 한편, 일상적인 수선·유지와 관련하여 발생하는 원가는 발생시점에 당기손익으로 인식하고 있습니다.&cr;</P>
<P>투자부동산 중 토지에 대해서는 감가상각을 하지 않으며, 토지를 제외한 투자부동산은 경제적 내용연수(건물: 내용연수 20~56년)에 따라 정액법으로 상각하고 있습니 다. 투자부동산의 감가상각방법, 잔존가치 및 내용연수는 매 보고기간말에 재검토하고 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 회계처리하고 있습니다.&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN>(</SPAN>
<SPAN>10)</SPAN>
<SPAN> 비</SPAN>
<SPAN>금융자산의 손상&cr;건설계약에서 발생한 자산, 종업원급여에서 발생한 자산, 재고자산, 이연법인세자산을 제외한 모든 비금융자산에 대해서는 매 보고기간말마다 자산손상을 시사하는 징후가 있는지를 검토하며, 만약 그러한 징후가 있다면 당해 자산의 회수가능액을 추정하고 있습니다. 단, 내용연수가 비한정인 무형자산, 아직 사용할 수 없는 무형자산에대해서는 자산손상을 시사하는 징후와 관계없이 매년 회수가능액과 장부금액을 비교하여 손상검사를 하고 있습니다.</SPAN>
</P>

<P>
<SPAN>&cr;회수가능액은 개별 자산별로, 또는 개별 자산의 회수가능액을 추정할 수 없다면 그 자산이 속하는 현금창출단위별로 회수가능액을 추정하고 있습니다. 회수가능액은 사용가치와 순공정가치 중 큰 금액으로 결정하고 있습니다. 사용가치는 자산이나 현금창출단위에서 창출될 것으로 기대되는 미래현금흐름을 화폐의 시간가치 및 미래현금흐름을 추정할 때 조정되지 아니한 자산의 특유위험에 대한 현행 시장의 평가를 반영한 적절한 할인율로 할인하여 추정합니다.&cr;&cr;자산이나 현금창출단위의 회수가능액이 장부금액에 미달하는 경우 자산의 장부금액을 감소시키며 즉시 당기손익으로 인식하고 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(</SPAN>
<SPAN>11)</SPAN>
<SPAN> 종업원급여&cr;가. 단</SPAN>
<SPAN>기종업원급여&cr;종업원이 관련 근무용역을 제공한 보고기간말부터 12개월 이내에 결제될 단기종업원급여는 근무용역과 교환하여 지급이 예상되는 금액을 근무용역이 제공된 때에 당기손익으로 인식하고 있습니다. 단기종업원급여는 할인하지 않은 금액으로 측정하고있습니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>나. 기타장기종업원급여&cr;종업원이 관련 근무용역을 제공한 보고기간말부터 12개월 이내에 지급되지 않을 기타장기종업원급여는 당기와 과거기간에 제공한 근무용역의 대가로 획득한 미래의 급여액을 현재가치로 할인하고 있습니다. 재측정에 따른 변동은 발생한 기간에 당기손익으로 인식하고 있습니다. &cr;&cr;다. 퇴직급여: 확정기여제도&cr;확정기여제도와 관련하여 일정기간 종업원이 근무용역을 제공하였을 때에는 그 근무용역과 교환하여 확정기여제도에 납부해야 할 기여금에 대하여 자산의 원가에 포함되는 경우를 제외하고는 당기손익으로 인식하고 있습니다. 납부해야 할 기여금은 이미 납부한 기여금을 차감한 후 부채로 인식하고 있습니다. 또한, 이미 납부한 기여금이 보고기간말 이전에 제공된 근무용역에 대해 납부하여야 하는 기여금을 초과하는 경우에는 초과 기여금 때문에 미래 지급액이 감소하거나 현금이 환급되는 만큼을 자산으로 인식하고 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(12)</SPAN>
<SPAN> 충</SPAN>
<SPAN>당부채&cr;충당부채는 과거사건의 결과로 존재하는 현재의무(법적의무 또는 의제의무)로서, 당해 의무를 이행하기 위하여 경제적효익을 갖는 자원이 유출될 가능성이 높으며 그  의무의 이행에 소요되는 금액을 신뢰성 있게 추정할 수 있는 경우에 인식하고 있습니다.&cr;&cr;충당부채로 인식하는 금액은 관련된 사건과 상황에 대한 불가피한 위험과 불확실성을 고려하여 현재의무를 보고기간말에 이행하기 위하여 소요되는 지출에 대한 최선의 추정치입니다. 화폐의 시간가치 효과가 중요한 경우 충당부채는 의무를 이행하기 위하여 예상되는 지출액의 현재가치로 평가하고 있습니다.&cr;&cr;충당부채를 결제하기 위해 필요한 지출액의 일부 또는 전부를 제 3자가 변제할 것이 예상되는 경우 이행한다면 변제를 받을 것이 거의 확실하게 되는 때에 한하여 변제금액을 인식하고 별도의 자산으로 회계처리하고 있습니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>매 보고기간말마다 충당부채의 잔액을 검토하고, 보고기간말 현재 최선의 추정치를 반영하여 조정하고 있습니다. 의무이행을 위하여 경제적효익이 내재된 자원이 유출될 가능성이 더 이상 높지 아니한 경우에는 관련 충당부채를 환입하고 있습니다.&cr;&cr;충당부채는 최초 인식과 관련 있는 지출에만 사용하고 있습니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(13)</SPAN>
<SPAN> 외화&cr;</SPAN>
<SPAN>재무제표 작성에 있어서 기능통화 외의 통화(외화)로 이루어진 거래는 거래일의 환율을 적용하여 기록하고 있습니다. 매 보고기간 말에 화폐성 외화항목은 보고기간 말의마감환율로 환산하고 있습니다. 공정가치로 측정하는 비화폐성 외화항목은 공정가치가 결정된 날의 환율로 환산하고, 역사적원가로 측정하는 비화폐성항목은 거래일의 환율로 환산하고 있습니다.</SPAN>
</P>
<P> </P>
<P>화폐성항목의 결제시점에 생기는 외환차이와 화폐성항목의 환산으로 인해 발생한 외환차이는 모두 당기손익으로 인식하고 있습니다. 비화폐성항목에서 발생한 손익을 기타포괄손익으로 인식하는 경우에는 그 손익에 포함된 환율변동효과도 기타포괄손익으로 인식하고, 당기손익으로 인식하는 경우에는 환율변동효과도 당기손익으로 인식하고 있습니다. </P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(14)</SPAN>
<SPAN> 납</SPAN>
<SPAN>입자본&cr;보통주는 자본으로 분류하며 자본거래와 직접 관련되어 발생하는 증분원가는 세금효과를 반영한 순액으로 자본에서 차감하고 있습니다.&cr;&cr;당사가 자기지분상품을 재취득하는 경우에 이러한 지분상품은 자기주식의 과목으로 자본에서 직접 차감하고 있습니다. 자기지분상품을 매입 또는 매도하거나 발행 또는 소각하는 경우의 손익은 당기손익으로 인식하지 아니합니다. &cr;&cr;(15) 주식기준보상거래 &cr;당사는 임직원의 근로용역에 대해 주식기준에 따른 보상을 제공하고 있는데 임직원에게 주식선택권을 부여하는 제도(주식결제형 주식기준보상거래)를 운영하고 있습니다.&cr;</SPAN>
</P>
<P>주식결제형 주식기준보상원가는 적절한 가치평가모델을 사용하여 부여일의 공정가치로 측정됩니다. </P>
<P> </P>
<P>주식기준보상원가는 용역제공조건(또는 성과조건)이 충족되는 기간(이하 '가득기간')에 걸쳐 종업원급여로 인식하고, 그에 상응한 자본의 증가를 인식합니다. 매 보고기간말에 누적 보상원가의 측정에는 가득기간의 완료 여부와 최종적으로 부여될 지분상품의 수량에 대한 추정이 반영됩니다. 보고기간 초와 보고기간 말의 누적 보상원가의 변동분은 당기 손익계산서에 가감됩니다.</P>
<P> </P>
<P>용역제공조건 및 비시장조건은 부여일 현재 주식선택권의 공정가치를 추정할 때 고려하지 아니하나 궁극적으로 가득되는 지분상품의 수량에 대한 추정 시 반영되고, 시장조건은 부여일 현재 공정가치 측정시 반영됩니다. 주식기준보상에 부여된 다른 조건(관련 용역조건이 없는 경우)은 비가득조건으로 간주됩니다. 비가득조건은 주식기준보상원가 공정가치 측정 시 반영되며 용역제공조건 (또는 성과조건)이 없는 경우에는 즉시 비용으로 인식합니다. </P>
<P> </P>

<P>
<SPAN>궁극적으로</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>가득되지</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>않는</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>주식기준보상에</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>대해서는</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>비용을</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>인식하지</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>않고</SPAN>
<SPAN USERMARK="F-8"> </SPAN>
<SPAN>있습니다.다만 시장조건이나 비가득조건이 있는 주식결제형 거래로서 다른 모든 성과조건이나용역 조건을 충족한다면 시장조건이나 비가득조건의 충족여부와 관계없이 가득된것으로 회계처리하고 있습니다.</SPAN>
</P>
<P> </P>
<P>주식결제형주식기준보상의 조건이 변경될 경우 지정된 가득조건이 충족되지 않아 지분상품이 가득되지 못하는 경우를 제외하고는 조건이 변경되지 않았을 경우에 인식하였어야 할 원가를 최소한으로 하여 인식하고 있습니다. 주식기준보상약정의 총공정가치를 증가시키거나 종업원에게 유리하게 조건을 변경하는 경우에는 추가로 조건변경의 효과를 인식하고 있습니다. 주식결제형보상이 취소될 경우 취소일에 가득된 것으로 보고 인식되지 않은 보상원가는 즉시 인식하고 있습니다. </P>
<P> </P>
<P>발행된 옵션의 희석효과는 희석주당이익을 계산할 때 희석주식으로 반영하고 있습니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>&cr;(16)</SPAN>
<SPAN> </SPAN>
<SPAN>고객과의 계약에서 생기는 수익&cr;</SPAN>가. 변동대가&cr;당사는 의약품을 제조 및 판매하는 사업을 영위하고 있으며 재화의 판매에 따른 수익은 재화가 구매자에게 인도되는 시점에 인식하고 있습니다. 당사는 고객에게 지급할 대가인 변동대가와 관련하여 불확실성이 나중에 해소 될 때, 이미 인식한 누적 수익 금액 중 유의적인 부분을 되돌리지 않을 가능성이 매우 높은 정도까지만 변동대가를 거래가격에 포함하여 수익으로 인식합니다.&cr;
</P>
<P>나. 수행의무의 식별&cr;당사는 신약개발과 관련된 기술이전으로 인한 수익이 발생하고 있습니다. 기술이전으로 인한 수익은 통상 계약체결시점에 수령하는 계약금(Upfront payment), 일정요건 달성시점에 수령하는 마일스톤 금액(Milestone payment), 및 매출액의 일정비율로 수령하는 로열티로 구성되어 있습니다. 계약금(Upfront payment)은 반환의무가 없고, 기술이전 시점 이후에 수행할 추가적인 의무가 없는 경우 일시에 수익으로 인식하고 있습니다. 특정 임상실험의 완료 등 추가적인 의무가 있다면, 의무가 종료될 것으로 예상되는 기간 동안 안분하여 수익으로 인식하고 있습니다. 마일스톤 금액(Milestone payment)은 특정 임상실험의 착수 및 종료, 규제당국의 승인 등 계약에서 규정된 일정요건이 만족되는 시점에 수익으로 인식하고 있습니다. 로열티(Royalty)는 관련된 계약의 경제적 실질을 반영하여 발생기준에 따라 인식하고 있습니다. 당사는 과거에 체결했던 라이선스 계약 중 수행의무를 이행한 때 또는 기간에 걸쳐 이행하는지에 따라 수익을 인식합니다.</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
<SPAN USERMARK=" 0X000000">다. 계약부채&cr;계약부채는 당사가 고객에게서 이미 받은 대가(또는 지급기일이 된 대가)에 상응하여고객에게 재화나 용역을 이전하여야 하는 기업의 의무입니다. 만약 당사가 재화나 용역을 고객에 이전하기 전에 고객이 대가를 지불한다면, 지급이 되었거나 지급기일 중이른 시점에 계약부채를 인식합니다. 계약부채는 </SPAN>
<SPAN USERMARK=" 0X000000">당사가 계약에 따라 수행의무를 이행할 때 수익으로 인식합니다&cr;</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
</P>

<P>
<SPAN>(17)</SPAN>
<SPAN> </SPAN>
<SPAN>리</SPAN>
<SPAN>스</SPAN>
</P>
<P>당사는 계약에서 대가와 교환하여, 식별되는 자산의 사용 통제권을 일정기간 이전하게 하는지를 고려하여 계약의 약정시점에, 계약자체가 리스인지, 계약이 리스를 포함하는지를 판단합니다.</P>
<P> </P>
<P>ㆍ리스이용자로서의 회계정책&cr;당사는 단기리스와 소액 기초자산 리스를 제외한 모든 리스에 대하여 하나의 인식 과 측정 접근법을 적용합니다. 당사는 리스료 지급의무를 나타내는 리스부채와 기초자산의 사용권을 나타내는 사용권자산을 인식합니다.</P>
<P> </P>
<P>가. 사용권자산</P>
<P>당사는 리스개시일(즉, 기초자산이 사용가능한 시점)에 사용권자산을 인식합니다. 사용권자산은 원가로 측정하고, 감가상각누계액과 손상차손누계액을 차감하고, 리스부채의 재측정에 따라 조정합니다. 사용권자산의 원가는 인식된 리스부채 금액, 최초 직접원가, 그리고 받은 리스 인센티브를 차감한 리스개시일이나 그 전에 지급한 리스료를 포함합니다. 사용권자산은 리스기간과 다음과 같은 자산의 추정된 내용연수 중 짧은 기간에 걸쳐 정액기준으로 감가상각됩니다.</P>
<P></P>

<P>
<SPAN>- 건물 1</SPAN>
<SPAN>~5</SPAN>
<SPAN>년</SPAN>
</P>

<P>
<SPAN>- </SPAN>
<SPAN>차량운반구 3~5년&cr;- 토지 </SPAN>
<SPAN>5~38</SPAN>
<SPAN>년 &cr;</SPAN>
</P>
<P>리스기간 종료시점에 당사에 기초자산의 소유권이 이전되는 경우나 사용권자산의 원가에 당사가 매수선택권을 행사할 것임이 반영되는 경우, 감가상각은 자산의 기초자산의 추정된 내용연수를 사용하여 계산됩니다.</P>

<P>
<SPAN>&cr;사용권자산도 손상의 대상이 됩니다. </SPAN>
<SPAN>비금융자산의 손상 </SPAN>
<SPAN>부분</SPAN>
<SPAN></SPAN>
<SPAN>의 회계정책을 참조합니다.</SPAN>
</P>

<P>
<SPAN>&cr;나</SPAN>
<SPAN>. 리스부채</SPAN>
</P>
<P>리스 개시일에, 당사는 리스기간에 걸쳐 지급될 리스료의 현재가치로 측정된 리스부채를 인식합니다. 리스료는 받을 리스 인센티브는 차감한 고정리스료(실질적인 고정리스료를 포함), 지수나 요율에 따라 달라지는 변동리스료 및 잔존가치보증에 따라 지급될 것으로 예상되는 금액을 포함합니다. 리스료는 또한 당사가 매수선택권을 행사할 것이 상당히 확실한 경우에 그 매수선택권의 행사가격과 리스기간이 당사의 종료선택권 행사를 반영하는 경우에 그 리스를 종료하기 위하여 부담하는 금액을 포함합니다.</P>
<P>지수나 요율에 따라 달라지지 않는 변동리스료는 (재고자산을 생산하는데 발생된 것이 아니라면) 리스료 발생을 유발하는 사건 또는 조건이 발생한 기간의 비용으로 인식합니다.</P>
<P> </P>
<P>당사는 리스료의 현재가치를 계산할 때, 리스의 내재이자율을 쉽게 산정할 수 없기 때문에 리스개시일의 증분차입이자율을 사용합니다. 리스개시일 이후 리스부채 금액은 이자부담을 반영하여 증가하고 리스료 지급으로 감소합니다. 또한, 리스부채의 장부금액은 리스기간의 변경, 리스료의 변경(예를 들어, 리스료를 산정할 때 사용한 지수나 요율의 변동으로 생기는 미래 리스료의 변동) 또는 기초자산을 매수하는 선택권 평가에 변동이 있는 경우 재측정됩니다.</P>
<P> </P>

<P>
<SPAN>당사의 리스부채는 이자부 차입금에 포함됩니다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P> </P>
<P>다. 단기리스와 소액 기초자산 리스</P>
<P>당사는 기계장치와 설비의 리스에 단기리스(즉, 이러한 리스는 리스기간이 리스개시일로부터 12개월 이하이고 매수선택권을 포함하지 않음)에 대한 인식 면제 규정을 적용합니다. 또한 당사는 소액자산으로 간주되는 사무용품의 리스에 소액자산 리스에 대한 인식 면제 규정을 적용합니다. 단기리스와 소액자산 리스에 대한 리스료는 리스기간에 걸쳐 정액기준으로 비용으로 인식합니다.</P>
<P></P>

<P>
<SPAN>ㆍ리스제공자로서의 회계정책&cr;당사는 기초자산의 소유에 따른 위험과 보상의 대부분을 이전하지 않는 리스는 운용리스로 분류합니다. 리스료 수익은 리스기간에 걸쳐 정액 기준으로 인식하며, 영업 성격에 따라 손익계산서에서 영업외수익에 포함됩니다. 운용리스 체결과정에서 부담하는 리스개설 직접원가를 기초자산의 장부금액에 더하고 리스료 수익과 같은 기준으로 리스기간에 걸쳐 비용으로 인식합니다. 조건부 임대료는 임대료를 수취하는 시점에 영업외수익으로 인식합니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(18)</SPAN>
<SPAN> 법</SPAN>
<SPAN>인세&cr;법인세비용은 당기법인세와 이연법인세로 구성되어 있으며, 기타포괄손익이나 자본에 직접 인식되는 거래나 사건에서 발생하는 세액을 제외하고는 당기손익으로 인식하고 있습니다.&cr;&cr;가. 당기법인세&cr;당기법인세는 당기의 과세소득을 기초로 산정하고 있습니다. 과세소득은 포괄손익계산서상의 법인세비용차감전순이익에서 다른 과세기간에 가산되거나 차감될 손익 및 비과세항목이나 손금불인정항목을 제외하므로 포괄손익계산서상 손익과 차이가 있습니다. 당사의 당기법인세와 관련된 미지급법인세는 제정되었거나 실질적으로 제정된 세율을 사용하여 계산하고 있습니다.&cr;&cr;나. 이연법인세&cr;이연법인세자산과 이연법인세부채를 측정할 때에는 보고기간말에 당사가 관련 자산과 부채의 장부금액을 회수하거나 결제할 것으로 예상되는 방식에 따른 세효과를 반영하고 있습니다. 종속기업, 관계기업 및 공동기업 투자지분에 관한 가산할 일시적차이에 대해서는 당사가 일시적차이의 소멸시점을 통제할 수 있으며, 예측가능한 미래에 일시적차이가 소멸하지 않을 가능성이 높은 경우를 제외하고는 모두 이연법인세부채를 인식하고 있습니다. 또한, 차감할 일시적차이로 인하여 발생하는 이연법인세자산은 일시적차이가 예측가능한 미래에 소멸할 가능성이 높고, 일시적차이가 사용될 수 있는 기간에 과세소득이 발생할 가능성이 높은 경우에 인식하고 있습니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>이연법인세자산의 장부금액은 매 보고기간말에 검토하고, 이연법인세자산으로 인한 혜</SPAN>
<SPAN>택이 사용되기에 충분한 과세소득이 발생할 가능성이 더 이상 높지 않은 경우 이연법인세자산의 장부금액을 감소시키고 있습니다.&cr;&cr;이연법인세자산과 부채는 보고기간말 제정되었거나 실질적으로 제정된 세법에 근거하여 당해 자산이 실현되거나 부채가 지급될 보고기간에 적용될 것으로 기대되는 세율을 사용하여 측정하고 있습니다. &cr;&cr;이연법인세자산과 부채는 동일 과세당국이 부과하는 법인세이고, 당사가 인식된 금액을 상계할 수 있는 법적 권한을 가지고 있으며 당기 법인세부채와 자산을 순액으로결제할 의도가 있는 경우에만 상계하고 있습니다. 배당금 지급에 따라 추가적으로 발생하는 법인세비용이 있다면 배당금 지급과 관련한 부채가 인식되는 시점에 인식하고 있습니다.&cr;&cr;</SPAN>
<SPAN>(19)</SPAN>
<SPAN> 주당이</SPAN>
<SPAN>익&cr;당사는 보통주 기본주당이익과 희석주당이익을 계속영업손익과 당기순손익에 대하여 계산하고 포괄손익계산서에 표시하고 있습니다. 기본주당이익은 보통주에 귀속되는 당기순손익을 보고기간 동안에 유통된 보통주식수를 가중평균한 주식수로 나누어계산하고 있습니다. 희석주당이익은 전환사채와 종업원에게 부여한 주식기준보상 등모든 희석화 효과가 있는 잠재적 보통주의 영향을 고려하여 보통주에 귀속되는 당기순손익 및 가중평균유통보통주식수를 조정하여 계산하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">(20)</SPAN>
<SPAN USERMARK=" 0X000000"> </SPAN>
<SPAN USERMARK=" 0X000000">미적용 제ㆍ개정 기준서</SPAN>
</P>
<P>당사의 재무제표 발행승인일 현재 공표되었으나 아직 시행되지 않아 당사가 채택하지 않은 한국채택국제회계기준의 기준서 및 해석서의 제ㆍ개정내역은 다음과 같습니다.</P>

<P>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>가. 기업회계기준서 제1001호 '재무제표 표시' 개정 - 부채의 유동ㆍ비유동 분류</SPAN>
<SPAN>&cr;기업회계기준서 제1001호 문단 69~76에 대한 개정사항은 부채의 유동ㆍ비유동 분류에 대한 다음의 요구사항을 명확히 합니다.&cr;ㆍ결제를 연기할 수 있는 권리의 의미&cr;ㆍ연기할 수 있는 권리가 보고기간종료일 현재 존재해야 함&cr;ㆍ기업이 연기할 수 있는 권리를 행사할 가능성은 유동성 분류에 영향을 미치지 않음&cr;ㆍ전환가능부채의 내재파생상품 자체가 지분상품일 경우에만 부채의 조건이 유동성    분류에 영향을 미치지 않음&cr;동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 적용하며 소급 적용합니다. 당사는 개정사항이 현행 실무에 미칠 영향과 기존의 대출 약정에 재협상이 필요한지를 평가하고 있습니다.&cr;&cr;</SPAN>
<SPAN>나. 기업회계기준서 제1103호 '사업결합' 개정 - 재무보고를 위한 개념체계 참조</SPAN>
<SPAN>&cr;동 개정사항의 목적은 1989년에 발표된 '재무제표의 작성과 표시를 위한 개념체계'를 2018년 3월에 발표된 '재무보고를 위한 개념체계'의 참조로 변경시, 유의적인 요구사항의 변경이 없도록 하는데 있습니다. 기업회계기준서 제1037호 '충당부채, 우발부채, 우발자산' 또는 기업회계기준해석서 제2121호 '부담금'의 범위인 부채와 우발부채에서 day 2 손익이 발생하지 않도록, 기업회계기준서 제1103호의 인식 원칙에 예외를 추가하였습니다. 아울러 재무보고를 위한 개념체계 변경의 영향이 없도록,기업회계기준서 제1103호의 우발자산 관련 지침을 명확히 하였습니다. 동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도부터 적용하며, 전진 적용합니다.&cr;&cr;</SPAN>
<SPAN>다. 기업회계기준서 제1016호 '유형자산' 개정 - 의도한 사용전의 매각금액&cr;</SPAN>
<SPAN>동 개정사항의 목적은 경영진이 의도하는 방식으로 자산을 가동하는 데 필요한 장소와 상태에 이르게 하는 동안 발생하는 재화의 순매각가액을 원가에서 차감하지 않도록 하는데 있습니다. 대신에, 기업은 그러한 품목을 판매하여 얻은 수익과 품목을 생산하는데 드는 원가를 각각 당기손익으로 인식합니다. &cr;동 개정사항은 2022년 1월 1일 이후 시작되는 회계연도부터 적용하며, 비교 표시되는 가장 이른 기간이나 그 후에 경영진이 의도하는 방식으로 가동될 수 있는 장소와 상태에 이르는 유형자산에 대해서 소급 적용하여야 합니다. 해당 개정사항은 당사에 중요한 영향을 미치지 않을 것으로 예상됩니다.&cr;&cr;</SPAN>
<SPAN>라. 기업회계기준서 제1037호 '충당부채, 우발부채, 우발자산' 개정 - 손실부담계약의 의무이행 원가</SPAN>
<SPAN>&cr;동 개정사항은 계약이 손실부담계약인지 또는 손실을 발생시키는 계약인지 평가할 때 기업이 포함해야할 원가를 명확하게 하였습니다.&cr;개정 기준서는 "직접 관련된 원가 접근법"을 적용합니다. 재화나 용역을 제공하는 계약에 직접적으로 관련되는 원가는 증분원가와 계약 활동에 직접적으로 관련되는 원가 배분액을 모두 포함합니다. 일반 관리 원가는 계약에 직접적으로 관련되지 않으며계약에 따라 거래상대방에게 명시적으로 부과될 수 없다면 제외됩니다.&cr;동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도에 적용됩니다. 당사는 이 개정 기준서를 최초로 적용하는 연차 보고기간 초에 모든 의무를 아직 이행하지 않은 계약에 적용할 것입니다.&cr;&cr;</SPAN>
<SPAN>마. 한국채택국제회계기준 2018-2020 연차개선</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>① </SPAN>
<SPAN></SPAN>
<SPAN>기업회계기준서 제1101호 '한국채택국제회계기준의 최초채택' -  최초채택기업인종속기업&cr;</SPAN>
<SPAN>개정 기준서는 종속기업이 기업회계기준서 제1101호 한국채택국제회계기준의 최초채택 문단 D16(1)을 적용하기로 선택한 경우 종속기업이 지배기업의 한국채택국제회계기준 전환일에 기초하여 지배기업이 보고한 금액을 사용하여 누적환산차이를 측정할 수 있도록 허용합니다. 이 개정사항은 동 기준서 문단 D16(1)을 적용하기로 선택한 관계기업 또는 조인트 벤처에도 적용됩니다.&cr;동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도에 적용하며 조기적용이 허용됩니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>②</SPAN>
<SPAN></SPAN>
<SPAN> 기업회계기준서 제1109호 '금융상품' - 금융부채 제거 목적의 10% 테스트 관련 수수료&cr;</SPAN>
<SPAN>동 개정사항은 새로운 금융부채나 변경된 금융부채의 조건이 기존의 금융부채의 조건과 실질적으로 다른지를 평가할 때 기업이 포함하는 수수료를 명확히 합니다. 이러한 수수료에는 채권자와 채무자 간에 지급하거나 수취한 수수료와 채권자와 채무자가 서로를 대신하여 지급하거나 수취한 수수료만 포함됩니다. 기업은 동 개정사항을 최초로 적용하는 회계연도 이후에 변경되거나 교환되는 금융부채에 동 개정사항을 적용합니다.&cr;동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도부터 적용하며 조기 적용이 허용됩니다. 당사는 시행일 이후 최초로 시작되는 회계연도 이후에 변경되거나 교환되는 금융부채에 동 개정사항을 적용할 것입니다. &cr;동 개정사항은 당사에 중요한 영향을 미치지 않을 것으로 예상됩니다.&cr;&cr;</SPAN>
<SPAN>③</SPAN>
<SPAN> </SPAN>
<SPAN>기업회계기준서 제1041호 '농림어업' - 공정가치 측정</SPAN>
<SPAN>&cr;개정 기준서는 동 기준서의 적용 범위에 포함되는 자산의 공정가치를 측정할 때 세금관련 현금흐름을 포함하지 않는 문단 22의 요구사항을 제거했습니다.&cr;동 개정사항은 2022년 1월 1일 이후 최초로 시작되는 회계연도부터 전진적으로 적용하며 조기 적용이 허용됩니다.&cr;동 개정사항은 당사에 중요한 영향을 미치지 않을 것으로 예상합니다.</SPAN>
</P>

<P>&cr;바. 
<SPAN>기업회계기준서 제1116호 '리스' (개정) - 코로나바이러스감염증-19 관련 임차료 할인 등&cr;</SPAN>
<SPAN>동 개정사항은 코로나19 세계적 유행의 직접적인 결과로 발생한 임차료 할인 등에 대한 리스이용자의 기업회계기준서 제 1116호 '리스'의 리스변경 회계처리 적용을 완화하였습니다. 실무적 간편법으로, 리스이용자는 코로나19와 관련하여 발생한 임차료 할인 등이 리스변경에 해당하는지 평가하지 않을 수 있습니다. 이러한 선택을 한 리스이용자는 임차료 할인 등으로 인한 리스료 변동을 그러한 변동이 리스변경이 아닐 경우에 이 기준서가 규정하는 방식과 일관되게 회계처리하여야 합니다. 동 개정사항은 2020년 6월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 가능합니다. 동 개정사항이 당사의 재무제표에 미치는 영향은 없습니다.</SPAN>&cr;
</P>
<PGBRK></PGBRK>
<P>4. 고객과의 계약에서 생기는 수익</P>
<P>당사의 고객과의 계약에서 생기는 수익은 다음과 같이 구분됩니다.</P>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="621" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" COLSPAN="3">주요 제품/용역</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 재화의 판매</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">471,001,022 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">530,833,122 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 상품의 판매</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">413,483,147 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">421,295,582 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 기타매출</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">60,267,422 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">53,051,032 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합      계</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">944,751,591 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,005,179,736 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" COLSPAN="3">지리적 시장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 수출</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">44,787,903 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">88,777,052 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 내수</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">899,963,688 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">916,402,684 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합      계</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">944,751,591 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,005,179,736 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">수익인식시기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 한 시점에 인식</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">944,186,376 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,004,945,849 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 기간에 걸쳐 인식</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">565,215 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">             233,887 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" ALIGN="CENTER" HEIGHT="30">합      계</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">944,751,591 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,005,179,736 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>5. 현금및현금성자산 및 단기금융자산&cr;(1) 당기말과 전기말 현재 현금및현금성자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="636">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="636" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구     분</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30">현금</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,211 </TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,641 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30">예적금</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,141,031 </TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,713,873 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합     계</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,142,242 </TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,718,514 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기말과 전기말 현재 단기금융자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="638">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="638" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구     분</TH>
<TH WIDTH="213" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" VALIGN="MIDDLE" HEIGHT="30">정기적금 등</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,300,000 </TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,050,000 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>6. 금융상품의 범주별 분류&cr;(1) 당기말과 전기말 현재 금융자산의 범주별 분류내역은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="873">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="159"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="873" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가로  측정하는 금융자산</TH>

<TH WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기손익-공정가치&cr;측정 금융자산</P>
</TH>
<TH WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">52,142,242 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">52,142,242 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">단기금융자산</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">18,300,000 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">18,300,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">매출채권 및 기타채권</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">143,302,761 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">143,302,761 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">장기금융자산</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">10,500 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">10,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">장기매출채권 및 기타채권</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">6,009,110 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">6,009,110 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="53">기타포괄손익-&cr;공정가치측정금융자산</TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">5,825,558 </TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">5,825,558 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="53">당기손익-공정가치&cr;측정 금융자산</TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">75,342,100 </TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">75,342,100 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합      계</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">201,464,613 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">93,642,100 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">5,825,558 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">300,932,271 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="873">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="159"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="873" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가로  측정하는 금융자산</TH>

<TH WIDTH="169" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기손익-공정가치&cr;측정 금융자산</P>
</TH>
<TH WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">19,718,514 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">19,718,514 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">단기금융자산</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">8,050,000 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">8,050,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">매출채권 및 기타채권</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">203,352,194 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">                            - </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">203,352,194 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">장기금융자산</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">10,500 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">                            - </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">10,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">장기매출채권 및 기타채권</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">8,646,753 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">                            - </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">8,646,753 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="53">기타포괄손익-&cr;공정가치측정금융자산</TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">                            - </TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,657,562 </TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,657,562 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="53">당기손익-공정가치&cr;측정 금융자산</TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="169" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,020 </TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합      계</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">231,727,961 </TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">9,050,020 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">3,657,562 </TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="RIGHT">244,435,543 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>(2) </SPAN>
<SPAN></SPAN>
<SPAN>당기말과 전기말 현재 금융부채의 범주별 분류내역은 다음과 같습니다.</SPAN>
</P>
<P>가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="616">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="616" HEIGHT="30" COLSPAN="2" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="308" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="308" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가로 측정하는 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">매입채무 및 기타채무</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">116,560,719 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">단기차입금</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">52,016,970 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">유동성사채</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">89,925,922 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">유동성리스부채</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">551,321 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">장기매입채무 및 기타채무</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">5,339,088 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">장기차입금</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">90,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">사채</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">199,640,496 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">리스부채</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">6,236,651 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" ALIGN="CENTER">합      계</TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">560,271,167 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="300"></COL>
<COL WIDTH="300"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="618" HEIGHT="30" COLSPAN="2" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="309" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="309" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가로 측정하는 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30">매입채무 및 기타채무</TD>
<TD WIDTH="309" HEIGHT="30" ALIGN="RIGHT">111,991,297 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30">단기차입금</TD>
<TD WIDTH="309" HEIGHT="30" ALIGN="RIGHT">4,355,409 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30">유동성사채</TD>
<TD WIDTH="309" HEIGHT="30" ALIGN="RIGHT">89,921,321 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30">유동성리스부채</TD>
<TD WIDTH="309" HEIGHT="30" ALIGN="RIGHT">474,050 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30">장기매입채무 및 기타채무</TD>
<TD WIDTH="309" HEIGHT="30" ALIGN="RIGHT">3,995,715 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30">사채</TD>
<TD WIDTH="309" HEIGHT="30" ALIGN="RIGHT">289,196,132 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30">리스부채</TD>
<TD WIDTH="309" HEIGHT="30" ALIGN="RIGHT">3,139,802 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30" ALIGN="CENTER">합      계</TD>
<TD WIDTH="309" HEIGHT="30" ALIGN="RIGHT">503,073,726 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<PGBRK></PGBRK>
<P>(3) 당기와 전기 중 자산의 범주별로 분석한 금융수익 및 금융원가의 내역은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="931">

<COLGROUP>
<COL WIDTH="178"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="931" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="187" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>

<TH WIDTH="186" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>상각후원가로</P>
<P>측정하는 금융자산/부채</P>
</TH>
<TH WIDTH="186" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-&cr;공정가치측정 금융자산</TH>
<TH WIDTH="186" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-&cr;공정가치측정 금융자산</TH>
<TH WIDTH="186" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합      계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="931" HEIGHT="30" COLSPAN="5">Ⅰ. 금융수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  이자수익</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">641,804 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">853,595 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">1,495,399 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  외환차익</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">4,731,618 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">4,731,618 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  외화환산이익</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">525,087 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">525,087 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="53">  공정가치 측정&cr;  금융자산평가이익</TD>
<TD WIDTH="186" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="186" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,514,240 </TD>
<TD WIDTH="186" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="186" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,514,240 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">금융수익 소계</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">5,898,509 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">4,367,835 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">10,266,344 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="931" HEIGHT="30" COLSPAN="5">Ⅱ. 금융원가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  이자비용</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(9,957,664)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(9,957,664)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  외환차손</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(3,735,783)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(3,735,783)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  외화환산손실</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(1,797,361)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(6,445,000)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(8,242,361)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="53">  공정가치 측정&cr;  금융자산평가손실</TD>
<TD WIDTH="186" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="186" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(892,160)</TD>
<TD WIDTH="186" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="186" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(892,160)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">금융원가 소계</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(15,490,808)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(7,337,160)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(22,827,968)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">Ⅲ. 순금융손익(Ⅰ+Ⅱ)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(9,592,299)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(2,969,325)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(12,561,624)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="931" HEIGHT="30" COLSPAN="5">Ⅳ. 판매관리비 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  대손상각비</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(3,712,124)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(3,712,124)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="931" HEIGHT="30" COLSPAN="5">V. 기타포괄손익 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  공정가치 측정 지분상품</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(782,304)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(782,304)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="931">

<COLGROUP>
<COL WIDTH="178"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="931" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="187" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>

<TH WIDTH="186" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>상각후원가로</P>
<P>측정하는 금융자산/부채</P>
</TH>
<TH WIDTH="186" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-&cr;공정가치측정 금융자산</TH>
<TH WIDTH="186" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-&cr;공정가치측정 금융자산</TH>
<TH WIDTH="186" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합      계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="931" HEIGHT="30" COLSPAN="5">Ⅰ. 금융수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  이자수익</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">581,421 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">270,484 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">851,905 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  외환차익</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">4,047,178 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">4,047,178 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  외화환산이익</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">1,641,894 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">1,641,894 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">금융수익 소계</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">6,270,493 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">270,484 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">6,540,977 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="931" HEIGHT="30" COLSPAN="5">Ⅱ. 금융원가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  이자비용</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(9,958,785)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(9,958,785)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  외환차손</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(3,103,723)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(3,103,723)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  외화환산손실</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(875,396)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(875,396)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">금융원가 소계</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(13,937,904)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(13,937,904)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">Ⅲ. 순금융손익(Ⅰ+Ⅱ)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(7,667,411)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">270,484 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(7,396,927)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="931" HEIGHT="30" COLSPAN="5">Ⅳ. 판매관리비 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  대손상각비</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(1,150,559)</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(1,150,559)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="931" HEIGHT="31" COLSPAN="5">V. 기타포괄손익 :</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" HEIGHT="30">  공정가치 측정 지분상품</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">153,819 </TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">153,819 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(4) 당기말과 전기말 현재 사용제한예금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="695" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="131" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구     분</TH>
<TH WIDTH="171" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">금융기관</TH>
<TH WIDTH="131" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="131" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
<TH WIDTH="131" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제한내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30">장기금융자산</TD>

<TD WIDTH="171" HEIGHT="30" ALIGN="CENTER">
<SPAN>(주)우리은행 외 </SPAN>
<SPAN>3</SPAN>
</TD>
<TD WIDTH="131" ALIGN="RIGHT" HEIGHT="30">10,500 </TD>
<TD WIDTH="131" ALIGN="RIGHT" HEIGHT="30">10,500 </TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER">당좌개설보증금</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(5) 금융자산 양도&cr;</SPAN>
<SPAN>당기말 현재 당사는 매출채권 </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>2,016,970</SPAN>
<SPAN>천원(전기말: </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>4,355,409천원)을</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>(주)신</SPAN>
<SPAN>한</SPAN>
<SPAN>은행 외 1</SPAN>
<SPAN>에</SPAN>
<SPAN> </SPAN>
<SPAN>양도하고 해당 채권의 예상 손실액에 대하여 신용보증을 제공하였습니다. 따라서 당사는 동 채권의 장부금액 전액을 계속하여 인식하였으며, 양도시 수령한 현금을 담보차입으로 인식하였</SPAN>
<SPAN>습니다(주석</SPAN>
<SPAN>16 </SPAN>
<SPAN>참조).&cr;</SPAN>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>
<P>7. 매출채권 및 기타채권&cr;(1) 당기말과 전기말 현재 매출채권 및 기타채권의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="684">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="5" WIDTH="684" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">구     분</TH>
<TH WIDTH="270" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="269" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">유동</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비유동</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">유동</TH>
<TH WIDTH="134" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="30">매출채권</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">122,948,295 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,530,201 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">175,458,715 </TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="30">대손충당금</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(15,706,305)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(11,994,181)</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="30">대여금</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,776,000 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,544,000 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,500,000 </TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    5,052,300 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="30">미수금</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,167,769 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,724,748 </TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="30">대손충당금</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(707,071)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(707,071)</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="30">미수수익</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,514,963 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">369,983 </TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="30">보증금</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,309,109 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,934,909 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,594,453 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합      계</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">143,302,760 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,009,110 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">203,352,194 </TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,646,753 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당사는 상기 매출채권 및 기타채권의 일부에 대해서 담보 혹은 지급보증을 제공받고 있습니다. 또한, 매출채권 및 기타채권의 공정가치는 장부금액과 중요한 차이가 없습니다.&cr;</P>
<P>(2) 당기말과 전기말 현재 매출채권 및 기타채권의 연령별 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="734">

<COLGROUP>
<COL WIDTH="216"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="734" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="2" ALIGN="CENTER" WIDTH="225" HEIGHT="60" USERMARK=" BC0XD7D7D7">구     분</TD>
<TD COLSPAN="2" WIDTH="255" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TD>
<TD COLSPAN="2" WIDTH="254" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">매출채권</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타채권</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">매출채권</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">기타채권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="734" HEIGHT="30" COLSPAN="5">Ⅰ. 손상되지 않은 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="225" HEIGHT="30">  6개월 이하</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">104,014,709 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">39,539,679 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">137,842,652 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">48,534,414 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="225" HEIGHT="30">  6개월 초과 ~ 1년 이하</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">1,955,183 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">6,145,151 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="225" HEIGHT="30">  1년 초과</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">3,802,300 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">19,476,731 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ALIGN="CENTER">소      계</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">109,772,192 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">39,539,679 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">163,464,534 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">48,534,414 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="734" HEIGHT="30" COLSPAN="5">Ⅱ. 손상된 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="225" HEIGHT="30">  집합적으로 손상된 금융자산</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">4,980,845 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">6,129,292 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">    - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="225" HEIGHT="30">  개별적으로 손상된 금융자산</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">10,725,460 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">707,071 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">5,864,889 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">707,071 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ALIGN="CENTER">소      계</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">15,706,305 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">707,071 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">11,994,181 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">707,071 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ALIGN="CENTER">합      계</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">125,478,497 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">40,246,750 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">175,458,715 </TD>
<TD WIDTH="127" ALIGN="RIGHT" HEIGHT="30">49,241,485 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(3) 당기와 전기 중 매출채권 및 기타채권의 대손충당금 변동내역은 다음과 같습니 다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="637">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="637" COLSPAN="3" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7">(단위: 천원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="213" HEIGHT="30" USERMARK=" BC0XD7D7D7">구     분</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30">기초금액</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">12,701,252 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">11,550,693 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30">대손상각비</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">3,712,124 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">1,150,559 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30">기말금액</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">16,413,376 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">12,701,252 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>8. 재고자산&cr;(1) 당기말과 전기말 현재 재고자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="680">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="7" WIDTH="680" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83">구     분</TH>
<TH COLSPAN="3" WIDTH="294" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH COLSPAN="3" WIDTH="292" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">취득원가</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">평가손실&cr; 충당금</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">장부금액</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">취득원가</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">평가손실&cr;충당금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30">상   품</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,598,788 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(963,070)</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,635,718 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,825,530 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(792,775)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,032,755 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30">제   품</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,855,215 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,692,642)</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,162,573 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,190,360 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,043,068)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,147,292 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30">재공품</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,933,577 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,656,110)</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,277,467 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,741,468 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,539,051)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,202,417 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30">원재료</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,025,738 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(175,543)</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,850,195 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,731,551 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(56,387)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,675,164 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30">포장재료</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,128,801 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(75,202)</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,053,599 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,131,003 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(163,018)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,967,985 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" HEIGHT="30">미착품</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,473,476 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,473,476 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,027,570 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       - </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,027,570 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,015,595 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,562,567)</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">141,453,028 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,647,482 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,594,299)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">146,053,183 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기말 현재 담보로 제공된 재고자산은 없습니다. </P>
<P></P>
<PGBRK></PGBRK>
<P>9. 기타자산</P>
<P>당기말과 전기말 현재 기타유동자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="5" WIDTH="622" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">구     분</TH>
<TH WIDTH="264" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7" COLSPAN="2">제 19(당) 기</TH>
<TH WIDTH="265" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="140" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">유동</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비유동</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">유동</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">선급금</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,707,389 </TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,944,572 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">대손충당금</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(82,000)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(82,000)</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">선급비용</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,494,027 </TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">413,075 </TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">810,592 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 569,251 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합      계</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,119,416 </TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">413,075 </TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,673,164 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">569,251 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;10. 공정가치측정금융자산&cr;(1) 당기말과 전기말 현재 공정가치측정금융자산의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="643" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="212"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="643" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="221" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구     분</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="211" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="643" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">기타포괄손익-공정가치측정 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30"> 시장성 있는 금융자산</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">974,980 </TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,626,684 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30"> 시장성 없는 금융자산</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">4,850,578 </TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">2,030,878 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소      계</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">5,825,558 </TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">3,657,562 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="643" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">당기손익-공정가치측정 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30"> 시장성 없는 금융자산</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소      계</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합      계</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">81,167,658 </TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">4,657,582 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(2) 당기와 전기 중 당사의 공정가치측정금융자산의 변동내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="645" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="206"></COL>
<COL WIDTH="206"></COL>
<COL WIDTH="206"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="645" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="215" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="215" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="215" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">기초금액</TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">4,657,582 </TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">3,454,639 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">취득 및 대체</TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">81,365,060 </TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">              1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">평가손익(법인세효과 차감 전)</TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">(4,854,984)</TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">202,927 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">처분</TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">(4)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">기말금액</TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">81,167,658 </TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">4,657,582 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">차감: 유동항목</TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">                           - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="215" HEIGHT="30">비유동항목</TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">81,167,658 </TD>
<TD WIDTH="215" ALIGN="RIGHT" HEIGHT="30">4,657,582 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;(3) 주요 시장성 없는 금융자산에 대하여 사용된 가치평가법과 투입변수는 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="987">

<COLGROUP>
<COL WIDTH="294"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="987" VALIGN="MIDDLE" COLSPAN="6" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 원, 1,000 USD)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주당 공정가치</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가치평가법</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준3 투입변수</TH>
<TH WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">투입변수의 범위</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="987" VALIGN="MIDDLE" HEIGHT="30">기타포괄손익-공정가치측정 금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" VALIGN="MIDDLE" WIDTH="303" HEIGHT="90">바이오넷 지분투자</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="121" HEIGHT="90">700원</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="90">227,136,000원</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="122" HEIGHT="90">유상증자 &cr;발행가격&cr;(시장접근법)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">시가의배수(PBR)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">1.66</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">시가의배수(EV/SALES)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">1.49</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">유상증자가격</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">700원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="303" HEIGHT="30">큐어바이오 지분투자</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="121" HEIGHT="30">99,036원</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="30">308,100,996원</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="122" HEIGHT="30">시장접근법</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">시가의배수(PBR)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">3.91</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" VALIGN="MIDDLE" WIDTH="303" HEIGHT="90">자일자동차판매 지분투자</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="121" HEIGHT="90">2,145원</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="90">200,098,470원</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="122" HEIGHT="90">이익접근법</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">영구성장률</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">1%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가중평균자본비용</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">10.87%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자기자본비용</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">20.35%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="303" HEIGHT="30">JTBC 지분투자</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="121" HEIGHT="30">278원</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="30">166,800,000원</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="122" HEIGHT="30">시장접근법</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">시가의배수(PBR)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">0.67</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="303" HEIGHT="30">진켐 지분투자</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="121" HEIGHT="30">11,341원</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="30">475,550,812원</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="122" HEIGHT="30">시장접근법</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">시가의배수(PBR)</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">6.28</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="987" VALIGN="MIDDLE" HEIGHT="30">당기손익-공정가치측정 금융자산 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="303" VALIGN="MIDDLE" HEIGHT="90">Aeon Biopharma Inc 전환사채 투자</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="121" HEIGHT="90">USD 24,180</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="90">26,307,840,000원</TD>
<TD ROWSPAN="3" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">옵션가격&cr;결정 모형</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">무위험이자율</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">0.34%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">할인율</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">4.88%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">기대주가변동성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">77.19%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="303" VALIGN="MIDDLE" HEIGHT="90">Evolus. Inc 전환사채 투자</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="121" HEIGHT="90">USD 43,230</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="90">47,034,240,000원</TD>
<TD ROWSPAN="3" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">옵션가격&cr;결정 모형</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">무위험이자율</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">0.32%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">할인율</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">2.73%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">기대주가변동성</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">97.67%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>11. 종속기업투자, 관계기업 및 공동기업투자</P>
<P>당기말과 전기말 현재 종속기업투자,  관계기업 및 공동기업투자의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1083">

<COLGROUP>
<COL WIDTH="341"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1083" HEIGHT="28" COLSPAN="9" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="350" HEIGHT="77" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">회사명</TH>
<TH WIDTH="85" HEIGHT="77" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">소재지</TH>
<TH WIDTH="88" HEIGHT="77" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">소유&cr;지분율(*1)</TH>
<TH WIDTH="281" HEIGHT="28" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10 BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="279" HEIGHT="28" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10 BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="94" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">취득가액</TH>
<TH WIDTH="94" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">손상차손&cr;누계액</TH>
<TH WIDTH="93" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">장부금액</TH>
<TH WIDTH="93" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">취득가액</TH>
<TH WIDTH="93" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">손상차손&cr;누계액</TH>
<TH WIDTH="93" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1083" HEIGHT="28" COLSPAN="9" VALIGN="MIDDLE" USERMARK="F-10">종속기업투자:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> (주)힐리언스(*2)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">75.97%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">27,310,924 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(12,876,304)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">14,434,620 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">27,310,924 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(8,646,102)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">18,664,822 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> DAEWOONG PHARMACEUTICAL HONGKONG(*3)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">홍콩</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">89.83%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">37,809,185 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(624,756)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">37,184,429 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">37,809,185 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">                  - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">37,809,185 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">필리핀</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">100.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">260,539 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">260,539 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">260,539 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">                  - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">260,539 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> Daewoong Pharmaceutical(Thailand)Co., Ltd.</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">태국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">100.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">205,389 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">205,389 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">205,389 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">                  - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">205,389 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> PT. Dewoong Pharmaceutical(Indonesia)Co., Ltd.(*4)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">인도네시아</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">100.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">7,812,111 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">7,812,111 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">7,812,111 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">                  - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">7,812,111 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> 북경대웅위업의약과기유한공사(*5)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">중국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">100.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">9,152,033 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(3,324,350)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">5,827,683 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">9,152,033 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(3,091,366)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">6,060,667 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> 한올바이오파마(주)(*6)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">31.48%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">116,111,366 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">116,111,366 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">106,111,335 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">                  - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">106,111,335 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> Daewoong America, Inc.</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">미국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">100.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">825,005 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(741,718)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">83,287 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">825,005 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(741,718)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">83,287 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> Daewoong Pharmaceutical India Pvt., Ltd.</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">인도</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">100.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">550,733 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">550,733 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">550,733 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">                  - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">550,733 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">일본</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">100.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">555,621 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">555,621 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">555,621 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">                  - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">555,621 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">아이엔테라퓨틱스(*7)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">97.54%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,118,330 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,118,330 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">아피셀테라퓨틱스(*7)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">54.10%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,960,780 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,960,780 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="523" HEIGHT="28" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">소          계</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">205,672,016 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(17,567,128)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">188,104,888 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">190,592,875 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(12,479,186)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">178,113,689 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1083" HEIGHT="28" COLSPAN="9" VALIGN="MIDDLE" USERMARK="F-10">관계기업 및 공동기업투자:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> (주)엠디웰아이앤씨(*8)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">50.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">500,000 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">500,000 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">500,000 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">   - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">500,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> (주)이피피미디어</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">20.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,000,000 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(1,000,000)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,000,000 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(1,000,000)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">  - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> (주)바이오시네틱스(*9)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">18.04%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,999,500 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(1,180,415)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">819,085 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,999,500 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(1,180,415)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">819,086 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> 건강한삶기술창업벤처PEF(*10)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">49.18%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,500,000 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,500,000 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,500,000 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">    - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,500,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> ㈜다나아데이터(*11)</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">대한민국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">51.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">5,100,000 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">5,100,000 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">5,100,000 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">    - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">5,100,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> Immplacate, Inc.</TD>
<TD WIDTH="85" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">미국</TD>
<TD WIDTH="88" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">20.00%</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,125,970 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,125,970 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,125,970 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">    - </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,125,970 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="523" HEIGHT="28" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">소          계</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">12,225,470 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(2,180,415)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">10,045,055 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">11,225,470 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(2,180,415)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">9,045,056 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="523" HEIGHT="28" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">합          계</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">217,897,486 </TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(19,747,543)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">198,149,943 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">201,818,345 </TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(14,659,601)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">187,158,744 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(*1) 해당지분율은 유효지분율입니다. &cr;(*2) (주)힐리언스에 대하여 당기 중 4,230,202천원(전기 2,254,414천원)의 손상차손을 인식하였으며 회수가능액은 사용가치에 근거하여 측정하였습니다. 사용가치 측정에 사용된 할인율은 12.65%, 영구성장률은 1%입니다.&cr;(*3) DAEWOONG PHARMACEUTICAL HONGKONG에 대하여 당기 중 624,756천원의 손상차손을 인식하였으며 회수가능액은 사용가치에 근거하여 측정하였습니다. 사용가치에 측정에 사용된 할인율은 10.76% 영구성장율은 1%입니다. &cr;</SPAN>
<SPAN>(*4) PT. Daewoong Pharmaceutical(Indonesia)Co., Ltd.에 대한 현금창출단위의 경우 주요 가정치의 합리적 변동에 따라 회수가능금액의 장부금액 초과분이 상쇄될 가능성도 존재합니다.&cr;(*5) 북경대웅위업의약과기유한공사에 대해 당기 중 232,984 천원(전기 2,042,265천원)의 손상차손을 인식하였으며 회수가능액은 사용가치에 근거하여 측정하였습니다. 사용가치 측정에 사용된 할인율은 13.31%, 영구성장률은 1%입니다.&cr;(*6) 한올바이오파마㈜에 대해 의결권 있는 지분율은 50%미만이나 사실상의 지배력이 있다고 판단하여 종속기업투자주식으로 분류하였습니다. 당기중 443,533 주를 취득하였으며, 당사가 보유한 한올바이오파마(주)의 시장가치는 604,340백만원입니다.(*7) 당기중 지분취득을 통해 종속회사로 편입되었습니다.&cr;(*8) 지분율을 50% 보유하고 있어 공동기업투자로 분류하였습니다.&cr;(*9)</SPAN>
<SPAN> (주)바이오시네틱스에 대해 의결권 있는 지분율은 20%미만이나 유의적인 영향력이 있다고 판단하여 관계기업투자주식으로 분류하였습니다.&cr;(*10) 당기중 잔여 출자잔액 1,000,000천원을 출자완료하였습니다. &cr;(*11) </SPAN>
<SPAN></SPAN>
<SPAN>지분율은 50%를 초과하나, 약정에 따라 지배력을 보유하지 않아서 공동기업투자로 분류하였습니다.&cr;</SPAN>
</P>
<P>12. 유형자산&cr;(1) 당기말과 전기말 현재 유형자산의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1101">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1101" HEIGHT="30" COLSPAN="9" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH WIDTH="490" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="488" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각누계액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각누계액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">토       지</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,829,995 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,829,995 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,829,995 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">             - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">    - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,829,995 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">건       물</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">148,911,828 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(36,590,080)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">112,321,748 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">148,443,981 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,825,320)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">115,618,661 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구  축  물</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">31,368,891 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(12,957,334)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(28,147)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,383,410 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,241,830 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(11,425,944)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(30,407)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,785,479 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">212,408,735 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(125,448,237)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86,960,498 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">209,448,587 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(114,041,860)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">95,406,727 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,063,849 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(915,332)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">148,517 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,044,909 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(811,200)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">233,709 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">공구와기구</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,035,542 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,399,921)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,635,621 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,180,609 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,690,692)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,489,917 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">집기비품</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,066,955 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(41,128,794)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,938,161 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,069,528 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(39,864,402)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,205,126 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타의유형자산</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">892,348 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(718,681)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">173,667 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">726,609 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(611,630)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">114,979 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,098,367 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,098,367 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,320,798 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">       - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  - </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,320,798 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합       계</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">525,676,510 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(221,158,379)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(28,147)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">304,489,984 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">508,306,846 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(202,271,048)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(30,407)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">306,005,391 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기와 전기 중 유형자산 변동내역은 다음과 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1099">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1099" HEIGHT="30" COLSPAN="11" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">토지</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구축물</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기계장치</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공구와기구</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">집기비품</TH>
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타유형자산</TH>
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건설중인자산</TH>
<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">기초 장부금액</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,829,995 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">115,618,662 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,785,479 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">95,406,728 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">233,709 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,489,916 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,205,125 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">114,979 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,320,798 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">306,005,391 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">취득</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,677 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">688,025 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,331,035 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,939 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">854,933 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">353,673 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">165,739 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,364,051 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,787,072 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">처분</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,980)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,053)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(8,033)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">감가상각비</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,764,760)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,529,130)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(14,608,889)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(104,131)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(709,228)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,628,830)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(107,051)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(23,452,019)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">대체</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">457,169 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">439,036 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,835,604 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,246 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,586,482)</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(842,427)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">기말 장부금액</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,829,995 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">112,321,748 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,383,410 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86,960,498 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">148,517 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,635,621 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,938,161 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">173,667 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,098,367 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">304,489,984 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>나</SPAN>
<SPAN></SPAN>
<SPAN>. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1099">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1099" HEIGHT="30" COLSPAN="11" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">토지</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구축물</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기계장치</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공구와기구</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">집기비품</TH>
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타유형자산</TH>
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건설중인자산</TH>
<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">기초 장부금액</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,319,917 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">107,905,024 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,520,206 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">77,314,265 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">351,409 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,796,995 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,809,730 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">232,459 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">51,452,137 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">314,702,142 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">취득</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">   272,714 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">   74,645 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,632,494 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,227 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">145,636 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">357,615 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">   - </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,812,217 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,313,548 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">처분</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(179)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(190,514)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(155,886)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(24,525)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     - </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,815)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">    - </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  - </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(403,919)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">감가상각비</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,729,893)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,502,441)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(13,950,543)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(111,402)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(606,845)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,538,182)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(117,480)</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> - </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(22,556,786)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">대체</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">510,078 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,170,996 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> 883,583 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,566,398 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">154,130 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,608,777 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> - </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(50,943,556)</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(5,049,594)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">기말 장부금액</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,829,995 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">115,618,662 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,785,479 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">95,406,728 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">233,709 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,489,916 </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,205,125 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">114,979 </TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,320,798 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">306,005,391 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(3) 당기말 현재 차입금에 대한 담보로 제공된 유형자산은 없습니다.&cr;&cr;</SPAN>
</P>
<P>13. 투자부동산&cr;(1) 당기말과 전기말 현재 투자부동산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="835">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="835" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" VALIGN="MIDDLE" ROWSPAN="2" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH WIDTH="358" VALIGN="MIDDLE" COLSPAN="3" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="357" VALIGN="MIDDLE" COLSPAN="3" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각누계액</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각누계액</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="30">토       지</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">40,407,568 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">40,407,568 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">49,277,928 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">           - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">49,277,928 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="30">건       물</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">53,826,369 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">(11,672,755)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">42,153,614 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">55,065,187 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">(10,662,912)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">44,402,275 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="30">합       계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="120" HEIGHT="30">94,233,937 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">(11,672,755)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">82,561,182 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">104,343,115 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">(10,662,912)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">93,680,203 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기 중 투자부동산의 변동내역은 다음과 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="825">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="825" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">토지</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">기초 장부금액</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">49,277,928 </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">44,402,275 </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">93,680,203 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">처분</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(8,870,360)</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(908,466)</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(9,778,826)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">투자부동산감가상각비</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">- </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(1,340,195)</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(1,340,195)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">기말 장부금액</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">40,407,568 </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">42,153,614 </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">82,561,182 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="825">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="825" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">토지</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">기초 장부금액</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">49,277,928 </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">45,767,607 </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">95,045,535 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">처분</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">                       - </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(14,528)</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(14,528)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">투자부동산감가상각비</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">                       - </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(1,350,804)</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(1,350,804)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">기말 장부금액</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">49,277,928 </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">44,402,275 </TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">93,680,203 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(3) 당기와 전기 중 투자부동산과 관련하여 인식한 임대수익 및 임대비용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="624" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">임대수익</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,806,680 </TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,664,183 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">임대비용(*)</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,443,213)</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,484,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">임대손익</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(636,533)</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(820,030)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*) 감가상각비 및 세금과공과 등으로 구성되어 있습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>(4) 리스제공자&cr;</SPAN>
<SPAN>가. 당사는 특정 토지 및 건물로 구성된 투자부동산 포트폴리오에 대한 운용리스 계약을 체결하였으며 이 리스들의 기간은 </SPAN>
<SPAN></SPAN>
<SPAN>1년에서 3년 사이</SPAN>
<SPAN>입</SPAN>
<SPAN>니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
</P>
<P>나. 해지불능 운용리스 하에서 미래 최소 임대료 채권</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="622" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="208" HEIGHT="30">
<P>1년 이내</P>
</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">2,498,842 </TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,381,674 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="208" HEIGHT="30">
<P>1년 초과 5년 이하</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,978,904 </TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,823,959 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,477,746 </TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,205,633 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(5)</SPAN>
<SPAN> 당기말 현재 차입금에 대한 담보로 제공되어 있는 투자부동산은 없습니다. </SPAN>
</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(6)</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>당기말 현재 투자부동산 토지의 공시지가는</SPAN>
<SPAN> </SPAN>
<SPAN>55,480,828</SPAN>
<SPAN>천원(전기 58,890,896천원)입니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN> </SPAN>
</P>
<PGBRK></PGBRK>
<P>14. 무형자산&cr;(1) 당기말과 전기말 현재 무형자산의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="824">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="824" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" VALIGN="MIDDLE" ROWSPAN="2" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH WIDTH="348" VALIGN="MIDDLE" COLSPAN="3" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="348" VALIGN="MIDDLE" COLSPAN="3" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="116" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="116" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액 및&cr;손상차손누계액</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="116" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="116" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득가액</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="116" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액 및&cr;손상차손누계액</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="116" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30"> 산업재산권 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">4,607,083 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(1,433,535)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">3,173,548 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">3,472,754 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(1,038,678)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">2,434,076 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30"> 개발비 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">38,159,677 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(4,352,691)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">33,806,986 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30"> 19,811,591 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(148,237)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">19,663,354 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30"> 회원권 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">14,470,505 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(391,500)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">14,079,005 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">15,805,808 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">15,805,808 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30"> 기타의무형자산 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">100,690,086 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(48,843,854)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">51,846,232 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">93,612,066 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(39,408,384)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">54,203,682 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="128" HEIGHT="30"> 합계 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">157,927,351 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(55,021,580)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">102,905,771 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">132,702,219 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">(40,595,299)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="116" HEIGHT="30">92,106,920 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(</SPAN>
<SPAN>2</SPAN>
<SPAN>) </SPAN>
<SPAN>당기와 전기 중 무형자산의 변동내역은 다음과 같습니다. &cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="823">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="823" VALIGN="MIDDLE" COLSPAN="6" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">산업재산권</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개발비</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회원권</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타의무형자산</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">기초금액</TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">2,434,076 </TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">19,663,354 </TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">15,805,808 </TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">54,203,682 </TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">92,106,920 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">취득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">108,643 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">18,348,086 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">1,359,260 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">6,235,594 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">26,051,583 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">처분</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(257,302)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(2,694,563)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(2,951,865)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">손상</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(3,973,672)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(391,500)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(2,845,478)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(7,210,650)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">무형자산상각비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(423,436)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(230,782)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(6,589,991)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(7,244,209)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">대체</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">1,311,567 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">842,425 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">2,153,992 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">기말금액</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">3,173,548 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">33,806,986 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">14,079,005 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">51,846,232 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">102,905,771 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="823">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="823" VALIGN="MIDDLE" COLSPAN="6" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">산업재산권</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개발비</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회원권</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타의무형자산</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">기초금액</TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">1,501,419 </TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">14,783,808 </TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">55,243,375 </TD>
<TD VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ALIGN="RIGHT">71,528,602 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">취득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">1,185,773 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">19,811,591 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">          1,022,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">2,657,791 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">24,677,155 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">처분</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(1,075)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">                       - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(1,494,725)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(1,495,800)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">손상</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(46,371)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">                       - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(556,850)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(603,221)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">무형자산상각비</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(252,041)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(101,866)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">                       - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(6,695,504)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">(7,049,411)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">대체</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">  - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">  - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">        5,049,595 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">        5,049,595 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="138" HEIGHT="30">기말금액</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">2,434,076 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">19,663,354 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">15,805,808 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">54,203,682 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="137" HEIGHT="30">92,106,920 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(3) 당사의 개발비 자산화 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1101">

<COLGROUP>
<COL WIDTH="49"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="278"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="161"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="10" WIDTH="1101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="58" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="98" USERMARK="F-10">단  계</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="98" USERMARK="F-10">구   분</TH>
<TH ROWSPAN="2" WIDTH="287" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="98" USERMARK="F-10">개별 자산명</TH>
<TH COLSPAN="3" WIDTH="262" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">제 19(당) 기</TH>
<TH COLSPAN="3" WIDTH="261" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">제 18(전) 기</TH>
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="98" ROWSPAN="2" USERMARK="F-10">잔여&cr;상각기간</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="88" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">취득가액</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">감가상각 및&cr; 손상차손&cr;누계액</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">장부금액</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">취득가액</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">감가상각 및&cr; 손상차손&cr;누계액</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWP14012302(NERD)(*1)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">3,456,808 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">(3,456,808)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">3,268,201 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">3,268,201 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 계획 변경</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWP14012301(GERD)(*2)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">4,049,146 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">4,049,146 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">3,303,649 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">3,303,649 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DW_UDCA005우루사(*3)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">380,525 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(126,023)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">254,502 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">374,381 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(49,918)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">324,463 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">3년 4개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWJ1351003(O+A+R3제복합제)(*4)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">235,126 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(82,294)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">152,832 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">235,126 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(35,269)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">199,857 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">3년 3개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWJ211301(국소지방분해주사제)(*5)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">1,172,929 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">1,172,929 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">879,904 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">879,904 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">HL036(*6)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">13,980,670 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">13,980,670 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">9,166,348 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">9,166,348 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWP14012101(APA)BE_1상(BE)(*7)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">581,796 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">581,796 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">457,231 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">457,231 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWJ1351005(OAR추가용량BE)(*8)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">538,579 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">(71,811)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">466,768 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">536,512 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">536,512 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">4년 4개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">생동</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">제네릭</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWJ1410(도네페질23mgBE)(*9)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">251,988 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">(251,988)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">245,194 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">245,194 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">중단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">제네릭</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWP450007(나보타안검경련)_3상(*10)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">142,972 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(45,274)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">97,698 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">142,972 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(16,679)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">126,293 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">3년 5개월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">생동</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">제네릭</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWJ1421(토파시티닙염변경5mgBE)생동(*11)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">299,719 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">299,719 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">219,088 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">219,088 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">생동</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">제네릭</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWJ1255(엔테카비르1mg(태국)BE(*12)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">111,223 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">(111,223)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">111,223 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">111,223 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">중단</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">제네릭</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DW_DWP450301 나보타 사각턱 3상(*13)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">1,203,112 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">1,203,112 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">레바미피드서방정_공동연구(*14)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">1,237,845 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">1,237,845 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWJ1451301(OARE4제)_3상(*15)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">2,268,187 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">2,268,187 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">637,791 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">637,791 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWP14012303 Fexuprazan ERD 유지요법 3상(*16)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">4,929,345 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">4,929,345 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWP14012305_20mg(위염)(*17)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">1,581,305 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">1,581,305 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWP16001301Enavogliflozin 3상 단독요법(*18)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">997,336 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">997,336 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">3상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">DWP16001302Enavogliflozin 3상 2제요법(*18)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">459,215 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">459,215 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">1상</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">신약</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">기타 신약임상(*19)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">82,605 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(53,618)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">28,987 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">81,589 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(46,371)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">35,218 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">4년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">생동</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9">제네릭</TD>
<TD VALIGN="MIDDLE" WIDTH="287" HEIGHT="27" USERMARK="F-9">기타 제네릭임상*(20)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">199,247 </TD>
<TD VALIGN="MIDDLE" WIDTH="87" HEIGHT="27" USERMARK="F-9" ALIGN="RIGHT">(153,653)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">45,594 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">152,382 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">- </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">152,382 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="408" VALIGN="MIDDLE" HEIGHT="27" USERMARK="F-9" ALIGN="CENTER">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="88" HEIGHT="27" USERMARK="F-9">38,159,678 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(4,352,692)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">33,806,986 </TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">19,811,591 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="87" HEIGHT="27" USERMARK="F-9">(148,237)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="27" USERMARK="F-9">19,663,354 </TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="27" ALIGN="CENTER" USERMARK="F-9">　</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN>(*1) Best-in Class 항궤양제 신약 개발 프로젝트이며 후속 적응증(비미란성 위식도 역류질환)을 득하기 위한 임상3상 진행하였으나, 최근 임상 전략이 변경되어 글로벌 개발 계획 등을 반영하여 재추진할 계획입니다.&cr;(*2) Best-in Class 항궤양제 신약 개발 프로젝트이며 현재 최초 적응증 GERD에 대한 허가 단계로 2022년 중 발매를 목표로 하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(*3) 우루사 제품의 적응증 추가(위암 수술 후 담석 예방)를 위한 임상시험으로 2019년 5월 적응증 추가하였습니다. &cr;(*4) 고혈압/고지혈증의 3제 복합제로 2019년 2월 판매 승인 후 2019년 5월 발매하였습니다.&cr;(*5) 국소지방분해 미용시장 진출을 위한 DWJ211 주사제 개발 임상시험으로 2021년 3분기 허가를 목표로 하고 있습니다.&cr;(*6) 안구건조증 치료제(점안액)로 한올바이오파마와 공동개발건으로 현재 미국 임상 3상 단계로 2023년 발매를 목표로 하고 있습니다.&cr;(*7) 허가 진행중인 DWP14012의 허가자료로 활용할 예정이며, 최종발매제형에 대한 임상1상 PK시험입니다.&cr;(*8) 2019년 2월 품목허가를 취득한 올로맥스정(고혈압/고지혈증 3제 복합제)의 추가용량에 대한 1상 임상시험으로 2020년 5월 발매 하였습니다.&cr;(*9) 동등성 확보하였으나, 시장 니즈 감소에 따라 미발매 결정 되었습니다.&cr;(*10) 본태성 눈꺼풀경련 적응증을 추가하였습니다.&cr;(*11) 류마티스관절염치료제로 2025년 4분기 발매를 목표로 하고 있습니다.&cr;(*12) 동등성 확보하였으나 시장성 저하로 사업 중단 결정하였습니다.&cr;(*13) 양성교근비대증(사각턱) 적응증 추가를 위한 3상 임상시험으로 2022년 2분기 허가적응증 추가 획득을 목표로 하고 있습니다.&cr;(*14) 유한양행과 공동개발로 20년 7월까지 3상 수행 후 허가 신청 완료하였으며 2021년 2분기 발매 계획입니다.&cr;(*15) 고혈압/고지혈증의 4제 복합제로 2022년 허가를 목표로 하고 있습니다.&cr;(*16) Best-in Class 항궤양제 신약 개발 프로젝트이며 현재 적응증 추가를 위한 ERD 유지요법에 대한 임상3상 단계로 2022년 3분기 허가를 목표로 하고 있습니다.&cr;(*17) Best-in Class 항궤양제 신약 개발 프로젝트이며 현재 적응증 추가를 위한 급성 또는 만성위염에 대한 임상3상 단계로 2022년 3분기 허가를 목표로 하고 있습니다.&cr;(*18) Best-in Class SGL2Ti 신약 개발 프로젝트이며 현재 임상 단계로 2023년 중 발매를 목표로 하고 있습니다.&cr;(*19) 개발비 자산화 요건을 충족한 기타 신약임상으로 구성되어 있으며, 발매가 완료된 건은 상각을 진행하고 있습니다.&cr;(*20) 개발비 자산화 요건을 충족한 기타 제네릭임상으로 구성되어 있습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(3) 비한정 내용연수의 무형자산인 회원권의 손상검사&cr;당사는 회원권의 시장가치 하락 등 손상 징후를 발견시 합리적으로 추정하여 손상을 반영합니다. 회원권의 회수가능액은 순공정가치와 사용가치 중에서 큰 금액이며 순공정가치가 존재한다면 이를 사용하고, 존재하지 않는다면 사용가치를 합리적으로 산정하여 회수가능액을 결정하였습니다.&cr;</SPAN>
</P>

<P>
<SPAN>(4) </SPAN>
<SPAN>당사의 기타의무형자산 중 </SPAN>
<SPAN>독점판매권 취득 등으로 인해 외부에 지급된 금액의 주요 내역은 아래와 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="954">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="954" HEIGHT="28" COLSPAN="8" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" HEIGHT="77" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" USERMARK="F-10">구분</TH>
<TH WIDTH="318" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" USERMARK="F-10">제 19(당) 기</TH>
<TH WIDTH="317" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" USERMARK="F-10">제 18(전) 기</TH>
<TH WIDTH="107" HEIGHT="77" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" USERMARK="F-10">잔여 상각기간</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="106" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">취득가액</TH>
<TH WIDTH="106" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">감가상각 및&cr;손상차손누계액</TH>
<TH WIDTH="106" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">장부금액</TH>
<TH WIDTH="106" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">취득가액</TH>
<TH WIDTH="106" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">감가상각 및&cr;손상차손누계액</TH>
<TH WIDTH="105" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">제품개발완료(*1)</TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">57,767,157 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(22,997,587)</TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">34,769,570 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">57,767,156 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(15,891,829)</TD>
<TD WIDTH="105" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">41,875,327 </TD>
<TD WIDTH="107" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">1개월~10년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">신규 의약품, 의료기기 개발</TD>
<TD WIDTH="106" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,737,825 </TD>
<TD WIDTH="106" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(9,000)</TD>
<TD WIDTH="106" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,728,825 </TD>
<TD WIDTH="106" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,729,828 </TD>
<TD WIDTH="106" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="105" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,729,828 </TD>
<TD WIDTH="107" HEIGHT="49" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">3년 11개월/&cr;개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">글로벌 신규 의약품, 의료기기 개발</TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">6,686,053 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">6,686,053 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,286,053 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">- </TD>
<TD WIDTH="105" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,286,053 </TD>
<TD WIDTH="107" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">개발 진행 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">합  계</TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">68,191,035 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(23,006,587)</TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">45,184,448 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">63,783,037 </TD>
<TD WIDTH="106" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(15,891,829)</TD>
<TD WIDTH="105" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">47,891,208 </TD>
<TD WIDTH="107" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10"></TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 당기 중 독점판매권 2,845,478천원에 대해서 손상차손을 인식하였습니다. &cr;</P>
<P>15. 매입채무 및 기타채무</P>
<P>(1) 당기말과 전기말 현재 매입채무 및 기타채무의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="736">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="5" WIDTH="736" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="158" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="290" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="288" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">유동</TH>
<TH WIDTH="145" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비유동</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">유동</TH>
<TH WIDTH="144" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">매입채무</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,131,807 </TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,389,097 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">미지급금</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,340,608 </TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,271,215 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">미지급비용</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,203,837 </TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,604,294 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">예수보증금</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,866,000 </TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,718,239 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">금융보증부채</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,467 </TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,847 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,453 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">임대보증금</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,337,241 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,995,715 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">116,560,719 </TD>
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,339,088 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">111,991,298 </TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,995,715 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기말과 전기말 현재 금융보증부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="765">

<COLGROUP>
<COL WIDTH="290"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="765" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="299" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN USERMARK=" BC0XD7D7D7">제공받은 기업</SPAN>
</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증제공처</TH>
<TH WIDTH="63" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical Japan Co., Ltd.</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">㈜신한은행</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER">0.70%</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">8,255 </TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">8,453 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">㈜국민은행</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER">0.65%</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">12,058 </TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="455" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3" ALIGN="CENTER">합계</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">20,313 </TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">8,453 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>16. 차입금 등&cr;(1) 당기말과 전기말 현재 차입금 등의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="738">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="738" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="148" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="296" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="294" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="148" HEIGHT="30">차입금</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">52,016,970 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">90,000,000 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">4,355,409 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">    - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="148" HEIGHT="30">사채</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">89,925,922 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">199,640,496 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">89,921,321 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">289,196,132 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="148" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">141,942,892 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">289,640,496 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">94,276,730 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">289,196,132 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기말과 전기말 현재 단기차입금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="738">

<COLGROUP>
<COL WIDTH="168"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="5" WIDTH="738" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="177" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융기관</TH>
<TH WIDTH="130" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">이자율</TH>
<TH WIDTH="130" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="30">단기차입금</TD>
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수출입은행</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1.72%</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,000,000 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" VALIGN="MIDDLE" HEIGHT="30">수출채권 할인(*)</TD>
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">㈜신한은행 외</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.81%~5.80%</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,016,970 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,355,409 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="479" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합계</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,016,970 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,355,409 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) L/C조건의 외화매출채권 중 할인 후 만기가 도래하지 않은 금액입니다.&cr;&cr;(3) 당기말과 전기말 현재 장기차입금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="738">

<COLGROUP>
<COL WIDTH="168"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="738" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="177" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="172" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="53" VALIGN="MIDDLE">장기차입금</TD>
<TD WIDTH="172" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">케이비그레이트&cr;베어제일차(유)</TD>
<TD WIDTH="130" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2.27%</TD>
<TD WIDTH="130" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">90,000,000 </TD>
<TD WIDTH="129" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(4) 당기말과 전기말 현재 사채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="741">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="5" WIDTH="741" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">만기일</TH>
<TH WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">표면이자율</TH>
<TH WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제11회 무보증사채</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.10.27</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.83%</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-  </TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제12회 무보증사채</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.07.23</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.57%</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,000,000 </TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제13회 무보증사채</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.04.25</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.05%</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000,000 </TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제14회 무보증사채</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.10.30</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.06%</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000,000 </TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="445" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감: 사채할인발행차금</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(433,582)</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(882,547)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="445" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감: 유동성사채</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(89,925,922)</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(89,921,321)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="445" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채</TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">199,640,496 </TD>
<TD WIDTH="148" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">289,196,132 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(4) 당기말 현재 차입금, 사채 및 금융거래 한도약정과 관련하여 당사가 차입처 등에 담보로 제공한 자산은 없습니다. &cr;</P>
<P>17. 이연수익&cr;당기말과 전기말 현재 이연수익의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="637">

<COLGROUP>
<COL WIDTH="322"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="637" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="331" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="331" HEIGHT="30">정부보조금 관련 이연수익</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,157,582 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;이연수익은 경상연구개발비 정부보조금으로 경상연구개발비에 대응하여 상계 되었습니다.&cr;</P>
<P>18. 기타부채&cr;(1) 당기말과 전기말 현재 기타부채의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="802" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="205"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="802" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="214" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" ALIGN="CENTER" ROWSPAN="2">구분</TH>
<TH WIDTH="294" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7" COLSPAN="2">제 19(당) 기</TH>
<TH WIDTH="294" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7" COLSPAN="2">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">유동</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">비유동</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">유동</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30">예수금</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">5,110,877 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">5,519,187 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">      - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30">부가세예수금</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">4,605,317 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">1,892,064 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">  - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30">계약부채</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">7,315,828 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">15,984,497 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">             6,606,846 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30"> 16,628,825 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30">기타충당부채</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">2,100,000 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30">종업원급여</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">11,258,429 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">2,213,283 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">9,921,729 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">1,512,512 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">30,390,451 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">18,197,780 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">23,939,826 </TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">18,141,337 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(2) 계약부채&cr;</SPAN>
<SPAN>1) 유동 계약부채 중 2,146,579천원 및 비유동 계약부채 15,984,497천원은 Upfront Fee 수취금액이며, 보고기간에 인식한 수익은 565,215천원입니다(주석 31참조</SPAN>
<SPAN>)</SPAN>
<SPAN>.</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;2) 반품관련 계약부채</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="611" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="203" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="611" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">Ⅰ. 계약부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기   초   잔   액</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">6,045,193 </TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">              5,417,458 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당  기  설 정 액</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">3,694,033 </TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">5,938,490 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당  기  사 용 액</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">(4,596,997)</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">(5,310,755)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기   말   잔   액</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">5,142,229 </TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">6,045,193 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="611" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">Ⅱ. 반환제품회수권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기   초   잔   액</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">1,826,622 </TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">              1,339,444 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당  기  설 정 액</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">1,127,930 </TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">2,091,882 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당  기  사 용 액</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">(1,394,574)</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">(1,604,704)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기   말   잔   액</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">1,559,978 </TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">1,826,622 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>19. 퇴직급여&cr;당사는 종업원을 위한 퇴직급여제도로서 확정기여제도를 운영하고 있습니다.&cr;</P>

<P>
<SPAN>당기와 전기 중 확정기여제도와 관련하여 비용으로 인식한 금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="629" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT">7,987,893 </TD>

<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">
<SPAN>7,267,882 </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>상기의 퇴직급여 중 미지급금으로 계상되어 있는 금액은 당기 </SPAN>
<SPAN></SPAN>
<SPAN>6,893,300</SPAN>
<SPAN>천원(전기 6,282,356천원)입니다. </SPAN>
</P>
<P></P>
<P>20. 자본금&cr;당기말과 전기말 현재 자본금의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="637" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="637" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">발행할 주식의 총수</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">32,000,000 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">32,000,000 주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">1주당 액면금액</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">2,500 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">2,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">발행한 주식의 수</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">11,586,575 주</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">11,586,575 주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">자본금</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">28,966,437,500 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">28,966,437,500 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>21. 자기주식&cr;당기말 현재 당사가 주가안정 등의 목적으로 보유 중인 </SPAN>
<SPAN>자기주식수는</SPAN>
<SPAN></SPAN>
<SPAN> 823,880주 이며, 장부금액은 29,236,490천원입니다. </SPAN>
<SPAN>상법상의</SPAN>
<SPAN> 규정에 따라 당기말 현재 당사가보유 중인 자기주식의 의결권은 제한되어 있으며, 동 자기주식은 주식시장의 여건을 고려하여 향후 매각될 예정입니다.</SPAN>
</P>
<P>&cr;</P>
<P>22. 기타불입자본 및 기타자본구성요소&cr;(1) 당기말과 전기말 현재 기타불입자본의 내역은 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="636" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="636" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">주식발행초과금</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">100,357,854 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">100,357,854 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">주식선택권</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">907,533 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">507,319 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">기타자본잉여금</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">10,856,488 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">62,639 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합      계</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">112,121,875 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">100,927,812 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>(2) 주식기준보상&cr;가. 당기말 현재 당사가 보유하고 있는 주식기준 보상약정은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="675">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="178"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="300" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구           분</TH>
<TH WIDTH="188" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2차</TH>
<TH WIDTH="187" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1차</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">부여일</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2019.03.06</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2018.09.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">부여주식의 총수</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,257 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,752 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">철회 및 소멸수량</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,148)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,912)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">기대소멸율</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.0%</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">행사수량</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">                          - </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">                              - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">당기말 수량</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,109 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,840 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">공정가치(단위 : 원)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,535 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,156 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">행사가격(단위 : 원)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">195,020 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">194,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">무위험이자율</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.85%</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2.07%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">행사가능기간</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2022.03.06~2023.03.06</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2021.09.21~2022.09.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">만기</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4년</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">기대존속기간</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.5년</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">가득조건</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">용역제공조건:3년</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">용역제공조건:3년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">총보상원가(단위 : 천원)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">683,592 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">646,699 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">잔여보상원가(단위 : 천원)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">267,574 </TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">155,184 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>나. 당기말과 전기말 현재 당사가 부여하고 있는 주식선택권 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="670" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="215"></COL>
<COL WIDTH="214"></COL>
<COL WIDTH="214"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="670" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 개)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="224" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구           분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기초</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">21,539 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">                  10,752 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">부여</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">12,257 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">상실</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">(1,590)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">(1,470)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">행사</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">                           - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기말</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">19,949 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">21,539 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30">기말 현재 행사가능수량</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30">                           - </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<P>
<SPAN>다. 당기 중 발생한 보상원가의 내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="667">

<COLGROUP>
<COL WIDTH="276"></COL>
<COL WIDTH="182"></COL>
<COL WIDTH="182"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="667" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="285" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">292,432 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">308,259 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30">경상연구비</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">51,993 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">                67,442 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30">제조원가</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">55,790 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">                 59,838 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">400,215 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT">435,539 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN></SPAN>
<SPAN>(3) </SPAN>
<SPAN>당기말과 전기말 현재 기타자본구성요소의 내역은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="673">

<COLGROUP>
<COL WIDTH="287"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="179"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="673" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="296" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구           분</TH>
<TH WIDTH="189" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="188" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="296" HEIGHT="30">기타포괄손익-공정가치금융자산평가손익</TD>
<TD WIDTH="189" HEIGHT="30" ALIGN="RIGHT">(7,535,378)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">(6,753,073)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>
<P>23. 이익잉여금&cr;(1) 당기말과 전기말 현재 이익잉여금의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="636" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="636" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="212" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">이익준비금(*)</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">12,336,721 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">11,717,469 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">임의적립금</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">455,050,000 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">441,650,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">미처분이익잉여금</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">4,330,723 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">21,403,746 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">471,717,444 </TD>
<TD WIDTH="212" ALIGN="RIGHT" HEIGHT="30">474,771,215 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 당사는 상법상의 규정에 따라 자본금의 50%에 달할 때까지 매 결산기마다 금전에 의한 이익배당액의 10% 이상을 이익준비금으로 적립하도록 되어 있으며, 동 이익준비금은 현금으로 배당할 수 없으나 자본전입 또는 결손보전을 위해서는 사용될 수 있습니다.&cr;</P>
<P>(2) 당기와 전기 중 이익잉여금의 처분(안)은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="746" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="283"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="746" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="292" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">과목</TH>
<TH COLSPAN="2" WIDTH="228" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="226" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">Ⅰ. 미처분이익잉여금</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">4,330,723 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">21,403,746 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">  1. 전기이월미처분이익잉여금</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">1,191,973 </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">1,175,399 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">  2. 당기순이익</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">3,138,750 </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">20,228,347 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">Ⅱ. 임의적립금등의이입액</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">4,000,000 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">  1. 연구및인력개발준비금</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">4,000,000 </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">Ⅲ. 이익잉여금처분액</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">(7,103,379)</TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">(20,211,773)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">  1. 이익준비금</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">645,762 </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30"> 619,252 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">  2. 연구및인력개발준비금</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30"> 3,350,000 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">  3. 시설적립금</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">6,700,000 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">  4. 사업확장적립금</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">3,350,000 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="292" HEIGHT="99">
<SPAN>  5. 배당금&cr;(현금배당&cr;</SPAN>
<SPAN> 주당배당금(율) 보통주: </SPAN>
<SPAN>당기</SPAN>
<SPAN>600</SPAN>
<SPAN>원(</SPAN>
<SPAN>24%</SPAN>
<SPAN>)</SPAN>
<SPAN>&cr; </SPAN>
<SPAN>                                전기600원(24%))</SPAN>
</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="99" VALIGN="MIDDLE"> 6,457,617 </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="99" VALIGN="MIDDLE"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="99" VALIGN="MIDDLE">6,192,521 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="99" VALIGN="MIDDLE">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" HEIGHT="30">Ⅳ. 차기이월미처분이익잉여금</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">1,227,344 </TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="113" ALIGN="RIGHT" HEIGHT="30">1,191,973 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>상기 이익잉여금처분의 당기 처분예정일</SPAN>
<SPAN>은 </SPAN>
<SPAN></SPAN>
<SPAN>2021년 3월</SPAN>
<SPAN> </SPAN>
<SPAN>26</SPAN>
<SPAN></SPAN>
<SPAN>일이며</SPAN>
<SPAN>, </SPAN>
<SPAN>전기 처분확정일은 2020년 3월 20일이었습니다.</SPAN>
</P>
<PGBRK></PGBRK>
<P>24. 배당금&cr;당기와 전기 배당금의 지급내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="623" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">보통주 배당금</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">6,192,521 </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">6,192,522 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;25. 판매관리비 및 경상연구개발비&cr;(1) 당기와 전기 중 판매관리비의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">54,397,657 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">56,217,694 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">4,402,538 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">3,995,137 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">복리후생비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">10,594,037 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">11,502,340 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">감가상각비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,070,088 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,100,358 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,488,548 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,219,148 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">사용권자산상각비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">959,625 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">774,608 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">지급임차료</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">283,139 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">576,761 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">세금과공과</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,675,032 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,703,683 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">여비교통비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">9,676,732 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">10,278,730 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">통신비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">56,737 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">34,297 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">수도광열비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">490,230 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">490,538 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">수선비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">220,327 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">372,728 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">보험료</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">460,767 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">474,940 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">접대비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">153,885 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">234,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">광고선전비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">45,698,961 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">68,146,579 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">운반비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">5,966,701 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">5,563,668 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">지급수수료</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">122,228,025 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">106,487,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">대손상각비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">3,712,124 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,150,559 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">회의비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">609,286 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">793,836 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">교육훈련비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">614,493 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,796,002 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">도서비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">563,672 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">941,529 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">시장조사비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">162,334 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">417,178 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">차량유지비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">98,816 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">129,358 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">판촉비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">968,361 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">440,367 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">문헌제작비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">735,787 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">468,863 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">소모품비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">410,346 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">501,963 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">해외시장개척비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">3,084,912 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">3,963,776 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">수출비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">356,607 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">369,791 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">292,432 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">308,259 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">272,432,199 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">282,454,282 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기 중 연구개발활동과 관련하여 지출된 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="625" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH USERMARK=" BC0XD7D7D7" WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">급여</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">10,497,061 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">9,962,913 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">975,700 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">833,671 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">복리후생비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">1,250,993 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">1,081,074 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">지급수수료</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">24,258,953 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">26,786,532 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">재료비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">14,499,750 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">24,644,599 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">기타시험연구비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">39,925,182 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">22,266,468 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">기타</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">13,566,025 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">14,150,423 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">104,973,664 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">99,725,680 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>26. 비용의 성격별 분류&cr;(1) 당기와 전기 중 발생한 비용을 성격별로 분류한 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">제품과 재공품의 변동</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,173,524 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">836,092 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">원재료와 저장품의 사용액</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">141,084,631 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">165,705,103 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">상품의 판매</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">301,848,933 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">308,982,736 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">종업원급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">100,454,710 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">103,053,229 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">지급수수료</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">161,558,306 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">147,665,625 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">광고비 및 판매촉진비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">46,667,321 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">68,914,852 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">복리후생비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">15,402,016 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">16,228,061 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">감가상각</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">31,655,854 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">30,390,399 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">외주가공비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">15,417,174 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">23,437,220 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">여비교통비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">9,986,793 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">10,621,966 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">교육훈련비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">659,430 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,741,937 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">운반비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">5,966,701 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">5,563,668 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">기타</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">100,249,835 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">89,591,574 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">932,125,228 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">973,732,462 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기와 전기 중 발생한 종업원급여의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">급여 및 상여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">92,066,602 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">95,349,809 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">7,987,893 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">7,267,882 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">주식보상비</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">400,215 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">435,539 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">100,454,710 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">103,053,230 </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>27. 기타수익비용</P>
<P>(1) 당기와 전기 중 기타수익 및 기타비용의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="625" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="625" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">Ⅰ. 기타수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">  임대료수익</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,806,680 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,664,183 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">  용역수익</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">907,683 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">1,026,101 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">  수수료수익</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">93,990 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">314,350 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">  유형자산처분이익</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">33,163 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">381,437 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">  투자부동산처분이익</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">8,069,640 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">  무형자산처분이익</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">633 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">  리스변경이익</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">501 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">  잡이익</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">825,473 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">895,529 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">기타수익 소계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">12,737,763 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">5,281,600 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="625" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="3">Ⅱ. 기타비용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  임대비용</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(3,443,213)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(3,484,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  용역비용</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(972,497)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(1,311,770)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  유형자산처분손실</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(6,433)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(337,389)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  투자부동산처분손실</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(278,467)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(14,528)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  무형자산처분손실</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(274,563)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  무형자산손상차손</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(7,210,650)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(603,220)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  종속기업투자주식손상차손</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(5,087,942)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(4,296,679)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  기부금</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(963,819)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(1,769,219)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">  잡손실</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(2,349,813)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(1,104,623)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">기타비용 소계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(20,587,397)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(12,921,641)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">Ⅲ. 기타손익(Ⅰ+Ⅱ)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(7,849,634)</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">(7,640,041)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>28. 법인세비용&cr;(1) 당기와 전기 중 법인세비용의 구성내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="648" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="340"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="648" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="349" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="349" HEIGHT="30">법인세부담액</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">1,882,888 </TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">1,222,053 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="349" HEIGHT="30">일시적차이 증감으로 인한 이연법인세 변동액</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">(9,610,238)</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">(5,099,567)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="349" HEIGHT="30">자본에 직접 가감되는 당기법인세</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">(3,196,298)</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">(49,108)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="349" HEIGHT="30">과거기간 법인세와 관련되어 인식한 당기조정액</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">108,579 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="349" HEIGHT="30">법인세비용(수익)</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">(10,923,648)</TD>
<TD WIDTH="149" ALIGN="RIGHT" HEIGHT="30">(3,818,043)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 당기와 전기 중 자본에 반영된 법인세비용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="653">

<COLGROUP>
<COL WIDTH="342"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="653" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="351" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">　구분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30">  기타포괄손익-공정가치금융자산평가손익</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">249,759 </TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">(49,108)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30">  자기주식처분이익</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">(3,446,057)</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">  합계</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">(3,196,298)</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">(49,108)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(3) 당기와 전기의 법인세비용차감전순이익과 법인세비용간의 관계는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="650">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="650" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="354" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="148" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="148" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">법인세비용 차감 전 순이익</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(7,784,897)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">16,410,305 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">적용세율에 따른 부담액</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">3,588,267 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="650" HEIGHT="30" COLSPAN="3">조정사항</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">  비공제비용</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">2,502,206 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT"> 2,294,203 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">  세액공제</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(7,224,951)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(6,798,620)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">  이월세액공제의 이연법인세효과</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(5,545,854)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(4,513,434)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">  과거기간 법인세와 관련되어 인식한 당기 조정액</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">108,579 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">  기타</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(655,049)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">1,502,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">법인세비용(수익)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(10,923,648)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(3,818,043)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">유효세율</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(4) 당기와 전기 중 당사의 일시적 차이 및 이연법인세자산(부채)의 증감내역과 상계전 총액기준 이연법인세자산(부채)의 증감내역은 다음과 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="839">

<COLGROUP>
<COL WIDTH="220"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="839" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="229" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">관련 계정과목</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">기초잔액</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">증가</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">감소</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">기말잔액</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">인식한 이연법인세&cr;자산(부채)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="839" VALIGN="MIDDLE" COLSPAN="6" HEIGHT="30"><차감할 일시적차이></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">재고자산평가충당금</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,594,299 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,968,267 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,562,566 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,072,141 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">대손충당금</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,598,216 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,172,528 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,770,744 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,574,520 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">반품관련계약부채</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,218,571 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">636,321 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,582,250 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">866,905 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">감가상각비</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,526,951 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">437,362 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,964,313 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,443,364 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">미지급연월차</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,921,728 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,336,701 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,258,429 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,724,540 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">장기종업원충당부채</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,512,513 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">700,770 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,213,283 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">535,614 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">공정가치측정금융자산</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,853,268 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,853,268 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,416,491 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">공정가치측정금융자산평가</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">348,147 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,590,016 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,241,869)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(300,532)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">장기선수수익</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,190,478 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">967,619 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,158,097 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,394,259 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,579,017 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,479,196 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,058,213 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,252,501 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소계</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,343,188 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,062,443 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,226,337 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">76,179,294 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,979,803 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="839" VALIGN="MIDDLE" COLSPAN="6" HEIGHT="30"><가산할 일시적차이></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">수수료매출</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,752,439)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(642,312)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(17,394,751)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,209,530)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">압축기장충당금</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(7,677,300)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(7,677,300)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,857,907)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">외화평가</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(766,497)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,483,772 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,717,275 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,867,580 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소계</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(25,196,236)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,841,460 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(17,354,776)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,199,857)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="839" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="6"><이월세액공제></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">연구인력개발비 세액공제 등</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,042,927 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,042,318 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,293,490 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,791,755 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,588,781 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">이연법인세자산(부채)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,758,489 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,368,727 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="839">

<COLGROUP>
<COL WIDTH="220"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="839" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="229" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">관련 계정과목</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">기초잔액</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">증가</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">감소</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">기말잔액</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">인식한 이연법인세&cr;자산(부채)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="839" VALIGN="MIDDLE" COLSPAN="6" HEIGHT="30"><차감할 일시적차이></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">재고자산평가충당금</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,226,584 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,367,715 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,594,299 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        1,111,820 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">대손충당금</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,667,309 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">930,907 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,598,216 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        2,564,768 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">반품관련계약부채</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,081,546 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 137,025 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,218,571 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        1,020,894 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">감가상각비</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,543,663 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,016,712 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,526,951 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        1,337,522 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">미지급연월차</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,508,916 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">412,812 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,921,728 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        2,401,058 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">장기종업원충당부채</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,208,043 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">304,470 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,512,513 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          366,028 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">공정가치측정금융자산</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,853,268 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,853,268 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        1,416,491 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">공정가치측정금융자산평가</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">551,074 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">202,927 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">348,147 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            84,252 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">장기선수수익</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 12,716,157 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,474,321 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,190,478 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        4,160,096 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,564,842 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 14,175 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,579,017 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        1,350,122 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소계</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,921,402 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   7,641,425 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,219,639 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,343,188 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      15,813,051 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="839" VALIGN="MIDDLE" COLSPAN="6" HEIGHT="30"><가산할 일시적차이></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">수수료매출</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(20,832,329)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,079,890)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,752,439)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,054,090)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">압축기장충당금</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(7,677,300)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(7,677,300)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,857,907)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">외화평가</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(686,856)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">79,641 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(766,497)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(185,492)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소계</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(29,196,485)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,000,249)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(25,196,236)</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,097,489)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="839" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="6"><이월세액공제></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">연구인력개발비 세액공제 등</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,529,493 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,025,526 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,512,091 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,042,928 </TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      10,042,927 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" HEIGHT="30">이연법인세자산(부채)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,658,922 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      19,758,489 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(5) 미인식 이연법인세자산ㆍ부채&cr;당사는 당기말 현재 일시적차이의 소멸시점을 통제할 수 있으며, 예측가능한 미래에 일시적차이가 소멸하지 않을 가능성이 높을 것으로 판단한 종속기업 및 관계기업 투자지분의 일시적차이에 대하여 이연법인세자산을 인식하지 않았습니다.&cr;</P>
<PGBRK></PGBRK>
<P>29. 주당이익&cr;주당이익은 보통주 1주에 대한 이익(기본주당이익) 또는 보통주 및 희석성 잠재적보통주 1주에 대한 이익(희석주당이익)을 계산한 것으로 그 내역은 다음과 같습니다.&cr;&cr;(1) 기본주당이익</P>

<TABLE BORDER="1" WIDTH="653" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="211"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="653" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="220" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="220" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">당기순이익</TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">3,138,750,606 </TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">20,228,347,713 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">가중평균유통보통주식수(*)</TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">10,662,499 주</TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">10,320,870 주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">기본주당이익</TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">294 </TD>
<TD WIDTH="220" ALIGN="RIGHT" HEIGHT="30">1,960 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 가중평균유통보통주식수는 발행한 주식수에서 당사가 보유하고 있는 자기주식을 차감하여 가중평균해서 산정하였습니다.&cr;</P>
<P>(2) 당기에 부여한 주식선택권의 희석효과가 발생하지 않아 희석주당이익은 기본주당이익과 동일합니다.</P>

<P>
<SPAN>&cr;30. 특수관계자 거래 </SPAN>
<SPAN>&cr;</SPAN>
<SPAN>(1) 당기말과 전기말 현재 당사의 특수관계자 현황은 다음과 같습니다.&cr;가. 지배기업 및 주요 주주</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="644">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">지배기업 등</TH>
<TH COLSPAN="2" WIDTH="322" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">당사에 대한 지분율</TH>
<TH ROWSPAN="2" WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" ALIGN="CENTER">(주)대웅</TD>
<TD WIDTH="161" ALIGN="CENTER" HEIGHT="30">45.07%</TD>
<TD WIDTH="161" ALIGN="CENTER" HEIGHT="30">41.25%</TD>
<TD WIDTH="161" ALIGN="CENTER" HEIGHT="30">지주회사</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>나. 종속기업, 관계기업 및 기타 특수관계자</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1000">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="253"></COL>
<COL WIDTH="253"></COL>
<COL WIDTH="341"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계 구분</TH>
<TH WIDTH="262" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="262" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
<TH WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비      고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="611" ROWSPAN="15" ALIGN="CENTER" VALIGN="MIDDLE">종속기업</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical (Thailand)Co., Ltd.</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical (Thailand)Co., Ltd.</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">PT. Dewoong Pharmaceutical (Indonesia)Co., Ltd.</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">PT. Dewoong Pharmaceutical (Indonesia)Co., Ltd.</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">PT. Dewoong Pharmaceutical (Indonesia)Co., Ltd.의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG의&cr; 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Daewoong America, Inc.</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Daewoong America, Inc.</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical India Pvt., Ltd.</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical India Pvt., Ltd.</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">HPI, INC.</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">HPI, INC.</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">한올바이오파마(주)의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아피셀 테라퓨틱스 (*1)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아이엔 테라퓨틱스 (*1)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">관계기업</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)엠디웰아이앤씨</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)엠디웰아이앤씨</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)이피피미디어</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)이피피미디어</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)바이오시네틱스</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)바이오시네틱스</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">건강한삶기술창업벤처PEF</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">건강한삶기술창업벤처PEF</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">㈜다나아데이터</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">㈜다나아데이터</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Immplacate, Inc.</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Immplacate, Inc.</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="690" ROWSPAN="23" ALIGN="CENTER" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">대웅바이오㈜</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">대웅바이오(주)</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">사천대웅생물기술유한공사</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">사천대웅생물기술유한공사</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대웅바이오(주)의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)HR그룹</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)HR그룹</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아이디에스앤트러스트</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아이디에스앤트러스트</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅경영개발원</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅경영개발원</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅생명과학</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅생명과학</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)디엔컴퍼니</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)디엔컴퍼니</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">대웅엔지니어링(주)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">대웅엔지니어링(주)</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)산웅개발</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)산웅개발</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피코프</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피코프</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)디톤</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)디톤</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피바이오</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피바이오</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피스페이스</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피스페이스</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)이지메디컴</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)이지메디컴</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">- (*2)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)인성정보</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅개발</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅개발</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)팜팩</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)팜팩</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">- (*2)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)인성디지탈</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">- (*2)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아이넷뱅크</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)시지바이오</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)시지바이오</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">STH이솔루션</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">STH이솔루션</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">- (*2)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)벤치비</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주) 엠서클 등</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주) 엠서클 등</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 당기 중 지분 취득을 통해 종속기업으로 편입되었습니다.&cr;(*2) 당기 중 기타 특수관계자에서 제외되었습니다.</P>
<P>&cr;(2) 당기와 전기 중 당사와 특수관계자간의 수익ㆍ비용거래 내역은 다음과 같습니다.가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1121">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="250"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1121" VALIGN="MIDDLE" COLSPAN="10" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="91" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH COLSPAN="4" WIDTH="387" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수익 등</TH>
<TH WIDTH="384" VALIGN="MIDDLE" COLSPAN="4" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비용 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제품/상품&cr;매출</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용역/서비스&cr;제공</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임대수익</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재고자산&cr;매입</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용역/서비스&cr;비용</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연구비용</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="91" HEIGHT="53" ALIGN="CENTER">최상위&cr;지배기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="53">(주)대웅</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,672 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">7,481 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">589,869 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">108,360 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">32,902,664 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">15,322,510 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">55,696 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="11" WIDTH="91" HEIGHT="399" ALIGN="CENTER">종속기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)힐리언스</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,309 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,563 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,600 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,274 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">162,000 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,703 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,526,618 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">한올바이오파마㈜</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,356,231 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,407 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,673 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,207 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,503,444 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,328,634 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,276,801 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">330,542 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">요녕대웅제약유한공사</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">503,823 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,316,320 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85,393 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,761,352 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">Daewoong Pharmaceutical(Thailand)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,644,279 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,214 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="53">PT. Dewoong Pharmaceutical&cr; (Indonesia)Co.,Ltd.</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,963 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">186,015 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">Daewoong America, Inc.</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">196,749 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="53">Daewoong Pharmaceutical&cr; India Pvt., Ltd.</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">995,349 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">PT. DAEWOONG INFION</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">136,233 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,652 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,907,013 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="53">DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">106,589 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">12,254 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,013 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="91" HEIGHT="30" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)엠디웰아이앤씨</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,652 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">536 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,962 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">698 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">214,819 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,384 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="15" WIDTH="91" HEIGHT="450" ALIGN="CENTER">기타&cr;특수관계자</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">대웅바이오㈜ (*1)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,598,022 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,538 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,114 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,592,434 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,986,187 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">115,214 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,990 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)아이디에스앤트러스트</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,494 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,594 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,868 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">786,458 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">444,232 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,655 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)대웅경영개발원</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">151 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">472,997 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,358 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,747 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,120,354 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">344,050 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)대웅생명과학</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">332 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,135 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,014 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">424,855 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)디엔컴퍼니</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,388,094 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,170 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">136,510 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,107 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,251 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,084,672 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,589 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,601,501 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">대웅엔지니어링㈜</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,674 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,174,474 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)산웅개발</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,231 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">128,411 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,231,459 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,961 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)알피바이오</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,729 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">255 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,185,143 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)이지메디컴</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">414,972 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,416 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">818,390 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,959,663 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)인성정보</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,252 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,352,900 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,680 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">674,339 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">568,290 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)팜팩</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">325 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">792 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,905,855 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)시지바이오</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,773,691 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,028 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,760 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,985 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,930,058 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">712,196 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,787 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)엠서클 (*2)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,337 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,649 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,106 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,197 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,715,687 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,410,712 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,318,574 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,040 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,911 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,402 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,655,149 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,296,714 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,425,797 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,455,902 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="350" HEIGHT="30" COLSPAN="2">합        계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,934,489 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">120,909 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,180,018 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">689,213 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,108,634 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">64,359,890 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,072,270 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,513,757 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) </SPAN>
<SPAN>대웅바이오㈜와의 거래에서 발생하는 연구비를 131,502천원 차감 처리하였습니다.&cr;(*2) (주)엠서클과의 거래에서 반품매출이 34,979천원 있습니다.&cr;</SPAN>
<SPAN>&cr;나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1125">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="250"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1125" VALIGN="MIDDLE" COLSPAN="11" ALIGN="RIGHT" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="91" HEIGHT="77" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="77" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">회사명</TH>
<TH COLSPAN="4" WIDTH="345" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">수익 등</TH>
<TH WIDTH="430" VALIGN="MIDDLE" COLSPAN="5" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">비용 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">제품/상품&cr;매출</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">용역/서비스&cr;제공</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">임대수익</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">기타</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">재고자산&cr;매입</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">고정자산&cr;매입</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">용역/서비스&cr;비용</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">연구비용</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">기타</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="91" HEIGHT="49" ALIGN="CENTER" USERMARK="F-10">최상위&cr;지배기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="49" USERMARK="F-10">(주)대웅 (*1)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">1,075 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">53,699 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">458,837 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">554,524 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">29,788,456 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">14,469,818 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">291,905 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="11" WIDTH="91" HEIGHT="371" ALIGN="CENTER" USERMARK="F-10">종속기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)힐리언스</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">14,955 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,622 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,600 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">62,199 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">10,762 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">60 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,682 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,919,232 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">한올바이오파마㈜ (*2)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,085,029 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,705 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">10,756 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">39,839 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,273,238 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">4,200,406 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,819,802 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">21,220 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">요녕대웅제약유한공사</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,072,586 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">8,647,693 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,345,070 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">Daewoong Pharmaceutical(Thailand)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,232,043 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">26,288 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="49" USERMARK="F-10">PT. Dewoong Pharmaceutical(Indonesia)Co.,Ltd.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">38,744 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">129,954 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">Daewoong America, Inc.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">108,845 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">312,312 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="49" USERMARK="F-10">Daewoong Pharmaceutical India Pvt., Ltd.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">849,577 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">PT. DAEWOONG INFION</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">9,923 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">176,051 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,409,959 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="49" USERMARK="F-10">DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">11,696,391 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">195,407 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">24,280 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="91" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">관계기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)엠디웰아이앤씨</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,161 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,351 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,858 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">235,417 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">30,004 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="15" WIDTH="91" HEIGHT="420" ALIGN="CENTER" USERMARK="F-10">기타&cr;특수관계자</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">대웅바이오㈜</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">13,031,904 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">18,496 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">20,669 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">79,376,989 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">505,372 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,138,815 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">224,943 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">20,249 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)아이디에스앤트러스트</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">14,057 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">68,463 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">62,135 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">50 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">415,612 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">67 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">15,348 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)대웅경영개발원</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">477,797 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">28,928 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">28,343 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,293,868 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">582,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)대웅생명과학</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,657 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,636 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">9,892 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">936 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">437,781 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)디엔컴퍼니</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,033,194 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">34,340 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">117,928 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">67,309 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">931,178 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,912,330 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">9,287 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,518,188 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">대웅엔지니어링㈜</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,555 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,195,274 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)산웅개발</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">11,369 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,455 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">120,517 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,273,575 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">273 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">46,292 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)알피바이오</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,403,693 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">19,666 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">10,000 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,852,961 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">91 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">120,615 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)이지메디컴</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">81,139 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">49,918 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">328,242 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">775,234 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,437,047 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)인성정보</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,368 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,333,188 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">58,010 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)대웅개발</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">618,500 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">346,661 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)팜팩</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">563 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">7,223,802 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)시지바이오</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,267,240 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">31,465 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">61,198 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">18,052 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,465,946 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,163,864 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">25,077 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)엠서클</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">277,374 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">126,613 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">58,793 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">80,877 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,401 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">6,093,287 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,100 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">4,204,822 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">기타</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">4,000 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">19,460 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">50,685 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">27,439 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,049,669 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">297,000 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">819,767 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,432,837 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="350" HEIGHT="28" COLSPAN="2" USERMARK="F-10">합        계</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">47,599,521 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">380,049 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,951,044 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,494,793 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">116,598,259 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">505,372 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">53,626,742 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">19,963,666 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">14,428,215 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 전기 중 (주)대웅과 기타무형자산 양수도 거래 1,379,057천원 발생하였습니다.&cr;(*2) 전기 중 한올바이오파마(주)와 HL036 공동개발계약 관련하여 1,500,000천원을 지급하였고, 개발비로 처리하였습니다. </P>
<P></P>
<PGBRK></PGBRK>
<P>(3) 당기말과 전기말 현재 특수관계자에 대한 채권ㆍ채무 내역은 다음과 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1030">

<COLGROUP>
<COL WIDTH="80"></COL>
<COL WIDTH="258"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="9" WIDTH="1030" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="267" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사명</TH>
<TH COLSPAN="4" WIDTH="383" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채권 등</TH>
<TH COLSPAN="3" WIDTH="291" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채무 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매출채권</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대여금</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">임차보증금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타채권</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매입채무</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">임대보증금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">최상위&cr;지배기업</TD>
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="53"> (주)대웅 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">590,688 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,722,988 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">19,210,315 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="89" VALIGN="MIDDLE" HEIGHT="316" ALIGN="CENTER">종속기업</TD>
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)힐리언스 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,600,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,338,293 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">107,720 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 한올바이오파마(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">508,331 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,844 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">928,661 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,800 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,080,683 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 북경대웅위업의약과기유한공사 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,657,793 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,777 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 요녕대웅제약유한공사 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,150,513 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">285,625 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> Daewoong Pharma PHILIPPINES INC. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132,856 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> Daewoong Pharmaceutical(Thailand) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,791,102 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">544,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,587 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="53"> PT. Dewoong Pharmaceutical&cr; (Indonesia)Co.,Ltd. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,963 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> PT. DAEWOONG INFION </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">127,523 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,176,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">309,833 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="53"> DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">20,360 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)엠디웰아이앤씨 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,242 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,838 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,019 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="14" WIDTH="89" VALIGN="MIDDLE" HEIGHT="420" ALIGN="CENTER">기타&cr;특수관계자</TD>
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 대웅바이오(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,383,946 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,231 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,777,047 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,781,706 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)아이디에스앤트러스트 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,822 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">314,337 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">228,551 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅경영개발원 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">362,537 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,575 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅생명과학 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">155,121 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)디엔컴퍼니 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">510,820 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,129 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,570 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">654,971 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,050,814 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 대웅엔지니어링(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,360 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,960 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)산웅개발 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">95,623 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">110,900 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)알피바이오 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">194,968 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,750 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">488,327 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)이지메디컴 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,034 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,014 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,851 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">111,286 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅개발 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">191,058 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,256 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)팜팩 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">94 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,450 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)시지바이오 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">272,399 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,445 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">883,275 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,200,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,418 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)엠서클 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">170 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,063 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">370,533 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,393,809 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 기타 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">415,205 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,894 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,827 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85,421 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">818,357 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="356" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,364,769 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,320,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">291,058 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,994,963 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,571,183 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,529,921 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,103,409 </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1030">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="257"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="9" WIDTH="1030" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사명</TH>
<TH COLSPAN="4" WIDTH="383" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채권 등</TH>
<TH COLSPAN="3" WIDTH="291" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채무 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매출채권</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대여금</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">임차보증금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타채권</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매입채무</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">임대보증금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">최상위&cr;지배기업</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53"> (주)대웅 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">197,814 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">779,743 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">12,820,453 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="90" VALIGN="MIDDLE" HEIGHT="339" ALIGN="CENTER">종속기업</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)힐리언스 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,544 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,500,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,265,499 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,888 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 한올바이오파마(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">320,945 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,494 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">318,865 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,800 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,303,852 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 북경대웅위업의약과기유한공사 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,048,257 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,777 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 요녕대웅제약유한공사 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">647,947 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> Daewoong Pharma PHILIPPINES INC. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,342,678 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53"> Daewoong Pharmaceutical(Thailand) Co.,Ltd. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,499,749 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">578,900 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">69,373 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53"> PT. Dewoong Pharmaceutical (Indonesia)Co.,Ltd. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">36,066 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> PT. DAEWOONG INFION </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">234,637 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,473,400 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,181 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53"> DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">15,615,352 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">20,763 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)엠디웰아이앤씨 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">628 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,520 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="15" WIDTH="90" VALIGN="MIDDLE" HEIGHT="450" ALIGN="CENTER">기타&cr;특수관계자</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 대웅바이오(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,217,024 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">198,130 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,803,974 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">260,832 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)아이디에스앤트러스트 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,853 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">234,062 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,379 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅경영개발원 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">130,187 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88,673 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅생명과학 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">155,121 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,210 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,219 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)디엔컴퍼니 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">552,166 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">126,931 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,394 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">386,387 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">288,674 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 대웅엔지니어링(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">126,028 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,600 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)산웅개발 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,640 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">293,414 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)알피바이오 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">194,968 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,266 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">777,587 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,032 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)이지메디컴 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,181 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">366,235 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,459 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,359 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)인성정보 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">344,406 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅개발 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,818 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,968 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)팜팩 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,680 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">313,079 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)시지바이오 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">220,048 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,069 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">572,746 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,434 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629,338 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)엠서클 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,147 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,655 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">195,018 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,223,546 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 기타 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,100 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,493 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,741 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,023,175 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,048 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="356" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,155,955 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,552,300 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,818 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,894,710 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,752,794 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,771,507 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,829,712 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(4) 당기와 전기 중 특수관계자와의 자금거래 내역은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1006">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="275"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1006" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" COLSPAN="8">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="127" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="284" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">회사명</TH>
<TH COLSPAN="2" WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자금대여 거래</TH>
<TH COLSPAN="2" WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">배당</TH>
<TH COLSPAN="2" WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지분투자</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="100" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대여</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회수</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지급</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수령</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">증자 및 취득</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감자 및 처분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">최상위 지배기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)대웅</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">2,867,833 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">29,918,985 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="150" VALIGN="MIDDLE" ROWSPAN="5">종속기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">10,000,031 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)아피셀 테라퓨틱스</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,967,800 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)아이엔 테라퓨틱스</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,127,925 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,595 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,129,400 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,100,000 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">건강한삶기술창업벤처</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1006">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="275"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1006" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" COLSPAN="8">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="127" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="284" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">회사명</TH>
<TH COLSPAN="2" WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자금대여 거래</TH>
<TH COLSPAN="2" WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">배당</TH>
<TH COLSPAN="2" WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지분투자</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="100" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대여</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회수</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지급</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수령</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">증자 및 취득</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감자 및 처분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">최상위 지배기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)대웅</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">2,831,527</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="143" VALIGN="MIDDLE" ROWSPAN="4">종속기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">힐리언스</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">500,000</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">492,840</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,066,732</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="53" VALIGN="MIDDLE"> Daewoong Pharmaceutical&cr; India Pvt., Ltd. </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">365,659</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,885,760</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">Immplacate, Inc.</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">1,125,970</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="90" VALIGN="MIDDLE" ROWSPAN="3">기타 특수관계자</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)아이넷뱅크</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">2,855</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)아이디에스앤트러스트</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">1,000,000</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)HR그룹</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">200,000</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>&cr;(5) 당사는 기업 활동의 계획, 운영, 통제에 대하여 중요한 권한과 책임을 가진 당기와 전기 중 주요 경영진에 대한 보상을 위해 지급한 금액은 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="637" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="225"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="637" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="234" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30">단기종업원급여</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">706,001 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">767,001 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">50,000 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">37,708 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">756,001 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">804,709 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>(6) 특수관계자간 주요 약정사항&cr;&cr;1) 당기말 현재 당사는 Daewoong Pharmaceutical Japan Co., Ltd.와 요녕대웅제약유한공사에게 지급보증을 제공하고 있습니다(</SPAN>
<SPAN>주석</SPAN>
<SPAN> 15, 31참</SPAN>
<SPAN>조).</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="290"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="299" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN USERMARK=" BC0XD7D7D7">제공받은 기업</SPAN>
</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증제공처</TH>
<TH WIDTH="63" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical Japan Co., Ltd.</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">㈜신한은행</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER">0.70%</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">250,000,000 JPY </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">㈜국민은행</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER">0.65%</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">1,200,000 EUR</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;2) 당사는 2016년 중 종속기업인 한올바이오파마(주)와 안구건조증 치료신약을 공동개발하는 계약을 체결하였습니다. 동 계약에 따라 당사가 지급하게 될 총 기술료는 7,800백만원이며 당기까지 4,450백만원을 지급하였습니다. 향후 연구개발비는 균등하게 부담하기로 약정하였습니다. &cr;&cr;3) 당사는 한올바이오파마(주), 대웅바이오(주) 및 기타 특수관계자간에 의약품, 의료기기 및 이와 유사한 품목 등에 대해 상호 판매대행계약을 체결하였습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;(7) 당기 중 특수관계자와의 리스 약정계약에 따라 지급한 금액과 재무제표에 인식한 리스관련 항목은 다음과 같습니다.&cr;&cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="906">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="906" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">구  분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">회사의 명칭</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">사용권자산</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">지급액</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">당기말&cr;리스부채</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">당기&cr;이자비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타특수관계자</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜대웅개발</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,270,056 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">474,192 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,308,091 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,616 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최상위지배기업</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜대웅</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">293,394 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,003 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">297,647 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,992 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="906">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="906" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">구  분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">회사의 명칭</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">사용권자산</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">지급액</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">당기말&cr;리스부채</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">당기&cr;이자비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">종속기업</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,229 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,641 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,785 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,150 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>31. 우발채무 및 약정사항&cr;(1) 소송사건&cr;가. 메디톡스 영업비밀침해 소송</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="664">

<COLGROUP>
<COL WIDTH="131"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>계류법원</P>
</TH>

<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>원고</P>
</TH>

<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>피고</P>
</TH>

<TH WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>사건내용</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>진행상황</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="140" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">
<P>미국 무역위원회 &cr;(International Trade Commission)</P>
</TD>

<TD WIDTH="151" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">
<P>앨러간, 메디톡스</P>
</TD>

<TD WIDTH="107" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">

<P>
<SPAN>대웅제약 및&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>에볼루스</SPAN>
<SPAN></SPAN>
</P>
</TD>

<TD WIDTH="165" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">
<P>영업비밀침해</P>
</TD>
<TD WIDTH="101" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">최종판결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="140" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">
<P>서울중앙지방법원</P>
</TD>

<TD WIDTH="151" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">
<P>메디톡스</P>
</TD>

<TD WIDTH="107" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">
<P>대웅 및&cr;대웅제약</P>
</TD>

<TD WIDTH="165" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">
<P>영업비밀침해</P>
</TD>

<TD WIDTH="101" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">
<P>1심 진행중</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>2019년 2월 4일 미국국제무역위원회에 제기되었던 영업비밀침해 소송에 대해서 2020년 12월 16일 미국국제무역위원회 행정판사는 최종판결에서 대웅제약의 보툴리늄 톡신 제제가 관세법 337조를 위반했다고 판결하고 21개월간의 미국 수입금지명령을 내렸으나 그 결과가 재무제표에 미치는 영향이 없다고 판단되어 기말 현재 충당부채로 인식한 금액은 없습니다. 또한, 2021년 2월 15일 당사는 미국국제무역위원회의 최종결정에 대해서 미국 연방순회항소법원(CAFC)에 항소하였고, 신속절차진행을 요청하였으며 법원은 미국국제무역위원회의 최종결정에 대해서 당사가 신청한 임시가처분 신청을 인용하였습니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>나. 상기의 건 이외에 당사가 피소되어 계류 중인 소송사건 1건이 있습니다. 당사의 경영진은 상기 소송사건 결과의 합리적인 예측이 불가능하고 자원의 유출금액 및 시기가 불확실하며 그 결과가 재무제표에 미치는 영향이 중요하지 않을 것으로판단하고 있어 당기말 현재 충당부채로 인식한 금액은 없습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>
<PGBRK></PGBRK>
<P>(2) 당기말 현재 금융기관과 체결한 주요 약정 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="648">

<COLGROUP>
<COL WIDTH="222"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="648" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(원화단위: 천원, 외화단위: USD,EUR,JPY)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="231" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="146" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정종류</TH>
<TH WIDTH="271" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">한도금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)산업은행</TD>
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당좌차월</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KRW</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">27,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)우리은행</TD>
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당좌차월</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KRW</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">13,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2">㈜국민은행</TD>
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">구매카드</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KRW</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">9,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">외화지급보증</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">EUR</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,200,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)신한카드</TD>
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">신용카드</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KRW</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,500,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">㈜현대카드</TD>
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">신용카드</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KRW</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3,600,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">㈜삼성카드</TD>
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">신용카드</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KRW</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,800,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="3">(주)신한은행</TD>
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">수입신용장</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">USD</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">10,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">수출 매입외환</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">USD</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">5,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">외화지급보증</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">JPY</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">250,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="377" HEIGHT="120" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="4" COLSPAN="2">합      계</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">USD</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">15,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">JPY</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">250,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">EUR</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,200,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KRW</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">57,900,000 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(3) 당기말 현재 당사는 </SPAN>
<SPAN>Daewoong Pharmaceutical Japan Co., Ltd.와 요녕대웅제약유한공사에게 지급보증을 제공하고 있습니다(주석</SPAN>
<SPAN> 15, 30참</SPAN>
<SPAN>조).&cr;</SPAN>
<SPAN>&cr;(4) 당기말 현재 당사가 타인으로부터 제공받은 보증의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="653" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="208"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="653" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제공자</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보증금액</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보증내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30" ALIGN="CENTER">서울보증보험(주)</TD>
<TD WIDTH="218" ALIGN="RIGHT" HEIGHT="30">497,274 </TD>
<TD WIDTH="217" HEIGHT="30" ALIGN="CENTER">계약이행보증 등</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(5)  영업 관련 주요 약정사항</SPAN>
</P>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">당</SPAN>
<SPAN USERMARK=" 0X000000">사는 미국의 Evolus외 14개사와 계약을 체결하고 2020년까지 Upfront Fee  USD 16,824,000를 수취하였습니다. 동 Upfront Fee는 향후 제품이 매출될 것으로 예상되는 기간동안 합리적으로 배분하여 수익으로 인식하고 있으며, 이와 관련하여 수취한 금액은 계약부채로 계상하고 있습니다.</SPAN>
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
<SPAN USERMARK=" 0X000000">&cr;</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">(6) 2019년 9월 26일 식품의약품안전처는 발암물질 성분인 NDMA가 포함되어 국내 유통 중인 라니티딘 원료의약품(7종)과 이를 사용한 완제의약품(269품목) 전체에 대해 잠정적으로 제조ㆍ수입ㆍ판매 중지 및 회수 조치하고 처방을 제한하도록 하였으며, 해당 조치에는 당사의 완제의약품인 알비스정 및 알비스D정이 포함되었습니다. 식품의약품안전처는 전문가 자문을 거쳐 라니티딘 성분 의약품을 단기 복용한 경우 인체 위해우려는 크지 않다고 밝혔으나, 해당 의약품에 장기적으로 노출되었을 때 인체에 미치는 영향을 조사ㆍ평가 할 계획입니다. 동 조사를 토대로 한 식품의약품안전처의 후속 조치 결과가 당사의 재무제표에 미칠 영향은 현재로서는 예측할 수 없습니다.</SPAN>
</P>
<P>&cr;32. 비현금거래&cr;당기의 현금의 유입과 유출이 없는 중요한 거래내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="675" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="393"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="675" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="402" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">내     용</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="402" HEIGHT="30">건설중인자산의 유형자산 및 무형자산 본계정 대체</TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">3,586,483 </TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30">50,943,556 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="402" HEIGHT="30">유형자산 취득 관련 미지급금 변동</TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">1,704,738 </TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30">211,077 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="402" HEIGHT="30">무형자산 취득 관련 미지급금 변동</TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">(2,308,978)</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30">1,939,549 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="402" HEIGHT="30">무형자산 취득 관련 선급금 변동</TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">(1,311,567)</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30">(1,138,923)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="402" HEIGHT="30">종속기업주식 취득 관련</TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">627,925 </TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30">365,659 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;33. 위험관리&cr;(1) 금융위험관리 &cr;당사는 여러 활동으로 인하여 시장위험(외환위험, 가격위험, 현금흐름 및 공정가치 이자율 위험), 신용위험 및 유동성 위험과 같은 다양한 금융 위험에 노출되어 있습니다. 당사의 전반적인 위험관리는 당사의 재무성과에 잠재적으로 불리할 수 있는 효과를 최소화하는데 중점을 두고 있습니다. </P>
<P></P>
<P>위험관리는 이사회에서 승인한 정책에 따라 중앙 자금부서(당사 재무팀)에 의해 이루어지고 있습니다. 당사 재무팀은 영업부서들과 긴밀히 협력하여 금융위험을 식별, 평가 및 회피하고 있습니다.&cr;</P>
<PGBRK></PGBRK>
<P>가. 시장위험 &cr;① 외환위험&cr;당사의 외환위험은 주로 인식된 자산과 부채의 환율변동과 관련하여 발생하고 있습니다. 외환위험은 미래예상거래 및 인식된 자산ㆍ부채가 기능통화 외의 통화로 표시될 때 발생하고 있습니다.</P>
<P>&cr;당기말과 전기말 현재 당사가 보유하고 있는 외화표시 화폐성자산 및 화폐성부채의 장부금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="714">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="714" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="286" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="285" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="142" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30">USD</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">102,141,296 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">6,386,861 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">45,058,383 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">9,240,719 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30">JPY</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">54,441 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,326,993 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">11,989,401 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">2,086,098 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30">기타통화</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">3,985,213 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,274,650 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">7,001,486 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">5,233,189 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당기말과 전기말 현재 장부통화인 원화에 대한 외화의 환율이 10% 상승 또는 하락하는 경우 법인세비용 차감전 손익에 영향을 미치는 효과는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="718">

<COLGROUP>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="718" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="144" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="288" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="286" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10%상승시</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10%하락시</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10%상승시</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">10%하락시</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30">USD </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">9,575,444 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(9,575,444)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">3,581,766 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(3,581,766)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30">JPY </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(427,255)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">427,255 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">990,330 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(990,330)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30">기타통화</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(28,944)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">28,944 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">176,830 </TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(176,830)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>② 가격위험&cr;</SPAN>
<SPAN>당사는 기타포괄손익-공정가치측정금융자산 및 당기손익-공정가치측정금융자산에서 발생하는 가격변동위험에 노출되어 있습니다.</SPAN>
<SPAN> </SPAN>
<SPAN>당기말 현재 공정가치로 평가하는 기타포괄손익-공정가치측정금융자산은 </SPAN>
<SPAN>5,825,558천원</SPAN>
<SPAN>으로, 다른 변수가 일정하고 지분상품의 가격이 10% 증가 및 감소할 경우 가격변동이 자본에 미치는 영향은 </SPAN>
<SPAN>441,577</SPAN>
<SPAN>천원</SPAN>
<SPAN>(</SPAN>
<SPAN>법인세효과 고려 후)입니다. 당기말 공정가치로 평가하는 당기손익-공정가치측정 금융상품은 </SPAN>
<SPAN>75,342,100</SPAN>
<SPAN>천원</SPAN>
<SPAN>으로 다른 변수가 일정하고 지분상품의 가격이 10% 증가 및 감소할 경우 가격변동이 손익에 미치는 영향은 5,710,931 </SPAN>
<SPAN></SPAN>
<SPAN>천원</SPAN>
<SPAN>(법인세효과 고려 후)입니다. </SPAN>
</P>
<P>&cr;③ 이자율 위험&cr;당사는 차입금과 관련하여 이자율변동위험에 노출되어 있습니다. 당사의 경영진은 시장이자율의 변동으로 인하여 금융상품의 공정가치 또는 미래현금흐름이 변동할 위험을 정기적으로 측정하고 있습니다. 한편, 당기말 현재 당사의 변동이자율을 적용받는 이자부부채의 규모를 고려할 때 이자율변동이 금융부채의 공정가치 또는 미래현금흐름에 미치는 영향은 중요하지 아니합니다.&cr;</P>
<P>나. 신용위험 &cr;신용위험은 거래 상대방이 금융상품이나 고객계약에 따른 의무를 이행하지 못하여 재정적 손실을 초래할 수 있는 위험입니다. 당사는 영업활동(주로 매출 채권)과 은행 및 금융기관 예금, 외환 거래 및 기타 금융 상품을 포함한 금융활동으로부터 신용 위험에 노출되어 있습니다.&cr;&cr;매출채권 및 계약자산&cr;고객신용위험은 고객신용위험 관리와 관련된 당사의 확립 된 정책, 절차 및 통제를 조건으로 하여 각 사업단위에 의해 관리됩니다. 고객의 신용도는 광범위한 신용등급평점표를 기준으로 평가되며 개별 신용한도는 이 평가에 따라 정의됩니다. &cr;손상보고는 예상되는 신용 손실을 측정하기 위해 충당금을 사용하여 보고기간종료일에 수행됩니다. 충당금율은 유사한 손실 패턴(즉, 고객 유형 및 등급, 신용장 또는 다른 형태의 신용 보험 적용 범위)에 따라 다양한 고객 세그먼트를 그룹화하여 만기일을 기준으로합니다. 이 계산은 확률 가중 결과, 시간 가치 및 미래의 경제 상황에 대한 과거 사건, 현재 상황 및 예측에 대해보고 일에 합리적이고 지원 가능한 정보를 반영합니다. &cr;&cr;예상 모형을 사용하여 표시한 당사의 매출채권의 신용위험노출에 대한 정보는 다음과 같습니다.&cr;&cr;</P>
<PGBRK></PGBRK>
<P>가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="751">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="751" HEIGHT="30" COLSPAN="7" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="628" HEIGHT="30" COLSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연체일수</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미연체</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월 이하</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월 초과~&cr;12개월 이하</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12개월 초과~&cr;36개월 이하</TH>

<TH WIDTH="104" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>36개월 초과</P>
</TH>

<TH WIDTH="104" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">장부금액</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,543,294 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">59,978,613 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,010,712 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,397,098 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,548,781 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">125,478,498</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="30">
<P>기대신용손실</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">395,905 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">156,386 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,605,233 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,548,781 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,706,305</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="751">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="751" HEIGHT="30" COLSPAN="7" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="628" HEIGHT="30" COLSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연체일수</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미연체</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월 이하</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월 초과~&cr;12개월 이하</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12개월 초과~&cr;36개월 이하</TH>

<TH WIDTH="104" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>36개월 초과</P>
</TH>

<TH WIDTH="104" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">장부금액</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,908,194 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">92,616,100 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,494,268 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,496,038 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,944,115 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">175,458,715</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="30">
<P>기대신용손실</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">           - </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">486,004 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">397,788 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,166,273 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,944,115 </TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,994,180</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;금융상품 및 현금 예금&cr;은행 및 금융기관과의 잔액에 대한 신용위험은 당사의 재무 정책에 따라 재무부서가 관리합니다. 당사는 은행 및 금융기관의 경우, 독립적인 신용등급기관으로부터의 신용등급이 최소 A이상인 경우에 한하여 거래를 하고있습니다. &cr;&cr;금융자산의 장부금액은 신용위험에 대한 최대노출정도를 나타냅니다. 보고기간종료일 현재 당사의 신용위험에 대한 최대 노출정도는 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="660" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="188"></COL>
<COL WIDTH="223"></COL>
<COL WIDTH="222"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="660" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="197" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="231" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="232" ALIGN="RIGHT" HEIGHT="30">52,141,031 </TD>
<TD WIDTH="231" ALIGN="RIGHT" HEIGHT="30">19,713,873 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">매출채권</TD>
<TD WIDTH="232" ALIGN="RIGHT" HEIGHT="30">107,241,991 </TD>
<TD WIDTH="231" ALIGN="RIGHT" HEIGHT="30">163,464,534 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">기타채권</TD>
<TD WIDTH="232" ALIGN="RIGHT" HEIGHT="30">36,060,770 </TD>
<TD WIDTH="231" ALIGN="RIGHT" HEIGHT="30">39,887,660 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">단기금융자산</TD>
<TD WIDTH="232" ALIGN="RIGHT" HEIGHT="30">18,300,000 </TD>
<TD WIDTH="231" ALIGN="RIGHT" HEIGHT="30">8,050,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">장기매출채권및기타채권</TD>
<TD WIDTH="232" ALIGN="RIGHT" HEIGHT="30">6,009,110 </TD>
<TD WIDTH="231" ALIGN="RIGHT" HEIGHT="30">8,646,753 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30">장기금융자산</TD>
<TD WIDTH="232" ALIGN="RIGHT" HEIGHT="30">10,500 </TD>
<TD WIDTH="231" ALIGN="RIGHT" HEIGHT="30">10,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="232" ALIGN="RIGHT" HEIGHT="30">219,763,402 </TD>
<TD WIDTH="231" ALIGN="RIGHT" HEIGHT="30">239,773,320 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>다. 유동성위험 &cr;신중한 유동성위험 관리는 충분한 현금 및 시장성 있는 유가증권의 유지, 적절하게 약정된 신용한도금액으로부터의 자금 여력 및 시장포지션을 결제할 수 있는 능력 등을 포함하고 있습니다. 활발한 영업활동을 통해 당사 재무팀은 신용한도 내에서 자금여력을 탄력적으로 유지하고 있습니다. &cr;</P>
<P>당기말 현재 비파생금융부채의 잔존계약만기에 따른 만기분석은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="653" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="182"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="145"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="653" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="4">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="191" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">1년미만</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">1년초과</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="191" HEIGHT="30">차입금 및 사채</TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">149,959,306 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">296,060,015 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">446,019,321 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="191" HEIGHT="30">매입채무 및 기타채무</TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">116,560,719 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">5,339,088 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">121,899,807 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="191" HEIGHT="30">리스부채</TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">730,011 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">9,655,987 </TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">10,385,998 </TD>
</TR>
</TBODY>
</TABLE>
<P>상기 만기분석은 할인하지 않은 현금흐름을 기초로 당사가 지급하여야 하는 가장 빠른 만기일에 근거하여 작성되었습니다.</P>
<P>&cr;(2) 자본 위험 관리&cr;당사의 자본관리 목적은 계속기업으로서 주주 및 이해당사자들에게 이익을 지속적으로 제공할 수 있는 능력을 보호하고 자본비용을 절감하기 위해 최적 자본구조를 유지하는 것입니다. &cr;&cr;자본구조의 유지 또는 조정을 위하여 당사는 주주에게 지급되는 배당을 조정하거나, 주주에 자본금을 반환하며, 부채감소를 위한 신주 발행 및 자산 매각 등을 실시하고 있습니다. &cr;</P>
<P>당사는 자본조달비율에 기초하여 자본을 관리하고 있습니다. 자본조달비율은 순차입금을 총자본으로 나누어 산출하고 있습니다. 순차입금은 차입금총계(재무상태표에 표시된 것)에서 현금및현금성자산을 차감한 금액이며 총자본은 재무상태표의 '자본'에 순차입금을 가산한 금액입니다. </P>
<P></P>
<PGBRK></PGBRK>
<P>당기말과 전기말 현재 자본조달비율은 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="658" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="211"></COL>
<COL WIDTH="210"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="658" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="220" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">차입금총계</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">431,583,388 </TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">383,472,861 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">차감: 현금및현금성자산</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">(52,142,241)</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">(19,718,514)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">순차입금(A)</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">379,441,147 </TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">363,754,347 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">자본총계(B)</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">576,033,889 </TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">552,996,822 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">총자본(C = A + B)</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">955,475,036 </TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">916,751,169 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="220" HEIGHT="30">자본조달비율(A / C)</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">39.71%</TD>
<TD WIDTH="219" ALIGN="RIGHT" HEIGHT="30">39.68%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 재무활동에서 생기는 부채의 변동&cr;당사의 당기 중 재무활동에서 생기는 부채의 변동은 아래와 같습니다. &cr;&cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="795" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규리스</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무활동&cr;현금흐름</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화환산</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,355,409 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">137,731,216 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(69,655)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">142,016,970 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">379,117,453 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(90,000,000)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">448,966 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">289,566,419 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">리스부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">3,613,852 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,350,846 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(1,019,100)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(157,625)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">6,787,973 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">387,086,714 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,350,846 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">46,712,116 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">291,341 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(69,655)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">438,371,362 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="795" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규리스</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무활동&cr;현금흐름</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화환산</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">2,564,761</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">1,856,700</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(66,052)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">4,355,409</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">379,350,662</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">  - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(233,209)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">379,117,453</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">리스부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30"> - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,305,187</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">(762,668)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">71,332</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">3,613,851</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">381,915,423</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">4,305,187</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="107" HEIGHT="30">1,094,032</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(161,877)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">(66,052)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="106" HEIGHT="30">387,086,713</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>34. 공정가치 서열체계 &cr;(1) 금융상품의 공정가치</P>
<P>당사의 금융상품 중 상각후원가로 측정하는 금융자산 및 금융부재는 장부금액과 공정가치의 차이가 유의적이지 않으며, 기타 금융상품은 장부금액과 공정가치가 일치합니다. &cr;&cr;(2) 공정가치 서열체계&cr;가. 공정가치 서열체계&cr;당사는 공정가치 측정에 사용된 투입변수의 유의성을 반영하는 공정가치 서열체계에따라 공정가치 측정치를 분류하고 있으며, 공정가치 서열체계의 수준은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="696" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="608"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="79" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="617" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">투입변수의 유의성</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수준 1</TD>
<TD WIDTH="617" HEIGHT="30">측정일에 동일한 자산이나 부채에 대한 접근 가능한 활성시장의 조정되지 않은 공시가격</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">수준 2</TD>
<TD WIDTH="617" HEIGHT="53">수준 1 의 공시가격 이외에 자산이나 부채에 대해 직접적으로 또는 간접적으로 관측가능한 투입변수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수준 3</TD>
<TD WIDTH="617" HEIGHT="30">자산이나 부채에 대한 관측가능하지 않은 투입변수</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 당기말과 전기말 현재 금융상품의 수준별 공정가치 측정치는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="665">

<COLGROUP>
<COL WIDTH="267"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="665" VALIGN="MIDDLE" COLSPAN="5" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="276" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 1</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 2</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 3</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="665" HEIGHT="30" COLSPAN="5">제 19(당) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="276" HEIGHT="30">  기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">974,980 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,850,578 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,825,558 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="276" HEIGHT="30">  당기손익-공정가치측정금융자산</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="276" HEIGHT="30">  단기금융상품</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,300,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,300,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="276" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">974,980 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,300,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,192,678 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,467,658 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="665" HEIGHT="30" COLSPAN="5">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="276" HEIGHT="30">  기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,626,685 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              - </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 2,030,877 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,657,562 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="276" HEIGHT="30">  당기손익-공정가치측정금융자산</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   1,000,020 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="276" HEIGHT="30">  단기금융상품</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,050,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,050,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="276" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,626,685 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,050,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,030,897 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,707,582 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>35.</SPAN>
<SPAN> 리스&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>(1) </SPAN>
<SPAN></SPAN>
<SPAN>사용권자산과 리스부채 변동내역</SPAN>
<SPAN>&cr;&cr;가. 제 19(당) 기</SPAN>
<SPAN></SPAN>
</P>

<TABLE BORDER="1" WIDTH="798" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="798" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">구  분</TH>
<TH COLSPAN="4" WIDTH="501" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">사용권자산</TH>
<TH WIDTH="125" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">리스부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">토지</TH>
<TH WIDTH="125" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">건물</TH>

<TH WIDTH="125" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>차량운반구</P>
</TH>

<TH WIDTH="125" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>합  계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30">
<P>당기초</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,737,753 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">744,486 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">232,288 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,714,527 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">3,613,852 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30"> 증가</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,424,278 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">633,833 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">4,058,111 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">4,350,846 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30"> 처분</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(30,988)</TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(30,988)</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(351,312)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30">
<P> 감가상각</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(170,439)</TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(688,914)</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(100,272)</TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(959,625)</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30" USERMARK=" 0X1814FF">
<P> 이자비용</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">193,686 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30" USERMARK=" 0X1814FF">
<P> 지급</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(1,019,100)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30">
<P>당기말</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">5,991,592 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">689,405 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">101,028 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">6,782,025 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">6,787,972 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">차감 : 유동성리스부채</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(551,321)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">차감계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,236,651 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;나. 제 18(전) 기</SPAN>
</P>

<TABLE BORDER="1" WIDTH="798" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="798" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="6">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">구  분</TH>
<TH COLSPAN="4" WIDTH="501" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE">사용권자산</TH>
<TH WIDTH="125" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">리스부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">토지</TH>
<TH WIDTH="125" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">건물</TH>

<TH WIDTH="125" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>차량운반구</P>
</TH>

<TH WIDTH="125" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>합  계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30">
<P>당기초</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">회계정책의 변경</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,814,187 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">938,359 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">383,864 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">4,136,410 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">3,981,538 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30"> 증가</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">   362,322 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30"> 362,322 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">          323,650 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30">
<P> 감가상각</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(76,433)</TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(556,195)</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(151,576)</TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(784,204)</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">                    - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30" USERMARK=" 0X1814FF">
<P> 이자비용</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">      - </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">71,332 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30" USERMARK=" 0X1814FF">
<P> 지급</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30"> - </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(762,668)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="172" HEIGHT="30">
<P>당기말</P>
</TD>
<TD WIDTH="126" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,737,754 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">744,486 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">232,288 </TD>
<TD WIDTH="125" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,714,528 </TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">3,613,852 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">차감 : 유동성리스부채</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">　</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(474,050)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30">차감계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,139,802 </TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(2) 사용권자산과 리스부채와 관련하여 손익계산서에 인식한 금액</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="319"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="624" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="328" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="328" HEIGHT="30">사용권자산에 대한 감가상각비</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">959,625 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">784,204 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="30">
<P>리스부채에 대한 이자비용</P>
</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">193,686 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">               71,332 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="30">
<P>단기리스료</P>
</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">77,066 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">300,434 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="30">
<P>단기리스가 아닌 소액자산 리스료</P>
</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">195,259 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">180,013 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="30">
<P>리스부채 측정치에 포함되지 않은 변동리스료</P>
</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(3) </SPAN>
<SPAN>리스기간에 포함되지 않은 행사되지 않을 것으로 예상되는 연장선택권의 할인되지 않은 잠재적인 미래 리스료는 당기 </SPAN>
<SPAN>790,742천원(전기 1,057,920천원)입니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN>&cr;36. COVID 19의 영향의 불확실성&cr;COVID19의 확산을 차단하기 위하여 전세계적으로 이동 제한을 포함한 다양한 예방및 통제가 시행되고 있으며, 그 결과 전세계 경제가 광범위한 영향을 받고 있습니다.또한, COVID19에 대처하기 위한 다양한 정부지원정책이 발표되고 있습니다. COVID-19의 영향을 받는 항목은 매출채권의 회수가능성, 재고자산 및 유ㆍ무형자산의 손상, 충당부채의 인식 등 입니다. 당사는 COVID19의 영향과 정부지원정책이 향후 당사에 미칠 영향을 보고기간말 현재 합리적으로 추정할 수 없었으며 이로 인한 영향은 재무제표에 반영되지 않았습니다. &cr;&cr;37. 보고기간 후 사건&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>미국국제무역위원회에 제기되었던 영업비밀침해 소송의 당사자인 에볼루스, 앨러간,메디톡스는 미국국제무역위원회 최종판결에 따라 2021년 2월 19일에 3자간 합의 계약을 완료하였습니다. 당사는 해당 합의의 당사자가 아니므로 이로 인한 재무제표에 미칠 영향을 알 수 없습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>또한, 당사는 2021년 3월 3일자로 공정거래위원회로부터 부당고객유인행위에 대한 과징금 2,146백만원을 부과 받아 이를 기타충당부채로 계상하였습니다.</SPAN>
<SPAN>&cr;</SPAN>
</P>
<P></P>
</SECTION-2>
</LIBRARY>
</INSERTION>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 기타 재무에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">1. 대손충당금 설정현황</SPAN>
<SPAN USERMARK=" B"> </SPAN>
<SPAN USERMARK=" B">(연결재무제표 기준)&cr;</SPAN>
</P>
<P>(1) 계정과목별 대손충당금 설정내역</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">구 분</TD>
<TD ROWSPAN="2" WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">계정과목</TD>
<TD ROWSPAN="2" WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">채권 총액</TD>
<TD ROWSPAN="2" WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">대손충당금</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">대손충당금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">설정률</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">제19기</TD>
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">매출채권</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">138,209,396 </TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,331,302 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13.99%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">미수금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,002,265 </TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">722,490 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.49%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">미수수익</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,524,608 </TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">대여금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">보증금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">942,625 </TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,678,894 </TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,053,792 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11.55%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">제18기</TD>
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">매출채권</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">183,800,731</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,883,845</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8.64%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">미수금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,473,748</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">707,701</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.84%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">미수수익</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,733,901</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">대여금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">보증금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,869</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">228,061,249</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,591,546</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.28%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">제17기</TD>
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">매출채권</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">176,355,010</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,556,436</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8.25%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">미수금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,718,088</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">712,473</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.02%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">미수수익</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,132</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">대여금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,215,893</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">보증금</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,233,444</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">201,562,567</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,268,909</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.58%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 대손충당금 변동현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구     분</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19기</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18기</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 17기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">1. 기초 대손충당금 잔액합계</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,591,546 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,268,909</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,064,199</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">2. 순대손처리액(①－②±③)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,521 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">120,560</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">232,285</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30"> ① 대손처리액(상각채권액)</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">249,587</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30"> ② 상각채권회수액</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-376,449</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30"> ③ 기타증감액</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,521 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-255,889</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-17,302</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">3. 대손상각비 계상(환입)액</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,595,767 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,443,197</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,436,995</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" HEIGHT="30">4. 기말 대손충당금 잔액합계</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,053,792 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,591,546</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,268,909</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(3) 매출채권관련 대손충당금 설정방침(대웅제약)&cr;1) 과거대손경험률을 기준으로 대손충당금을 설정하는 방법과 발생기간별로 비율을 구분하여 설정하는 방법을 함께 적용하고 있음.&cr;2) 경험률로 산정하는 경우 추적 및 회수가능성에 따라 등급별로 구분하고 과거 회수경험률에 근거하여 50%와 100%를 적용함.&cr;3) 발생기간별로 매출채권을 구분하여 설정하는 경우 1년이하는 4.2%, 1년~3년은 50%, 3년 초과 채권은 100%를 적용함.&cr;</SPAN>
</P>
<P>(4) 당해 사업연도말 현재 경과기간별 매출채권잔액 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">구  분</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">6월이하</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">6월초과 1년이하</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">1년초과 3년이하</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30">매출채권</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">112,878,729 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,171,812 </TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,158,855 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">138,209,396 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30">비율</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">81.67%</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.57%</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16.76%</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">2. 재고자산의 보유 및 실사내역 등 (연결재무제표 기준)</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
</P>
<P>(1) 최근 3사업연도의 재고자산의 사업부문별 보유현황</P>

<TABLE WIDTH="811" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="802"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="811" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="810">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">사업부문</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">계정과목</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제19기</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제18기</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제17기</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">비고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="7" WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">의약품 제조 및 판매</TD>
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">상품</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        52,407,856,457 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        51,883,333,022 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        50,848,887,634 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">제품</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        62,672,760,213 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        53,230,702,952 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        58,348,431,712 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">재공품</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        17,992,871,115 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        33,934,197,248 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        23,821,047,615 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">원료</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        32,553,053,822 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        29,552,299,708 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        39,406,319,721 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">포장재료</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          6,558,667,192 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          5,560,569,844 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          5,530,374,270 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          1,785,434,070 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          3,448,152,798 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        11,080,130,769 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">소계</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,970,642,869</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">177,609,255,572</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">189,035,191,721</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="7" WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">합계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">상품</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,407,856,457 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,883,333,022 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,848,887,634 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">제품</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">62,672,760,213 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,230,702,952 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,348,431,712 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">재공품</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,992,871,115 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,934,197,248 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,821,047,615 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">원료</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,553,053,822 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,552,299,708 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,406,319,721 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">포장재료</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,558,667,192 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,560,569,844 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,530,374,270 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,785,434,070 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,448,152,798 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,080,130,769 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">소계</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,970,642,869 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">177,609,255,572 </TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">189,035,191,721 </TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" HEIGHT="53">총자산대비 재고자산 구성비율(%)&cr;[재고자산합계÷기말자산총계×100]</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">12.73%</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">14.27%</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">15.65%</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="260" VALIGN="MIDDLE" HEIGHT="53">재고자산회전율(회수)&cr;
<SPAN USERMARK="F-8">[연환산 매출원가÷{(기초재고＋기말재고)÷2}]</SPAN>
</TD>
<TD WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3.5회</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3.5회</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3.3회</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>
</TBODY>
</TABLE>

<P>* 당분기말 현재 담보로 제공된 재고자산은 없습니다.&cr;&cr;(2) 재고자산의 실사내역 등&cr;&cr;
<SPAN></SPAN>
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B"> (주)대웅제약</SPAN>
</P>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN>① 제 </SPAN>
<SPAN>19기 기말재고실사&cr;  </SPAN>
<SPAN>- 실사일자 : 2021년 01월 04일 &cr;  - 실사방법 : 2020년 12월31일 재고를 기준으로 장부금액과 실제 재고를 대조&cr;  - 실사입회자 : 회계팀 실무자와 한영회계법인 소속 공인회계사의 입회 하에&cr;                       재고실사 실시</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B">한올바이오파마(주)&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN>① 제 48기 기말재고실사&cr;  - 실사일자 : 2021년 01월 04일 &cr;  - 실사방법 : 2020년 12월31일 재고를 기준으로 2021년 01월 01일부터 &cr;                     2021년 01월 04일 사이의 입고 및 출고를 반영하여 장부와 대조 &cr;  - 실사입회자 : 재경팀 실무자와 한영회계법인 소속 공인회계사의 입회하에&cr;                       재고실사&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN>② 제 48기 반기말 재고실사&cr;</SPAN>
<SPAN>  - 실사일자 : 2020년 07월 01일&cr;  - 실사방법 : 2020년 06월 30일 재고를 기준으로 2020년 07월 01일 재고실사하여&cr;                     2020년 07월 01일의 입고 및 출고를 반영하여 장부와 대조&cr;</SPAN>
<SPAN>  - 실사입회자 : 자체 재고실사 &cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>③ </SPAN>
<SPAN>종속회사 재고자산의 실사내역&cr;  - 해당사항 없음&cr;</SPAN>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>(3) </SPAN>
<SPAN>장기체화재고 등의 내역 &cr;</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B"> (주)대웅제약&cr; </SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>당사는 2020년 연간 재무제표를 작성함에 있어 2021년 1월 4일 대웅제약 향남공장 및 오송공장 재고실사를 진행하였으며, 장기체화재고 등의 현황은 없습니다.</SPAN>
<SPAN> 제19기기말 기준 재고자산에 대한 평가내역은 다음과 같습니다</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="626">

<COLGROUP>
<COL WIDTH="617"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="626" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="626" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보유금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기 평가손실</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">상품</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">53,485,515,799</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">53,485,515,799</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">1,077,659,342</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">52,407,856,457</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">제품</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">68,641,703,031</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">68,641,703,031</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">5,968,942,818</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">62,672,760,213</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">재공품</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">19,648,980,755</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">19,648,980,755</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">1,656,109,640</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">17,992,871,115</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">원료</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">32,938,556,990</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">32,938,556,990</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">385,503,168</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">32,553,053,822</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">포장재료</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">6,668,429,968</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">6,668,429,968</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">109,762,776</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">6,558,667,192</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">기타</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">1,785,434,070</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">1,785,434,070</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">1,785,434,070</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">함계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">183,168,620,613</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">183,168,620,613</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">9,197,977,744</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30">173,970,642,869</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">◆</SPAN>
<SPAN USERMARK=" B">한올바이오파마(주)</SPAN>
</P>

<P>
<SPAN>당사는 주기적으로 재고자산에 대한 감액의 징후를 원가와 순실현가능가치 중 작은 금액을 재무상태표가액으로 표시하고 있습니다. 당기말 현재 재고자산에 대한    평가내역은 다음과 같습니다</SPAN>
</P>

<TABLE WIDTH="623" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보유금액</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가손실</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">상품</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,270,038,829</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">8,270,038,829</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(110,057,725)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,159,981,104</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,690,632,932</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,690,632,932</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(276,300,599)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,414,332,333</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">재공품</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">715,404,038</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">715,404,038</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">715,404,038</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">원·부재료</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,781,095,738</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,781,095,738</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(244,521,050)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,536,574,688</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미착품</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">저장품</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">65,033,944</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">65,033,944</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,033,944</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">20,522,205,481</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">20,522,205,481</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">(630,879,374)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,891,326,107</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">3. 공정가치&cr;</SPAN>
</P>
<P>(1) 금융상품의 공정가치</P>
<P>연결실체의 금융상품 중 상각후원가로 측정하는 금융자산 및 금융부재는 장부금액과 공정가치의 차이가 유의적이지 않으며, 기타 금융상품은 장부금액과 공정가치가 일치합니다. </P>
<P>&cr;(2) 공정가치 서열체계&cr;가. 공정가치 서열체계&cr;연결실체는 공정가치 측정에 사용된 투입변수의 유의성을 반영하는 공정가치 서열체계에따라 공정가치 측정치를 분류하고 있으며, 공정가치 서열체계의 수준은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="764" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="676"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="79" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="685" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">투입변수의 유의성</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수준 1</TD>
<TD WIDTH="685" HEIGHT="30">측정일에 동일한 자산이나 부채에 대한 접근 가능한 활성시장의 조정되지 않은 공시가격</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수준 2</TD>
<TD WIDTH="685" HEIGHT="30">수준 1 의 공시가격 이외에 자산이나 부채에 대해 직접적으로 또는 간접적으로 관측가능한 투입변수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수준 3</TD>
<TD WIDTH="685" HEIGHT="30">자산이나 부채에 대한 관측가능하지 않은 투입변수</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 당기말과 전기말 현재 금융상품의 수준별 공정가치 측정치는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="764">

<COLGROUP>
<COL WIDTH="275"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="764" VALIGN="MIDDLE" COLSPAN="5" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="284" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 1</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 2</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 3</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="764" HEIGHT="30" COLSPAN="5">제 19(당) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">  기타포괄손익-공정가치측정 금융자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,184,012 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,389,579 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,573,591 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">  당기손익-공정가치 측정 금융자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,342,100 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">  단기금융자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,805,315 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,805,315 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,184,012 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,805,315 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85,731,679 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">238,721,006 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="764" HEIGHT="30" COLSPAN="5">제 18(전) 기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">
<SPAN>  기타포괄손익-공정가치측정 금융자산</SPAN>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,817,172 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,091,052 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,908,224 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">
<SPAN>  당기손익-공정가치 측정 금융자산</SPAN>
</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30">  단기금융자산</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="284" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,817,172 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,736,962 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,091,072 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">119,645,206 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="SE2" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『진행률적용 수주계약 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*진행률적용수주계약현황*.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK=" B">4. 채무증권 발행실적 (연결재무제표 기준)</SPAN>&cr;
</P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1058" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="756"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="765" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="3">(단위 : 백만원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1057" BORDER="1">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="105" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_CMPY">(주)대웅제약</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_STC" AUNITVALUE="1">공모</TU>
<TU WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_DAT" AUNITVALUE="20180723">2018년 07월 23일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_MON">90,000</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_RATE">2.57%</TE>
<TE WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_LEV">A+&cr; (한기평, NICE)</TE>
<TU WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_LAS" AUNITVALUE="20210723">2021년 07월 23일</TU>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_REC">미상환</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_SUC">미래에셋대우</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_CMPY">(주)대웅제약</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_STC" AUNITVALUE="1">공모</TU>
<TU WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_DAT" AUNITVALUE="20190425">2019년 04월 25일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_MON">100,000</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_RATE">2.05%</TE>
<TE WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_LEV">A+&cr; (한기평, NICE)</TE>
<TU WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_LAS" AUNITVALUE="20220425">2022년 04월 25일</TU>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_REC">미상환</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_SUC">미래에셋대우</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="BSS_PIS_CMPY">(주)대웅제약</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUNIT="BSS_PIS_STC" AUNITVALUE="1">공모</TU>
<TU WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUNIT="BSS_PIS_DAT" AUNITVALUE="20191030">2019년 10월 30일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="BSS_PIS_MON">100,000</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="BSS_PIS_RATE">2.06%</TE>
<TE WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="BSS_PIS_LEV">A+&cr; (한기평, NICE)</TE>
<TU WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUNIT="BSS_PIS_LAS" AUNITVALUE="20221030">2022년 10월 30일</TU>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="BSS_PIS_REC">미상환</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="BSS_PIS_SUC">미래에셋대우&cr; 한국투자증권(주)&cr; NH투자증권</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">290,000</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆ 『사채관리계약 주요내용 및 충족여부 등』 삽입</COMMENT>
<LIBRARYLIST>11011#*사채관리계약주요내용.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">26_사채관리계약주요내용</FILENAME>
<P>사채관리계약 주요내용 및 충족여부 등</P>

<TABLE-GROUP ACLASS="SUB_BND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="267"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="110" HEIGHT="30" AUPDATECONT="N">(작성기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="166" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="48" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="276" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="3">(단위 : 백만원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">채권명</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행액</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">사채관리&cr;계약체결일</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">사채관리회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BND_NAME">제12회 회사채</TE>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="ISU_DATE" AUNITVALUE="20180723">2018.07.23</TU>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="EXP_DATE" AUNITVALUE="20210723">2021.07.23</TU>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISU_AMO">90,000</TE>
<TU WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="CNT_DATE" AUNITVALUE="20180711">2018.07.11</TU>
<TE WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRI_CMY">이베스트투자증권</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BND_NAME">제13회 회사채</TE>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="ISU_DATE" AUNITVALUE="20190425">2019.04.25</TU>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="EXP_DATE" AUNITVALUE="20220425">2022.04.25</TU>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISU_AMO">100,000</TE>
<TU WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="CNT_DATE" AUNITVALUE="20190412">2019.04.12</TU>
<TE WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRI_CMY">이베스트투자증권</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BND_NAME">제14회 회사채</TE>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="ISU_DATE" AUNITVALUE="20191030">2019.10.30</TU>
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="EXP_DATE" AUNITVALUE="20221030">2022.10.30</TU>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ISU_AMO">100,000</TE>
<TU WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="CNT_DATE" AUNITVALUE="20191018">2019.10.18</TU>
<TE WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRI_CMY">DB금융투자㈜</TE>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="599" BORDER="0">

<COLGROUP>
<COL WIDTH="126"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="135" HEIGHT="30" AUPDATECONT="N">(이행현황기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="163" HEIGHT="30" AUNIT="FIX_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUPDATECONT="N">)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="179"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="289"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">재무비율 유지현황</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계약내용</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="30" ACODE="RAT_CNT">부채비율 250%</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">이행현황</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="30" ACODE="RAT_IPM">이행</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">담보권설정 제한현황</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계약내용</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="30" ACODE="ASS_CNT">자기자본 100%</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">이행현황</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="30" ACODE="ASS_IPM">이행</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">자산처분 제한현황</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계약내용</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="30" ACODE="SEL_CNT">자산총계 100%</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">이행현황</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="30" ACODE="SEL_IPM">이행</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" AUPDATECONT="N" ROWSPAN="2">지배구조변경 제한현황</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">계약내용</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="53" ACODE="COR_CNT">사채 원리금 지급의무 이행 완료 전 &cr;지배구조변경 제한</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">이행현황</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="30" ACODE="COR_IPM">이행</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">이행상황보고서 제출현황</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">이행현황</TD>
<TE WIDTH="298" VALIGN="MIDDLE" HEIGHT="30" ACODE="RPT_IPM">2020.08.28</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>* 이행현황기준일은 이행현황 판단 시 적용한 회계감사인의 감사의견(확인 및 의견표시)이 표명된 가장 최근의 재무제표의 작성기준일이며, 지배구조변경 제한현황은 공시서류작성기준일임.</P>
</LIBRARY>
</INSERTION>
<P></P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="92" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32" ACODE="BSS_CN_DA1">90,000</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32" ACODE="BSS_CN_DA2">200,000</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="32" ACODE="BSS_CN_DATT">290,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">90,000</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">200,000</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">290,000</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과&cr;20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<P>
<SPAN USERMARK=" B">5. 회</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">계정책 등 유의사항&cr;</SPAN>
<SPAN>- 자세한 내용은 '연결재무제표 주석' 및 '재무제표 주석'을 참조하시기 바랍니다.&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>1) 회계정책의 변경&cr;아래에서 설명하고 있는 2020년 1월 1일부터 최초로 적용되는 제ㆍ개정 기준서의 적용을 제외하고 연결실체는 당기 및 비교 표시된 전기 재무제표에 동일한 회계정책을 적용하고 있습니다. 동 개정으로 인해 연결실체의 연결재무제표에 미치는 영향은 유의적이지 않다고 판단하고 있습니다.&cr;&cr;가. 기업회계기준서 제1103호 '사업결합' (개정) - 사업의 정의&cr;기업회계기준서 제1103호의 개정사항은 활동과 자산의 집합이 사업의 정의를 충족하기 위해서는 적어도 산출물의 창출에 함께 유의적으로 기여할 수 있는 능력을 가진 투입물과 실질적인 과정을 반드시 포함해야 한다는 것을 명확히 하였습니다. 또한 산출물을 창출하는 데 필요한 모든 투입물과 과정을 포함하지 않더라도 사업이 존재할 수 있다는 것을 명확히 하였습니다. 이 개정사항이 연결재무제표에 미치는 영향은 없으나, 향후 에 사업결합이 발생할 경우 영향을 미칠 수 있습니다&cr;&cr;나. 기업회계기준서 제1107호 '금융상품: 공시', 제1109호 '금융상품' 및 제1039호 '금융상품: 인식과 측정' (개정) - 이자율 지표 개혁&cr;기업회계기준서 제1109호와 제1039호 '금융상품: 인식과 측정' 개정은 이자율지표 개혁의 직접적인 영향을 받는 모든 위험회피관계에 적용되는 많은 완화 규정을 제공합니다. 위험회피관계는 이자율 지표 개혁이 위험회피대상항목이나 위험회피수단의 이자율지표에 근거한 현금흐름의 시기 또는 금액에 대한 불확실성을 야기하는 경우에 영향을 받습니다. 연결실체의 연결재무제표에는 어떠한 이자율위험회피관계도 없기 때문에 동 개정사항이 미치는 영향은 없습니다.&cr;&cr;다. 기업회계기준서 제1001호 '재무제표 표시'와 제1008호 '회계정책, 회계추정의 변경 및 오류' (개정) - 중요성의 정의&cr;기업회계기준서 제1001호와 제1008호 개정사항은 '특정 보고기업에 대한 재무정보를 제공하는 일반목적재무제표에 정보를 누락하거나 잘못 기재하거나 불분명하게 하여, 이를 기초로 내리는 주요 이용자의 의사결정에 영향을 줄 것으로 합리적으로 예상할 수 있다면 그 정보는 중요'하다는 중요성의 새로운 정의를 제공합니다. 동 개정사항은 중요성이 개별적으로 또는 다른 정보와 결합하여 재무제표에서의 정보의 성격 또는 규모에 의존한다는 것을 명확히 하였습니다. 만약 주요 재무정보이용자의 결정에 영향을 줄 것이라는 합리적으로 예상 가능하다면 해당 정보의 오류는 중요합니다. 동 개정사항이 연결실체의 연결재무제표 및 향후에 미치는 영향은 없을 것으로 예상합니다.&cr;&cr;라. 재무보고를 위한 개념체계(2018 개정)&cr;개념체계는 회계기준이 아니며, 개념체계의 어떠한 내용도 회계기준이나 그 요구사항에 우선하지 않습니다. 개념체계의 목적은 회계기준위원회가 한국채택국제회계기준을 제ㆍ개정하는 데 도움을 주며, 적용할 회계기준이 없는 경우에 재무제표 작성자가 일관된 회계정책을 개발하는 데 도움을 줍니다. 또한 모든 이해관계자가 회계기준을 이해하고 해석하는 데 도움을 줍니다. 이 개념체계 개정은 일부 새로운 개념을 포함하고 있으며, 자산과 부채의 정의와 인식기준의 변경을 제시하고, 일부 중요한 개념을 명확히 합니다. 동 개정이 연결실체의 연결재무제표에 미치는 영향은 없습니다.&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">1. 예측정보에 대한 주의사항 </SPAN>&cr;&cr;당사가 동 사업보고서에서 미래에 발생할 것으로 예상·예측한 활동, 사건 또는 현상은 당해 공시서류 작성시점의 사건 및 재무성과에 대하여 회사의 견해를 반영한 것입니다. 동 예측정보는 미래 사업환경과 관련된 다양한 가정에 기초하고 있으며, 동 가정들은 결과적으로 부정확한 것으로 판명될 수도 있습니다. 또한, 이러한 가정들에는예측정보에서 기재한 예상치와 실제 결과 간에 중요한 차이를 초래할 수 있는 위험, 불확실성 및 기타 요인을 포함하고 있습니다. 이러한 중요한 차이를 초래할 수 있는 요인에는 회사 내부경영과 관련된 요인과 외부환경에 관한 요인이 포함되어 있으며, 이에 한하지 않습니다.당사는 동 예측정보 작성시점이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다.결론적으로, 동 사업보고서상에 회사가 예상한 결과 또는 사항이 실현되거나 회사가당초에 예상한 영향이 발생한다는 확신을 제공할 수 없습니다. 동 보고서에 기재된 예측정보는 동 보고서 작성시점을 기준으로 작성한 것이며, 회사가 이러한 위험요인이나 예측정보를 업데이트할 예정이 없음을 유의하시기 바랍니다. &cr;&cr;
<SPAN USERMARK=" B">2. 경영진단의 개요&cr;</SPAN>&cr;(주)대웅제약 이사회는 2020년 1월 1일부터 2020년 12월 31일까지 제19기 사업년도의 회계 및 업무에 관하여 이사의 경영진단에 관한 의견을 아래와 같이 보고합니다.&cr;&cr;1) 경영진단의 개요&cr;회사의 경영에 대한 전반적인 사항을 파악하기 위하여 장부와 관계서류를 열람하고 재무제표 및 동 부속명세서에 대하여도 면밀히 검토하였습니다.경영진단을 위하여 필요하다고 인정되는 경우 관계서류에 대한 업무위탁회사의 보고를 받았으며,경영활동에 중대한 영향을 미칠 수 있는 사항에 대하여는 그 내용을 면밀히 검토하는등 적정한 방법으로 회사경영에 대한 내용을 진단하였습니다.&cr;
<SPAN USERMARK=" B">&cr;3. 재무상태 및 영업실적 (연</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">결기준)&cr;&cr;</SPAN>
<SPAN USERMARK=" B">*</SPAN>
<SPAN USERMARK=" B">요약 연결재무제표</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE WIDTH="614" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="614" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="616" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">구 분</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 19기</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 18기</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" USERMARK=" B">제 17기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[유동자산]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">528,351</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">526,256</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">515,666</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ현금및현금성 자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,299</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,094</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,334</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ매출채권 및 기타채권</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">148,887</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">205,736</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,888</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ단기금융자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,821</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,737</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ재고자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,971</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">177,609</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">189,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,374</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,080</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,366</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[비유동자산]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">838,557</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">719,412</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">692,180</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ유형자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">386,162</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">387,215</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">401,129</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ무형자산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,742</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">164,686</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149,574</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ투자부동산</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,718</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">91,803</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">93,133</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">192,935</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,708</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,344</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">자산총계</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,366,908</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,245,668</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,207,846</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">326,750</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">262,080</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">367,401</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ매입채무및기타채무</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132,748</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">121,980</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,824</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ단기차입금</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">57,053</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,415</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,499</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">136,950</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">130,685</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">257,077</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">344,909</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">347,668</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">232,636</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ사채</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">199,640</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">289,196</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">179,486</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ퇴직급여채무</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,213</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ장기매입채무 및 기타채무</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,172</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,495</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">ㆍ기타</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135,096</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,977</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,636</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">부채총계</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">671,659</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">609,748</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">600,037</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[자본금]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,966</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[자기주식]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-29,236</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-44,916</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-44,916</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[기타불입자본]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,097</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,705</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,560</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[기타자본구성요소]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-2,635</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-6,857</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-9,362</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[이익잉여금]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">452,802</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">445,415</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">422,884</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[비지배지분]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">144,255</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">116,606</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">113,677</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">자본총계</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">695,249</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">635,920</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">607,809</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">매출액</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,055,424</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,113,426</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,031,427</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">영업이익</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,980</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,687</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,596</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">당기순이익</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,148</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,866</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-15,417</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[지배회사지분순이익]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,753</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,006</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-15,151</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">[소수주주지분순이익]</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,395</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,860</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">총포괄이익</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,506</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,360</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-14,082</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">주당순이익(원)</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,196</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,132</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-1,468</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">연결에 포함된 회사수</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">4. 유동성 및 자금조달 현황(연결 기준)</SPAN>
</P>
<P></P>
<P>(1) 당기말과 전기말 현재 현금및현금성자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="723">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="229"></COL>
<COL WIDTH="228"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="723" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="248" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="238" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH WIDTH="237" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" HEIGHT="30">현금</TD>
<TD WIDTH="238" ALIGN="RIGHT" HEIGHT="30">184,660 </TD>
<TD WIDTH="237" ALIGN="RIGHT" HEIGHT="30">324,035 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" HEIGHT="30">예적금</TD>
<TD WIDTH="238" ALIGN="RIGHT" HEIGHT="30">72,114,590 </TD>
<TD WIDTH="237" ALIGN="RIGHT" HEIGHT="30">31,770,159 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="238" ALIGN="RIGHT" HEIGHT="30">72,299,250 </TD>
<TD WIDTH="237" ALIGN="RIGHT" HEIGHT="30">32,094,194 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기말과 전기말 현재 단기금융자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="723">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="215"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="723" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="274" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="225" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="224" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30">정기적금 등</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="RIGHT">15,438 </TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30">당기손익-공정가치측정금융자산</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="RIGHT">104,805,315 </TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT">97,736,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="RIGHT">104,820,753 </TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT">97,736,962 </TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">5. 차입금 등&cr;</SPAN>
</P>
<P>(1) 당기말과 전기말 현재 차입금의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="783" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="783" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" HEIGHT="60">구분</TH>
<TH COLSPAN="2" WIDTH="316" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 19(당) 기</TH>
<TH COLSPAN="2" WIDTH="316" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">제 18(전) 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">유동</TH>
<TH WIDTH="158" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30">차입금</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">57,052,620 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">91,524,819 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">9,414,842 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30">사채</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">89,925,923 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">199,640,496 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">89,921,321 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">289,196,132 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">146,978,543 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">291,165,315 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">99,336,163 </TD>
<TD WIDTH="158" ALIGN="RIGHT" HEIGHT="30">289,196,132 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(2) 당기말과 전기말 현재 차입금의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="738">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="738" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="225" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" VALIGN="MIDDLE">원화장기차입금</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">케이비그레이트베어제일차(유)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2.27%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">          90,000,000 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30">외화장기차입금</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">국민은행</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EURIBOR+1.35%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">            1,524,819 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">원화단기차입금</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">수출입은행</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">1.72%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">            50,000,000 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">중소기업은행</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">2.83%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">            2,000,000 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">4.17%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">400,000 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">400,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30">수출채권 할인(*)</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">㈜신한은행 외</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">0.81%~5.80%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">2,016,970 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">4,355,409 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">외화단기차입금</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">Local Bank</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">2.30%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">1,933 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" ALIGN="CENTER">일본신한은행</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="CENTER">1.20%</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">2,635,650 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">2,657,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="487" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">         148,577,439 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">9,414,842 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="487" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감 : 단기차입금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">         (57,052,620)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(9,414,842)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="487" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">91,524,819 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>
</TBODY>
</TABLE>
<P>(*) L/C조건의 외화매출채권 중 할인 후 만기가 도래하지 않은 금액입니다.&cr;</P>
<P>(3) 당기말과 전기말 현재 사채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="777">

<COLGROUP>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="777" HEIGHT="30" COLSPAN="5" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만기일</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">표면이자율</TH>
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 19(당) 기</TH>
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">제11회 무보증사채</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">2020.10.27</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">2.83%</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">90,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">제12회 무보증사채</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">2021.07.23</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">2.57%</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">90,000,000 </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">90,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">제13회 무보증사채</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">2022.04.25</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">2.05%</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">제14회 무보증사채</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">2022.10.30</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">2.06%</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="431" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감: 사채할인발행차금</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(433,582)</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(882,547)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="431" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감: 유동성사채</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(89,925,922)</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">(89,921,321)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="431" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차  감  계</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">199,640,496 </TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">289,196,132 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(4</SPAN>
<SPAN>) 당기말 현재 </SPAN>
<SPAN>중소기업은행</SPAN>
<SPAN>에 원화단기차입금과 관련하여</SPAN>
<SPAN> </SPAN>
<SPAN>토지</SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>장부금</SPAN>
<SPAN>액 </SPAN>
<SPAN>2,765,833천</SPAN>
<SPAN>원</SPAN>
<SPAN>)</SPAN>
<SPAN>를</SPAN>
<SPAN> </SPAN>
<SPAN>담보로 제공하고 있습니</SPAN>
<SPAN>다.</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">6. 채무증권 발행실적 (연결재무제표 기준)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="1058" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="756"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="765" HEIGHT="30">(단위 : 백만원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="1057" BORDER="1">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="105" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">(주)대웅제약</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">공모</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2018년 07월 23일</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">90,000</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2.57%</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+&cr; (한기평, NICE)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021년 07월 23일</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미상환</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미래에셋대우</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">(주)대웅제약</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사채</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">공모</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019년 04월 25일</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">100,000</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2.05%</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">A+&cr; (한기평, NICE)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022년 04월 25일</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미상환</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">미래에셋대우</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">(주)대웅제약</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">회사채</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">공모</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2019년 10월 30일</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">100,000</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76">2.06%</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">A+&cr; (한기평, NICE)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2022년 10월 30일</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">미상환</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">미래에셋대우&cr; 한국투자증권(주)&cr; NH투자증권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">290,000</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 감사인의 감사의견 등</TITLE>
<P></P>
<WARNING>※ 회계감사인의 감사(검토)의견, 회계감사인과의 감사/비감사 용역 체결현황이 있을 경우&cr;    아래 『회계감사인의 감사의견』단위서식을 클릭하여 삽입하신 후 입력하세요.</WARNING>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『회계감사인의 감사의견』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인의감사의견.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">25_회계감사인의감사의견</FILENAME>

<P>
<SPAN USERMARK=" B">1. 회계감사인의 명칭 및 감사의견</SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="30" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제19기</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_AUR1" VALIGN="MIDDLE">한영회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_CMT1" VALIGN="MIDDLE">적정(주1)</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="112" HEIGHT="30" ACODE="OPN_POT1" VALIGN="MIDDLE">- (주2)</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="30" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제18기</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_AUR2" VALIGN="MIDDLE">한영회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="112" HEIGHT="30" ACODE="OPN_POT2" VALIGN="MIDDLE">무형자산</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="30" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제17기</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_AUR3" VALIGN="MIDDLE">한영회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="112" HEIGHT="30" ACODE="OPN_POT3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">(주1) 감사의견 (연결)</P>

<P>우리는 주식회사 대웅제약과 그 종속기업(이하 "연결실체")의 연결재무제표를 감사하였습니다. 해당 연결재무제표는 2020년 12월 31일과 2019년 12월 31일 현재의 연결재무상태표, 동일로 종료되는 양 보고기간의 연결포괄손익계산서, 연결자본변동표, 연결현금흐름표 그리고 유의적인 회계정책의 요약을 포함한 재무제표의 주석으로 구성되어 있습니다.&cr;&cr;우리의 의견으로는 별첨된 연결실체의 연결재무제표는 연결실체의 2020
<SPAN></SPAN>년 12월 31일과 201
<SPAN>9</SPAN>년 12월 31일 현재의 연결재무상태와 동일로 종료되는 보고기간의 재무성과 및 현금흐름을 한국채택국제회계기준에 따라 중요성의 관점에서 공정하게 표시하고 있습니다.&cr;
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">(주2) </SPAN>
<SPAN USERMARK=" B">핵심감사사항</SPAN>
<SPAN USERMARK=" B"> (연결)</SPAN>
<SPAN></SPAN>
</P>

<P>핵심감사사항은 우리의 전문가적 판단에 따라 당기 재무제표감사에서 가장 유의적인사항들입니다. 해당 사항들은 재무제표 전체에 대한 감사의 관점에서 우리의 의견형성시
<SPAN USERMARK="F-8"> </SPAN>다루어 졌으며,
<SPAN USERMARK="F-8"> </SPAN>우리는
<SPAN USERMARK="F-8"> </SPAN>이런
<SPAN USERMARK="F-8"> </SPAN>사항에 대하여 별도의 의견을 제공하지는 않습니다.
</P>
<P USERMARK=" B"></P>
<P>재무제표에 대한 주석 14에서 기술한 바와 같이 회사는 의약품의 개발과 관련하여 2020년 12월말 현재 44,788 백만원의 개발비, 51,500 백만원의 독점판매권 및 기타자산을 인식하고 있습니다. </P>
<P>&cr;회사는 무형자산의 인식요건을 모두 충족하는 경우에 개발비, 독점판매권 및 기타자산을 인식하고 있습니다. 이 중 개발이 완료되어 제품 발매가 진행된 개발비 1,001 백만원 및 독점판매권 및 기타자산 41,121백만원을 각각 적정하게 추정된 내용연수로 상각하고 있습니다. 개발비, 독점판매권 및 기타자산에서 손상징후가 파악되는 경우 손상여부를 검토하고 있습니다.</P>
<P>&cr;개발비, 독점판매권 및 기타자산의 자산화 여부는 기술적 실현 가능성, 미래경제적 효익 등 경영자의 판단에 따라 결정되며, 손상평가시에는 미래의 현금 흐름 예측 등 경영자의 추정이 필요합니다. 이러한 경영자의 판단과 추정에는 과정의 복잡성, 경영자의 주관적 판단의 개입 등으로 인한 오류가능성이 존재합니다. 따라서 개발비, 독점판매권 및 기타자산의 인식과 손상이 당기손익(또는 미래 손익)에 중요한 영향을 미칠 가능성이 존재한다고 판단하여 유의적인 위험으로 식별하였습니다.</P>
<P>&cr;핵심감사사항에 대응하기 위한 우리의 감사절차는 다음을 포함합니다.</P>
<P>- 무형자산 인식 회계정책의 적정성 검토</P>
<P>- 개발비 발생비용의 프로젝트별 배부기준 적정성에 대한 검토</P>
<P>- 당기 중 발생한 주요 무형자산에 대한 계약서 및 지출내역에 대한 증빙 징구 및 검토</P>
<P>- 당기말 현재 개발중인 주요 프로젝트의 진행상황 및 업계전망에 대한 질문과 업계 관행과의 비교를 통해 규제 승인 획득 가능성에 관한 회사 가정을 검토</P>
<P>- 무형자산 상각 내용연수의 추정근거 및 경제적 효익의 유입가능성 관련 경영진 평가 결과에 대한 문서 검사</P>
<P>- 과거 기간의 가정 변경 사항을 확인 및 분석하여 가정의 일관성을 평가</P>
<P>- 공시사항 적정성에 대한 평가</P>

<P>
<SPAN></SPAN>
</P>
<P></P>
<P USERMARK=" B">2. 감사용역 체결현황</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="657" BORDER="1">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="46"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="183" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="30" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제19기</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR1" VALIGN="MIDDLE">한영회계법인</TE>
<TE ALIGN="CENTER" WIDTH="183" HEIGHT="30" ACODE="SIGK_CNT1" VALIGN="MIDDLE">개별, 연결재무제표 감사</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">340,000</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">3,900</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">340,000</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">4,742</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="30" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">제18기</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR2" VALIGN="MIDDLE">한영회계법인</TE>
<TE ALIGN="CENTER" WIDTH="183" HEIGHT="30" ACODE="SIGK_CNT2" VALIGN="MIDDLE">개별, 연결재무제표 감사</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">229,500</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">2,700</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">229,500</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">3,306</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="114" HEIGHT="30" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">제17기</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR3" VALIGN="MIDDLE">한영회계법인</TE>
<TE ALIGN="CENTER" WIDTH="183" HEIGHT="30" ACODE="SIGK_CNT3" VALIGN="MIDDLE">개별, 연결재무제표 감사</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">195,000</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">(*)</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">195,000</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">2,712</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>(*) 개정 외감법 시행 이전으로 관련 자료 부재로 해당사항 없음&cr;</P>
<P USERMARK=" B">3. 회계감사인과의 비감사용역 계약체결 현황</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="647" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="182" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_YEAR1" VALIGN="MIDDLE">제19기</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">2020.07.01</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">세무조정</TE>
<TE ALIGN="CENTER" WIDTH="182" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">2020.07.01~2021.03.31</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">32,500</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">한영회계법인</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_YEAR2" VALIGN="MIDDLE">제18기</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">2019.07.16</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">세무조정</TE>
<TE ALIGN="CENTER" WIDTH="182" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">2019.07.16~ 2020.03.31</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">32,500</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">한영회계법인</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="90" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="3">제17기</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">2018.07.30</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">세무조정</TE>
<TE ALIGN="CENTER" WIDTH="182" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">2018.04.01~2019.03.31</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">29,440</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">한영회계법인</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">2018.09.03</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">세무자문용역</TE>
<TE ALIGN="CENTER" WIDTH="182" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">2018.09.03~2018.10.31</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">95,000</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">한영회계법인</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">2018.09.10</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">세무자문용역</TE>
<TE ALIGN="CENTER" WIDTH="182" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">2018.09.10~2018.11.31</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">115,000</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">한영회계법인</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『내부감사기구가 회계감사인과 논의한 결과』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인과논의한결과.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">46_회계감사인과논의한결과</FILENAME>
<P USERMARK=" B">4. 재무제표 중 이해관계자의 판단에 상당한 영향을 미칠 수 있는 사항에 대해 내부감사기구가 회계감사인과 논의한 결과</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="669" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="178" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="61" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU WIDTH="137" HEIGHT="61" AUNIT="DIS_DATE" AUNITVALUE="20200507" VALIGN="MIDDLE">2020년 05월 07일</TU>

<TE WIDTH="216" HEIGHT="61" ACODE="DIS_ATT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">회사 : 감사 외 2인&cr;감사인 : 업무수행이사 외 2인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="90" HEIGHT="61" ACODE="DIS_WAY" VALIGN="MIDDLE">
<P USERMARK="F-GL11">대면 회의</P>
</TE>

<TE ALIGN="CENTER" WIDTH="178" HEIGHT="61" ACODE="DIS_CONT" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1분기 검토 결과보고</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20200730" VALIGN="MIDDLE">2020년 07월 30일</TU>
<TE WIDTH="216" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사 : 감사 외 2인&cr;감사인 : 업무수행이사 외 2인</TE>
<TE ALIGN="CENTER" WIDTH="90" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE" USERMARK="F-10">서면(전자문서)</TE>

<TE ALIGN="CENTER" WIDTH="178" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">
<P USERMARK="F-GL10">반기 검토 결과보고</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="57" ACODE="DIS_DIV" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="57" AUNIT="DIS_DATE" AUNITVALUE="20200924" VALIGN="MIDDLE">2020년 09월 24일</TU>

<TE WIDTH="216" HEIGHT="57" ACODE="DIS_ATT" VALIGN="MIDDLE">
<P USERMARK="F-GL10">회사 : 감사 외 2인&cr;  감사인 : 업무수행이사 외 2인</P>
</TE>
<TE ALIGN="CENTER" WIDTH="90" HEIGHT="57" ACODE="DIS_WAY" VALIGN="MIDDLE" USERMARK="F-10">서면(전자문서)</TE>

<TE ALIGN="CENTER" WIDTH="178" HEIGHT="57" ACODE="DIS_CONT" VALIGN="MIDDLE">
<P USERMARK="F-GL10">3분기 보고</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="57" ACODE="DIS_DIV" VALIGN="MIDDLE">4</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="57" AUNIT="DIS_DATE" AUNITVALUE="20210107" VALIGN="MIDDLE">2021년 01월 07일</TU>

<TE WIDTH="216" HEIGHT="57" ACODE="DIS_ATT" VALIGN="MIDDLE">
<P USERMARK="F-GL10">회사 : 감사 외 2인&cr;  감사인 : 업무수행이사 외 2인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="90" HEIGHT="57" ACODE="DIS_WAY" VALIGN="MIDDLE">
<P USERMARK="F-GL10">서면(전자문서)</P>
</TE>

<TE ALIGN="CENTER" WIDTH="178" HEIGHT="57" ACODE="DIS_CONT" VALIGN="MIDDLE">
<P USERMARK="F-GL10">중간감사 결과보고</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="57" ACODE="DIS_DIV" VALIGN="MIDDLE">5</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="57" AUNIT="DIS_DATE" AUNITVALUE="20210309" VALIGN="MIDDLE">2021년 03월 09일</TU>

<TE WIDTH="216" HEIGHT="57" ACODE="DIS_ATT" VALIGN="MIDDLE">
<P USERMARK="F-GL10">회사 : 감사 외 2인&cr;  감사인 : 업무수행이사 외 2인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="90" HEIGHT="57" ACODE="DIS_WAY" VALIGN="MIDDLE">
<P USERMARK="F-GL10">서면(전자문서)</P>
</TE>

<TE ALIGN="CENTER" WIDTH="178" HEIGHT="57" ACODE="DIS_CONT" VALIGN="MIDDLE">
<P USERMARK="F-GL10">기말감사 결과보고</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<P>
<SPAN USERMARK=" B">5. 내부통제에 관한 사항</SPAN>
</P>
<P></P>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">1) 내부통제  당사의 내부감시장치는 다음과 같으며 그 기능은 다음과 같습니다.   &cr;- 이사회 : 이사의 직무집행을 감독합니다.  &cr;- 감   사 : 이사의 직무집행을 감사합니다. 이를 위하여 이사에 대하여 영업에 관한      보고를 요구하거나 회사의 업무상태와 재산상태를 조사합니다. &cr;- 기타의 내부감시장치 : 감사는 직무를 수행하기 위하여 필요한 때에는 자회사에       대하여 영업의 보고를 요구하거나 자회사의 업무상태와 재산상태를 조사합니다.&cr;   보고서 제출기준일 현재 내부감시장치는 효과적으로 작동되고 있으며, 감사 결과&cr;   지적사항 등은 없습니다.&cr;</SPAN>&cr;
<SPAN USERMARK=" 0X000000">2) 내부회계관리제도&cr;- 당해 사업연도 중 내부회계관리규정의 주요 개선내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개선일자</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개선전</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개선후</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고(개선이유등)</P>
</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="76">
<P>2020. 7. 1</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="76">
<P>운영실태 검토수준</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="76">
<P>운영실태 감사수준</P>
</TD>

<TD WIDTH="150" HEIGHT="76">
<P>외감법 개정에 따른 내부회계관리제도 인증수준 상향</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">&cr;
<SPAN USERMARK=" 0X000000">3) 내부회계관리제도 보고 내용 </SPAN>
</P>

<TABLE BORDER="1" WIDTH="617" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="312"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보고일자</TH>
<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보 고 자</TH>
<TH WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보   고   내   용</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비    고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.2.24</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">윤재춘&cr;(장영호)</TD>
<TD WIDTH="321" VALIGN="MIDDLE" HEIGHT="53">대표이사 및 내부회계관리자의 내부회계관리제도 운영실태보고</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.2.25</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">전우방</TD>
<TD WIDTH="321" VALIGN="MIDDLE" HEIGHT="53">감사의 내부회계관리제도 운영실태 평가보고</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">㈜대웅 감사&cr;(*)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.3.11</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한영회계법인</TD>
<TD WIDTH="321" VALIGN="MIDDLE" HEIGHT="30">외부감사인의 내부회계관리제도 감사보고</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『조정협의회내용 및 재무제표 불일치정보』 삽입</COMMENT>
<LIBRARYLIST>11011#*조정협의회내용및재무제표불일치정보.dsl</LIBRARYLIST>
</INSERTION>
<P>- 당사의 감사직무규정 제2조 제3항에 근거하여, (주)대웅의 전우방 감사가 대행하여 보고하였습니다.&cr;</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P></P>
<P USERMARK=" B">1) 이사회 구성의 개요</P>
<P> 2020년 12월 31일 기준, 당사의 이사회는 2인의 사내이사, 1인의 사외이사, 총 3인의 이사로 구성되어 있습니다. 이사회 의장은 정관에 따라 대표이사 (전승호)가 담당하고 있습니다. 이사회 내 위원회는 별도로 구성되어 있지 않습니다.&cr;&cr;*임기 등 자세한 사항은 'VIII. 임원 및 직원 등에 관한 사항', '1. 임원 및 직원의 현황'을 참고하시기 바랍니다.&cr;</P>

<P>
<SPAN USERMARK=" B">2) 중요의결사항 및 사외이사 참석현황</SPAN>
</P>

<TABLE BORDER="1" WIDTH="840" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="332"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="106">회차</TH>
<TH ROWSPAN="2" WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="106">개최일자</TH>
<TH ROWSPAN="2" WIDTH="341" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="106">의 안 내 용</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="106">가결여부</TH>
<TH COLSPAN="2" WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사내이사</TH>
<TH COLSPAN="2" WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사외이사</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">윤재춘&cr;(참석률&cr;100%)</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">전승호&cr;(참석률&cr;100%)</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">김홍철&cr;(참석률&cr;71%)</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">양윤선&cr;(참석률&cr;100%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="30"> 2020.2.27</TD>

<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="30">
<P>1. 주주총회 소집일자 및 의안 확정 건</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결 </TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="30"> 2020.3.5</TD>

<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="30">
<P>1. 별도재무제표 및 연결재무제표 승인의 건</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결 </TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="30"> 2020.3.23</TD>
<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="30">1. 자기주식 처분의 건</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">불참</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="30"> 2020.5.7</TD>
<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="30">1. 이온채널 법인설립 및 대표이사 겸직 건</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="30"> 2020.7.7</TD>
<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="30">1. 전환사채권 취득</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">불참</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="30"> 2020.7.30</TD>
<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="30">1. 내부회계관리규정 및 감사직무규정 제정의 건</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7</TD>
<TD WIDTH="97" VALIGN="MIDDLE" HEIGHT="30"> 2020.10.21</TD>
<TD WIDTH="341" VALIGN="MIDDLE" HEIGHT="30"> 1. 자금조달의 건</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>* 양윤선 사외이사는 2020년 3월 20일 임기만료로 퇴임하였습니다.&cr;</P>
<P> - 회차별 사외이사 참석 현황</P>

<TABLE ACLASS="NORMAL" WIDTH="511" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="51"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="60" USERMARK=" BC0XD7D7D7">회차</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="60" USERMARK=" BC0XD7D7D7">개최일자</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="60" USERMARK=" BC0XD7D7D7">사외이사 &cr;참석인원</TD>
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" USERMARK=" BC0XD7D7D7">사외이사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30" USERMARK=" BC0XD7D7D7">양윤선</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">김홍철</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30">1</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">     2020.2.27</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30">2(2)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">참석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30">2</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">     2020.3.5</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30">2(2)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">참석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">참석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30">3</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">     2020.3.23</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30">0(1)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30">4</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">     2020.5.7</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30">1(1)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">참석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30">5</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ALIGN="CENTER"> 2020.7.7</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30">0(1)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30">6</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ALIGN="CENTER"> 2020.7.30</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30">1(1)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">참석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30">7</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ALIGN="CENTER"> 2020.10.21</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30">1(1)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">참석</TD>
</TR>
</TBODY>
</TABLE>
<P>* 양윤선 사외이사는 2020년 3월 20일 임기만료로 퇴임하였습니다.&cr;</P>
<P> - 사외이사 및 그 변동현황</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">1</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>* 양윤선 사외이사는 2020년 3월 20일 임기만료로 퇴임하였습니다.&cr;</P>

<P>
<SPAN USERMARK=" B">3) 이사의 독립성&cr;</SPAN>- 당사는 이사회의 추천을 받은 이사 후보자에 대하여 정기주주총회에서 승인을 얻어 이사로 선임하고  있습니다.&cr;
</P>
<P>- 이사현황</P>

<TABLE BORDER="1" WIDTH="791" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="249"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">성 명</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">추 천 인</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">담 당 업 무</TH>
<TH WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">선임배경</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">최대주주&cr;와의 관계</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">연임여부&cr;(횟수)</TH>
<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">임기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">전승호</TD>
<TD WIDTH="73" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">이사회</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">총괄</TD>
<TD WIDTH="258" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">당사의 업무 총괄 및 대내외 업무를 &cr;안정적으로 수행하기 위함</TD>
<TD WIDTH="95" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">3년&cr;(2018.3~2021.3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">윤재춘</TD>
<TD WIDTH="73" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">이사회</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">총괄</TD>
<TD WIDTH="258" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">당사의 업무 총괄 및 대내외 업무를 &cr;안정적으로 수행하기 위함</TD>
<TD WIDTH="95" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">(주)대웅의 &cr;대표이사</TD>
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">3년&cr;(2018.3~2021.3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">김홍철</TD>
<TD WIDTH="73" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">이사회</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">사외이사</TD>
<TD WIDTH="258" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">법률전문가</TD>
<TD WIDTH="95" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">3년&cr;(2018.3~2021.3)</TD>
</TR>
</TBODY>
</TABLE>
<P>* 상기 사외이사의 임기만료일은 취임후 3년 내의 최종 결산기에 대한 주주총회       개최일입니다.&cr;* 임기 등 자세한 사항은 'VIII. 임원 및 직원 등에 관한 사항', '1. 임원 및 직원의 현황'을 참고하시기 바랍니다.&cr;</P>

<P>
<SPAN USERMARK=" B">4) 사외이사 지원조직</SPAN>
</P>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="162"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">직위</TH>
<TH WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기획팀</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">4</TD>
<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">팀장 외</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회 관련 업무 지원</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『사외이사 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_사외이사_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">40_02_사외이사_교육_미실시내역</FILENAME>
<P>사외이사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ODRT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="99" ACODE="ODRT_EDU_NOT_DTL">교육을 대신하여 이사회 개최 전 해당 안건 내용을 충분히 검토할 수 있도록 사전에 자료를 제공하며,사내 주요 현안 및 요청사항 등에 대해서도 수시로 정보를 제공하고 있습니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">1) 감사기구 관련 사항&cr;</SPAN>  2020년 12월 31일 기준, 현재 당사는 감사위원회를 별도로 설치하고 있지 않으며, 상근감사 1인이 감사업무를 수행하고 있습니다.&cr;
</P>
<P> - 감사의 인적사항</P>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="362"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">성  명</TH>
<TH WIDTH="371" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주 요 경 력</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사외이사 여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">이충우</TD>

<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="168">
<P>법무법인(유한) 에이펙스 구성원변호사 </P>
<P>법무법인 서린 대표변호사</P>
<P>경제사회발전노사정위원회 고용차별개선연구회 위원</P>
<P>법무법인(유한) 에이펙스   변호사&cr;중앙노동위원회 공익위원</P>
<P>(사)대한상사중재원 중재인</P>
<P>법무법인 화현 강남분사무소 대표변호사</P>
</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">X</TD>
</TR>
</TBODY>
</TABLE>

<P>*재임기간 : 2017년 3월 24일 ~ &cr;*겸직현황 : 법무법인 화현 강남분사무소 대표변호사 &cr;*연임여부 : 2017년 3월 신규선임 이후 2020년 3월 주주총회에서 재선임 되었습니다. (연임 1회)&cr;&cr;
<SPAN USERMARK=" B">2) 감사의 독립성&cr;</SPAN>  감사는 이사회에 참석하여 독립적으로 이사의 업무를 감독할 수 있으며, 제반업무 와 관련하여 장부 및 관계서류의 제출을 해당부서에 요구할 수 있습니다. 또한 필요시 회사로부터 영업에 관한 사항을 보고 받을 수 있으며, 적절한 방법으로 경영정보에 접근할 수 있습니다&cr;
</P>

<P>
<SPAN USERMARK=" B">3) 감사의 주요 활동내용&cr;</SPAN>
<SPAN> - 이사회 출석 현황</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="332"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회 차</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>
<TH WIDTH="341" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의 안 내 용</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가결여부</TH>
<TH WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1 </TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.2.27</TD>

<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">
<P>1. 주주총회 소집일자 및 의안 확정 건</P>
</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.3.5</TD>

<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">
<P>1. 별도재무제표 및 연결재무제표 승인의 건</P>
</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 2020.3.23</TD>
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">1. 자기주식 처분의 건</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.5.7</TD>
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">1. 이온채널 법인설립 및 대표이사 겸직 건</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 2020.7.7</TD>
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">1. 전환사채권 취득</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 2020.7.30</TD>
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE">1. 내부회계관리규정 및 감사직무규정 제정의 건</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 2020.10.21</TD>
<TD WIDTH="341" HEIGHT="30" VALIGN="MIDDLE"> 1. 자금조달의 건</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">불참</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회 위원의 인적사항 및 사외이사 여부』 삽입</COMMENT>
<LIBRARYLIST>11011#*감사위원현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">41_04_감사_교육_미실시내역</FILENAME>
<P USERMARK=" B">4) 감사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ADT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="99" ACODE="ADT_EDU_NOT_DTL">교육을 대신하여 이사회 개최 전 해당 안건 내용을 충분히 검토할 수 있도록 사전에 자료를 제공하며,사내 주요 현안 및 요청사항 등에 대해서도 수시로 정보를 제공하고 있습니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">42_02_감사_지원조직_현황</FILENAME>
<P USERMARK=" B">5) 감사 지원조직 현황</P>

<TABLE-GROUP ACLASS="ADT_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_OGN_NM">회계팀</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_OGN_CNT">11</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_OGN_PST" ALIGN="CENTER">팀장 외</TE>
<TE WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_OGN_DTL" ALIGN="CENTER">감사 업무 지원</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『준법지원인 등 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_준법지원인등_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">43_02_준법지원인등_지원조직_해당사항없음</FILENAME>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>지원조직이 없는 경우에는 그 사실을 기재한다.</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK=" B">6) 준법지원인 등에 관한 사항</SPAN>
</P>
</LIBRARY>
</INSERTION>
<P>- 준법지원인 선임에 대해 현재 검토 중입니다.&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주의 의결권 행사에 관한 사항</TITLE>

<P>
<SPAN USERMARK=" B">&cr;1) 투표제도&cr;</SPAN>- 당사는 집중투표제, 서면투표제를 채택하고 있지 않습니다.&cr;- 당사는 2021년 3월 26일 개최되는 제19기 정기주주총회에서 전자투표를 도입하였습니다.&cr;
</P>
<P>* 전자투표에 관한 사항</P>
<P>당사는 이번 주주총회부터 주주님께서 주주총회에 직접 참석하지 않고도 의결권을</P>
<P>행사하실 수 있도록 전자투표제도(상법 제368조의 4)를 도입하였습니다. </P>
<P>주주님들께서는 아래의 방법에 따라 전자투표에 참여하실 수 있습니다.    </P>
<P> </P>
<P>① 전자투표시스템</P>
<P>   - 인터넷 주소: http://evote.ksd.or.kr</P>
<P>   - 모바일 주소: http://evote.ksd.or.kr/m</P>
<P>② 전자투표 행사기간 : 2021년 3월 16일 오전 9시 ~ 2021년 3월 25일 오후 5시</P>
<P>   - 기간 중 24시간 이용 가능함</P>
<P>   - 단, 시작일에는 오전 9시부터 가능하며, 마지막 날은 오후 5시까지만 가능함</P>
<P>③ 시스템에서 인증서를 통해 주주 본인 확인 후 의안별 의결권 행사</P>
<P>   - 주주확인용 인증서의 종류 : </P>
<P>      코스콤 증권거래용 인증서, 금융결제원 개인용도제한용 인증서 등</P>
<P>④ 수정동의안 처리</P>
<P>   - 주주총회에서 상정된 의안에 관하여 수정동의가 제출되는 경우 기권으로 처리</P>

<P>&cr;
<SPAN USERMARK=" B">2) 소수주주권&cr; - </SPAN>당사는 공시대상기간 중 소수주주권이 행사되지 않았습니다.&cr;&cr;
<SPAN USERMARK=" B">3) 경영권 경쟁&cr;</SPAN> - 당사는 공시대상기간 중 경영권 경쟁이 발생하지 않았습니다. 
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P></P>
<P USERMARK=" B">1. 최대주주 및 특수관계인의 주식소유 현황</P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="619" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="308" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="619" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="310" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">(주)대웅</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">최대주주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">4,779,721</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">41.25</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">5,221,547</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">45.07</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">장봉애</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">59,933</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.52</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">59,933</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.52</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">박현령</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">34,632</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.30</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">34,632</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.30</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">대웅재단</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">재단</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">998,453</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">8.62</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">998,453</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">8.62</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">(주)아이넷뱅크</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">4,759</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.04</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">4,759</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.04</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">전승호</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">10</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">1,114</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">윤재춘</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">178</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">178</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김홍철</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">70,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.60</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="198" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">5,947,686</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">51.33</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">6,320,616</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">54.55</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B">2. 최대주주의 개요</SPAN>
</P>
<P USERMARK="F-16"></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주가 법인 또는 투자조합 등 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주가단체인경우.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">33_최대주주가단체인경우</FILENAME>
<P>(1) 최대주주(법인 또는 단체)의 기본정보</P>

<TABLE-GROUP ACLASS="THD_ASN_BAS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="65"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">명 칭</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">출자자수&cr;(명)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="151" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">대표이사&cr;(대표조합원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">업무집행자&cr;(업무집행조합원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">최대주주&cr;(최대출자자)</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="76" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="74" HEIGHT="60" ACODE="BAS_NAME" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2">(주)대웅</TE>
<TE WIDTH="73" HEIGHT="60" ACODE="BAS_CNT" VALIGN="MIDDLE" ALIGN="RIGHT" ROWSPAN="2">43,475</TE>
<TE WIDTH="76" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">윤재춘</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.06</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE ALIGN="CENTER" WIDTH="75" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE">윤재승</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">11.61</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="76" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE ALIGN="CENTER" WIDTH="75" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE">-</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 법인 또는 단체의 대표이사, 업무집행자, 최대주주의 지분율을 기재</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P>* (주)대웅의 지분율 : 5,221,547주 (45.07%)&cr;* 출자자수는 최근 주주명부 폐쇄일 (2020.12.31) 기준 주주수임.&cr;* 업무집행자와 대표이사가 동일하므로 업무집행자의 기재를 생략하였음.&cr;* 윤재춘 대표이사 지분율 변동 내역&cr;  - 변동일 및 증감주식수&cr;     1) 2020년 3월 5일, 증감 주식수 : 18,825주 (지분율 0.06%)&cr;     2) 2020년 3월 24일, 증감주식수 : 4,496주 (지분율 0.06%)&cr;  - 공시기준일 현재 보유 주식수 : 37,121주, 지분율 0.06%&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『공시대상기간 중 법인 또는 단체의 대표이사, 업무집행자, 최대주주의 성명 또는&cr; 지분율 변동이 있는경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*성명또는지분율변동인경우.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">34_성명또는지분율변동인경우</FILENAME>
<P>법인 또는 단체의 대표이사, 업무집행자, 최대주주의 변동내역</P>

<TABLE-GROUP ACLASS="THD_ASN_BASK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="66"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">변동일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="167" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">대표이사&cr;(대표조합원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">업무집행자&cr;(업무집행조합원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">최대주주&cr;(최대출자자)</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="107" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20200305" VALIGN="MIDDLE" ALIGN="CENTER">2020.03.05</TU>
<TE WIDTH="84" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">윤재춘</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.06</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="107" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20200324" VALIGN="MIDDLE" ALIGN="CENTER">2020.03.24</TU>
<TE WIDTH="84" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">윤재춘</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.06</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="83" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="75" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
<P>(2) 최대주주(법인 또는 단체)의 최근 결산기 재무현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="THD_ASN_FIN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="290"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">구    분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N"></TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">법인 또는 단체의 명칭</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_NAME">(주)대웅</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">자산총계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_AST">371,342</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">부채총계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_DEB">20,940</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">자본총계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_CAP">350,403</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">매출액</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_SAL">87,608</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">영업이익</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_BUF">47,799</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">당기순이익</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_PRF">45,919</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>*상기 재무현황은 2020년말 별도 기준임.&cr;</P>
<P>(3) 사업현황 등 회사 경영 안정성에 영향을 미칠 수 있는 주요 내용</P>
<P>- 해당 사항 없음</P>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주의 최대주주(최대출자자)가 법인 또는 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주의최대출자자가단체인경우.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『최대주주 변동내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주변동내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK=" B">3. 주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">(주)대웅</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">5,221,547</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">45.07</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">대웅재단</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">998,453</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">8.62</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">3,817</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">0.03</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B">4. 소액주주 현황</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『소액주주현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*소액주주현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">10_소액주주현황</FILENAME>

<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">소액주주현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="41"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="237" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="234" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="91" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="91" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="54" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNT">49,719</TE>
<TE WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNTT">49,730</TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_RT">99.99</TE>
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNT">4,098,210</TE>
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNTT">10,762,695</TE>
<TE WIDTH="54" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_RT">38.08</TE>
<TE WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>

<P>
<SPAN></SPAN>
<SPAN USERMARK=" B">5. 주식사무</SPAN>
</P>

<TABLE BORDER="1" WIDTH="740" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="268"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="835">정관상 신주인수권의 &cr;내용</TD>

<TD COLSPAN="3" WIDTH="559" HEIGHT="835">
<P>제 9조 (주식의 발행 및 배정) &cr;</P>
<P>①  이 회사가 이사회의 결의로 신주를 발행하는 경우 다음 각 호의 방식에 의한다.</P>
<P>1. 주주에게 그가 가진 주식 수에 따라서 신주를 배정하기 위하여 신주인수의 청약을 할 기회를 부여하는 방식</P>
<P>2. 발행주식수의 100분의 20을 초과하지 않는 범위 내에서 신기술의 도입, 재무구조의 개선 등 회사의 경영상 목적을 달성하기 위하여 필요한 경우 제1호 외의 방법으로 특정한 자(회사의 주주를 포함한다)에게 신주를 배정하기 위하여 신주인수의 청약을 할 기회를 부여하는 방식</P>
<P>3. 발행주식수의 100분의 50을 초과하지 않는 범위 내에서  제1호 외의 방법으로 불특정 다수인(회사의 주주를 포함한다)에게 신주인수의 청약을 할 기회를 부여하고 이에 따라 청약을 한 자에 대하여 신주를 배정하는 방식</P>
<P> </P>
<P>②제1항제3호의 방식으로 신주를 배정하는 경우에는 이사회의 결의로 다음 각 호의 어느 하나에 해당하는 방식으로 신주를 배정하여야 한다. </P>
<P>1. 신주인수의 청약을 할 기회를 부여하는 자의 유형을 분류하지 아니하고 불특정 다수의 청약자에게 신주를 배정하는 방식</P>
<P>2. 관계 법령에 따라 우리사주조합원에 대하여 신주를 배정하고 청약되지 아니한 주식까지 포함하여 불특정 다수인에게 신주인수의 청약을 할 기회를 부여하는 방식</P>
<P>3. 주주에 대하여 우선적으로 신주인수의 청약을 할 수 있는 기회를 부여하고 청약되지 아니한 주식이 있는 경우 이를 불특정 다수인에게 신주를 배정받을 기회를 부여하는 방식</P>
<P>4. 투자매매업자 또는 투자중개업자가 인수인 또는 주선인으로서 마련한 수요예측 등 관계 법규에서 정하는 합리적인 기준에 따라 특정한 유형의 자에게 신주인수의 청약을 할 수 있는 기회를 부여하는 방식</P>
<P> </P>
<P>③  제1항 각호의 어느 하나의 방식에 의해 신주를 발행할 경우에는 발행할 주식의 종류와 수 및 발행가격 등은 이사회의 결의로 정한다.&cr;</P>
<P>④  회사는 신주를 배정하는 경우 그 기일까지 신주인수의 청약을 하지 아니하거나 그 액을 납입하지 아니한 주식이 발생하는 경우에 그 처리방법은 발행가액의 적정성 등 관련 법령에서 정하는 바에 따라  이사회 결의로 정한다.&cr;</P>
<P>⑤  회사는 신주를 배정하면서 발생하는 단주에 대한 처리방법은 이사회의 결의로 정한다</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" ALIGN="CENTER" HEIGHT="30">결 산 일</TD>
<TD WIDTH="149" ALIGN="CENTER" HEIGHT="30">1월 1일 ~ 12월 31일</TD>
<TD WIDTH="133" ALIGN="CENTER" HEIGHT="30">정기주주총회</TD>
<TD WIDTH="277" ALIGN="CENTER" HEIGHT="30">결산일에서 3개월이내</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" ALIGN="CENTER" HEIGHT="30">주주명부폐쇄시기</TD>
<TD COLSPAN="3" WIDTH="559" ALIGN="CENTER" HEIGHT="30">1월 1일 ~ 1월 31일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" ALIGN="CENTER" HEIGHT="30">명의개서대리인</TD>
<TD COLSPAN="3" WIDTH="559" ALIGN="CENTER" HEIGHT="30">한국예탁결제원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" ALIGN="CENTER" HEIGHT="30">공고방법</TD>
<TD COLSPAN="3" WIDTH="559" ALIGN="CENTER" HEIGHT="30">www.daewoong.co.kr/ 한국경제신문</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">6. 최근 6개월 간의 주가 및 주식 거래실적</SPAN>
</P>

<TABLE WIDTH="706" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="697"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="706" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 원,주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="705" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" ROWSPAN="2">종류</TH>
<TH WIDTH="504" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="6">2020년</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">7월</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">8월</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">9월</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10월</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">11월</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">12월</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">보통주</TD>
<TD ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">주가</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최 고</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">133,500</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">135,000</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">119,000</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">108,000</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">104,000</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">275,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최 저</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">106,000</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">106,500</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">99,600</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">90,400</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">90,800</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">110,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">거래량</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최고(일)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">1,522,642</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">3,434,964</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">292,230</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">170,724</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">753,229</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">6,454,045</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최저(일)</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">74,384</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">90,165</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">56,193</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">31,912</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">26,791</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">211,472</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>
<P>1) 임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1158" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="809"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="818" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1162" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당&cr;업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="213" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">전승호</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="197510" VALIGN="MIDDLE">1975.10</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사&cr;사장</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE">CEO</TE>
<TE WIDTH="213" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">서울대학교 약학 &cr;서울대학교 대학원 제약학 석사&cr;(주)대웅제약 글로벌사업본부장&cr;現) (주)대웅제약 대표이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">1,114</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="97" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">2003.4~現</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="20210323" VALIGN="MIDDLE">2021.03.23</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">윤재춘</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="195910" VALIGN="MIDDLE">1959.10</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사&cr;사장</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE">CEO</TE>
<TE WIDTH="213" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">카이스트 경영대학원&cr;現)(주)대웅제약 대표이사,&cr;現)(주)대웅 대표이사,&cr;現)한올바이오파마(주) 대표이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">178</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="97" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">1985.8~現</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="20210323" VALIGN="MIDDLE">2021.03.23</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE">김홍철</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="197110" VALIGN="MIDDLE">1971.10</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE">자문</TE>
<TE WIDTH="213" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">서울대학교 법학 졸업 &cr;브릿지바이오㈜ 감사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="97" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE">1918.3~現</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="20210322" VALIGN="MIDDLE">2021.03.22</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">이충우</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="196603" VALIGN="MIDDLE">1966.03</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">감사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE">감사</TE>
<TE WIDTH="213" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">법무법인 서린 대표, &cr;경제사회발전노사정위원회 &cr;고용차별개선연구회 위원&cr;現)(주)대웅제약 상근감사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="97" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">2017.3~現</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="20230320" VALIGN="MIDDLE">2023.03.20</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE">박성수</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="197602" VALIGN="MIDDLE">1976.02</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE">본부장</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE">본부장</TE>
<TE WIDTH="213" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">서울대학교 약학&cr;서울대학교 대학원 제약학 석사&cr;미국지사 지사장&cr;現) 나보타사업본부 본부장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="97" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE">1999.12~現</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="70" ACODE="SH5_NM_T" VALIGN="MIDDLE">지창원</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="70" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="70" AUNIT="SH5_BIH" AUNITVALUE="196401" VALIGN="MIDDLE">1964.01</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="70" ACODE="SH5_LEV" VALIGN="MIDDLE">본부장</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="70" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="70" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="70" ACODE="SH5_OBJ" VALIGN="MIDDLE">본부장</TE>
<TE WIDTH="213" HEIGHT="70" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">강원대학교일반대학원 약제학박사&cr;얀센백신㈜ 본부장&cr;現) 생산본부 본부장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="70" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="97" HEIGHT="70" ACODE="SH5_PER" VALIGN="MIDDLE">2016.4~現</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="70" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>* 양윤선 사외이사는 2020년 3월 20일 임기만료로 퇴임하였습니다.&cr;* 전승호 대표이사는 2021년 3월 26일 개최되는 제19기 정기주주총회에서 사내이사 재선임 안건이 상정됨.&cr;* 윤재춘 대표이사는 2021년 3월 26일 개최되는 제19기 정기주주총회에서 사내이사 재선임 안건이 상정됨.&cr;* 김홍철 사외이사는 2021년 3월 26일 개최되는 제19기 정기주주총회에서 재선임 안건이 상정됨.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『등기임원후보자 및 해임대상자』 삽입</COMMENT>
<LIBRARYLIST>11011#*등기임원후보자및해임대상자.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">51_등기임원후보자및해임대상자</FILENAME>
<P USERMARK=" B">2) 등기임원 선임 후보자 및 해임 대상자 현황</P>

<TABLE-GROUP ACLASS="PSN_MBER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="796" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="537"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="170" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20210318">2021년 03월 18일</TU>
<TD VALIGN="BOTTOM" WIDTH="546" HEIGHT="30" AUPDATECONT="N"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="799" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="284"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사외이사&cr;후보자&cr;해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선ㆍ해임&cr;예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="91" ACODE="PSN_NAM" VALIGN="MIDDLE">전승호</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="PSN_BIH" AUNITVALUE="197510" VALIGN="MIDDLE">1975.10</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="91" ACODE="PSN_DIR" VALIGN="MIDDLE">사내이사</TE>

<TE WIDTH="293" HEIGHT="91" ACODE="PSN_CAR" VALIGN="MIDDLE">
<P>㈜대웅제약 글로벌전략팀 팀장&cr;㈜대웅제약 글로벌사업본부 본부장</P>
<P>㈜대웅제약 대표이사 (현)</P>
</TE>
<TU ALIGN="CENTER" WIDTH="84" HEIGHT="91" AUNIT="PSN_DAT" AUNITVALUE="20210326" VALIGN="MIDDLE">2021.03.26</TU>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="91" ACODE="PSN_RSP" VALIGN="MIDDLE">없음</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="175" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="175" ACODE="PSN_NAM" VALIGN="MIDDLE">윤재춘</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="175" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="175" AUNIT="PSN_BIH" AUNITVALUE="195910" VALIGN="MIDDLE">1959.10</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="175" ACODE="PSN_DIR" VALIGN="MIDDLE">사내이사</TE>

<TE WIDTH="293" HEIGHT="175" ACODE="PSN_CAR" VALIGN="MIDDLE">

<P>㈜대웅제약 경영지원본부 본부장&cr;㈜대웅제약 COO&cr;㈜대웅 대표이사 사장 (현)&cr;한올바이오파마㈜ 대표이사 (현)&cr;
<SPAN>대웅바이오㈜ 대표이사 (현)</SPAN>
</P>
<P>㈜대웅제약 대표이사 (현)</P>
</TE>
<TU ALIGN="CENTER" WIDTH="84" HEIGHT="175" AUNIT="PSN_DAT" AUNITVALUE="20210326" VALIGN="MIDDLE">2021.03.26</TU>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="175" ACODE="PSN_RSP" VALIGN="MIDDLE">없음</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="PSN_NAM" VALIGN="MIDDLE">이창재</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="PSN_BIH" AUNITVALUE="197706" VALIGN="MIDDLE">1977.06</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="PSN_DIR" VALIGN="MIDDLE">사내이사</TE>
<TE WIDTH="293" HEIGHT="99" ACODE="PSN_CAR" VALIGN="MIDDLE">㈜대웅제약 ETC본부 소장&cr;㈜대웅제약 마케팅본부 본부장&cr;㈜대웅 사내이사 (현)&cr;㈜대웅제약 부사장 (현)</TE>
<TU ALIGN="CENTER" WIDTH="84" HEIGHT="99" AUNIT="PSN_DAT" AUNITVALUE="20210326" VALIGN="MIDDLE">2021.03.26</TU>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="99" ACODE="PSN_RSP" VALIGN="MIDDLE">없음</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="PSN_NAM" VALIGN="MIDDLE">김홍철</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="PSN_BIH" AUNITVALUE="197110" VALIGN="MIDDLE">1971.10</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="PSN_DIR" VALIGN="MIDDLE">사외이사</TE>
<TE WIDTH="293" HEIGHT="99" ACODE="PSN_CAR" VALIGN="MIDDLE">기업리서치 이사&cr;한올바이오파마㈜ 사외이사 &cr;브릿지바이오테라퓨틱스㈜ 감사&cr;㈜대웅제약 사외이사 (현)</TE>
<TU ALIGN="CENTER" WIDTH="84" HEIGHT="99" AUNIT="PSN_DAT" AUNITVALUE="20210326" VALIGN="MIDDLE">2021.03.26</TU>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="99" ACODE="PSN_RSP" VALIGN="MIDDLE">없음</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="PSN_NAM" VALIGN="MIDDLE">김영진</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="PSN_BIH" AUNITVALUE="197106" VALIGN="MIDDLE">1971.06</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="PSN_DIR" VALIGN="MIDDLE">사외이사</TE>
<TE WIDTH="293" HEIGHT="99" ACODE="PSN_CAR" VALIGN="MIDDLE">가톨릭대학교 중앙의료원&cr;세종시 효성병원 응급센터 과장&cr;가톨릭대학교 의과대학 외래조교수 (현)&cr;구로우리들의원 대표원장 (현)</TE>
<TU ALIGN="CENTER" WIDTH="84" HEIGHT="99" AUNIT="PSN_DAT" AUNITVALUE="20210326" VALIGN="MIDDLE">2021.03.26</TU>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="99" ACODE="PSN_RSP" VALIGN="MIDDLE">없음</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="PSN_NAM" VALIGN="MIDDLE">이건행</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="PSN_BIH" AUNITVALUE="196104" VALIGN="MIDDLE">1961.04</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="PSN_DIR" VALIGN="MIDDLE">감사</TE>
<TE WIDTH="293" HEIGHT="99" ACODE="PSN_CAR" VALIGN="MIDDLE">법무법인(유) 에이펙스 부대표&cr;(주)대웅 사외이사 (현)</TE>
<TU ALIGN="CENTER" WIDTH="84" HEIGHT="99" AUNIT="PSN_DAT" AUNITVALUE="20210326" VALIGN="MIDDLE">2021.03.26</TU>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="99" ACODE="PSN_RSP" VALIGN="MIDDLE">없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P>* 2021년 3월 26일 개최되는 제 19기 정기주주총회에서 상기 등기임원 후보자들의 선임 안건이 상정되었습니다.&cr;</P>

<P>
<SPAN USERMARK=" B">3) 회사와 계열회사간 임원 겸직 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="445">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="146" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">겸   직   임   원 </TH>
<TH WIDTH="221" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">겸     직     회    사 </TH>
<TH WIDTH="78" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비     고 </TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성  명 </TH>
<TH WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직      위 </TH>
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회  사  명 </TH>
<TH WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직      위 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>윤재춘</P>
</TD>

<TD WIDTH="83" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대웅</TD>

<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>

<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>한올바이오파마</P>
</TD>

<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대웅개발</P>
</TD>

<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>

<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대웅바이오</P>
</TD>

<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>

<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">전승호</TD>
<TD WIDTH="83" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">대표이사</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">아피셀테라퓨틱스</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대표이사</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">아이엔테라퓨틱스</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사내이사</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대웅테라퓨틱스</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사내이사</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">4) 직원 등 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="854" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="496" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="854" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="33"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외&cr;근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="42" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="343" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균&cr;근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여&cr;총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균&cr;급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="142" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이&cr;없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제&cr;근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">전체</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">998</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">11</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">1,009</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">7.7</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">71,382</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">71</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="3">166</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="3">138</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="3">304</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">전체</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">391</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">15</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">406</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">6.1</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">21,454</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">53</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">1,389</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">26</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">1,415</TE>
<TE ALIGN="RIGHT" WIDTH="73" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">7.1</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">92,836</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">66</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 직원 현황 표는 미등기임원을 포함하여 작성한다</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P></P>
<P>미등기임원 보수 현황</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="234"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="243" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="601" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="52"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">연간급여 총액</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인평균 급여액</TH>
<TH WIDTH="61" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_CNT">2</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">534</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">267</TE>
<TE WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">1. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">등기이사(사외이사포함)</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">3</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">3,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">200</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>* 등기이사/감사 보수 한도는 2020년3월20일 개최된 정기주주총회에서 승인된 금액입니다.&cr;* 2021년 3월 26일 개최되는 제19기 정기주주총회에서 동일한 금액으로 이사 보수한도 승인의 건이 상정되었습니다.&cr;</P>
<P USERMARK=" B">2. 보수지급금액</P>
<P>2-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">4</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUM">706</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_VIC">177</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>2-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당&cr;평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사&cr;(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM">600</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC">300</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사&cr;(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM">36</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC">36</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_SUM">70</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_VIC">70</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>- 해당사항 없음&cr;</P>
<P>2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권&cr; 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>- 해당사항 없음&cr;</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>- 해당사항 없음&cr;</P>
<P>2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권&cr; 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>- 해당사항 없음&cr;&cr;
<SPAN USERMARK=" B">3. 이사ㆍ감사의 보수지급기준&cr;</SPAN>
<SPAN>이사 및 감사의 보수한도는 주주총회의 결의로 정함.&cr; - 이사 보수한도 : 30억원&cr; - 감사 보수한도 : 2억원&cr;&cr;*상기 보수한도는 2020년 3월 개최된 주주총회에서 승인된 금액이며,&cr;2021년 3월 26일 개최되는 제19기 정기주주총회에서 동일한 금액으로 이사 보수한도 승인의 건, 감사 보수한도 승인의 건이 상정되었습니다.&cr;&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『주식매수선택권의 부여 및 행사현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*주식매수선택권의부여및행사현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">14_주식매수선택권의부여및행사현황</FILENAME>
<P><주식매수선택권의 부여 및 행사현황></P>
<P><표1></P>

<TABLE-GROUP ACLASS="SUB_SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="232"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="241" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주식매수선택권의 공정가치 총액</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">등기이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="RRT_PAY_NUM">-</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="RRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사외이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ORT_PAY_NUM">-</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ORT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">감사위원회 위원 또는 감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">-</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P><표2></P>

<TABLE-GROUP ACLASS="SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="882" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="153" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="497" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1001" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여&cr;받은자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="183" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여방법</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초&cr;부여&cr;수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기변동수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총변동수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기말&cr;미행사수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사&cr;가격</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="53" ACODE="SH5_NM">김OO외&cr;100명</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20180921">2018.09.21</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="183" HEIGHT="53" ACODE="SH5_MTH">신주교부, 자기주식교부,&cr;차액보상 중 택1</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_START_CNT">10,752</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">1,202</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_CNL_CNT">1,912</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">8,840</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" ACODE="SH5_PER">2021.9.21 ~&cr;2022.9.21</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_PRC">194,000</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="53" ACODE="SH5_NM">김OO외&cr;127명</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20190306">2019.03.06</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="183" HEIGHT="53" ACODE="SH5_MTH">신주교부, 자기주식교부,&cr;차액보상 중 택1</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_START_CNT">12,257</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">388</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_CNL_CNT">1,148</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">11,109</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" ACODE="SH5_PER">2022.3.6 ~ &cr;2023.3.6</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_PRC">195,020</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>- 2020년 12월말 종가는 165,000원입니다.&cr;- 2021년 3월 26일 개최되는 제19기 정기주주총회에서 주식매수선택권 부여의 건이 의안 상정될 예정이며, 상기 표에는 반영되지 않았습니다.</P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">1. 기업집단의 명칭&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN> - 대웅그룹&cr; - 공정거래법상 상호출자 제한, 출자총액 제한, 채무보증 제한에 해당하지 않습니다&cr;
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B">2. 기업집단의 소속회사의 명칭 </SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="839">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="376"></COL>
<COL WIDTH="259"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="385" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회사명</P>
</TH>

<TH WIDTH="268" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주업종</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>상장법인</P>
</TD>
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">지주회사(기타서비스업)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지주회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅제약</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">한올바이오파마(주)</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">손자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="30" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="900">
<P>비상장법인</P>
</TD>
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">대웅바이오(주)</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">원료의약품 제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅생명과학</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">식품 가공업 및 판매업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅경영개발원</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">경영 및 산업연수사업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)산웅개발</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">용역업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅이엔지</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">공무, 시설관리 용역업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)팜팩</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약외품의 포장업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">부동산 임대 및 공급업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)아이디에스앤트러스트</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">통신관련 기기의 제조 및 판매업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">㈜에이치알그룹</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">리더십교육, 코칭, HR컨설팅, 솔루션</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">㈜에스티에이치이솔루션</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">구강위생용품 개발 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)대웅테라퓨틱스</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">신규 의약 기술개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)힐리언스</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">생활습관병 예방 및 연구업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">손자회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">다나아데이터㈜</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">응용소프트웨어 개발 및 공급업</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">(주)엠디웰아이엔씨</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">환자식 제조판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">농업회사법인(주)대웅낙원</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">농지임대 및 매매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">아피셀테라퓨틱스</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">신규 의약 기술개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">아이엔테라퓨틱스</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">신규 의약 기술개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해외법인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 연구개발, 기술이전, 기술개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical(Thailand)Co.,Ltd</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong America, Inc.</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">PT. Daewoong Pharmaceutical(Indonesia)Co.Ltd</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">사천대웅생물기술유한공사</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">연구개발</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">지주회사</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical India Pvt.,Ltd</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 수출입 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Pharmaceutical Japan Co., Ltd.</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">HPI,INC</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">해외임상 진행 및 라이센싱아웃 업무</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">요녕대웅제약유한공사</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">PT. DAEWOONG INFION</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 제조 및 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="385" VALIGN="MIDDLE" HEIGHT="30">Daewoong Bio Indonesia</TD>
<TD WIDTH="268" VALIGN="MIDDLE" HEIGHT="30">의약품 판매</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">〃</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계</P>
</TD>
<TD WIDTH="385" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">33개사</TD>
<TD WIDTH="268" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P> </P>

<P>
<SPAN USERMARK=" B">3. 계열회사간 출자현황&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="442" ALIGN="CENTER" HSPACE="0">출자현황.jpg</IMG>
<IMG-CAPTION ATOC="N">출자현황</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK=" B">4.회사와 계열회사간 임원 겸직 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="445">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="146" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">겸   직   임   원 </TH>
<TH WIDTH="221" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">겸     직     회    사 </TH>
<TH WIDTH="78" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비     고 </TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성  명 </TH>
<TH WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직      위 </TH>
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회  사  명 </TH>
<TH WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직      위 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>윤재춘</P>
</TD>

<TD WIDTH="83" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대웅</TD>

<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>

<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>한올바이오파마</P>
</TD>

<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대웅개발</P>
</TD>

<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>

<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대웅바이오</P>
</TD>

<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>

<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">전승호</TD>
<TD WIDTH="83" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">대표이사</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">아피셀테라퓨틱스</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대표이사</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">아이엔테라퓨틱스</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사내이사</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대웅테라퓨틱스</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사내이사</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>※ 당사는 2인의 각자대표체제입니다.&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『타법인출자 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*타법인출자현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">6_타법인출자현황</FILENAME>
<P USERMARK=" B">5. 타법인출자 현황</P>

<TABLE-GROUP ACLASS="INV_PRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1388" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="934"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="213" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="943" HEIGHT="30" AUNIT="WONSTOCKPERCENT" AUNITVALUE="4">(단위 : 천원, 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1393" BORDER="1">

<COLGROUP>
<COL WIDTH="212"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" WIDTH="221" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">법인명</TH>
<TH ROWSPAN="3" WIDTH="100" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득일자</TH>
<TH ROWSPAN="3" WIDTH="65" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">출자&cr;목적</TH>
<TH ROWSPAN="3" WIDTH="104" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득금액</TH>
<TH COLSPAN="3" WIDTH="246" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기초잔액</TH>
<TH COLSPAN="3" WIDTH="245" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">증가(감소)</TH>
<TH COLSPAN="3" WIDTH="243" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기말잔액</TH>
<TH COLSPAN="2" WIDTH="169" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">최근사업연도&cr;재무현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" WIDTH="82" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="82" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="82" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부&cr;가액</TH>
<TH COLSPAN="2" WIDTH="164" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">취득(처분)</TH>
<TH ROWSPAN="2" WIDTH="81" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">평가&cr;손익</TH>
<TH ROWSPAN="2" WIDTH="81" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="81" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="81" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부&cr;가액</TH>
<TH ROWSPAN="2" WIDTH="85" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">총자산</TH>
<TH ROWSPAN="2" WIDTH="84" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">당기&cr;순손익</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="82" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">수량</TH>
<TH WIDTH="82" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">한올바이오파마(주) (상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">인수</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">104,020,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">15,672,192</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">30</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">106,111,335</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">443,553</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">10,000,031</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">16,115,745</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">31</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">116,111,366</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">219,483,648</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">19,863,538</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">힐리언스 (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">인수</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">800,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">2,753,300</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">76</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">18,664,822</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-2,235,573</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">2,753,300</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">76</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">16,429,249</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">31,160,612</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-2,964,072</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">Daewoong Pharma PHILIPPINES, INC. (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">54,483</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">100</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">260,539</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">260,539</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">2,610,449</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">253,627</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">Daewoong Pharmaceutical(Thailand)Co.,Ltd (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">61,294</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">100</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">205,389</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">205,389</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">3,542,105</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">727,562</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">PT. DAEWOONG PHARMACEUTICAL &cr;COMPANY INDONESIA (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">959,423</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">100</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">7,812,111</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">7,812,111</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">2,386,331</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-707,166</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">DAEWOONG PHARMACEUTICAL&cr; HONGKONG (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">17,660,725</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">269,255,424</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">90</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">37,809,184</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">269,255,424</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">90</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">37,809,184</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">0</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">0</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">북경대웅위업의약과기유한공사 (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">99,953</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">100</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">6,060,668</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-232,984</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">5,827,684</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">4,193,618</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">734,568</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">바이오시네틱스 (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">사업관련</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">2,000,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">645,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">18</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">819,086</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">645,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">18</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">819,086</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">2,139,099</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-1,473,558</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">이피피미디어 (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">사업관련</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">1,000,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">100,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">20</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">100,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">20</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">-</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">6,815,780</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-296,971</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">엠디웰아이엔씨 (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">500,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">100,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">50</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">500,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">100,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">50</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">500,000</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">9,829,663</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">1,669,222</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">Daewoong America, Inc. (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20091230">2009.12.30</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">117,111</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">100</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">83,286</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">83,286</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">97,102</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">84,033</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">Daewoong Pharmaceutical India &cr;Pvt.,Ltd (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">67,478</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">100</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">550,733</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">550,733</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">849,678</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">225,637</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">DAEWOONG PHARMACEUTICAL&cr;JAPAN CO.,LTD</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">555,621</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">1,100</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">100</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">555,621</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">1,100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">555,621</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">7,671,649</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="45" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">659,692</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">건강한삶기술창업벤처PEF</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">1,500,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">1,500,000,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">49</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">1,500,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">1,000,000,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">1,000,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">2,500,000,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">50</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">2,500,000</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">4,658,995</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-145,967</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">㈜다나아데이터</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20181123">2018.11.23</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">5,100,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">102,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">51</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">5,100,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">102,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">51</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">5,100,000</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">10,127,138</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">139,274</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">Immplacate, Inc.</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">사업관련</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">1,125,970</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">1,428,571</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">20</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">1,125,970</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">1,428,571</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">20</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">1,125,970</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">26,949</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-187,662</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">아피셀테라퓨틱스</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">1,960,780</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">1,960,780</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">1,960,780</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">54</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">1,960,780</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">5,688,129</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-1,174,712</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">아이엔테라퓨틱스</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">설립</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">17,414,405</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">3,118,330</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">17,414,405</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">100</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">3,118,330</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">2,125,940</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-2,566,132</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">진켐 (비상장)(주3)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">사업관련</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">500,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">41,932</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">3</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">114,516</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">361,035</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">41,932</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">3</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">475,551</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">17,124,130</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-6,055,033</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">바이오넷 (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20011222">2001.12.22</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">사업관련</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">700,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">32,448</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">6</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">736,213</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">292,032</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-509,077</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">324,480</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">3</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">227,136</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">15,420,980</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">124,314</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">큐어바이오 (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">사업관련</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">999,902</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">3,111</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">2</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">337,867</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-29,766</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">3,111</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">2</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">308,101</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">11,886,803</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-2,895,288</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">3D Matrix (해외상장)(주2)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">사업관련</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">1,362,230</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">320,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">2</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">1,626,684</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-651,704</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">320,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">2</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">974,980</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">3,020,843</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">1,965,654</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">카이페리온</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20191016">2019.10.16</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">단순투자</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">1,000,020</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">28,572</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">3</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">1,000,020</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">28,572</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">3</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">1,000,020</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">5,018,113</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-1,224,456</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">JTBC (비상장)(주3)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">단순투자</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">3,000,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">600,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">1</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">247,800</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-81,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">600,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">1</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">166,800</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">293,084</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-24,880</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">향남제약공단 (비상장)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">단순투자</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">34,156</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">217,879</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">217,879</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">0</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">0</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">자일자동차판매 (비상장)(주3)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">단순투자</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">639,011</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">0</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">321,650</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-121,552</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">0</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">200,098</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">224,256,874</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">2,247,139</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">인벤티지랩(주3)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">단순투자</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">83,326</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">999,995</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">83,326</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">1</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">999,995</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">9,866,951</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-3,796,403</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">Cistem(주3)</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">단순투자</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">9,091</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">2,000,002</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">9,091</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">9</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">2,000,002</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">58,101</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-114,828</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">데일리 임파워링 바이오 헬스케어 펀드4호</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">단순투자</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">1,000</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">1,000,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">1,000</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">7</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">1,000,000</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">15,235,722</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-70,585</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="221" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM" USERMARK="F-8">서울의료정보연구소</TE>
<TU WIDTH="100" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20201211">2020.12.11</TU>
<TE WIDTH="65" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ" USERMARK="F-8">단순투자</TE>
<TE WIDTH="104" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK="F-8">1,067</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK="F-8">200,063</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN" USERMARK="F-8">1,067</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR" USERMARK="F-8">6</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM" USERMARK="F-8">200,063</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM" USERMARK="F-8">297,475</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM" USERMARK="F-8">-310,550</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="4" WIDTH="490" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE">합 계</TD>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTNT" USERMARK="F-8">-</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPRT" USERMARK="F-8">0</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTMT" USERMARK="F-8">191,761,373</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTNT" USERMARK="F-8">1,020,205,254</TE>
<TE WIDTH="82" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTMT" USERMARK="F-8">20,279,201</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPMT" USERMARK="F-8">-3,500,621</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTNT" USERMARK="F-8">-</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPRT" USERMARK="F-8">0</TE>
<TE WIDTH="81" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTMT" USERMARK="F-8">208,539,953</TE>
<TE WIDTH="85" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTMT" USERMARK="F-8">615,885,961</TE>
<TE WIDTH="84" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPMT" USERMARK="F-8">4,685,997</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P>(주1) 상기 최근사업연도 재무현황은 20년 기말 재무제표 기준입니다.&cr;(주2) 3D Matrix는 19년 4월말 재무제표이며 단위는 천엔입니다.&cr;(주3) 20년 기말 시점 재무제표가 확정 되지 않아, 19년 기말 재무현황입니다. &cr;&cr;* 장부가액 감액 사유</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="602">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="612" BORDER="1">

<COLGROUP>
<COL WIDTH="282"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="291" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">법인명</TH>
<TH WIDTH="157" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감액금액</TH>
<TH WIDTH="164" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감액 사유</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" HEIGHT="30">바이오넷 (비상장)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">(509,077)</TD>
<TD ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="150">시가평가에 따른&cr;공정가치 감소</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" HEIGHT="30">큐어바이오 (비상장)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">(29,766)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" HEIGHT="30">3D Matrix (해외상장)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">(651,704)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" HEIGHT="30">JTBC (비상장)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">(81,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" HEIGHT="30">자일자동차판매 (비상장)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">(121,552)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" HEIGHT="30">힐리언스 (비상장)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">(2,235,573)</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="60">종속법인 손상검토에 따른  손상인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" HEIGHT="30">북경대웅위업의약과기유한공사 (비상장)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">(232,984)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 이해관계자와의 거래내용</TITLE>
<P></P>

<P>
<SPAN>1. 특수관계자 거래 </SPAN>
<SPAN>&cr;&cr;</SPAN>
<SPAN>(1) 당기말과 전기말 현재 당사의 특수관계자 현황은 다음과 같습니다.&cr;가. 지배기업 및 주요 주주</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="644">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">지배기업 등</TH>
<TH COLSPAN="2" WIDTH="322" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">당사에 대한 지분율</TH>
<TH ROWSPAN="2" WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="161" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" ALIGN="CENTER">(주)대웅</TD>
<TD WIDTH="161" ALIGN="CENTER" HEIGHT="30">45.07%</TD>
<TD WIDTH="161" ALIGN="CENTER" HEIGHT="30">41.25%</TD>
<TD WIDTH="161" ALIGN="CENTER" HEIGHT="30">지주회사</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 종속기업, 관계기업 및 기타 특수관계자</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1000">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="253"></COL>
<COL WIDTH="253"></COL>
<COL WIDTH="341"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계 구분</TH>
<TH WIDTH="262" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="262" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
<TH WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비      고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="611" ROWSPAN="15" ALIGN="CENTER" VALIGN="MIDDLE">종속기업</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical (Thailand)Co., Ltd.</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical (Thailand)Co., Ltd.</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">PT. Dewoong Pharmaceutical (Indonesia)Co., Ltd.</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">PT. Dewoong Pharmaceutical (Indonesia)Co., Ltd.</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">PT. Dewoong Pharmaceutical (Indonesia)Co., Ltd.의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL HONGKONG의&cr; 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Daewoong America, Inc.</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Daewoong America, Inc.</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical India Pvt., Ltd.</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">Daewoong Pharmaceutical India Pvt., Ltd.</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="262" HEIGHT="53" VALIGN="MIDDLE">DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="350" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">HPI, INC.</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">HPI, INC.</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">한올바이오파마(주)의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아피셀 테라퓨틱스 (*1)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아이엔 테라퓨틱스 (*1)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">관계기업</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)엠디웰아이앤씨</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)엠디웰아이앤씨</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)이피피미디어</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)이피피미디어</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)바이오시네틱스</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)바이오시네틱스</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">건강한삶기술창업벤처PEF</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">건강한삶기술창업벤처PEF</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">㈜다나아데이터</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">㈜다나아데이터</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Immplacate, Inc.</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">Immplacate, Inc.</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="690" ROWSPAN="23" ALIGN="CENTER" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">대웅바이오㈜</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">대웅바이오(주)</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">사천대웅생물기술유한공사</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">사천대웅생물기술유한공사</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대웅바이오(주)의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)HR그룹</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)HR그룹</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아이디에스앤트러스트</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아이디에스앤트러스트</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅경영개발원</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅경영개발원</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅생명과학</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅생명과학</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)디엔컴퍼니</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)디엔컴퍼니</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">대웅엔지니어링(주)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">대웅엔지니어링(주)</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)산웅개발</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)산웅개발</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피코프</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피코프</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)디톤</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)디톤</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피바이오</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피바이오</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피스페이스</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)알피스페이스</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)알피코프의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)이지메디컴</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)이지메디컴</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">- (*2)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)인성정보</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅개발</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)대웅개발</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)팜팩</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)팜팩</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">- (*2)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)인성디지탈</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">- (*2)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)아이넷뱅크</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)시지바이오</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)시지바이오</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">STH이솔루션</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">STH이솔루션</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대웅의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">- (*2)</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주)벤치비</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주) 엠서클 등</TD>
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE">(주) 엠서클 등</TD>
<TD WIDTH="350" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 당기 중 지분 취득을 통해 종속기업으로 편입되었습니다.&cr;(*2) 당기 중 기타 특수관계자에서 제외되었습니다.</P>
<P>&cr;(2) 당기와 전기 중 당사와 특수관계자간의 수익ㆍ비용거래 내역은 다음과 같습니다.가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1121">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="250"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1121" VALIGN="MIDDLE" COLSPAN="10" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="91" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH COLSPAN="4" WIDTH="387" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수익 등</TH>
<TH WIDTH="384" VALIGN="MIDDLE" COLSPAN="4" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비용 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제품/상품&cr;매출</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용역/서비스&cr;제공</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임대수익</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재고자산&cr;매입</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용역/서비스&cr;비용</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연구비용</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="91" HEIGHT="53" ALIGN="CENTER">최상위&cr;지배기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="53">(주)대웅</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,672 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">7,481 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">589,869 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">108,360 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">32,902,664 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">15,322,510 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">55,696 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="11" WIDTH="91" HEIGHT="399" ALIGN="CENTER">종속기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)힐리언스</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,309 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,563 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,600 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,274 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">162,000 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,703 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,526,618 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">한올바이오파마㈜</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,356,231 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,407 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,673 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,207 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,503,444 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,328,634 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,276,801 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">330,542 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">요녕대웅제약유한공사</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">503,823 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,316,320 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85,393 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,761,352 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">Daewoong Pharmaceutical(Thailand)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,644,279 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,214 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="53">PT. Dewoong Pharmaceutical&cr; (Indonesia)Co.,Ltd.</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,963 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">186,015 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">Daewoong America, Inc.</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">196,749 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="53">Daewoong Pharmaceutical&cr; India Pvt., Ltd.</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">995,349 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="30">PT. DAEWOONG INFION</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">136,233 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,652 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,907,013 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="53">DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">106,589 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">12,254 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,013 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="91" HEIGHT="30" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)엠디웰아이앤씨</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,652 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">536 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,962 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">698 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">214,819 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,384 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="15" WIDTH="91" HEIGHT="450" ALIGN="CENTER">기타&cr;특수관계자</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">대웅바이오㈜ (*1)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,598,022 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,538 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">178,114 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,592,434 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,986,187 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">115,214 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,990 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)아이디에스앤트러스트</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,494 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,594 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,868 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">786,458 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">444,232 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,655 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)대웅경영개발원</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">151 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">472,997 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,358 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,747 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,120,354 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">344,050 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)대웅생명과학</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">332 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,135 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,014 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">424,855 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)디엔컴퍼니</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,388,094 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,170 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">136,510 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,107 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,251 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,084,672 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,589 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,601,501 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">대웅엔지니어링㈜</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,674 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,174,474 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)산웅개발</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,231 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">128,411 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,231,459 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,961 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)알피바이오</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,729 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">255 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,185,143 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)이지메디컴</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">414,972 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,416 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">818,390 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,959,663 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)인성정보</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,252 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,352,900 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,680 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">674,339 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">568,290 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)팜팩</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">325 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">792 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,905,855 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)시지바이오</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,773,691 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,028 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,760 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,985 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,930,058 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">712,196 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36,787 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">(주)엠서클 (*2)</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,337 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,649 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,106 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,197 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,715,687 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,410,712 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,318,574 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,040 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,911 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,402 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,655,149 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,296,714 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,425,797 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,455,902 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="350" HEIGHT="30" COLSPAN="2">합        계</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,934,489 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">120,909 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,180,018 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">689,213 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,108,634 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">64,359,890 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,072,270 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,513,757 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(*1) </SPAN>
<SPAN>대웅바이오㈜와의 거래에서 발생하는 연구비를 131,502천원 차감 처리하였습니다.&cr;(*2) (주)엠서클과의 거래에서 반품매출이 34,979천원 있습니다.&cr;</SPAN>
<SPAN>&cr;나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1125">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="250"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1125" VALIGN="MIDDLE" COLSPAN="11" ALIGN="RIGHT" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="91" HEIGHT="77" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="77" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">회사명</TH>
<TH COLSPAN="4" WIDTH="345" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">수익 등</TH>
<TH WIDTH="430" VALIGN="MIDDLE" COLSPAN="5" ALIGN="CENTER" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">비용 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">제품/상품&cr;매출</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">용역/서비스&cr;제공</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">임대수익</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">기타</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">재고자산&cr;매입</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">고정자산&cr;매입</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">용역/서비스&cr;비용</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">연구비용</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">기타</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="91" HEIGHT="49" ALIGN="CENTER" USERMARK="F-10">최상위&cr;지배기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="49" USERMARK="F-10">(주)대웅 (*1)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">1,075 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">53,699 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">458,837 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">554,524 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">29,788,456 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">14,469,818 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">291,905 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="11" WIDTH="91" HEIGHT="371" ALIGN="CENTER" USERMARK="F-10">종속기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)힐리언스</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">14,955 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,622 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,600 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">62,199 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">10,762 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">60 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,682 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,919,232 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">한올바이오파마㈜ (*2)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,085,029 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,705 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">10,756 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">39,839 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,273,238 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">4,200,406 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,819,802 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">21,220 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">요녕대웅제약유한공사</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,072,586 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">8,647,693 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">Daewoong Pharma PHILIPPINES INC.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,345,070 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">Daewoong Pharmaceutical(Thailand)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,232,043 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">26,288 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="49" USERMARK="F-10">PT. Dewoong Pharmaceutical(Indonesia)Co.,Ltd.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">38,744 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">129,954 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">Daewoong America, Inc.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">108,845 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">312,312 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="49" USERMARK="F-10">Daewoong Pharmaceutical India Pvt., Ltd.</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">849,577 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="28" USERMARK="F-10">PT. DAEWOONG INFION</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">9,923 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">176,051 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,409,959 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="259" HEIGHT="49" USERMARK="F-10">DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">11,696,391 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">195,407 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">24,280 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="49" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="91" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">관계기업</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)엠디웰아이앤씨</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,161 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,351 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,858 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">235,417 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">30,004 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ROWSPAN="15" WIDTH="91" HEIGHT="420" ALIGN="CENTER" USERMARK="F-10">기타&cr;특수관계자</TD>
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">대웅바이오㈜</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">13,031,904 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">18,496 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">20,669 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">79,376,989 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">505,372 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,138,815 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">224,943 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">20,249 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)아이디에스앤트러스트</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">14,057 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">68,463 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">62,135 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">50 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">415,612 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">67 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">15,348 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)대웅경영개발원</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">477,797 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">28,928 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">28,343 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,293,868 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">582,157 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)대웅생명과학</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,657 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,636 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">9,892 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">936 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">437,781 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)디엔컴퍼니</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,033,194 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">34,340 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">117,928 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">67,309 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">931,178 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,912,330 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">9,287 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,518,188 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">대웅엔지니어링㈜</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,555 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,195,274 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)산웅개발</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">11,369 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,455 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">120,517 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,273,575 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">273 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">46,292 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)알피바이오</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,403,693 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">19,666 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">10,000 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,852,961 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">91 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">120,615 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)이지메디컴</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">81,139 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">49,918 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">328,242 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">775,234 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,437,047 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)인성정보</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,368 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,333,188 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">58,010 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)대웅개발</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">618,500 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">346,661 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)팜팩</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">563 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">7,223,802 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)시지바이오</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,267,240 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">31,465 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">61,198 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">18,052 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,465,946 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,163,864 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">25,077 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">(주)엠서클</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">277,374 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">126,613 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">58,793 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">80,877 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,401 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">6,093,287 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">5,100 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">4,204,822 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" VALIGN="MIDDLE" HEIGHT="28" USERMARK="F-10">기타</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">4,000 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">19,460 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">50,685 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">27,439 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,049,669 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">- </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">297,000 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">819,767 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">2,432,837 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="350" HEIGHT="28" COLSPAN="2" USERMARK="F-10">합        계</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">47,599,521 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">380,049 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,951,044 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,494,793 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">116,598,259 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">505,372 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">53,626,742 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">19,963,666 </TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">14,428,215 </TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 전기 중 (주)대웅과 기타무형자산 양수도 거래 1,379,057천원 발생하였습니다.&cr;(*2) 전기 중 한올바이오파마(주)와 HL036 공동개발계약 관련하여 1,500,000천원을 지급하였고, 개발비로 처리하였습니다. </P>
<P></P>
<P>(3) 당기말과 전기말 현재 특수관계자에 대한 채권ㆍ채무 내역은 다음과 같습니다. &cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1030">

<COLGROUP>
<COL WIDTH="80"></COL>
<COL WIDTH="258"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="9" WIDTH="1030" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="267" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사명</TH>
<TH COLSPAN="4" WIDTH="383" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채권 등</TH>
<TH COLSPAN="3" WIDTH="291" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채무 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매출채권</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대여금</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">임차보증금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타채권</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매입채무</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">임대보증금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">최상위&cr;지배기업</TD>
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="53"> (주)대웅 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">590,688 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,722,988 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">19,210,315 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="89" VALIGN="MIDDLE" HEIGHT="316" ALIGN="CENTER">종속기업</TD>
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)힐리언스 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,600,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,338,293 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">107,720 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 한올바이오파마(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">508,331 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,844 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">928,661 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,800 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,080,683 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 북경대웅위업의약과기유한공사 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,657,793 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,777 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 요녕대웅제약유한공사 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,150,513 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">285,625 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> Daewoong Pharma PHILIPPINES INC. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132,856 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> Daewoong Pharmaceutical(Thailand) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,791,102 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">544,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,587 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="53"> PT. Dewoong Pharmaceutical&cr; (Indonesia)Co.,Ltd. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,963 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> PT. DAEWOONG INFION </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">127,523 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,176,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">309,833 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="53"> DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">20,360 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)엠디웰아이앤씨 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,242 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,838 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,019 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="14" WIDTH="89" VALIGN="MIDDLE" HEIGHT="420" ALIGN="CENTER">기타&cr;특수관계자</TD>
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 대웅바이오(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,383,946 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,231 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,777,047 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,781,706 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)아이디에스앤트러스트 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,822 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">314,337 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">228,551 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅경영개발원 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">362,537 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,575 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅생명과학 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">155,121 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)디엔컴퍼니 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">510,820 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,129 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,570 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">654,971 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,050,814 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 대웅엔지니어링(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,360 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,960 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)산웅개발 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">95,623 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">110,900 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)알피바이오 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">194,968 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,750 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">488,327 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)이지메디컴 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,034 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">157,014 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,851 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">111,286 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅개발 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">191,058 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,256 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)팜팩 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">94 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,450 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)시지바이오 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">272,399 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,445 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">883,275 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,200,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,418 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> (주)엠서클 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">170 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,063 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">370,533 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,393,809 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="267" VALIGN="MIDDLE" HEIGHT="30"> 기타 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">415,205 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,894 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,827 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85,421 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">818,357 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="356" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,364,769 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,320,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">291,058 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,994,963 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,571,183 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,529,921 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,103,409 </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>나. 제 18(전) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1030">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="257"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="9" WIDTH="1030" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사명</TH>
<TH COLSPAN="4" WIDTH="383" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채권 등</TH>
<TH COLSPAN="3" WIDTH="291" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채무 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매출채권</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대여금</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">임차보증금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타채권</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매입채무</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">임대보증금</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">최상위&cr;지배기업</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53"> (주)대웅 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">197,814 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">779,743 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">12,820,453 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="90" VALIGN="MIDDLE" HEIGHT="339" ALIGN="CENTER">종속기업</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)힐리언스 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,544 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,500,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,265,499 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,888 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 한올바이오파마(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">320,945 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,494 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">318,865 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,800 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,303,852 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 북경대웅위업의약과기유한공사 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,048,257 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,777 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 요녕대웅제약유한공사 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">647,947 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> Daewoong Pharma PHILIPPINES INC. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,342,678 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53"> Daewoong Pharmaceutical(Thailand) Co.,Ltd. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,499,749 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">578,900 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">69,373 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53"> PT. Dewoong Pharmaceutical (Indonesia)Co.,Ltd. </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">36,066 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> PT. DAEWOONG INFION </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">234,637 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,473,400 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,181 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="53"> DAEWOONG PHARMACEUTICAL JAPAN CO.,LTD </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">15,615,352 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">20,763 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)엠디웰아이앤씨 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">628 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,520 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="15" WIDTH="90" VALIGN="MIDDLE" HEIGHT="450" ALIGN="CENTER">기타&cr;특수관계자</TD>
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 대웅바이오(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,217,024 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">198,130 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,803,974 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">260,832 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)아이디에스앤트러스트 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,853 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">234,062 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,379 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅경영개발원 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">130,187 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88,673 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅생명과학 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">155,121 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,210 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,219 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)디엔컴퍼니 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">552,166 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">126,931 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,394 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">386,387 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">288,674 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 대웅엔지니어링(주) </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">126,028 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,600 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)산웅개발 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,640 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">293,414 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)알피바이오 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">194,968 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,266 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">777,587 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,032 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)이지메디컴 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,181 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">366,235 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,459 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,359 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)인성정보 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">344,406 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)대웅개발 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,818 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,968 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)팜팩 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,680 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">313,079 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)시지바이오 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">220,048 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78,069 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">572,746 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,434 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629,338 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> (주)엠서클 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,147 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,655 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">195,018 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,223,546 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" VALIGN="MIDDLE" HEIGHT="30"> 기타 </TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,100 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,493 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,741 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,023,175 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,048 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="356" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,155,955 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,552,300 </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,818 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,894,710 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,752,794 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,771,507 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,829,712 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(4) 당기와 전기 중 특수관계자와의 자금거래 내역은 다음과 같습니다.&cr;가. 제 19(당) 기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1006">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="275"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1006" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" COLSPAN="8">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="127" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="284" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">회사명</TH>
<TH COLSPAN="2" WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자금대여 거래</TH>
<TH COLSPAN="2" WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">배당</TH>
<TH COLSPAN="2" WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지분투자</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="100" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대여</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회수</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지급</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수령</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">증자 및 취득</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감자 및 처분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">최상위 지배기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)대웅</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">2,867,833 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">29,918,985 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="150" VALIGN="MIDDLE" ROWSPAN="5">종속기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">한올바이오파마(주)</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">10,000,031 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)아피셀 테라퓨틱스</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,967,800 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">7,020 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)아이엔 테라퓨틱스</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,127,925 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">9,595 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,129,400 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)힐리언스</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,100,000 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">건강한삶기술창업벤처</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">1,000,000 </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN>나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1006">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="275"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1006" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" COLSPAN="8">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="127" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">특수관계&cr;구분</TH>
<TH ROWSPAN="2" WIDTH="284" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">회사명</TH>
<TH COLSPAN="2" WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자금대여 거래</TH>
<TH COLSPAN="2" WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">배당</TH>
<TH COLSPAN="2" WIDTH="198" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지분투자</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="100" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대여</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회수</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지급</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수령</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">증자 및 취득</TH>
<TH WIDTH="99" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감자 및 처분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">최상위 지배기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)대웅</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">2,831,527</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="143" VALIGN="MIDDLE" ROWSPAN="4">종속기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">힐리언스</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">500,000</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">북경대웅위업의약과기유한공사</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">492,840</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,066,732</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="53" VALIGN="MIDDLE"> Daewoong Pharmaceutical&cr; India Pvt., Ltd. </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">365,659</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">PT. DAEWOONG INFION</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,885,760</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">Immplacate, Inc.</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">1,125,970</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" ALIGN="CENTER" HEIGHT="90" VALIGN="MIDDLE" ROWSPAN="3">기타 특수관계자</TD>
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)아이넷뱅크</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">2,855</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)아이디에스앤트러스트</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">1,000,000</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" VALIGN="MIDDLE">(주)HR그룹</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">200,000</TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="99" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>&cr;(5) 당사는 기업 활동의 계획, 운영, 통제에 대하여 중요한 권한과 책임을 가진 당기와 전기 중 주요 경영진에 대한 보상을 위해 지급한 금액은 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="637" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="225"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="637" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="234" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구분</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 19(당) 기</TH>
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">제 18(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30">단기종업원급여</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">706,001 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">767,001 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">50,000 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">37,708 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">756,001 </TD>
<TD WIDTH="201" ALIGN="RIGHT" HEIGHT="30">804,709 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<P>
<SPAN>(6) 특수관계자간 주요 약정사항&cr;&cr;1) 당기말 현재 당사는 Daewoong Pharmaceutical Japan Co., Ltd.와 요녕대웅제약유한공사에게 지급보증을 제공하고 있습니다(</SPAN>
<SPAN>주석</SPAN>
<SPAN> 15, 31참</SPAN>
<SPAN>조).</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="290"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="299" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN USERMARK=" BC0XD7D7D7">제공받은 기업</SPAN>
</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증제공처</TH>
<TH WIDTH="63" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">Daewoong Pharmaceutical Japan Co., Ltd.</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">㈜신한은행</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER">0.70%</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">250,000,000 JPY </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="299" HEIGHT="30" VALIGN="MIDDLE">요녕대웅제약유한공사</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">㈜국민은행</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER">0.65%</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT">1,200,000 EUR</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;2) 당사는 2016년 중 종속기업인 한올바이오파마(주)와 안구건조증 치료신약을 공동개발하는 계약을 체결하였습니다. 동 계약에 따라 당사가 지급하게 될 총 기술료는 7,800백만원이며 당기까지 4,450백만원을 지급하였습니다. 향후 연구개발비는 균등하게 부담하기로 약정하였습니다. &cr;&cr;3) 당사는 한올바이오파마(주), 대웅바이오(주) 및 기타 특수관계자간에 의약품, 의료기기 및 이와 유사한 품목 등에 대해 상호 판매대행계약을 체결하였습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;(7) 당기 중 특수관계자와의 리스 약정계약에 따라 지급한 금액과 재무제표에 인식한 리스관련 항목은 다음과 같습니다.&cr;&cr;가. 제 19(당) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="906">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="906" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">구  분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">회사의 명칭</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">사용권자산</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">지급액</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">당기말&cr;리스부채</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">당기&cr;이자비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타특수관계자</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜대웅개발</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,270,056 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">474,192 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,308,091 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,616 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최상위지배기업</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜대웅</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">293,394 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,003 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">297,647 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,992 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;나. 제 18(전) 기</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="906">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="906" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">구  분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">회사의 명칭</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">사용권자산</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">지급액</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">당기말&cr;리스부채</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">당기&cr;이자비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">종속기업</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(주)대웅개발</TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,229 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,641 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,785 </TD>
<TD WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,150 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>

<P>
<SPAN USERMARK="F-16 0XFF0000 B">&cr;1. 공시상의 진행, 변경상황&cr;</SPAN>
<SPAN></SPAN>- 해당사항 없음.&cr;&cr;
<SPAN USERMARK="F-16 0XFF0000"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">2. 주주총회 의사록 요약</SPAN>
</P>
<P></P>

<TABLE BORDER="1" WIDTH="591" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="79"></COL>
<COL WIDTH="283"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="65"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주총일자</TH>
<TH WIDTH="292" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">안 건</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">결 의 내 용</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제18기&cr;주주총회&cr;(20.03.20)</TD>
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="99">-제2호: 정관 변경의 건&cr;-제3호: 감사 선임의 건&cr;-제4호: 이사 보수 한도 승인의 건&cr;-제5호: 감사 보수 한도 승인의 건</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">원안대로 승인</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제17기&cr;주주총회&cr;(19.03.22)</TD>
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="99">-제1호: 정관 변경의 건&cr;-제2호: 이사 보수 한도 승인의 건&cr;-제3호: 감사 보수 한도 승인의 건&cr;-제4호: 주식매수선택권 부여 승인의 건</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">원안대로 승인</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제16기&cr;주주총회&cr;(18.03.23)</TD>
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="99">-제1호: 이사 선임의 건&cr;-제2호: 이사 보수 한도 승인의 건&cr;-제3호: 감사 보수 한도 승인의 건&cr;-제4호: 정관 변경의 건</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">원안대로 승인</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN>주1)</SPAN>
<SPAN> 제1호 의안이었던 제18기 재무제표 및 연결재무제표 승인의 건은 이사회 결의로 승인되어 주주총회에서는 보고로 갈음하였습</SPAN>
<SPAN>니다.&cr;</SPAN>
<SPAN>&cr;* 제 19기 주주총회는 2021년 3월 26일에 개최될 예정입니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="592">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="426"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주총일자(예정)</TH>
<TH WIDTH="435" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">안 건</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="260" ALIGN="CENTER" VALIGN="MIDDLE">제19기&cr;주주총회&cr;(21.03.26)</TD>
<TD WIDTH="435" HEIGHT="260" VALIGN="MIDDLE">-제1호 : 정관 변경의 건&cr;-제2호 : 이사 선임의 건&cr;    제2-1호: 사내이사 선임의 건 (후보자: 전승호)&cr;    제2-2호: 사내이사 선임의 건 (후보자: 윤재춘)&cr;    제2-3호: 사내이사 선임의 건 (후보자: 이창재)&cr;    제2-4호: 사외이사 선임의 건 (후보자: 김홍철)&cr;    제2-5호: 사외이사 선임의 건 (후보자: 김영진)&cr;-제3호: 감사 선임의 건 (상근감사 이건행)  &cr;-제4호: 이사 보수 한도 승인의 건&cr;-제5호: 감사 보수 한도 승인의 건&cr;-제6호: 주식매수선택권 부여의 건 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">3. 우발채무와 약정사항 등 </SPAN>
<SPAN USERMARK=" B">(연결기준)&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN>(1) 소송사건&cr;</SPAN>
</P>

<P>
<SPAN>가. 메디톡스 영업비밀침해 소송&cr;&cr;*아래 내용은 2021년 8월 17일 보고서 제출일 기준입니다.&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1314">

<COLGROUP>
<COL WIDTH="154"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="273"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="341"></COL>
<COL WIDTH="74"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">계류법원</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">소송 제기일</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">원고</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">피고</TH>
<TH WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">사건내용</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">진행상황</TH>
<TH WIDTH="350" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">향후 일정</TH>
<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">미국 무역위원회&cr;(International Trade&cr; Commission)</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">2019.01.30</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">앨러간,&cr;메디톡스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">대웅제약 및 &cr;에볼루스</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">영업비밀침해&cr;(원고가 피고에 대해 영업비밀침해를 이유로&cr;미국내 수입 및 판매 금지를 요청하는 사건)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">최종판결&cr;완료</TD>
<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10">-</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10 B">주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">서울중앙지방법원</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">2017.10.30</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">메디톡스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">대웅제약 외 1명</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">영업비밀침해&cr;(원고가 피고에 대해 영업비밀침해를 이유로 &cr;손해배상금 등을 청구하는 사건)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">1심 진행중</TD>
<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10">2017.10.30. 소장 접수&cr;2019.9.15 전문가 감정보고서 제출&cr;2021.1.13, 2021.2.17, 2021.4.14, 2021.7.7 변론 준비기일&cr;2021.8. 27 변론준비기일 예정</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10 B">주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">미국 연방항소법원 &cr;(US Court of Appeals for the Federal Circuit)</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">2021.02.12</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">대웅제약,&cr;에볼루스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">미국 무역위원회&cr;(International Trade&cr;Commission)</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">영업비밀침해&cr;(미국 ITC 최종결정에 대해서 &cr;연방항소법원에 항소한 항소심 사건)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="154" USERMARK="F-10">기각 및 환송 결정</TD>
<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="154" USERMARK="F-10">2021.2.12 가처분 신청&cr;2021.2.15 임시가처분 인용 결정&cr;2021.2.18 메디톡스, 엘러간, 에볼루스 3자 합의  &cr;2021.5.17 앨러간, 에볼루스 - 항소심 철회 의견 제출&cr;2021.6.8 대웅, ITC - 항소심 기각요청서면 제출&cr;2021.6.22 메디톡스 - 항소심 기각에 동의한다는 서면 제출&cr;2021.7.27 미국국제무역위원회에 환송 결정</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="154" USERMARK="F-10 B">주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">캘리포니아 중부지방법원</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">2021.05.14</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">메디톡스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">대웅제약 및 &cr;이온바이오파마</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">영업비밀침해&cr;(원고가 피고에 대해 미국 영업비밀보호법(DTSA) 위반을 이유로 손해배상 등을 청구한 사건</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="91" USERMARK="F-10">소장접수</TD>
<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10">2021.5.14 소장 제출&cr;2021.6.22 메디톡스- 이온바이오파마와 합의&cr;2021.6.28 메디톡스 - 이온바이오파마 상대 소취하</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="91" USERMARK="F-10 B">주3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">버지니아 중부지방법원</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">2021.05.14</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">메디톡스</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">대웅제약, 대웅</TD>
<TD WIDTH="282" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">특허 &cr;(원고가 피고에 대해 대웅의 미국 특허를 &cr;양도해 줄 것을 청구하는 사건)</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="70" USERMARK="F-10">소장접수</TD>

<TD WIDTH="350" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10">
<SPAN>2021.5.14 소장 제출</SPAN>&cr;미정 (송달 당사 도달 전)
</TD>
<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="70" USERMARK="F-10 B">주4)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF"></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">주1)</SPAN>
</P>

<P>
<SPAN>  </SPAN>
<SPAN>2019년 1월 메디톡스와 미국 앨러간은 미국 ITC(국제무역위원회)에 당사 및 에볼루스를 상대로 영업비밀 침해를 이유로 나보타 제품의 미국내 수입 및 판매금지 등을 내용으로 제소하였습니다. 본 소송은 미국 관세법 337조항에 따라 진행되는 지적재산권 침해 여부를 가리는 소송으로, 특허권, 상표권, 저작권 등의 침해에 따른 불공정 무역관행을 규제하기 위하여 해당 상품의 수입을 금지시키거나 불공정 행위를 정지시킬 수 있습니다. 그러나 미국 ITC(국제무역위원회)의 영업비밀 침해 소송은 미국에서 경쟁품이 출시될 때 통상적으로 시장방어 전략 차원에서 진행되기도 하며, 나보타 제품은 2019년 2월 미국 FDA로부터 최종 시판허가가 승인되어 2019년 4월부터 미국 출시가 완료되었습니다. </SPAN>
<SPAN></SPAN>
<SPAN>ITC 재판부의 결정으로 메디톡스 및 당사는 보툴리눔 균주에 대해 각사가 선임한 전문가를 통해 감정 시험을 진행하고, ITC의 일정에 맞춰 메디톡스는 9월 균주에 대한 유전자 분석 보고서 제출을 완료하였습니다. 이후, 당사는10월 그에 따른 반박 보고서를 제출하였습니다. &cr;  2020년 12월 나보타(주보)의 수입이 21개월간 금지되는 내용의 ITC 최종결정이 판결되었고, 이에 당사는 2021년 2월 12일 CAFC(미국 연방순회항소법원)에 수입금지 명령 집행정지 관련 긴급 임시 가처분 신청을 하였습니다. 2월 15일 CAFC(연방순회항소법원) 수입금지 명령 관련 긴급가처분 신청이 인용되었습니다. 한편, 2021년 2월 18일 메디톡스, 엘러간 및 에볼루스의 제3자 합의 계약이 체결되었습니다. 이후 5월 17일 앨러간과 에볼루스는 항소심 철회 의견을 제출하였으며, 6월 8일 대웅에서 항소심 기각요청 서면을, 6월 22일에는 메디톡스에서 항소심 기각에 동의한다는 서면을 제출하였습니다. </SPAN>
<SPAN>2021년 7월 27일 미국연방순회항소법원은 미국국제무역위원회의 최종명령에 항소가 무의미하므로 해당 명령을 무효화 시킬 수 있도록 미국국제무역위원회에 환송한다는 결정을 내렸습니다.</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">주2)&cr;</SPAN>
<SPAN>  2017년 10월 메디톡스는 당사 등을 상대로 국내에서 보톨리눔 균주 및 독소제제 제조기술정보의 사용금지 및 손해배상청구 내용의 민사소송을 제기하였습니다. 해당 소송은 2019년 4월부터 1심 재판을 시작하여 7월 균주 포자에 대한 감정을 실시하였고, 8월 균주에 대한 유전자 감정 보고서 제출을 완료하였습니다. 국내에서 진행되는 소송은 현재 진행중이며, 당사는 보고서 제출일 현재로서는 소송사건의 결과와 소송 결과에 따른 나보타 제품의 판매영향에 대하여 합리적인 결과를 예측하기 어렵습니다. &cr;&cr;</SPAN>
<SPAN USERMARK=" B">주3)&cr;</SPAN>
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN> </SPAN>
<SPAN>2021년 5월 14일 메디톡스는 당사와 당사의 미국 파트너스 이온바이오파마를 상대로 미국 캘리포니아 중부지방법원에 영업비밀침해 관련 청구 소송을 제기하였고, 6월 22일 메디톡스와 이온바이오파마의 합의가 진행되었습니다. 이후 6월 28일 메디톡스</SPAN>
<SPAN>는</SPAN>
<SPAN> 이오이온바이오파마를 상대</SPAN>
<SPAN>로 소취하 하였</SPAN>
<SPAN>으</SPAN>
<SPAN>며, 당사는 소장을 송달 받은 후에 대응할 예정입니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B">주4)&cr;</SPAN>
<SPAN>   2021년 5월 14일 메디톡스(원고)가 대웅제약, 대웅(피고)에 대해 대웅의 미국 특허를 양도해줄 것을 청구하였으며, 당사는 소장을 송달 받은 후에 대응할 예정입니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;나. 상기의 건 이외에 상기의 건 이외에 연결 실체가 피소되어 계류 중인 소송사건 1건이 있습니다. 연결실체의 경영진은 상기 소송사건 결과의 합리적인 예측이 불가능하고 자원의 유출금액 및 시기가 불확실하며 그 결과가 재무제표에 미치는 영향이 중요하지 않을 것으로 판단하고 있어 당기말 현재 충당부채로 인식한 금액은 없습니다.</SPAN>
<SPAN></SPAN>
</P>
<P></P>
<P>(2) 당기말 현재 연결실체가 금융기관 등과 체결한 주요 약정사항은 다음과 같습니 다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="667">

<COLGROUP>
<COL WIDTH="158"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="667" HEIGHT="30" COLSPAN="4" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(원화단위: 천원, 외화단위: USD,EUR,JPY)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="167" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정종류</TH>
<TH WIDTH="333" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">한도금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">KEB하나은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구매론</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">2,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)우리은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당좌차월</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">13,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)현대카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신용카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">3,600,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)삼성카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신용카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">2,800,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)신한카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신용카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">2,500,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">산업은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당좌차월</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">27,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2">(주)국민은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구매카드</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">9,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">외화지급보증</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> EUR </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">1,200,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">(주)신한은행</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">수입신용장</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> USD </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">11,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">수출매입외환</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> USD </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">5,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전자방식외담대</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">3,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">외화지급보증</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> JPY </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">250,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="334" HEIGHT="120" COLSPAN="2" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합      계</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> KRW </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">62,900,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> USD </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">16,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> EUR </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">1,200,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> JPY </TD>
<TD WIDTH="166" HEIGHT="30" ALIGN="RIGHT">250,000,000 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
<P>(3) 당기말 현재 연결실체가 금융기관에 제공한 담보내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="661" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="133" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">금융기관명</TH>
<TH WIDTH="132" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">차입금 등의 내역</TH>
<TH WIDTH="132" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">담보제공자산</TH>
<TH WIDTH="132" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">장부금액</TH>
<TH WIDTH="132" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">채권최고액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">중소기업은행</TD>
<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">일반자금</TD>
<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">토지</TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">2,765,833 </TD>
<TD WIDTH="132" ALIGN="RIGHT" HEIGHT="30">2,400,000 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>4) 당기말 현재 연결실체가 타인으로부터 제공받은 지급보증의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="651" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="208"></COL>
<COL WIDTH="208"></COL>
<COL WIDTH="208"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="651" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="217" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제공자</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보증금액</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보증내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="217" HEIGHT="30" ALIGN="CENTER">서울보증보험(주)</TD>
<TD WIDTH="217" ALIGN="RIGHT" HEIGHT="30">1,041,173 </TD>
<TD WIDTH="217" HEIGHT="30" ALIGN="CENTER">계약이행보증 등</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN>(5) </SPAN>
<SPAN>연결실체가 체결한 주요 약정 내용은 다음과 같습니다.&cr;</SPAN>
<SPAN>&cr;가. 지배기업은 미국의 Evolus외 14개사와 계약을 체결하고 2020년까지 Upfront Fee USD 16,824,000를 수취하였습니다. 동 Upfront Fee는 향후 제품이 매출될 것으로 예상되는 기간동안 합리적으로 배분하여 수익으로 인식하고 있으며, 이와 관련하여 수취한 금액은 계약부채로 계상하고 있습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P>나. 하버바이오메드사</P>
<P>연결실체 내 한올바이오파마(주)는 2017년 9월 12일자로 중국에 소재한 하버바이오메드사와 자가면역질환 치료항체신약 HL161BKN 물질과 항TNF 단백질 바이오베터 HL036 점안액에 대한 기술이전 계약을 각각 체결하였습니다. 동 계약으로 인하여 하버바이오메드사는 중국(대만, 홍콩, 마카오 포함)에서 HL161BKN과 HL036에 대한 임상개발, 생산, 품목허가 및 판매에 대한 독점적 권리를 확보하였습니다. 연결실체는 물질에 대해 반환조건 없는 계약금(Upfront payment) USD 4,000,000(각 계약별USD 2,000,000)을 전기 이전에 일시에 수령하였습니다. 기술이전 시점 이후에 수행할 추가적인 의무가 존재하지 않으므로 일시에 수익으로 인식하였습니다. 또한, 연결실체는 규제당국의 허가 및 상업화에 성공할 경우 최대 USD 77,000,000 규모의 마일스톤 금액(Milestone payment)을 수령할 수 있고, 전기에 USD 3,000,000, 당기에 USD 1,000,000을 수령하였습니다. HL036 점안액은 한올바이오파마(주)와 (주)대웅제약이 공동개발계약을 맺은 과제로 계약조건에 의해 관련 수익을 양사간 각각 50%씩 인식하고 있습니다.</P>
<P> </P>
<P>다. 로이반트사이언스사</P>
<P>연결실체 내 한올바이오파마(주)는 2017년 12월 19일자로 스위스에 소재한 로이반트사이언스사와 자가면역질환 치료 항체신약 HL161BKN 물질에 대한 기술이전 계약을 체결하였습니다. 동계약으로 인하여 로이반트사이언스사는 북미(미국 포함)와 중남미, EU국가, 영국, 스위스, 중동, 북아프리카 지역에서 HL161BKN에 대한 임상개발, 생산, 품목허가 및 판매에 대한 독점적 권리를 확보하였습니다. 연결실체는 반환조건 없는 계약금(Upfront payment) USD 30,000,000을 2017년 12월에 일시에 수령하였고, 계약과 관련된 의무가 종료되는 기간까지 분할하여 수익으로 인식하고 있습니다. 또한, 연결실체는 규제당국의 허가 및 상업화에 성공할 경우 최대 USD 452,500,000 규모의 마일스톤 금액(Milestone payment)을 수령할 수 있고, 2019년 6월에 USD 10,000,000 을 수령하였습니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN>라. 기술이전계약과 관련된 불확실성 및 기타사항</SPAN>
</P>

<P>
<SPAN>연결실체 내 한올바이오파마(주)의 향후 마일스톤 및 로열티 수익은 임상시험, 관계당국의 허가 등 개발의 성공여부에 따라 달라질 수 있으므로 발생가능성에 불확실성이 내포되어 있습니다. 또한 상기 HL161BKN 물질에 대한 기술이전계약과 관련하여 리간드사에게 지적재산 실시계약에 따라 일정 수수료를 지급하기로 약정하고 있습니다.&cr;&cr;마. 2015년 8월 18일 및 2016년 1월 8일에 연결실체 내 한올바이오파마(주)가 지분을 보유하고 있는 ImmunoMET Therapeutics, Inc.에 특허권등을 양도하였으며, ImmunoMET Therapeutics, Inc.가 양도 받은 특허권 등을 활용하여 일으킨 순매출액의 8%를 판매개시일로부터 10년 또는 동 특허권의 존속기간 만료일 중 늦은 날까지 양도대가로 수취할 예정입니다. 또한, ImmunoMETTherapeutics, Inc.가 동 특허권을 바탕으로 제3자에게 기술이전계약을 체결하는 경우, 제3자로부터 받을 총 기술료의 일정비율을 양도대가로 수취할 예정입니다.&cr;</SPAN>
</P>
<P>(6) 연결실체 내 한올바이오파마(주)는 2019년 12월 19일 대전지방식품의약품안전청에서 실시한 정기약사감시에서 제조업무정지 3개월에 해당하는 위반사항이 지적되어, 2020년 5월 8일에 '2020년 5월 17일부터 3개월간 자사 허가품목(의약품 제조업) 제조업무정지 처분' 통지서를 수령하였습니다. 한올바이오파마(주)는 제조업무정지 행정처분에 대하여 대전지방법원에 집행정지 처분을 신청하였고, 2020년 5월 22일부로 행정처분 효력이 정지되어 의약품제조업무를 진행할 수 있습니다. 지적된 사항의 처분은 아직 확정되지 않은 상태이며, 이로 인하여 연결실체의 재무제표에 미칠 영향 여부를 현재로서는 예측할 수 없습니다.&cr;</P>
<P>(7) 2019년 9월 26일 식품의약품안전처는 발암물질 성분인 NDMA가 포함되어 국내 유통 중인 라니티딘 원료의약품(7종)과 이를 사용한 완제의약품(269품목) 전체에 대해 잠정적으로 제조ㆍ수입ㆍ판매 중지 및 회수 조치하고 처방을 제한하도록 하였으며, 해당 조치에는 지배기업의 완제의약품인 알비스정 및 알비스D정이 포함되었습니다. 식품의약품안전처는 전문가 자문을 거쳐 라니티딘 성분 의약품을 단기 복용한 경우 인체 위해우려는 크지 않다고 밝혔으나, 해당 의약품에 장기적으로 노출되었을 때 인체에 미치는 영향을 조사ㆍ평가 할 계획입니다. 동 조사를 토대로 한 식품의약품안전처의 후속 조치 결과가 당사의 재무제표에 미칠 영향은 현재로서는 예측할 수 없습니다.&cr;&cr;(8) 연결실체 내 한올바이오파마(주)가 주식을 보유중이던 Immunovant, Inc.가 2019년 12월 HSAC와 SPAC 합병을 통해 상장하면서 기존 Immunovant, Inc.주주에게 Earn-out Payment 조건을 부여하였습니다. 상장 후 Immunovant, Inc.의 주가가 20일 거래일 이상 $17.5, $31.5을 초과할 경우 각각 10,000,000주를 상장 이전 지분 비율에 따라 지급하는 조건이며,  당기 중 조건을 충족하여 한올바이오파마(주)는 보통주 302,590주를 수령하였고,수령한 주식의 공정가치에 해당하는 금액을 파생상품거래이익으로 인식하였습니다.</P>

<P>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">4.제재현황</SPAN>
<SPAN USERMARK=" B">&cr;&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">◆한올바이오파마(주)</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
</P>
<P USERMARK=" 0X1814FF"></P>

<TABLE BORDER="1" WIDTH="995" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="236"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">처분일자</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">처분권자</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">처분내용</TD>
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">처분사유</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">회사의 조치</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">재발방지대책</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.05.08.</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">대전지방식품&cr; 의약품안전청장</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">전제조업무정지&cr;3개월 행정처분</TD>
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">약사법 제36조 제1항&cr;(의약품 등의 제조관리자) 등 위반</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">집행정지 및 취소 소송 제기</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">복수의 제조업무관리자&cr; 배치 등 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0X1814FF B"></SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">5. 기타 주요사항</SPAN>
<SPAN USERMARK=" B">&cr;&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>(1) COVID19의 영향의 불확실성&cr;</SPAN>COVID19의 확산을 차단하기 위하여 전세계적으로 이동 제한을 포함한 다양한 예방및 통제가 시행되고 있으며, 그 결과 전세계 경제가 광범위한 영향을 받고 있습니다.또한, COVID19에 대처하기 위한 다양한 정부지원정책이 발표되고 있습니다. COVID-19의 영향을 받는 항목은 매출채권의 회수가능성, 재고자산 및 유ㆍ무형자산의 손상, 충당부채의 인식 등 입니다. 연결실체는 COVID19의 영향과 정부지원정책이 향후 연결실체에 미칠 영향을 보고기간말 현재 합리적으로 추정할 수 없었으며 이로 인한 영향은 연결재무제표에 반영되지 않았습니다. &cr;
<SPAN></SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">6. 작성기준일 이후에 발생한 주요사항</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B">◆(주)</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">대</SPAN>
<SPAN USERMARK=" B">웅</SPAN>
<SPAN USERMARK=" B">제</SPAN>
<SPAN USERMARK=" B">약</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>미국국제무역위원회에 제기되었던 영업비밀침해 소송의 당사자인 에볼루스, 앨러간,매디톡스는 미국국제무역위원회 최종판결에 따라 2021년 2월 19일에 3자간 합의 계약을 완료하였습니다. 지배기업은 해당 합의의 당사자가 아니므로 이로 인한 연결재무제표에 미칠 영향을 알 수 없습니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>또한, 지배기업은 2021년 3월 3일자로 공정거래위원회로부터 부당고객유인행위에 대한 과징금 2,146백만원을 부과 받아 이를 기타충당부채로 계상하였습니다.</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN>&cr;</SPAN>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK=" B">◆한올바이오파마(주)</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>임직원의 주식매수선택권 행사로 작성일 현재 자기주식 보유상황은 1,037,185주입니다.&cr;- 2021년 1월 28일 주식매수선택권 행사 (17,370주)&cr;- 2021년 2월 03일 주식매수선택권 행사 (6,880주)&cr;
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『신용보강 제공 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*신용보강제공현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『장래매출채권 유동화 현황 및 채무비중』 삽입</COMMENT>
<LIBRARYLIST>11011#*장래매출채권유동화현황및채무비중.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『단기매매차익 미환수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*단기매매차익미환수현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『공모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*공모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">18_공모자금의사용내역</FILENAME>
<P></P>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 0XFF0000 B">7. 공모자금의 사용내역</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN>공모자금의 사용내역</SPAN>
</P>

<TABLE-GROUP ACLASS="FUND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="641" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="341" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="675" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증권신고서 등의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">회사채</TE>
<TE ALIGN="CENTER" WIDTH="82" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">제12회&cr;회사채</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20180723">2018.07.23</TU>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">차환자금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">90,000</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">차환자금</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">90,000</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">회사채</TE>
<TE ALIGN="CENTER" WIDTH="82" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">제13회&cr;회사채</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20190425">2019.04.25</TU>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">차환자금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">100,000</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">차환자금</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">100,000</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">회사채</TE>
<TE ALIGN="CENTER" WIDTH="82" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">제14회&cr;회사채</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20191030">2019.10.30</TU>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">차환자금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">100,000</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">차환자금</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">100,000</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-16 0XFF0000 B">8. 정부의 인정 및 그 취소에 관한 사항</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>
<P USERMARK=" B">가. 정부인증명: 가족친화기업</P>

<P>1) 내용 : 근로자의 일 가정 양립 지원을 위하여 가족친화제도를 모범적으로 운영하                는 기업 및 기관에 대하여 심사를 통해 인증을 부여하는 제도&cr;2) 인증부처 : 여성가족부&cr;3) 근거법령 : 「가족친화 사회환경의 조성 촉진에 관한 법률」 제15조&cr;4) 인증날짜 / 유효기간 : 2019.12.01~2022.11.30&cr;&cr;
<SPAN USERMARK=" B">나. 정부인증명 : 근무혁신 우수기업(SS등급)&cr;</SPAN>1) 내용 : 일·생활 균형의 고용환경을 조성하기 위해 근무혁신 우수기업을 선정하고              인센티브를 부여하여, 기업의 자발적이고 적극적인 근무혁신 유도.&cr;              기업의 일하는 방식과 문화를 개선하여 업무생산성을 향상시키고, 근로자                의 일과 생활의 균형을 도모&cr;2) 인증부처 : 고용노동부, 노사발전재단&cr;3) 근거법령 : - &cr;4) 인증날짜 / 유효기간 : 2020.09.21~2023.09.20&cr;&cr;
<SPAN USERMARK=" B">다. 정부인증명 : Best HRD&cr;</SPAN>1) 내용 : 정부가 설정한 HRD·HRM에 대한 심사기준을 달성한 기업을 HRD 우수기               관으로 인증함으로써 기업의 인적자원개발에 대한 투자를 촉진하고 기업                 및 국가 경쟁력 강화에 기여하고자 함&cr;2) 인증부처 : 고용노동부&cr;3) 근거법령 :「인적자원개발 기본법」제14조「인적자원개발 기본법 시행령」&cr;                    (제18조, 제19조, 제20조) 및 「인적자원개발 우수기관 인증제 &cr;                    운영규정」(교육부 고시 제2019-174호)&cr;4) 인증날짜 / 유효기간 : 2020.09.18~2023.09.17
</P>
<P>&cr;</P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『사모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*사모자금의사용내역.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『미사용자금의 운용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*미사용자금의운용내역.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『합병등 전후의 재무사항 비교표』 삽입</COMMENT>
<LIBRARYLIST>11011#*합병등전후의재무사항비교표.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『보호예수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*보호예수현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『특례상장기업 관리종목 지정유예 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*특례상장기업관리종목지정유예현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P>- 해당사항 없음&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P>- 해당사항 없음&cr;</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>